sampleID,AJCC_Stage_nature2012,Age_at_Initial_Pathologic_Diagnosis_nature2012,Days_to_Date_of_Last_Contact_nature2012,ER_Status_nature2012,Gender_nature2012,HER2_Final_Status_nature2012,Metastasis_Coded_nature2012,Metastasis_nature2012,Node_Coded_nature2012,Node_nature2012,OS_Time_nature2012,OS_event_nature2012,PAM50Call_RNAseq,PAM50_mRNA_nature2012,PR_Status_nature2012,Tumor_T1_Coded_nature2012,Tumor_nature2012,Vital_Status_nature2012,age_at_initial_pathologic_diagnosis,anatomic_neoplasm_subdivision,axillary_lymph_node_stage_method_type,breast_carcinoma_estrogen_receptor_status,breast_carcinoma_progesterone_receptor_status,breast_carcinoma_surgical_procedure_name,cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr,days_to_birth,days_to_collection,days_to_initial_pathologic_diagnosis,days_to_last_followup,distant_metastasis_present_ind2,er_level_cell_percentage_category,followup_case_report_form_submission_reason,form_completion_date,gender,her2_immunohistochemistry_level_result,histological_type,history_of_neoadjuvant_treatment,icd_10,icd_o_3_histology,icd_o_3_site,informed_consent_verified,initial_pathologic_diagnosis_method,initial_weight,is_ffpe,lab_proc_her2_neu_immunohistochemistry_receptor_status,lab_procedure_her2_neu_in_situ_hybrid_outcome_type,lost_follow_up,lymph_node_examined_count,margin_status,menopause_status,new_tumor_event_after_initial_treatment,number_of_lymphnodes_positive_by_he,number_of_lymphnodes_positive_by_ihc,oct_embedded,other_dx,pathologic_M,pathologic_N,pathologic_T,pathologic_stage,pathology_report_file_name,patient_id,person_neoplasm_cancer_status,postoperative_rx_tx,primary_lymph_node_presentation_assessment,progesterone_receptor_level_cell_percent_category,radiation_therapy,sample_type,sample_type_id,system_version,targeted_molecular_therapy,vial_number,vital_status,year_of_initial_pathologic_diagnosis,Subtype,OS,OS.time,DSS,DSS.time,DFI,DFI.time,PFI,PFI.time
TCGA-3C-AAAU-01,,,,,,,,,,,,,,,,,,,55.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-20211.0,3599.0,0.0,4047.0,,50-59%,,2015-3-24,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,60.0,NO,Negative,,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,,True,No,MX,NX,TX,Stage X,TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf,AAAU,WITH TUMOR,NO,YES,50-59%,NO,Primary Tumor,1,6th,,A,LIVING,2004.0,BRCA.LumA,0,4047.0,0.0,4047.0,1.0,1808.0,1,1808.0
TCGA-3C-AALI-01,,,,,,,,,,,,,,,,,,,50.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,,-18538.0,3772.0,0.0,4005.0,,<10%,,2014-11-13,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Positive,,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf,AALI,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2003.0,BRCA.Her2,0,4005.0,0.0,4005.0,0.0,4005.0,0,4005.0
TCGA-3C-AALJ-01,,,,,,,,,,,,,,,,,,,62.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-22848.0,,0.0,1474.0,,90-99%,,2015-3-27,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Indeterminate,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,,No,M0,N1a,T2,Stage IIB,,AALJ,TUMOR FREE,NO,YES,30-39%,NO,Primary Tumor,1,7th,,,LIVING,2011.0,BRCA.LumB,0,1474.0,0.0,1474.0,0.0,1474.0,0,1474.0
TCGA-4H-AAAK-01,,,,,,,,,,,,,,,,,,,50.0,Left|Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-18371.0,35.0,0.0,348.0,,60-69%,,2014-11-13,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,770.0,NO,Equivocal,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf,AAAK,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,348.0,0.0,348.0,0.0,348.0,0,348.0
TCGA-A1-A0SB-01,Stage I,70.0,259.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,259.0,0.0,Normal,,Negative,T1,T1,LIVING,70.0,Left,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,,-25833.0,,0.0,259.0,NO,70-79%,,2011-6-30,FEMALE,,"Other, specify",No,C50.9,8200/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,,No,M0,N0,T1c,Stage I,,A0SB,TUMOR FREE,,YES,,,Primary Tumor,1,6th,,,LIVING,2008.0,BRCA.Normal,0,259.0,0.0,259.0,0.0,259.0,0,259.0
TCGA-A1-A0SD-01,Stage IIA,59.0,437.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,437.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,59.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,,-21793.0,1697.0,0.0,437.0,,90-99%,,2011-9-7,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,50.0,NO,Negative,,,3.0,Positive,,,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B.pdf,A0SD,,,YES,90-99%,,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumA,0,437.0,0.0,437.0,0.0,437.0,0,437.0
TCGA-A1-A0SE-01,Stage I,56.0,1320.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1320.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,56.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,,-20717.0,,0.0,1321.0,,80-89%,,2010-12-6,FEMALE,1+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,,8.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,,,No,M0,N0 (i-),T1c,Stage I,,A0SE,TUMOR FREE,,,90-99%,,Primary Tumor,1,6th,,,LIVING,2005.0,BRCA.LumA,0,1321.0,0.0,1321.0,0.0,1321.0,0,1321.0
TCGA-A1-A0SF-01,Stage IIA,54.0,1463.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1463.0,0.0,LumA,,Positive,T_Other,T2,LIVING,54.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,,-19731.0,1648.0,0.0,1463.0,NO,90-99%,,2011-5-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,190.0,NO,Negative,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf,A0SF,TUMOR FREE,,YES,90-99%,,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,1463.0,0.0,1463.0,0.0,1463.0,0,1463.0
TCGA-A1-A0SG-01,Stage IIB,61.0,433.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,433.0,0.0,LumA,,Positive,T_Other,T2,LIVING,61.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,,-22380.0,1581.0,0.0,434.0,,90-99%,,2011-5-31,FEMALE,,"Other, specify",No,C50.9,8507/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf,A0SG,,,YES,90-99%,,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,434.0,0.0,434.0,0.0,434.0,0,434.0
TCGA-A1-A0SH-01,Stage IIA,39.0,1437.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1437.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,39.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Positive,Lumpectomy,,-14595.0,1305.0,0.0,1437.0,,,,2010-12-6,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,240.0,NO,Equivocal,Negative,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6.pdf,A0SH,TUMOR FREE,,,90-99%,,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,1437.0,0.0,1437.0,0.0,1437.0,0,1437.0
TCGA-A1-A0SI-01,Stage IIB,52.0,634.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,634.0,0.0,LumB,,Positive,T_Other,T2,LIVING,52.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,,-19250.0,1267.0,0.0,635.0,NO,50-59%,,2011-6-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,40.0,NO,Negative,,,23.0,Negative,,,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf,A0SI,TUMOR FREE,,YES,10-19%,,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumB,0,635.0,0.0,635.0,0.0,635.0,0,635.0
TCGA-A1-A0SJ-01,Stage IIIA,39.0,426.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,426.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,39.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,,-14383.0,1399.0,0.0,416.0,,70-79%,,2010-12-6,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Equivocal,Negative,,19.0,Negative,,,3.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3.pdf,A0SJ,TUMOR FREE,,,10-19%,,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,416.0,0.0,416.0,0.0,416.0,0,416.0
TCGA-A1-A0SM-01,Stage IIA,77.0,242.0,Positive,MALE,Positive,Negative,M0,Negative,N0,242.0,0.0,LumA,Luminal B,Negative,T_Other,T2,LIVING,77.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Modified Radical Mastectomy,,-28198.0,,0.0,242.0,,20-29%,,2010-12-6,MALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Positive,Positive,,3.0,Negative,,,0.0,,,No,M0,N0 (i-),T2,Stage IIA,,A0SM,TUMOR FREE,,,,,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,242.0,0.0,242.0,0.0,242.0,0,242.0
TCGA-A1-A0SN-01,Stage IIIA,50.0,1196.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1196.0,0.0,LumB,,Positive,T1,T1,LIVING,50.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,,-18401.0,1091.0,0.0,1196.0,,90-99%,,2011-5-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Positive,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,4.0,,True,No,MX,N1,T1c,Stage IIA,TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf,A0SN,TUMOR FREE,,YES,60-69%,,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumB,0,1196.0,0.0,1196.0,0.0,1196.0,0,1196.0
TCGA-A1-A0SO-01,Stage IIB,67.0,852.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,852.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,67.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Modified Radical Mastectomy,,-24826.0,1057.0,0.0,852.0,,,,2010-12-6,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Equivocal,Negative,,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3.pdf,A0SO,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Basal,0,852.0,0.0,852.0,0.0,852.0,0,852.0
TCGA-A1-A0SP-01,Stage IIA,40.0,583.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,583.0,0.0,Basal,,Negative,T_Other,T2,LIVING,40.0,Right,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,,-14954.0,,0.0,584.0,,,,2010-12-6,FEMALE,0,Infiltrating Ductal Carcinoma,,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,3.0,Negative,,,0.0,,,Yes,M0,N0 (i-),T2,Stage IIA,,A0SP,TUMOR FREE,,,,,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.Basal,0,584.0,0.0,584.0,0.0,584.0,0,584.0
TCGA-A1-A0SQ-01,Stage IIB,45.0,553.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,553.0,0.0,LumA,,Positive,T_Other,T2,LIVING,45.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,,-16458.0,967.0,0.0,554.0,NO,90-99%,,2011-6-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,15.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,,True,No,MX,N1,T2,Stage IIB,TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf,A0SQ,TUMOR FREE,,YES,90-99%,,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,554.0,0.0,554.0,0.0,554.0,0,554.0
TCGA-A2-A04N-01,Stage IA,66.0,3188.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3188.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,66.0,Right,Other (specify),Positive,Positive,Lumpectomy,YES,-24155.0,2850.0,0.0,4354.0,,,,2014-5-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,130.0,NO,,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A.pdf,A04N,TUMOR FREE,YES,,,YES,Primary Tumor,1,5th,YES,A,LIVING,2002.0,BRCA.LumA,0,4354.0,0.0,4354.0,0.0,4354.0,0,4354.0
TCGA-A2-A04Q-01,Stage IA,48.0,1275.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1275.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,48.0,Right Upper Outer Quadrant|Right,Other (specify),Negative,Negative,Simple Mastectomy,YES,-17660.0,2260.0,0.0,2385.0,,<10%,,2014-5-8,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",230.0,NO,Equivocal,Negative,YES,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,True,No,M0,N0 (i-),T1,Stage IA,TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484.pdf,A04Q,TUMOR FREE,YES,,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.Basal,0,2385.0,0.0,2385.0,0.0,2385.0,0,2385.0
TCGA-A2-A04R-01,Stage IA,36.0,2499.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2499.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,36.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-13483.0,2233.0,0.0,3709.0,,60-69%,,2014-5-8,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Equivocal,Negative,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T1,Stage IA,TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35.pdf,A04R,TUMOR FREE,YES,,80-89%,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.LumB,0,3709.0,0.0,3709.0,0.0,3709.0,0,3709.0
TCGA-A2-A04T-01,Stage IIA,62.0,2246.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,2246.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,62.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-22707.0,1979.0,0.0,2246.0,,<10%,,2011-3-17,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf,A04T,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.Basal,0,2246.0,0.0,2246.0,0.0,2246.0,0,2246.0
TCGA-A2-A04U-01,Stage IIA,47.0,670.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,670.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,47.0,Right,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-17474.0,1924.0,0.0,2654.0,,<10%,,2014-5-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Negative,Positive,YES,3.0,Negative,Peri (6-12 months since last menstrual period),,0.0,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf,A04U,TUMOR FREE,YES,,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.Basal,0,2654.0,0.0,2654.0,0.0,2654.0,0,2654.0
TCGA-A2-A04V-01,Stage IIA,39.0,1920.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1920.0,1.0,LumA,Luminal A,Positive,T_Other,T2,DECEASED,39.0,Right Lower Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-14250.0,1812.0,0.0,,,90-99%,,2011-3-18,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26.pdf,A04V,WITH TUMOR,,,10-19%,NO,Primary Tumor,1,6th,YES,A,DECEASED,2005.0,BRCA.LumA,1,1920.0,1.0,1920.0,1.0,1470.0,1,1470.0
TCGA-A2-A04W-01,Stage IIB,50.0,1948.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,1948.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,50.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-18345.0,1630.0,0.0,3102.0,,<10%,,2014-5-8,FEMALE,,"Other, specify",No,C50.9,8401/3,C50.9,YES,Core needle biopsy,420.0,NO,Positive,Positive,NO,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1mi,T2,Stage IIB,TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4.pdf,A04W,TUMOR FREE,YES,,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.Her2,0,3102.0,0.0,3102.0,0.0,3102.0,0,3102.0
TCGA-A2-A04X-01,Stage IIA,34.0,1686.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1686.0,0.0,Her2,HER2-enriched,Positive,T_Other,T2,LIVING,34.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-12642.0,1390.0,0.0,1686.0,,80-89%,,2011-3-18,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,180.0,NO,Positive,Positive,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31.pdf,A04X,TUMOR FREE,,,50-59%,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Her2,0,1686.0,0.0,1686.0,0.0,1686.0,0,1686.0
TCGA-A2-A04Y-01,Stage IIB,53.0,1099.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1099.0,0.0,LumB,Luminal A,Positive,T_Other,T2,LIVING,53.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-19533.0,756.0,0.0,1099.0,,90-99%,,2011-3-18,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,Negative,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,0.0,True,No,M0,N1mi,T2,Stage IIB,TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E.pdf,A04Y,TUMOR FREE,,,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1099.0,0.0,1099.0,0.0,1099.0,0,1099.0
TCGA-A2-A0CK-01,,,,,,,,,,,,,,,,,,,60.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-22094.0,3080.0,0.0,4159.0,NO,40-49%,,2013-4-18,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Excisional Biopsy,230.0,NO,Negative,Negative,NO,20.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,4.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf,A0CK,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,5th,,A,LIVING,2001.0,BRCA.LumA,0,4159.0,0.0,4159.0,1.0,1364.0,1,1364.0
TCGA-A2-A0CM-01,Stage IIA,40.0,754.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,754.0,1.0,Basal,Basal-like,Negative,T_Other,T2,DECEASED,40.0,Left,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-14969.0,2546.0,0.0,,,<10%,,2010-9-6,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,300.0,NO,Negative,,,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf,A0CM,WITH TUMOR,,,<10%,NO,Primary Tumor,1,6th,YES,A,DECEASED,2003.0,BRCA.Basal,1,754.0,1.0,754.0,1.0,382.0,1,382.0
TCGA-A2-A0CP-01,Stage IA,60.0,2813.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2813.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,60.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-22133.0,2445.0,0.0,2813.0,,90-99%,Scheduled Follow-up Submission,2011-6-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B.pdf,A0CP,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.LumA,0,2813.0,0.0,2813.0,0.0,2813.0,0,2813.0
TCGA-A2-A0CQ-01,Stage IA,62.0,2694.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2694.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,62.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-22810.0,2310.0,0.0,2695.0,,90-99%,Scheduled Follow-up Submission,2011-6-10,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Equivocal,Negative,,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1,Stage IA,TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096.pdf,A0CQ,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.LumA,0,2695.0,0.0,2695.0,0.0,2695.0,0,2695.0
TCGA-A2-A0CT-01,Stage IIA,71.0,2288.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2288.0,0.0,LumA,Luminal B,Negative,T_Other,T2,LIVING,71.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Simple Mastectomy,YES,-25959.0,,0.0,2289.0,,90-99%,Scheduled Follow-up Submission,2011-6-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0 (i-),T2,Stage IIA,,A0CT,TUMOR FREE,,,<10%,NO,Primary Tumor,1,6th,YES,,LIVING,2005.0,BRCA.LumA,0,2289.0,0.0,2289.0,0.0,2289.0,0,2289.0
TCGA-A2-A0CV-01,Stage IIB,41.0,1929.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1929.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,41.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-15289.0,,0.0,3011.0,,90-99%,Scheduled Follow-up Submission,2014-5-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,NO,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,0.0,,No,M0,N1a,T2,Stage IIB,,A0CV,TUMOR FREE,YES,,90-99%,YES,Primary Tumor,1,6th,YES,,LIVING,2005.0,BRCA.LumA,0,3011.0,0.0,3011.0,0.0,3011.0,0,3011.0
TCGA-A2-A0CW-01,Stage IIB,67.0,1947.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1947.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,67.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-24541.0,1533.0,0.0,3283.0,,90-99%,Scheduled Follow-up Submission,2015-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,290.0,NO,Equivocal,Negative,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D.pdf,A0CW,TUMOR FREE,YES,,10-19%,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,3283.0,0.0,3283.0,0.0,3283.0,0,3283.0
TCGA-A2-A0CX-01,Stage IIA,52.0,1728.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1728.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,52.0,Left,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,YES,-19152.0,1316.0,0.0,1728.0,,,Scheduled Follow-up Submission,2011-6-10,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,560.0,NO,Positive,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06.pdf,A0CX,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Her2,0,1728.0,0.0,1728.0,0.0,1728.0,0,1728.0
TCGA-A2-A0CY-01,Stage IIB,63.0,1673.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1673.0,0.0,,HER2-enriched,Positive,T_Other,T2,LIVING,63.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-23229.0,1274.0,0.0,1673.0,,90-99%,Scheduled Follow-up Submission,2011-6-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,Negative,,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21.pdf,A0CY,TUMOR FREE,,,10-19%,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,1673.0,0.0,1673.0,0.0,1673.0,0,1673.0
TCGA-A2-A0D0-01,Stage IIA,60.0,643.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,643.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,60.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Simple Mastectomy,NO,-22115.0,720.0,0.0,2048.0,,<10%,Scheduled Follow-up Submission,2014-5-12,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,500.0,NO,Negative,Negative,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf,A0D0,TUMOR FREE,YES,,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Basal,0,2048.0,0.0,2048.0,0.0,2048.0,0,2048.0
TCGA-A2-A0D1-01,Stage IIA,76.0,1051.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,1051.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,76.0,Left Lower Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-28084.0,637.0,0.0,1051.0,,<10%,Scheduled Follow-up Submission,2011-6-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,340.0,NO,Positive,Positive,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3.pdf,A0D1,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Her2,0,1051.0,0.0,1051.0,0.0,1051.0,0,1051.0
TCGA-A2-A0D2-01,Stage IIB,45.0,1027.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1027.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,45.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-16623.0,614.0,0.0,1027.0,,<10%,Scheduled Follow-up Submission,2011-6-9,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,330.0,NO,Negative,Negative,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,4.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf,A0D2,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Basal,0,1027.0,0.0,1027.0,0.0,1027.0,0,1027.0
TCGA-A2-A0D3-01,Stage IA,42.0,875.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,875.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,42.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-15524.0,545.0,0.0,1873.0,,90-99%,Scheduled Follow-up Submission,2014-5-13,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,420.0,NO,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592.pdf,A0D3,TUMOR FREE,YES,,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1873.0,0.0,1873.0,0.0,1873.0,0,1873.0
TCGA-A2-A0D4-01,Stage IIB,37.0,767.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,767.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,37.0,Left,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-13805.0,384.0,0.0,767.0,,90-99%,Scheduled Follow-up Submission,2011-6-10,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,Negative,,23.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1.pdf,A0D4,TUMOR FREE,,,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,767.0,0.0,767.0,0.0,767.0,0,767.0
TCGA-A2-A0EM-01,Stage IA,73.0,3093.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3093.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,73.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-26845.0,2696.0,0.0,3094.0,,,Scheduled Follow-up Submission,2011-6-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,20.0,NO,,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1,Stage IA,TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615.pdf,A0EM,TUMOR FREE,,,,YES,Primary Tumor,1,5th,YES,A,LIVING,2002.0,BRCA.LumA,0,3094.0,0.0,3094.0,0.0,3094.0,0,3094.0
TCGA-A2-A0EN-01,Stage IIA,70.0,2717.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2717.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,70.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-25771.0,2348.0,0.0,2718.0,,,Scheduled Follow-up Submission,2011-6-10,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Excisional Biopsy,110.0,NO,Equivocal,Negative,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E.pdf,A0EN,TUMOR FREE,,,50-59%,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.LumA,0,4088.0,0.0,4088.0,0.0,4088.0,0,4088.0
TCGA-A2-A0EP-01,,,,,,,,,,,,,,,,,,,56.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Negative,Simple Mastectomy,YES,-20585.0,,0.0,3603.0,,80-89%,,2014-4-11,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,,No,M0,N0 (i+),T1,Stage I,,A0EP,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,,LIVING,2004.0,BRCA.LumA,0,3603.0,0.0,3603.0,0.0,3603.0,0,3603.0
TCGA-A2-A0EQ-01,Stage IIA,64.0,2426.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,2426.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,64.0,Left,Other (specify),Negative,Negative,Lumpectomy,YES,-23543.0,,0.0,2426.0,,<10%,Scheduled Follow-up Submission,2011-6-13,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Positive,Negative,,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0 (i-),T2,Stage IIA,,A0EQ,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,,LIVING,2004.0,BRCA.Her2,0,2426.0,0.0,2426.0,0.0,2426.0,0,2426.0
TCGA-A2-A0ER-01,Stage IB,63.0,2262.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2262.0,0.0,LumA,Luminal B,Positive,T1,T1,LIVING,63.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-23021.0,1862.0,0.0,2263.0,,90-99%,Scheduled Follow-up Submission,2011-6-13,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,300.0,NO,Equivocal,Negative,,14.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1mi,T1c,Stage IB,TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02.pdf,A0ER,TUMOR FREE,,,80-89%,YES,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.LumA,0,2263.0,0.0,2263.0,0.0,2263.0,0,2263.0
TCGA-A2-A0ES-01,Stage IIA,52.0,1127.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1127.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,52.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-19160.0,756.0,0.0,2190.0,,60-69%,Scheduled Follow-up Submission,2014-5-12,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,460.0,NO,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05.pdf,A0ES,TUMOR FREE,YES,,10-19%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,2190.0,0.0,2190.0,0.0,2190.0,0,2190.0
TCGA-A2-A0ET-01,Stage IIIA,58.0,1066.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1066.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-21464.0,674.0,0.0,1066.0,,90-99%,Scheduled Follow-up Submission,2011-6-10,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,890.0,NO,Equivocal,Negative,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,0.0,True,No,M0,N2a,T2,Stage IIIA,TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf,A0ET,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1066.0,0.0,1066.0,0.0,1066.0,0,1066.0
TCGA-A2-A0EU-01,Stage IA,79.0,1043.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1043.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,79.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-29144.0,644.0,0.0,1043.0,,90-99%,Scheduled Follow-up Submission,2011-6-10,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,610.0,NO,Negative,Negative,,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB.pdf,A0EU,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,6th,NO,A,LIVING,2008.0,BRCA.LumA,0,1043.0,0.0,1043.0,0.0,1043.0,0,1043.0
TCGA-A2-A0EV-01,Stage IA,80.0,968.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,968.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,80.0,Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-29285.0,590.0,0.0,968.0,,90-99%,Scheduled Follow-up Submission,2011-6-10,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,960.0,NO,Negative,Negative,,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A.pdf,A0EV,TUMOR FREE,,,90-99%,NO,Primary Tumor,1,6th,NO,A,LIVING,2008.0,BRCA.LumA,0,968.0,0.0,968.0,0.0,968.0,0,968.0
TCGA-A2-A0EX-01,Stage IIB,46.0,549.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,549.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,46.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-16858.0,468.0,0.0,752.0,,60-69%,Scheduled Follow-up Submission,2011-6-10,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,650.0,NO,Negative,Negative,,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T3,Stage IIB,TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF.pdf,A0EX,TUMOR FREE,,,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,752.0,0.0,752.0,0.0,752.0,0,752.0
TCGA-A2-A0EY-01,Stage IIB,62.0,735.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,735.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Lumpectomy,YES,-22872.0,358.0,0.0,1925.0,,60-69%,Scheduled Follow-up Submission,2011-6-10,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,580.0,NO,Positive,Positive,,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD.pdf,A0EY,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,1925.0,0.0,1925.0,0.0,1925.0,0,1925.0
TCGA-A2-A0ST-01,Stage IIA,62.0,1643.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1643.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-22922.0,2597.0,0.0,3017.0,,,Scheduled Follow-up Submission,2011-7-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,210.0,NO,,Negative,,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,3.0,0.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf,A0ST,WITH TUMOR,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.Basal,0,3017.0,0.0,3017.0,0.0,3017.0,0,3017.0
TCGA-A2-A0SU-01,Stage IIA,66.0,1661.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1661.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,66.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-24219.0,1317.0,0.0,1662.0,,90-99%,Scheduled Follow-up Submission,2011-7-12,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,380.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740.pdf,A0SU,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.LumA,0,1662.0,0.0,1662.0,0.0,1662.0,0,1662.0
TCGA-A2-A0SX-01,Stage IA,48.0,1288.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1288.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,48.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-17774.0,1177.0,0.0,1534.0,,,Scheduled Follow-up Submission,2011-7-14,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,910.0,NO,Negative,,,1.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf,A0SX,WITH TUMOR,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.Basal,0,1534.0,0.0,1534.0,1.0,1239.0,1,1239.0
TCGA-A2-A0SY-01,Stage IIIA,62.0,1347.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1347.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-22928.0,1083.0,0.0,1347.0,,80-89%,Scheduled Follow-up Submission,2011-7-18,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,510.0,NO,,Positive,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1,T3,Stage IIIA,TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F.pdf,A0SY,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,1347.0,0.0,1347.0,0.0,1347.0,0,1347.0
TCGA-A2-A0T0-01,Stage IIB,59.0,533.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,533.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,59.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-21575.0,268.0,0.0,533.0,,<10%,Scheduled Follow-up Submission,2011-7-18,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf,A0T0,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,533.0,0.0,533.0,0.0,533.0,0,533.0
TCGA-A2-A0T1-01,Stage IIIC,55.0,520.0,Negative,FEMALE,Positive,Negative,M0,Positive,N3,520.0,0.0,Her2,HER2-enriched,Negative,T_Other,T3,LIVING,55.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-20227.0,233.0,0.0,521.0,,<10%,Scheduled Follow-up Submission,2011-7-18,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,230.0,NO,Positive,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,,True,No,M0,N3,T3,Stage IIIC,TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7.pdf,A0T1,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Her2,0,521.0,0.0,521.0,0.0,521.0,0,521.0
TCGA-A2-A0T3-01,Stage IA,37.0,569.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,569.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,37.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-13680.0,,0.0,1516.0,NO,90-99%,Scheduled Follow-up Submission,2014-5-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,13.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,0.0,,No,M0,N1mi,T1c,Stage IB,,A0T3,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,YES,,LIVING,2009.0,BRCA.LumB,0,1516.0,0.0,1516.0,0.0,1516.0,0,1516.0
TCGA-A2-A0T4-01,Stage IIA,62.0,624.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,624.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,62.0,Right Upper Inner Quadrant,Other (specify),Positive,Positive,Simple Mastectomy,YES,-22849.0,303.0,0.0,624.0,,90-99%,Scheduled Follow-up Submission,2011-7-12,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1500.0,NO,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5.pdf,A0T4,TUMOR FREE,,,60-69%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,624.0,0.0,624.0,0.0,624.0,0,624.0
TCGA-A2-A0T5-01,Stage IIB,39.0,531.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,531.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,39.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-14503.0,263.0,0.0,531.0,,90-99%,Scheduled Follow-up Submission,2011-7-12,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1740.0,NO,Negative,Negative,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F.pdf,A0T5,TUMOR FREE,,,90-99%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,531.0,0.0,531.0,0.0,531.0,0,531.0
TCGA-A2-A0T6-01,Stage IIB,50.0,575.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,575.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,50.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-18334.0,,0.0,575.0,,90-99%,Scheduled Follow-up Submission,2011-7-12,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,,No,M0,N0 (i-),T3,Stage IIB,,A0T6,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,,YES,,LIVING,2009.0,BRCA.LumA,0,575.0,0.0,575.0,0.0,575.0,0,575.0
TCGA-A2-A0T7-01,Stage IIA,51.0,631.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,631.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,51.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,YES,-18756.0,280.0,0.0,631.0,,90-99%,Scheduled Follow-up Submission,2011-7-12,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,990.0,NO,Negative,,,2.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E.pdf,A0T7,TUMOR FREE,,,70-79%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,631.0,0.0,631.0,0.0,631.0,0,631.0
TCGA-A2-A0YD-01,Stage IIB,63.0,769.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,769.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,63.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-23021.0,,0.0,769.0,,90-99%,Scheduled Follow-up Submission,2011-8-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,,No,M0,N0 (i+),T3,Stage IIB,,A0YD,TUMOR FREE,,,80-89%,NO,Primary Tumor,1,,YES,,LIVING,2009.0,BRCA.LumA,0,769.0,0.0,769.0,0.0,769.0,0,769.0
TCGA-A2-A0YE-01,Stage IIB,48.0,553.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,553.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,48.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-17727.0,238.0,0.0,554.0,,<10%,Scheduled Follow-up Submission,2011-8-30,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,Negative,,,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8.pdf,A0YE,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.Basal,0,554.0,0.0,554.0,0.0,554.0,0,554.0
TCGA-A2-A0YF-01,Stage IA,67.0,469.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,469.0,0.0,LumA,Luminal A,Negative,T1,T1,LIVING,67.0,Right,Sentinel node biopsy alone,Positive,Negative,Simple Mastectomy,YES,-24660.0,343.0,0.0,1535.0,,90-99%,Scheduled Follow-up Submission,2014-5-12,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,600.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T1b,Stage I,TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217.pdf,A0YF,TUMOR FREE,YES,,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1535.0,0.0,1535.0,0.0,1535.0,0,1535.0
TCGA-A2-A0YG-01,Stage IIIC,63.0,665.0,Positive,FEMALE,Positive,Negative,M0,Positive,N3,665.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,63.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-23058.0,329.0,0.0,666.0,,90-99%,Scheduled Follow-up Submission,2011-9-16,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1530.0,NO,Positive,,,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,14.0,,True,No,M0,N3a,T2,Stage IIIC,TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf,A0YG,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumB,0,666.0,0.0,666.0,0.0,666.0,0,666.0
TCGA-A2-A0YH-01,Stage IIIA,53.0,658.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,658.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,53.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-19596.0,321.0,0.0,659.0,,80-89%,Scheduled Follow-up Submission,2011-9-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,480.0,NO,Negative,,,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626.pdf,A0YH,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumB,0,659.0,0.0,659.0,0.0,659.0,0,659.0
TCGA-A2-A0YI-01,Stage IA,62.0,441.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,441.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,62.0,Right Upper Outer Quadrant,Other (specify),Positive,Positive,Lumpectomy,YES,-22961.0,303.0,0.0,1505.0,,90-99%,Scheduled Follow-up Submission,2014-5-12,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8522/3,C50.9,YES,Core needle biopsy,340.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T1c,Stage I,TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5.pdf,A0YI,TUMOR FREE,YES,,60-69%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1505.0,0.0,1505.0,0.0,1505.0,0,1505.0
TCGA-A2-A0YJ-01,Stage IIIA,39.0,565.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,565.0,0.0,Basal,Basal-like,Negative,T_Other,T3,LIVING,39.0,Left,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-14448.0,264.0,0.0,566.0,,<10%,Scheduled Follow-up Submission,2011-9-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1080.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,5.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514.pdf,A0YJ,WITH TUMOR,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.Basal,0,566.0,0.0,566.0,1.0,559.0,1,559.0
TCGA-A2-A0YL-01,Stage IIIA,48.0,445.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,445.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,48.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-17702.0,205.0,0.0,1474.0,,70-79%,Scheduled Follow-up Submission,2014-5-12,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,730.0,NO,Negative,,NO,29.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,0.0,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE.pdf,A0YL,TUMOR FREE,YES,,90-99%,YES,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.LumA,0,1474.0,0.0,1474.0,0.0,1474.0,0,1474.0
TCGA-A2-A0YM-01,Stage IIA,67.0,964.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,964.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,67.0,Left Upper Outer Quadrant,Other (specify),Negative,Negative,Lumpectomy,YES,-24831.0,691.0,0.0,965.0,,<10%,Scheduled Follow-up Submission,2011-8-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf,A0YM,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,NO,A,LIVING,2008.0,BRCA.Basal,0,965.0,0.0,965.0,0.0,965.0,0,965.0
TCGA-A2-A0YT-01,Stage IIIB,56.0,669.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,723.0,1.0,LumB,,Negative,T_Other,T4,DECEASED,56.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-20482.0,884.0,0.0,,,90-99%,Scheduled Follow-up Submission,2011-8-30,FEMALE,,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,Core needle biopsy,950.0,NO,,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,True,No,M0,N2a,T4b,Stage IIIB,TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD.pdf,A0YT,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,DECEASED,2008.0,BRCA.LumB,1,723.0,0.0,723.0,0.0,723.0,0,723.0
TCGA-A2-A1FV-01,Stage IIB,74.0,460.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,460.0,0.0,LumA,,Positive,T_Other,T3,LIVING,74.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-27287.0,372.0,0.0,714.0,NO,90-99%,Scheduled Follow-up Submission,2012-1-9,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T3,Stage IIB,TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf,A1FV,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,714.0,0.0,714.0,0.0,714.0,0,714.0
TCGA-A2-A1FW-01,Stage IIIA,62.0,221.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,221.0,0.0,LumB,,Negative,T_Other,T3,LIVING,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Modified Radical Mastectomy,NO,-22779.0,198.0,0.0,528.0,NO,90-99%,Scheduled Follow-up Submission,2012-1-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,640.0,NO,Negative,,,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf,A1FW,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,528.0,0.0,528.0,0.0,528.0,0,528.0
TCGA-A2-A1FX-01,Stage IIIA,61.0,935.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,935.0,0.0,LumB,,Positive,T_Other,T3,LIVING,61.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-22344.0,937.0,0.0,1847.0,NO,70-79%,Scheduled Follow-up Submission,2014-5-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,,Negative,NO,24.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,6.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf,A1FX,TUMOR FREE,YES,YES,60-69%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1847.0,0.0,1847.0,0.0,1847.0,0,1847.0
TCGA-A2-A1FZ-01,Stage IIA,63.0,409.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,409.0,0.0,LumA,,Positive,T_Other,T2,LIVING,63.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-23055.0,335.0,0.0,683.0,NO,90-99%,Scheduled Follow-up Submission,2012-1-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,740.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf,A1FZ,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,683.0,0.0,683.0,0.0,683.0,0,683.0
TCGA-A2-A1G0-01,Stage IIB,49.0,380.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,380.0,0.0,LumA,,Positive,T_Other,T2,LIVING,49.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-18002.0,315.0,0.0,616.0,NO,90-99%,Scheduled Follow-up Submission,2012-1-9,FEMALE,2+,"Other, specify",No,C50.9,8500/3,C50.9,YES,Core needle biopsy,730.0,NO,Equivocal,Negative,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf,A1G0,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,616.0,0.0,616.0,0.0,616.0,0,616.0
TCGA-A2-A1G1-01,Stage IIB,85.0,371.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,371.0,0.0,Basal,,Negative,T_Other,T2,LIVING,85.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-31223.0,338.0,0.0,584.0,NO,,Scheduled Follow-up Submission,2012-1-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Equivocal,Positive,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf,A1G1,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.Basal,0,584.0,0.0,584.0,0.0,584.0,0,584.0
TCGA-A2-A1G4-01,Stage IIIA,71.0,372.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,372.0,0.0,LumB,,Positive,T_Other,T3,LIVING,71.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-25966.0,310.0,0.0,595.0,NO,90-99%,Scheduled Follow-up Submission,2012-1-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,710.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,Yes,M0,N1a,T3,Stage IIIA,TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf,A1G4,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,595.0,0.0,595.0,0.0,595.0,0,595.0
TCGA-A2-A1G6-01,Stage IIIA,50.0,132.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,132.0,0.0,Normal,,Negative,T_Other,T2,LIVING,50.0,Right,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-18514.0,229.0,0.0,501.0,NO,,Scheduled Follow-up Submission,2012-1-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,770.0,NO,Negative,,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf,A1G6,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Normal,0,501.0,0.0,501.0,0.0,501.0,0,501.0
TCGA-A2-A25A-01,Stage IIA,44.0,2968.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2968.0,0.0,Normal,,Positive,T_Other,T2,LIVING,44.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Simple Mastectomy,YES,-16084.0,2927.0,0.0,3276.0,NO,<10%,Scheduled Follow-up Submission,2012-4-19,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,160.0,NO,Equivocal,Negative,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,Yes,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf,A25A,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.Normal,0,3276.0,0.0,3276.0,0.0,3276.0,0,3276.0
TCGA-A2-A25C-01,Stage IIB,50.0,285.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,285.0,0.0,LumB,,Positive,T_Other,T2,LIVING,50.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-18508.0,,0.0,523.0,NO,90-99%,Scheduled Follow-up Submission,2012-4-17,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,,No,M0,N1a,T2,Stage IIB,,A25C,TUMOR FREE,,YES,20-29%,YES,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumB,0,523.0,0.0,523.0,0.0,523.0,0,523.0
TCGA-A2-A25E-01,Stage IIIA,34.0,2511.0,Positive,FEMALE,Equivocal,Negative,M0,Positive,N2,2511.0,0.0,LumB,,Positive,T_Other,T2,LIVING,34.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-12601.0,2441.0,0.0,3204.0,NO,80-89%,Scheduled Follow-up Submission,2013-7-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,200.0,NO,Equivocal,Equivocal,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,6.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf,A25E,TUMOR FREE,YES,YES,60-69%,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.LumB,0,3204.0,0.0,3204.0,1.0,2989.0,1,2989.0
TCGA-A2-A25F-01,Stage IIA,66.0,113.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,113.0,0.0,Basal,,Positive,T_Other,T2,LIVING,66.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Positive,Lumpectomy,YES,-24319.0,86.0,0.0,322.0,NO,,Scheduled Follow-up Submission,2012-4-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,390.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf,A25F,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,322.0,0.0,322.0,0.0,322.0,0,322.0
TCGA-A2-A3KC-01,,,,,,,,,,,,,LumA,,,,,,55.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-20401.0,299.0,0.0,1102.0,NO,90-99%,,2014-5-5,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,780.0,NO,Equivocal,Negative,NO,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf,A3KC,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1102.0,0.0,1102.0,0.0,1102.0,0,1102.0
TCGA-A2-A3XS-01,,,,,,,,,,,,,,,,,,,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-23000.0,3355.0,0.0,,YES,,Additional New Tumor Event,2012-8-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,40.0,NO,,Negative,,19.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,9.0,0.0,True,No,M0,N2a,T1,Stage IIIA,TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf,A3XS,WITH TUMOR,,YES,,NO,Primary Tumor,1,6th,YES,A,DECEASED,2003.0,BRCA.Basal,1,1032.0,1.0,1032.0,1.0,682.0,1,682.0
TCGA-A2-A3XT-01,,,,,,,,,,,,,,,,,,,45.0,Left,Other (specify),Negative,Negative,Modified Radical Mastectomy,NO,-16649.0,2164.0,0.0,2770.0,,,,2014-1-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,340.0,NO,Negative,Negative,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf,A3XT,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.Basal,0,2770.0,0.0,2770.0,0.0,2770.0,0,2770.0
TCGA-A2-A3XU-01,,,,,,,,,,,,,,,,,,,35.0,Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-13046.0,2089.0,0.0,,,,,2012-8-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,350.0,NO,,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,3.0,0.0,True,No,M0,N1mi,T2,Stage IIB,TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf,A3XU,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,6th,,A,DECEASED,2006.0,BRCA.Basal,1,912.0,1.0,912.0,1.0,574.0,1,574.0
TCGA-A2-A3XV-01,,,,,,,,,,,,,,,,,,,46.0,Right,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,YES,-16971.0,,0.0,996.0,,<10%,,2014-5-1,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Positive,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A3XV,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,,LIVING,2011.0,BRCA.Her2,0,996.0,0.0,996.0,0.0,996.0,0,996.0
TCGA-A2-A3XW-01,,,,,,,,,,,,,,,,,,,42.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,YES,-15670.0,,0.0,1712.0,NO,90-99%,,2014-1-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,NO,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,0.0,,No,M0,N1a,T2,Stage IIB,,A3XW,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,,LIVING,2009.0,BRCA.Normal,0,1712.0,0.0,1712.0,0.0,1712.0,0,1712.0
TCGA-A2-A3XX-01,,,,,,,,,,,,,,,,,,,49.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-17981.0,1143.0,0.0,1168.0,NO,,,2013-5-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,780.0,NO,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf,A3XX,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,DECEASED,2009.0,BRCA.Basal,1,1439.0,0.0,1439.0,0.0,1439.0,0,1439.0
TCGA-A2-A3XY-01,,,,,,,,,,,,,,,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-18059.0,703.0,0.0,786.0,NO,,,2014-1-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,950.0,NO,Negative,Negative,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf,A3XY,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,,A,DECEASED,2010.0,BRCA.Basal,1,1093.0,1.0,1093.0,1.0,802.0,1,802.0
TCGA-A2-A3XZ-01,,,,,,,,,,,,,,,,,,,46.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-16978.0,909.0,0.0,1532.0,,,,2014-4-28,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1100.0,NO,Positive,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0,T1c,Stage I,TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf,A3XZ,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.Her2,0,1532.0,0.0,1532.0,0.0,1532.0,0,1532.0
TCGA-A2-A4RW-01,,,,,,,,,,,,,,,,,,,49.0,Right|Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-18060.0,,0.0,222.0,,80-89%,,2014-5-1,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,YES,27.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,27.0,0.0,,No,M0,N3a,T2,Stage IIIC,,A4RW,TUMOR FREE,,YES,90-99%,,Primary Tumor,1,7th,,,LIVING,2011.0,BRCA.LumA,0,222.0,0.0,222.0,0.0,222.0,0,222.0
TCGA-A2-A4RX-01,,,,,,,,,,,,,,,,,,,67.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-24779.0,,0.0,742.0,,<10%,,2014-4-11,FEMALE,1+,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A4RX,TUMOR FREE,,YES,<10%,,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.Basal,0,742.0,0.0,742.0,0.0,742.0,0,742.0
TCGA-A2-A4RY-01,,,,,,,,,,,,,,,,,,,46.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-17157.0,149.0,0.0,648.0,,90-99%,,2014-5-5,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1180.0,NO,Negative,,NO,30.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,18.0,0.0,True,No,M0,N3a,T3,Stage IIIC,TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf,A4RY,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Normal,0,648.0,0.0,648.0,0.0,648.0,0,648.0
TCGA-A2-A4S0-01,,,,,,,,,,,,,,,,,,,77.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-28416.0,159.0,0.0,706.0,,90-99%,,2014-5-1,FEMALE,1+,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,960.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf,A4S0,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,706.0,0.0,706.0,0.0,706.0,0,706.0
TCGA-A2-A4S1-01,,,,,,,,,,,,,,,,,,,66.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,YES,-24353.0,282.0,0.0,820.0,,<10%,,2014-4-28,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,350.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf,A4S1,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,820.0,0.0,820.0,0.0,820.0,0,820.0
TCGA-A2-A4S2-01,,,,,,,,,,,,,,,,,,,62.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22936.0,112.0,0.0,643.0,,90-99%,,2014-4-30,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8524/3,C50.9,YES,Core needle biopsy,1390.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,0.0,True,No,M0,N2,T3,Stage IIIA,TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf,A4S2,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,643.0,0.0,643.0,0.0,643.0,0,643.0
TCGA-A2-A4S3-01,,,,,,,,,,,,,,,,,,,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-21762.0,147.0,0.0,666.0,,90-99%,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1500.0,NO,Negative,,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf,A4S3,TUMOR FREE,,YES,90-99%,,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumB,0,666.0,0.0,666.0,0.0,666.0,0,666.0
TCGA-A7-A0CD-01,Stage IA,66.0,372.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,372.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,66.0,Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-24242.0,157.0,0.0,1165.0,,90-99%,,2013-2-4,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,420.0,NO,Equivocal,Negative,NO,2.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,False,Yes,M0,N0,T1,Stage I,TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C.pdf,A0CD,TUMOR FREE,YES,,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1165.0,0.0,1165.0,0.0,1165.0,0,1165.0
TCGA-A7-A0CE-01,Stage IIA,57.0,309.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,309.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,57.0,Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-20863.0,129.0,0.0,1074.0,,<10%,,2013-1-14,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,330.0,NO,Equivocal,Negative,NO,1.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf,A0CE,TUMOR FREE,YES,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Basal,0,1074.0,0.0,1074.0,0.0,1074.0,0,1074.0
TCGA-A7-A0CE-11,,57.0,309.0,,FEMALE,,,,,,309.0,0.0,,,,,,LIVING,57.0,Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-20863.0,129.0,0.0,1074.0,,<10%,,2013-1-14,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,290.0,NO,Equivocal,Negative,NO,1.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,,A0CE,TUMOR FREE,YES,,<10%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,1074.0,0.0,1074.0,0.0,1074.0,0,1074.0
TCGA-A7-A0CH-01,Stage IIA,79.0,232.0,,FEMALE,Negative,Negative,M0,Negative,N0,232.0,0.0,LumA,Luminal A,,T_Other,T2,LIVING,79.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,,,Simple Mastectomy,YES,-29104.0,121.0,0.0,1079.0,,,,2013-1-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0.pdf,A0CH,TUMOR FREE,YES,,,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,1079.0,0.0,1079.0,0.0,1079.0,0,1079.0
TCGA-A7-A0CH-11,,79.0,232.0,,FEMALE,,,,,,232.0,0.0,,,,,,LIVING,79.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,,,Simple Mastectomy,YES,-29104.0,121.0,0.0,1079.0,,,,2013-1-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,390.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,,A0CH,TUMOR FREE,YES,,,NO,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,1079.0,0.0,1079.0,0.0,1079.0,0,1079.0
TCGA-A7-A0D9-01,Stage IIA,37.0,272.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,272.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,37.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Negative,Simple Mastectomy,YES,-13836.0,173.0,0.0,1139.0,,90-99%,,2013-2-1,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1760.0,NO,Negative,,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495.pdf,A0D9,TUMOR FREE,YES,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,1139.0,0.0,1139.0,0.0,1139.0,0,1139.0
TCGA-A7-A0D9-11,,37.0,272.0,,FEMALE,,,,,,272.0,0.0,Normal,,,,,LIVING,37.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Negative,Simple Mastectomy,YES,-13836.0,173.0,0.0,1139.0,,90-99%,,2013-2-1,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1830.0,NO,Negative,,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,,A0D9,TUMOR FREE,YES,,<10%,NO,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,1139.0,0.0,1139.0,0.0,1139.0,0,1139.0
TCGA-A7-A0DA-01,Stage IIA,62.0,373.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,373.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,62.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,,-22708.0,177.0,0.0,1085.0,,,,2012-12-14,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,350.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf,A0DA,TUMOR FREE,YES,,,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Basal,0,1085.0,0.0,1085.0,0.0,1085.0,0,1085.0
TCGA-A7-A0DC-01,Stage IA,63.0,386.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,386.0,0.0,LumA,,Negative,T1,T1,LIVING,63.0,Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,YES,-23294.0,238.0,0.0,906.0,,90-99%,,2013-2-25,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,200.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage IA,TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2.pdf,A0DC,TUMOR FREE,YES,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,906.0,0.0,906.0,0.0,906.0,0,906.0
TCGA-A7-A0DC-11,,63.0,386.0,,FEMALE,,,,,,386.0,0.0,Normal,,,,,LIVING,63.0,Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,YES,-23294.0,238.0,0.0,906.0,,90-99%,,2013-2-25,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,470.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage IA,,A0DC,TUMOR FREE,YES,,<10%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,906.0,0.0,906.0,0.0,906.0,0,906.0
TCGA-A7-A13D-01,Stage IIA,46.0,267.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,267.0,0.0,Basal,Basal-like,Positive,T_Other,T2,LIVING,46.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Positive,Lumpectomy,NO,-17070.0,240.0,0.0,965.0,,<10%,,2013-2-1,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,Equivocal,Negative,NO,4.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf,A13D,TUMOR FREE,YES,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.Basal,0,965.0,0.0,965.0,0.0,965.0,0,965.0
TCGA-A7-A13E-01,Stage IIB,62.0,326.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,326.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Lumpectomy,NO,-22690.0,220.0,0.0,326.0,,20-29%,Additional New Tumor Event,2012-4-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,730.0,NO,Equivocal,Negative,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,,False,No,MX,N1,T2,Stage IIB,TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf,A13E,WITH TUMOR,,,<10%,NO,Primary Tumor,1,,YES,A,DECEASED,2010.0,BRCA.Basal,1,614.0,1.0,614.0,1.0,556.0,1,556.0
TCGA-A7-A13E-11,,62.0,326.0,,FEMALE,,,,,,326.0,0.0,Normal,,,,,LIVING,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Lumpectomy,NO,-22690.0,220.0,0.0,326.0,,20-29%,Additional New Tumor Event,2012-4-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,770.0,NO,Equivocal,Negative,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,,False,No,MX,N1,T2,Stage IIB,,A13E,WITH TUMOR,,,<10%,NO,Solid Tissue Normal,11,,YES,A,DECEASED,2010.0,BRCA.Normal,1,614.0,1.0,614.0,1.0,556.0,1,556.0
TCGA-A7-A13F-01,Stage IIIA,44.0,387.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,387.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-16363.0,,0.0,765.0,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,,No,M0,N1a,T3,Stage IIIA,,A13F,TUMOR FREE,YES,,,YES,Primary Tumor,1,,YES,,LIVING,2010.0,BRCA.LumB,0,765.0,0.0,765.0,0.0,765.0,0,765.0
TCGA-A7-A13F-11,,44.0,387.0,,FEMALE,,,,,,387.0,0.0,Normal,,,,,LIVING,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-16363.0,121.0,0.0,765.0,,,Scheduled Follow-up Submission,2013-2-1,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,960.0,NO,Equivocal,Negative,NO,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,False,No,M0,N1a,T3,Stage IIIA,,A13F,TUMOR FREE,YES,,,YES,Solid Tissue Normal,11,,YES,A,LIVING,2010.0,BRCA.Normal,0,765.0,0.0,765.0,0.0,765.0,0,765.0
TCGA-A7-A13G-01,Stage IIA,79.0,348.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,348.0,0.0,LumA,,Positive,T_Other,T2,LIVING,79.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-28969.0,,0.0,718.0,NO,90-99%,Scheduled Follow-up Submission,2012-9-14,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,,Yes,MX,N0,T2,Stage IIA,,A13G,TUMOR FREE,YES,YES,50-59%,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,718.0,0.0,718.0,0.0,718.0,1,586.0
TCGA-A7-A13G-11,,79.0,348.0,,FEMALE,,,,,,348.0,0.0,LumA,,,,,LIVING,79.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-28969.0,69.0,0.0,718.0,NO,90-99%,Scheduled Follow-up Submission,2012-9-14,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,880.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,False,Yes,MX,N0,T2,Stage IIA,,A13G,TUMOR FREE,YES,YES,50-59%,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,718.0,0.0,718.0,0.0,718.0,1,586.0
TCGA-A7-A13H-01,,,,,,,,,,,,,,,,,,,61.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-22643.0,62.0,0.0,899.0,NO,80-89%,,2013-3-25,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,Equivocal,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,2.0,False,No,MX,N1a,T2,Stage IIB,TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf,A13H,TUMOR FREE,NO,YES,30-39%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,899.0,0.0,899.0,0.0,899.0,1,795.0
TCGA-A7-A26E-01,Stage IIIA,71.0,421.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,421.0,0.0,LumA,,Positive,T_Other,T3,LIVING,71.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-26274.0,372.0,0.0,954.0,NO,90-99%,Scheduled Follow-up Submission,2013-2-1,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,230.0,NO,Negative,,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,Yes,MX,N1a,T3,Stage IIIA,TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf,A26E,TUMOR FREE,YES,YES,20-29%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,954.0,0.0,954.0,0.0,954.0,0,954.0
TCGA-A7-A26F-01,Stage IA,55.0,257.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,257.0,0.0,Basal,,Negative,T1,T1,LIVING,55.0,Left,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-20210.0,173.0,0.0,738.0,NO,,Scheduled Follow-up Submission,2012-12-14,FEMALE,2+,"Other, specify",No,C50.9,8575/3,C50.9,YES,Fine needle aspiration biopsy,190.0,NO,Equivocal,Negative,NO,1.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,Yes,M0,N0,T1,Stage IA,TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf,A26F,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,738.0,0.0,738.0,0.0,738.0,0,738.0
TCGA-A7-A26G-01,Stage IIA,50.0,209.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,209.0,0.0,Basal,,Negative,T_Other,T2,LIVING,50.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,NO,-18362.0,161.0,0.0,722.0,NO,,Scheduled Follow-up Submission,2013-1-9,FEMALE,,"Other, specify",No,C50.9,8575/3,C50.9,YES,Core needle biopsy,410.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0 (i+),T2,Stage IIA,TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf,A26G,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,722.0,0.0,722.0,0.0,722.0,0,722.0
TCGA-A7-A26H-01,Stage IIA,72.0,64.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,64.0,0.0,LumA,,Negative,T1,T1,LIVING,72.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,NO,-26423.0,79.0,0.0,724.0,NO,90-99%,Scheduled Follow-up Submission,2013-2-5,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Equivocal,Positive,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,1.0,False,Yes,M0,N1a,T1,Stage IIA,TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf,A26H,WITH TUMOR,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,724.0,0.0,724.0,1.0,291.0,1,291.0
TCGA-A7-A26I-01,Stage IIA,65.0,122.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,122.0,0.0,Basal,,Negative,T_Other,T2,LIVING,65.0,Left,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-23948.0,40.0,0.0,661.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,120.0,NO,Equivocal,Negative,NO,2.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,Yes,M0,N0,T2,Stage IIA,TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf,A26I,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,661.0,0.0,661.0,0.0,661.0,0,661.0
TCGA-A7-A26J-01,Stage IIA,49.0,67.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,67.0,0.0,LumA,,Positive,T_Other,T2,LIVING,49.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-17930.0,,0.0,627.0,NO,90-99%,Scheduled Follow-up Submission,2013-2-1,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A26J,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,627.0,0.0,627.0,0.0,627.0,0,627.0
TCGA-A7-A2KD-01,,,,,,,,,,,,,LumB,,,,,,53.0,Right,No axillary staging,Positive,Positive,Modified Radical Mastectomy,NO,-19563.0,141.0,0.0,679.0,,90-99%,Scheduled Follow-up Submission,2013-2-1,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,8.0,0.0,False,Yes,MX,N2a,T2,Stage IIIA,TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf,A2KD,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,679.0,0.0,679.0,0.0,679.0,0,679.0
TCGA-A7-A3IY-01,,,,,,,,,,,,,LumA,,,,,,71.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-26042.0,,0.0,345.0,NO,90-99%,Scheduled Follow-up Submission,2012-7-20,FEMALE,,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,,,Negative,,,1.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A3IY,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,345.0,0.0,345.0,0.0,345.0,0,345.0
TCGA-A7-A3IZ-01,,,,,,,,,,,,,LumA,,,,,,62.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Lumpectomy,YES,-22997.0,86.0,0.0,322.0,NO,90-99%,,2012-8-16,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,290.0,NO,Equivocal,Negative,NO,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,1.0,False,No,M0,N0 (i+),T2,Stage IIA,TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf,A3IZ,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,322.0,0.0,322.0,0.0,322.0,0,322.0
TCGA-A7-A3J0-01,,,,,,,,,,,,,LumA,,,,,,62.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-22672.0,78.0,0.0,313.0,NO,90-99%,,2012-10-12,FEMALE,1+,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf,A3J0,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,313.0,0.0,313.0,0.0,313.0,0,313.0
TCGA-A7-A3J1-01,,,,,,,,,,,,,LumA,,,,,,63.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,,-23209.0,49.0,0.0,343.0,NO,90-99%,,2012-11-12,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,Yes,MX,N0,T1c,Stage IA,TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf,A3J1,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,343.0,0.0,343.0,0.0,343.0,0,343.0
TCGA-A7-A3RF-01,,,,,,,,,,,,,,,,,,,79.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-29184.0,61.0,0.0,408.0,,90-99%,,2013-2-19,FEMALE,,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,,NO,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf,A3RF,WITH TUMOR,YES,YES,30-39%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,408.0,0.0,408.0,1.0,174.0,1,174.0
TCGA-A7-A425-01,,,,,,,,,,,,,,,,,,,70.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-25678.0,198.0,0.0,447.0,,90-99%,,2013-3-25,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,400.0,NO,Indeterminate,Negative,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,12.0,,False,No,MX,N3a,T3,Stage IIIC,TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf,A425,WITH TUMOR,YES,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,447.0,0.0,447.0,1.0,419.0,1,419.0
TCGA-A7-A426-01,,,,,,,,,,,,,,,,,,,50.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-18296.0,132.0,0.0,364.0,,70-79%,,2013-3-26,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,180.0,NO,Negative,,NO,20.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,13.0,,False,Yes,MX,N3a,T3,Stage IIIC,TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf,A426,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,364.0,0.0,364.0,0.0,364.0,0,364.0
TCGA-A7-A4SA-01,,,,,,,,,,,,,,,,,,,40.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,YES,-14906.0,127.0,0.0,454.0,,80-89%,,2013-10-3,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf,A4SA,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,454.0,0.0,454.0,0.0,454.0,0,454.0
TCGA-A7-A4SB-01,,,,,,,,,,,,,,,,,,,56.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-20539.0,75.0,0.0,418.0,,70-79%,,2013-10-4,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,NO,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,False,No,M0,N1mi,T3,Stage IIIA,TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf,A4SB,TUMOR FREE,YES,YES,50-59%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,418.0,0.0,418.0,0.0,418.0,0,418.0
TCGA-A7-A4SC-01,,,,,,,,,,,,,,,,,,,62.0,Right Upper Outer Quadrant,,Positive,Negative,Simple Mastectomy,YES,-23008.0,110.0,0.0,446.0,,90-99%,,2013-10-8,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,360.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0,T3,Stage IIB,TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf,A4SC,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,446.0,0.0,446.0,0.0,446.0,0,446.0
TCGA-A7-A4SD-01,,,,,,,,,,,,,,,,,,,52.0,Right,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-19131.0,63.0,0.0,441.0,,,,2013-12-5,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,230.0,NO,Equivocal,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf,A4SD,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,441.0,0.0,441.0,0.0,441.0,0,441.0
TCGA-A7-A4SE-01,,,,,,,,,,,,,,,,,,,54.0,Left,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-20080.0,306.0,0.0,644.0,,,,2013-10-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,YES,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf,A4SE,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Basal,0,644.0,0.0,644.0,0.0,644.0,0,644.0
TCGA-A7-A56D-01,,,,,,,,,,,,,,,,,,,84.0,Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-30783.0,140.0,0.0,448.0,,90-99%,,2013-10-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf,A56D,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,448.0,0.0,448.0,0.0,448.0,0,448.0
TCGA-A7-A5ZV-01,,,,,,,,,,,,,,,,,,,62.0,Left,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-22966.0,,0.0,368.0,,,,2013-11-8,FEMALE,2+,Infiltrating Carcinoma NOS,No,C50.9,8010/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A5ZV,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.Basal,0,368.0,0.0,368.0,0.0,368.0,0,368.0
TCGA-A7-A5ZW-01,,,,,,,,,,,,,,,,,,,47.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-17529.0,77.0,0.0,326.0,,90-99%,,2013-11-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,60.0,NO,Negative,,NO,1.0,Negative,Peri (6-12 months since last menstrual period),NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf,A5ZW,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,326.0,0.0,326.0,0.0,326.0,0,326.0
TCGA-A7-A6VV-01,,,,,,,,,,,,,,,,,,,51.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Modified Radical Mastectomy,NO,-18695.0,85.0,0.0,313.0,,,,2014-3-6,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,1100.0,NO,Negative,,NO,5.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf,A6VV,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,313.0,0.0,313.0,0.0,313.0,0,313.0
TCGA-A7-A6VX-01,,,,,,,,,,,,,,,,,,,68.0,Left|Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-25066.0,73.0,0.0,317.0,,90-99%,,2014-3-13,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf,A6VX,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,317.0,0.0,317.0,0.0,317.0,0,317.0
TCGA-A7-A6VY-01,,,,,,,,,,,,,,,,,,,48.0,Right|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-17640.0,29.0,0.0,266.0,,,,2014-3-6,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Negative,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1,T2,Stage IIB,TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf,A6VY,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,266.0,0.0,266.0,0.0,266.0,0,266.0
TCGA-A8-A06N-01,Stage IIIB,66.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,Luminal B,Negative,T_Other,T4,LIVING,66.0,Left,,Positive,Negative,Other,,-24288.0,241.0,0.0,0.0,,,,2011-5-27,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,510.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T4b,Stage IIIB,TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84.pdf,A06N,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A06O-01,Stage I,60.0,396.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,396.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,60.0,Left,,Positive,Positive,Other,,-22157.0,272.0,0.0,396.0,,,,2013-3-1,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T1c,Stage I,TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3.pdf,A06O,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,396.0,0.0,396.0,0.0,396.0,0,396.0
TCGA-A8-A06P-01,Stage IIIA,63.0,396.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,396.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,63.0,Right,,Positive,Positive,Other,,-23011.0,241.0,0.0,396.0,,,,2013-3-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,210.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N2a,T1c,Stage IIIA,TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31.pdf,A06P,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,396.0,0.0,396.0,0.0,396.0,0,396.0
TCGA-A8-A06Q-01,Stage IIIA,63.0,31.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,31.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,63.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-23164.0,1184.0,0.0,31.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,50.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N2,T3,Stage IIIA,TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF.pdf,A06Q,TUMOR FREE,,,,,Primary Tumor,1,5th,,A,LIVING,2007.0,BRCA.LumB,0,31.0,0.0,31.0,0.0,31.0,0,31.0
TCGA-A8-A06R-01,Stage IIB,69.0,546.0,Positive,FEMALE,Equivocal,Negative,M0,Positive,N1,546.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,69.0,Right Upper Outer Quadrant,,Positive,Negative,Other,,-25477.0,1184.0,0.0,547.0,,,,2013-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,220.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1a,T2,Stage IIB,TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871.pdf,A06R,TUMOR FREE,YES,,,YES,Primary Tumor,1,5th,,A,LIVING,2007.0,BRCA.LumB,0,547.0,0.0,547.0,0.0,547.0,0,547.0
TCGA-A8-A06T-01,Stage IIIA,75.0,1249.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1249.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,75.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-27393.0,,0.0,1614.0,,,,2013-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,Yes,M0,N1a,T3,Stage IIIA,,A06T,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,1614.0,0.0,1614.0,0.0,1614.0,0,1614.0
TCGA-A8-A06U-01,Stage IIB,80.0,882.0,Positive,FEMALE,Equivocal,Negative,M0,Positive,N1,882.0,1.0,LumA,Luminal A,Positive,T_Other,T2,DECEASED,80.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-29525.0,759.0,0.0,,,,,2013-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,250.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,Yes,M0,N1a,T2,Stage IIB,TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf,A06U,TUMOR FREE,,,,NO,Primary Tumor,1,6th,,A,DECEASED,2008.0,BRCA.LumA,1,883.0,0.0,883.0,0.0,883.0,0,883.0
TCGA-A8-A06X-01,Stage IIB,77.0,943.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,943.0,1.0,LumB,Luminal B,Negative,T_Other,T3,DECEASED,77.0,Right Upper Outer Quadrant,,Positive,Negative,Other,,-28338.0,1276.0,0.0,,,,,2013-3-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,760.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T3,Stage IIB,TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070.pdf,A06X,TUMOR FREE,,,,YES,Primary Tumor,1,6th,,A,DECEASED,2006.0,BRCA.LumB,1,943.0,0.0,943.0,0.0,943.0,0,943.0
TCGA-A8-A06Y-01,Stage IIA,66.0,791.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,791.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,66.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-24442.0,667.0,0.0,791.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,130.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26.pdf,A06Y,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,791.0,0.0,791.0,1.0,791.0,1,791.0
TCGA-A8-A075-01,Stage IIB,42.0,517.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,517.0,0.0,LumB,HER2-enriched,Positive,T_Other,T2,LIVING,42.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-15369.0,394.0,0.0,518.0,,,,2013-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,120.0,NO,Positive,Positive,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,False,No,M0,N1a,T2,Stage IIB,TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31.pdf,A075,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,518.0,0.0,518.0,0.0,518.0,0,518.0
TCGA-A8-A076-01,Stage IIA,66.0,1641.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1641.0,0.0,LumB,HER2-enriched,Positive,T_Other,T2,LIVING,66.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-24230.0,1518.0,0.0,1642.0,,,,2013-3-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,210.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9.pdf,A076,TUMOR FREE,YES,,,NO,Primary Tumor,1,5th,,A,LIVING,2006.0,BRCA.LumB,0,1642.0,0.0,1642.0,0.0,1642.0,0,1642.0
TCGA-A8-A079-01,Stage IIIB,69.0,274.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,274.0,0.0,LumB,Luminal B,Positive,T_Other,T4,LIVING,69.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-25294.0,1033.0,0.0,274.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,380.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N3,T4b,Stage IIIB,TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42.pdf,A079,TUMOR FREE,YES,,,YES,Primary Tumor,1,5th,,A,LIVING,2007.0,BRCA.LumB,0,274.0,0.0,274.0,0.0,274.0,0,274.0
TCGA-A8-A07B-01,Stage IIA,69.0,1004.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1004.0,0.0,LumA,HER2-enriched,Positive,T_Other,T2,LIVING,69.0,Left Lower Outer Quadrant,,Positive,Positive,Other,,-25475.0,880.0,0.0,1308.0,,,,2013-3-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,90.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA.pdf,A07B,TUMOR FREE,NO,,,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,1308.0,0.0,1308.0,0.0,1308.0,0,1308.0
TCGA-A8-A07C-01,Stage IIA,57.0,580.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,580.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,57.0,Right Upper Outer Quadrant,,Negative,Negative,Other,,-20820.0,637.0,0.0,1034.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,80.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71.pdf,A07C,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,1034.0,0.0,1034.0,0.0,1034.0,0,1034.0
TCGA-A8-A07E-01,Stage X,81.0,608.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,608.0,0.0,LumA,Luminal A,Positive,T_Other,T4,LIVING,81.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-29800.0,545.0,0.0,608.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,260.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,Yes,MX,N3a,T4b,Stage X,TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7.pdf,A07E,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,608.0,0.0,608.0,0.0,608.0,0,608.0
TCGA-A8-A07F-01,Stage IIB,65.0,576.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,576.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,65.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-23742.0,453.0,0.0,577.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,150.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1a,T2,Stage IIB,TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156.pdf,A07F,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,577.0,0.0,577.0,0.0,577.0,0,577.0
TCGA-A8-A07G-01,Stage IIA,65.0,576.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,576.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,65.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-23926.0,,0.0,577.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N1a,T1c,Stage IIA,,A07G,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,,LIVING,2009.0,BRCA.LumA,0,577.0,0.0,577.0,0.0,577.0,0,577.0
TCGA-A8-A07I-01,Stage IIIA,69.0,426.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,426.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,69.0,Left Upper Outer Quadrant,,Positive,Negative,Other,,-25263.0,302.0,0.0,426.0,,,,2013-3-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,130.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N2a,T2,Stage IIIA,TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B.pdf,A07I,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.Her2,0,426.0,0.0,426.0,0.0,426.0,0,426.0
TCGA-A8-A07J-01,Stage IIB,35.0,365.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,365.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,35.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-12965.0,,0.0,365.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,,No,M0,N1a,T2,Stage IIB,,A07J,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,,LIVING,2009.0,BRCA.LumA,0,365.0,0.0,365.0,0.0,365.0,0,365.0
TCGA-A8-A07L-01,Stage IIIA,58.0,517.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,517.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,58.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-21428.0,394.0,0.0,975.0,,,,2013-3-2,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,80.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1a,T3,Stage IIIA,TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851.pdf,A07L,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,975.0,0.0,975.0,0.0,975.0,0,975.0
TCGA-A8-A07O-01,Stage IIA,51.0,304.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,304.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,51.0,Right Upper Outer Quadrant,,Negative,Negative,Other,,-18870.0,180.0,0.0,304.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,220.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf,A07O,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.Basal,0,304.0,0.0,304.0,0.0,304.0,0,304.0
TCGA-A8-A07P-01,Stage IIB,68.0,334.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,334.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,68.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-24929.0,210.0,0.0,334.0,,,,2013-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,120.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N1,T2,Stage IIB,TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959.pdf,A07P,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,334.0,0.0,334.0,0.0,334.0,0,334.0
TCGA-A8-A07U-01,Stage IIIA,66.0,303.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,303.0,0.0,Basal,Basal-like,Positive,T_Other,T2,LIVING,66.0,Right Upper Outer Quadrant,,Negative,Positive,Other,,-24411.0,210.0,0.0,760.0,,,,2013-3-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N2a,T2,Stage IIIA,TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A.pdf,A07U,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.Basal,0,760.0,0.0,760.0,0.0,760.0,0,760.0
TCGA-A8-A07Z-01,Stage IIA,85.0,853.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,853.0,0.0,,Luminal B,Positive,T_Other,T2,LIVING,85.0,Left,,Positive,Positive,Other,,-31351.0,,0.0,1371.0,,,,2013-3-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N0,T2,Stage IIA,,A07Z,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,,LIVING,2008.0,BRCA.LumA,0,1371.0,0.0,1371.0,0.0,1371.0,0,1371.0
TCGA-A8-A081-01,Stage IIA,80.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,HER2-enriched,Positive,T_Other,T2,LIVING,80.0,Right,,Positive,Positive,Other,,-29555.0,637.0,0.0,0.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,150.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62.pdf,A081,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A082-01,Stage IIB,58.0,549.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,549.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,58.0,Right,,Positive,Positive,Other,,-21338.0,606.0,0.0,-31.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,130.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1a,T2,Stage IIB,TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C.pdf,A082,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,549.0,0.0,549.0,0.0,549.0,0,549.0
TCGA-A8-A083-01,Stage IIB,67.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,67.0,Left,,Positive,Positive,Other,,-24746.0,575.0,0.0,0.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,300.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T3,Stage IIB,TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517.pdf,A083,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A085-01,Stage IIB,44.0,1124.0,Positive,MALE,Negative,Negative,M0,Positive,N1,1124.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,44.0,Left,,Positive,Positive,Other,,-16377.0,788.0,0.0,1124.0,,,,2013-3-2,MALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,130.0,NO,Negative,Negative,NO,,Negative,,NO,,,False,No,M0,N1a,T2,Stage IIB,TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E.pdf,A085,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,1124.0,0.0,1124.0,0.0,1124.0,0,1124.0
TCGA-A8-A086-01,Stage IIA,59.0,396.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,396.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,59.0,Right,,Positive,Positive,Other,,-21731.0,272.0,0.0,396.0,,,,2013-3-2,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,150.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1a,T1c,Stage IIA,TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8.pdf,A086,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,396.0,0.0,396.0,0.0,396.0,0,396.0
TCGA-A8-A08A-01,Stage I,89.0,30.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,30.0,0.0,,Luminal A,Positive,T1,T1,LIVING,89.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-32750.0,1033.0,0.0,30.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,160.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T1c,Stage I,TCGA-A8-A08A.6D2212CE-C80F-4545-A895-3F1B6E4C6DB6.pdf,A08A,TUMOR FREE,,,,,Primary Tumor,1,5th,,A,LIVING,2007.0,BRCA.LumA,0,30.0,0.0,30.0,0.0,30.0,0,30.0
TCGA-A8-A08B-01,Stage IIA,52.0,702.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,702.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,52.0,Right Upper Inner Quadrant,,Positive,Negative,Other,,-19114.0,759.0,0.0,1156.0,,,,2013-3-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Positive,Positive,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80.pdf,A08B,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Her2,0,1156.0,0.0,1156.0,0.0,1156.0,0,1156.0
TCGA-A8-A08C-01,Stage IIA,65.0,607.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,607.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,65.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-24017.0,484.0,0.0,881.0,,,,2013-3-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,110.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06.pdf,A08C,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,881.0,0.0,881.0,0.0,881.0,0,881.0
TCGA-A8-A08F-01,Stage IIIC,59.0,549.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,549.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,59.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,-21641.0,637.0,0.0,1004.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,Yes,M0,N3a,T2,Stage IIIC,TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647.pdf,A08F,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,1004.0,0.0,1004.0,0.0,1004.0,0,1004.0
TCGA-A8-A08G-01,Stage IIA,41.0,606.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,606.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,41.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-14976.0,422.0,0.0,607.0,,,,2013-3-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,180.0,NO,Positive,Positive,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7.pdf,A08G,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,607.0,0.0,607.0,0.0,607.0,0,607.0
TCGA-A8-A08H-01,Stage IIA,66.0,0.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,0.0,0.0,Normal,Basal-like,Positive,T_Other,T2,LIVING,66.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-24137.0,1184.0,0.0,0.0,,,,2011-5-27,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,250.0,NO,Positive,Positive,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7.pdf,A08H,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Normal,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A08I-01,Stage IIA,53.0,365.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,365.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,53.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,-19389.0,241.0,0.0,365.0,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,80.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6.pdf,A08I,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,365.0,0.0,365.0,0.0,365.0,0,365.0
TCGA-A8-A08L-01,Stage IIIA,89.0,304.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,304.0,1.0,Her2,HER2-enriched,Negative,T_Other,T3,DECEASED,89.0,Left,,Positive,Negative,Other,,-32842.0,698.0,0.0,,,,,2013-3-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,200.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N2a,T3,Stage IIIA,TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf,A08L,TUMOR FREE,,,,YES,Primary Tumor,1,6th,,A,DECEASED,2008.0,BRCA.Her2,1,304.0,0.0,304.0,0.0,304.0,0,304.0
TCGA-A8-A08P-01,Stage IIIA,70.0,942.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,942.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,70.0,Right,,Positive,Positive,Other,,-25598.0,819.0,0.0,943.0,,,,2013-2-24,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,210.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N2a,T2,Stage IIIA,TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1.pdf,A08P,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,943.0,0.0,943.0,0.0,943.0,0,943.0
TCGA-A8-A08R-01,Stage IIB,52.0,30.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,30.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,52.0,Left,,Negative,Negative,Other,,-19298.0,728.0,0.0,30.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,90.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N1a,T2,Stage IIB,TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf,A08R,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,30.0,0.0,30.0,0.0,30.0,0,30.0
TCGA-A8-A08S-01,Stage IIA,71.0,580.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,580.0,0.0,LumB,,Positive,T1,T1,LIVING,71.0,Left,,Positive,Positive,Other,,-25994.0,637.0,0.0,1004.0,,,,2013-2-24,FEMALE,3+,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,,80.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,Yes,M0,N1,T1c,Stage IIA,TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25.pdf,A08S,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,1004.0,0.0,1004.0,0.0,1004.0,0,1004.0
TCGA-A8-A08X-01,Stage IIIC,43.0,1034.0,Negative,FEMALE,Positive,Negative,M0,Positive,N3,1034.0,0.0,Her2,HER2-enriched,Negative,T_Other,T4,LIVING,43.0,Left,,Negative,Negative,Other,,-15705.0,941.0,0.0,1308.0,,,,2013-2-24,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,170.0,NO,Positive,Positive,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,,,False,No,M0,N3a,T4d,Stage IIIC,TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf,A08X,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Her2,0,1308.0,0.0,1308.0,1.0,366.0,1,366.0
TCGA-A8-A08Z-01,Stage IIIB,76.0,1217.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,1217.0,0.0,LumA,Luminal A,Positive,T_Other,T4,LIVING,76.0,Left,,Positive,Positive,Other,,-28003.0,2036.0,0.0,1217.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,350.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N3a,T4b,[Discrepancy],TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696.pdf,A08Z,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2004.0,BRCA.LumA,0,1217.0,0.0,1217.0,0.0,1217.0,0,1217.0
TCGA-A8-A090-01,Stage IIA,74.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,74.0,Right,,Positive,Positive,Other,,-27121.0,667.0,0.0,0.0,,,,2011-5-27,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,110.0,NO,Positive,Positive,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831.pdf,A090,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A091-01,Stage IIA,61.0,580.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,580.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,61.0,Right,,Positive,Negative,Other,,-22554.0,637.0,0.0,1004.0,,,,2013-2-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,180.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,,,False,Yes,M0,N0,T2,Stage IIA,TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf,A091,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,1004.0,0.0,1004.0,1.0,243.0,1,243.0
TCGA-A8-A092-01,Stage IIIA,48.0,518.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,518.0,0.0,LumB,HER2-enriched,Positive,T_Other,T2,LIVING,48.0,Left,,Positive,Positive,Other,,-17807.0,575.0,0.0,942.0,,,,2013-2-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,False,No,M0,N2a,T2,Stage IIIA,TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9.pdf,A092,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,942.0,0.0,942.0,0.0,942.0,0,942.0
TCGA-A8-A093-01,Stage IIA,61.0,545.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,545.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,61.0,Right,,Positive,Positive,Other,,-22373.0,422.0,0.0,546.0,,,,2013-2-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,Yes,M0,N0,T2,Stage IIA,TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7.pdf,A093,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,546.0,0.0,546.0,0.0,546.0,0,546.0
TCGA-A8-A094-01,Stage IIA,75.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,75.0,Left,,Positive,Negative,Other,,-27729.0,363.0,0.0,0.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,400.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235.pdf,A094,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.Her2,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A095-01,Stage I,45.0,1276.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1276.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,45.0,Left,,Positive,Positive,Other,,-16742.0,1153.0,0.0,1277.0,,,,2013-2-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,160.0,NO,Negative,Negative,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,False,No,M0,N0,T1c,Stage I,TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1.pdf,A095,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumB,0,1277.0,0.0,1277.0,0.0,1277.0,0,1277.0
TCGA-A8-A096-01,Stage IIA,73.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,73.0,Right,,Positive,Positive,Other,,-26723.0,394.0,0.0,0.0,,,,2011-5-27,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,110.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf,A096,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A097-01,Stage IIB,65.0,365.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,365.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,65.0,Left,,Positive,Positive,Other,,-23741.0,241.0,0.0,365.0,,,,2013-2-23,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1,T2,Stage IIB,TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077.pdf,A097,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,365.0,0.0,365.0,0.0,365.0,0,365.0
TCGA-A8-A09B-01,Stage IIIB,58.0,365.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,365.0,0.0,LumA,Luminal A,Positive,T_Other,T4,LIVING,58.0,Left,,Positive,Positive,Other,,-21520.0,,0.0,365.0,,,,2013-2-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,No,M0,N1a,T4b,Stage IIIB,,A09B,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,,LIVING,2009.0,BRCA.LumA,0,365.0,0.0,365.0,0.0,365.0,0,365.0
TCGA-A8-A09D-01,Stage IIB,47.0,396.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,396.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,47.0,Right Lower Outer Quadrant,,Positive,Positive,Other,,-17440.0,,0.0,1522.0,,,,2013-2-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N1,T2,Stage IIB,,A09D,TUMOR FREE,YES,,,YES,Primary Tumor,1,5th,,,LIVING,2007.0,BRCA.LumA,0,1522.0,0.0,1522.0,0.0,1522.0,0,1522.0
TCGA-A8-A09G-01,Stage IIIC,79.0,0.0,Positive,FEMALE,Positive,Negative,M0,Positive,N3,0.0,0.0,Her2,HER2-enriched,Negative,T_Other,T3,LIVING,79.0,Right Lower Outer Quadrant,,Positive,Negative,Other,,-29006.0,759.0,0.0,0.0,,,,2011-5-27,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,270.0,NO,Positive,Positive,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N3a,T3,Stage IIIC,TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C.pdf,A09G,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Her2,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-A8-A09I-01,Stage IIA,84.0,1006.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1006.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,84.0,Right Lower Outer Quadrant,,Positive,Positive,Other,,-30711.0,698.0,0.0,1371.0,,,,2013-2-17,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,430.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,Yes,M0,N0,T2,Stage IIA,TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf,A09I,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,1371.0,0.0,1371.0,0.0,1371.0,0,1371.0
TCGA-A8-A09K-01,Stage IIA,68.0,911.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,911.0,0.0,LumA,,Positive,T1,T1,LIVING,68.0,Left Lower Outer Quadrant,,Positive,Positive,Other,,-24960.0,788.0,0.0,912.0,,,,2013-2-17,FEMALE,0,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,,240.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,Yes,M0,N1,T1c,Stage IIA,TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566.pdf,A09K,TUMOR FREE,NO,,,NO,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,912.0,0.0,912.0,0.0,912.0,0,912.0
TCGA-A8-A09M-01,Stage IIIC,75.0,457.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,457.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,75.0,Right Lower Outer Quadrant,,Positive,Positive,Other,,-27455.0,333.0,0.0,1006.0,,,,2013-2-17,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,170.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N3a,T2,Stage IIIC,TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591.pdf,A09M,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,1006.0,0.0,1006.0,0.0,1006.0,0,1006.0
TCGA-A8-A09N-01,Stage IIIC,57.0,31.0,Positive,FEMALE,Positive,Negative,M0,Positive,N3,31.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,57.0,Right Lower Outer Quadrant,,Positive,Positive,Other,,-21002.0,1276.0,0.0,31.0,,,,2011-5-27,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,70.0,NO,Positive,Positive,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N3a,T2,Stage IIIC,TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF.pdf,A09N,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumB,0,31.0,0.0,31.0,0.0,31.0,0,31.0
TCGA-A8-A09R-01,Stage IIB,82.0,273.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,273.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,82.0,Left Lower Inner Quadrant,,Positive,Positive,Other,,-30196.0,149.0,0.0,273.0,,,,2013-2-17,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,180.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N1,T2,Stage IIB,TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf,A09R,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumB,0,273.0,0.0,273.0,0.0,273.0,0,273.0
TCGA-A8-A09T-01,Stage X,68.0,578.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,578.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,68.0,Left,,Positive,Positive,Other,,-25110.0,,0.0,579.0,,,,2013-2-17,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,MX,N0,T1c,Stage X,,A09T,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,,LIVING,2009.0,BRCA.LumA,0,579.0,0.0,579.0,0.0,579.0,0,579.0
TCGA-A8-A09V-01,Stage IIA,51.0,457.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,457.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,51.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,-18628.0,333.0,0.0,457.0,,,,2013-2-17,FEMALE,0,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,60.0,NO,Negative,Negative,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090.pdf,A09V,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,457.0,0.0,457.0,0.0,457.0,0,457.0
TCGA-A8-A0A1-01,Stage IIA,84.0,365.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,365.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,84.0,Right,,Positive,Positive,Other,,-30742.0,241.0,0.0,365.0,,,,2011-5-27,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,90.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf,A0A1,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,365.0,0.0,365.0,0.0,365.0,0,365.0
TCGA-A8-A0A2-01,Stage IIA,66.0,578.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,578.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,66.0,Right Lower Outer Quadrant,,Positive,Positive,Other,,-24380.0,394.0,0.0,579.0,,,,2011-5-27,FEMALE,0,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,70.0,NO,Negative,Negative,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE.pdf,A0A2,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,579.0,0.0,579.0,0.0,579.0,0,579.0
TCGA-A8-A0A4-01,Stage IIA,73.0,396.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,396.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,73.0,Left,,Positive,Positive,Other,,-26693.0,272.0,0.0,396.0,,,,2013-2-16,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,160.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9.pdf,A0A4,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,396.0,0.0,396.0,0.0,396.0,0,396.0
TCGA-A8-A0A6-01,Stage IIIC,64.0,640.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,640.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,64.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-23404.0,394.0,0.0,640.0,,,,2013-2-16,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,90.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N3a,T2,Stage IIIC,TCGA-A8-A0A6.161A2735-C3CF-466D-AE21-C6A2C987BB1E.pdf,A0A6,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,640.0,0.0,640.0,0.0,640.0,0,640.0
TCGA-A8-A0A7-01,Stage IIB,57.0,30.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,30.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,57.0,Right Upper Outer Quadrant,,Negative,Negative,Other,,-20940.0,,0.0,30.0,,,,2011-5-27,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,,,Positive,Positive,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,No,M0,N1a,T2,Stage IIB,,A0A7,TUMOR FREE,,,,,Primary Tumor,1,6th,,,LIVING,2009.0,BRCA.Her2,0,30.0,0.0,30.0,0.0,30.0,0,30.0
TCGA-A8-A0A9-01,Stage IIA,80.0,396.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,396.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,80.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-29370.0,272.0,0.0,822.0,,,,2013-2-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf,A0A9,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,822.0,0.0,822.0,0.0,822.0,0,822.0
TCGA-A8-A0AB-01,Stage IIA,54.0,517.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,517.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-19814.0,394.0,0.0,518.0,,,,2013-2-16,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,70.0,NO,Positive,Positive,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-A8-A0AB.E4D30B42-383A-40BF-BB91-511A90227655.pdf,A0AB,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,518.0,0.0,518.0,0.0,518.0,0,518.0
TCGA-A8-A0AD-01,Stage I,83.0,1157.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1157.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,83.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-30407.0,,0.0,1157.0,,,,2013-2-16,FEMALE,1+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,,,,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N0,T1c,Stage I,,A0AD,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,1157.0,0.0,1157.0,0.0,1157.0,0,1157.0
TCGA-AC-A23C-01,,62.0,29.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,29.0,0.0,LumA,,Positive,T_Other,T2,LIVING,62.0,Left,,Positive,Positive,Modified Radical Mastectomy,,-22751.0,198.0,0.0,585.0,NO,90-99%,,2013-5-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Positive,Positive,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf,A23C,TUMOR FREE,YES,YES,50-59%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,585.0,0.0,585.0,0.0,585.0,0,585.0
TCGA-AC-A23E-01,,50.0,72.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,72.0,0.0,LumA,,Positive,T_Other,T2,LIVING,50.0,Right,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,,-18500.0,158.0,0.0,698.0,NO,30-39%,,2013-5-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,,,NO,2.0,Negative,,NO,1.0,,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf,A23E,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,698.0,0.0,698.0,0.0,698.0,0,698.0
TCGA-AC-A23G-01,,,,,,,,,,,,,LumA,,,,,,76.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,-27934.0,1590.0,0.0,2248.0,NO,90-99%,,2013-5-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,40.0,NO,Positive,Positive,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,MX,N1,T1c,Stage IIA,TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf,A23G,TUMOR FREE,YES,YES,80-89%,NO,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,2248.0,0.0,2248.0,0.0,2248.0,0,2248.0
TCGA-AC-A2B8-01,,,,,,,,,,,,,LumA,,,,,,84.0,Right,Axillary lymph node dissection alone,Positive,Positive,Simple Mastectomy,,-31003.0,101.0,0.0,677.0,NO,90-99%,,2013-5-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,0.0,False,No,M0,N0 (i-),T3,Stage IIB,TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf,A2B8,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,677.0,0.0,677.0,0.0,677.0,1,654.0
TCGA-AC-A2BK-01,,,,,,,,,,,,,Basal,,,,,,78.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-28625.0,1717.0,0.0,2222.0,NO,,,2013-6-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,6.0,,False,No,MX,N2a,T2,Stage IIIA,TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf,A2BK,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.Basal,0,2222.0,0.0,2222.0,0.0,2222.0,0,2222.0
TCGA-AC-A2BM-01,,,,,,,,,,,,,LumB,,,,,,41.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-15212.0,2164.0,0.0,3022.0,NO,60-69%,,2014-10-3,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,120.0,NO,,Negative,NO,13.0,Negative,,NO,1.0,1.0,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf,A2BM,TUMOR FREE,NO,YES,10-19%,NO,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumB,0,3022.0,0.0,3022.0,0.0,3022.0,0,3022.0
TCGA-AC-A2FB-01,,,,,,,,,,,,,LumA,,,,,,65.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-23851.0,576.0,0.0,1234.0,NO,90-99%,,2013-7-17,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,Positive,,NO,1.0,Negative,,NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf,A2FB,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,1234.0,0.0,1234.0,0.0,1234.0,0,1234.0
TCGA-AC-A2FB-11,,,,,,,,,,,,,Normal,,,,,,65.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-23851.0,,0.0,1234.0,NO,90-99%,,2013-7-17,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Positive,,NO,1.0,Negative,,NO,0.0,,,No,MX,N0,T2,Stage IIA,,A2FB,TUMOR FREE,YES,YES,<10%,NO,Solid Tissue Normal,11,6th,,,LIVING,2009.0,BRCA.Normal,0,1234.0,0.0,1234.0,0.0,1234.0,0,1234.0
TCGA-AC-A2FE-01,,,,,,,,,,,,,,,,,,,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-22746.0,2228.0,0.0,791.0,,60-69%,,2013-8-28,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,120.0,NO,,,NO,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,18.0,,False,No,MX,N3a,T3,Stage IIIC,TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf,A2FE,WITH TUMOR,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,DECEASED,2005.0,BRCA.LumA,1,2636.0,1.0,2636.0,1.0,766.0,1,766.0
TCGA-AC-A2FF-01,,,,,,,,,,,,,LumA,,,,,,40.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,,1904.0,0.0,2759.0,NO,30-39%,,2014-4-17,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,130.0,NO,,Negative,NO,7.0,Negative,,NO,3.0,0.0,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf,A2FF,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,2759.0,0.0,2759.0,0.0,2759.0,0,2759.0
TCGA-AC-A2FF-11,,,,,,,,,,,,,Normal,,,,,,40.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,,1904.0,0.0,2759.0,NO,30-39%,,2014-4-17,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,80.0,NO,,Negative,NO,7.0,Negative,,NO,3.0,0.0,False,No,MX,N1,T2,Stage IIB,,A2FF,TUMOR FREE,YES,YES,70-79%,YES,Solid Tissue Normal,11,6th,,A,LIVING,2006.0,BRCA.Normal,0,2759.0,0.0,2759.0,0.0,2759.0,0,2759.0
TCGA-AC-A2FG-01,,,,,,,,,,,,,LumA,,,,,,79.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Modified Radical Mastectomy,YES,-29211.0,1517.0,0.0,1853.0,NO,90-99%,,2013-5-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,120.0,NO,,Negative,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,1.0,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf,A2FG,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,1853.0,0.0,1853.0,0.0,1853.0,0,1853.0
TCGA-AC-A2FK-01,,,,,,,,,,,,,Normal,,,,,,45.0,Left Upper Outer Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-16627.0,1833.0,0.0,2650.0,NO,90-99%,,2014-10-3,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,80.0,NO,,Negative,NO,3.0,Negative,,NO,3.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf,A2FK,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.Normal,0,2650.0,0.0,2650.0,0.0,2650.0,0,2650.0
TCGA-AC-A2FM-01,,,,,,,,,,,,,,,,,,,87.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,,Modified Radical Mastectomy,YES,-31805.0,2606.0,0.0,,YES,,,2013-5-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,170.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,0.0,False,No,M0,N1mi,T2,Stage IIB,TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf,A2FM,WITH TUMOR,NO,YES,,NO,Primary Tumor,1,6th,,A,DECEASED,2004.0,BRCA.LumA,1,792.0,1.0,792.0,1.0,780.0,1,780.0
TCGA-AC-A2FM-11,,,,,,,,,,,,,,,,,,,87.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,,,Modified Radical Mastectomy,YES,-31805.0,2733.0,0.0,,YES,,,2013-5-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,220.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,0.0,False,No,M0,N1mi,T2,Stage IIB,,A2FM,WITH TUMOR,NO,YES,,NO,Solid Tissue Normal,11,6th,,B,DECEASED,2004.0,BRCA.Normal,1,792.0,1.0,792.0,1.0,780.0,1,780.0
TCGA-AC-A2FO-01,,,,,,,,,,,,,LumA,,,,,,65.0,Left Upper Outer Quadrant,Other (specify),Positive,Negative,Simple Mastectomy,NO,-23928.0,,0.0,2255.0,NO,90-99%,,2013-5-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,Indeterminate,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,,No,MX,N1,T2,Stage IIB,,A2FO,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,,LIVING,2005.0,BRCA.LumA,0,2255.0,0.0,2255.0,0.0,2255.0,0,2255.0
TCGA-AC-A2QH-01,,,,,,,,,,,,,Basal,,,,,,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,YES,-21488.0,,0.0,1005.0,NO,,,2014-8-26,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,MX,N0,T3,Stage IIB,,A2QH,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,,LIVING,2011.0,BRCA.Basal,0,1005.0,0.0,1005.0,0.0,1005.0,0,1005.0
TCGA-AC-A2QI-01,,,,,,,,,,,,,,,,,,,76.0,Right,Sentinel node biopsy alone,Positive,Negative,Other,,-27865.0,91.0,0.0,588.0,NO,90-99%,,2014-2-28,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf,A2QI,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,588.0,0.0,588.0,0.0,588.0,0,588.0
TCGA-AC-A2QJ-01,,,,,,,,,,,,,,,,,,,48.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Other (specify),Negative,Negative,Other,NO,-17569.0,160.0,0.0,69.0,NO,,,2013-6-28,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),YES,0.0,,False,No,M0,N0,T4b,Stage IIIB,TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf,A2QJ,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,,A,DECEASED,2011.0,BRCA.Basal,1,446.0,1.0,446.0,1.0,237.0,1,237.0
TCGA-AC-A3BB-01,,,,,,,,,,,,,,,,,,,46.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-16983.0,106.0,0.0,987.0,NO,90-99%,,2014-4-29,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,NO,14.0,Negative,,NO,5.0,,False,No,MX,N2a,T3,Stage IIIA,TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf,A3BB,TUMOR FREE,YES,,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,987.0,0.0,987.0,0.0,987.0,0,987.0
TCGA-AC-A3EH-01,,,,,,,,,,,,,,,,,,,79.0,Right,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-29014.0,67.0,0.0,17.0,,,,2014-9-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8022/3,C50.9,YES,Excisional Biopsy,150.0,NO,Negative,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,12.0,,False,No,M0,N3,T3,Stage IIIC,TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf,A3EH,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,DECEASED,2011.0,BRCA.LumA,1,197.0,0.0,197.0,0.0,197.0,0,197.0
TCGA-AC-A3HN-01,,,,,,,,,,,,,LumA,,,,,,87.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-32061.0,97.0,0.0,496.0,NO,90-99%,,2014-9-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf,A3HN,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,496.0,0.0,496.0,0.0,496.0,0,496.0
TCGA-AC-A3OD-01,,,,,,,,,,,,,LumA,,,,,,68.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-25186.0,63.0,0.0,451.0,NO,90-99%,,2013-7-17,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,30.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,MX,N1mi,T2,Stage IIB,TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf,A3OD,TUMOR FREE,NO,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,451.0,0.0,451.0,0.0,451.0,0,451.0
TCGA-AC-A3QP-01,,,,,,,,,,,,,,,,,,,79.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,,-29113.0,184.0,0.0,675.0,NO,70-79%,,2014-1-29,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,150.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,1.0,True,No,MX,N1mi,T2,Stage IIB,TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf,A3QP,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,675.0,0.0,675.0,0.0,675.0,0,675.0
TCGA-AC-A3TM-01,,,,,,,,,,,,,,,,,,,50.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-18535.0,136.0,0.0,762.0,NO,90-99%,,2014-5-31,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,160.0,NO,Equivocal,Equivocal,NO,4.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,2.0,False,No,M0,N1mi,T3,Stage IIIA,TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf,A3TM,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,762.0,0.0,762.0,0.0,762.0,0,762.0
TCGA-AC-A3TN-01,,,,,,,,,,,,,,,,,,,75.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,,-27421.0,78.0,0.0,456.0,NO,90-99%,,2014-5-31,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,"Other method, specify:",140.0,NO,Positive,Indeterminate,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,MX,N0,T3,Stage IIB,TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf,A3TN,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,456.0,0.0,456.0,0.0,456.0,0,456.0
TCGA-AC-A3W6-01,,,,,,,,,,,,,,,,,,,90.0,Right,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,YES,-32872.0,101.0,0.0,602.0,,90-99%,,2014-2-28,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,3.0,False,Yes,MX,N1,T3,Stage IIIA,TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf,A3W6,TUMOR FREE,NO,YES,20-29%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,602.0,0.0,602.0,0.0,602.0,0,602.0
TCGA-AC-A3W7-01,,,,,,,,,,,,,,,,,,,66.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Simple Mastectomy,NO,-24327.0,65.0,0.0,471.0,,90-99%,,2014-3-27,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf,A3W7,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,471.0,0.0,471.0,0.0,471.0,0,471.0
TCGA-AC-A3YI-01,,,,,,,,,,,,,,,,,,,74.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-27143.0,87.0,0.0,707.0,,90-99%,,2014-6-30,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,120.0,NO,Positive,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,12.0,,False,No,MX,N3a,T1c,Stage IIIC,TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf,A3YI,TUMOR FREE,YES,YES,20-29%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Normal,0,707.0,0.0,707.0,0.0,707.0,0,707.0
TCGA-AC-A3YJ-01,,,,,,,,,,,,,,,,,,,66.0,Right,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,YES,-24439.0,114.0,0.0,754.0,,,,2014-5-31,FEMALE,,"Other, specify",No,C50.9,8050/3,C50.9,YES,Core needle biopsy,220.0,NO,,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf,A3YJ,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,754.0,0.0,754.0,0.0,754.0,0,754.0
TCGA-AC-A4ZE-01,,,,,,,,,,,,,,,,,,,63.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-23284.0,169.0,0.0,890.0,,,,2015-6-9,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,180.0,NO,Positive,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T3,Stage IIB,TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf,A4ZE,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,890.0,0.0,890.0,0.0,890.0,0,890.0
TCGA-AC-A5EH-01,,,,,,,,,,,,,,,,,,,76.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-27964.0,,0.0,511.0,,20-29%,,2014-5-31,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,14.0,Negative,,NO,1.0,,,No,MX,N1mi,T2,Stage IIB,,A5EH,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.Her2,0,511.0,0.0,511.0,0.0,511.0,0,511.0
TCGA-AC-A5XS-01,,,,,,,,,,,,,,,,,,,74.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-27160.0,127.0,0.0,588.0,,,,2014-8-26,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,NO,8.0,Negative,,NO,0.0,,False,Yes,MX,N0,T2,Stage IIA,TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf,A5XS,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,588.0,0.0,588.0,0.0,588.0,0,588.0
TCGA-AC-A5XU-01,,,,,,,,,,,,,,,,,,,74.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,,-27191.0,,0.0,455.0,,90-99%,,2014-5-31,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,2.0,Negative,,NO,0.0,,,No,MX,N0 (i-),T3,Stage IIB,,A5XU,TUMOR FREE,YES,YES,60-69%,YES,Primary Tumor,1,7th,,,LIVING,2013.0,BRCA.LumA,0,455.0,0.0,455.0,0.0,455.0,0,455.0
TCGA-AC-A62X-01,,,,,,,,,,,,,,,,,,,72.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-26627.0,70.0,0.0,417.0,,<10%,,2014-8-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,Yes,MX,N0,T2,Stage IIA,TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905.pdf,A62X,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,417.0,0.0,417.0,0.0,417.0,0,417.0
TCGA-AC-A6IV-01,,,,,,,,,,,,,,,,,,,47.0,Right,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,YES,-17521.0,289.0,0.0,568.0,,90-99%,,2014-10-1,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8524/3,C50.9,YES,Core needle biopsy,110.0,NO,Equivocal,,NO,1.0,Negative,,NO,1.0,1.0,False,No,MX,N1,T2,Stage IIB,TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf,A6IV,TUMOR FREE,YES,YES,60-69%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,568.0,0.0,568.0,0.0,568.0,0,568.0
TCGA-AC-A6IW-01,,,,,,,,,,,,,,,,,,,73.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-26896.0,74.0,0.0,413.0,,<10%,,2014-8-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf,A6IW,TUMOR FREE,NO,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,413.0,0.0,413.0,0.0,413.0,0,413.0
TCGA-AC-A6IX-01,,,,,,,,,,,,,,,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-17969.0,107.0,0.0,373.0,,90-99%,,2014-10-1,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,,,NO,21.0,Negative,Peri (6-12 months since last menstrual period),NO,19.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-AC-A6IX.3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1.pdf,A6IX,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,373.0,0.0,373.0,0.0,373.0,0,373.0
TCGA-AC-A6IX-06,,,,,,,,,,,,,,,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-17969.0,107.0,0.0,373.0,,90-99%,,2014-10-1,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,40.0,NO,,,NO,21.0,Negative,Peri (6-12 months since last menstrual period),NO,19.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-AC-A6IX.A92859DA-41AD-4CF9-86AF-E4073E6276ED.pdf,A6IX,TUMOR FREE,YES,YES,<10%,YES,Metastatic,6,7th,,A,LIVING,2013.0,BRCA.LumA,0,373.0,0.0,373.0,0.0,373.0,0,373.0
TCGA-AC-A6NO-01,,,,,,,,,,,,,,,,,,,43.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-15996.0,605.0,0.0,51.0,,,,2014-4-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,150.0,NO,Negative,,,16.0,Negative,,NO,2.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf,A6NO,TUMOR FREE,,YES,,,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,51.0,0.0,51.0,0.0,51.0,0,51.0
TCGA-AC-A7VB-01,,,,,,,,,,,,,,,,,,,51.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Modified Radical Mastectomy,NO,-18806.0,,0.0,250.0,,80-89%,,2014-10-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,,NO,15.0,Negative,,NO,3.0,,,No,MX,N1a,T1c,Stage IIA,,A7VB,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,,LIVING,2013.0,BRCA.LumB,0,250.0,0.0,250.0,0.0,250.0,0,250.0
TCGA-AC-A7VC-01,,,,,,,,,,,,,,,,,,,56.0,Left,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-20479.0,,0.0,1.0,,,,2014-3-29,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Tumor resection,,,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,MX,N0,T3,Stage IIB,,A7VC,TUMOR FREE,,YES,,,Primary Tumor,1,7th,,,LIVING,2013.0,BRCA.Basal,0,1.0,0.0,1.0,0.0,1.0,0,1.0
TCGA-AC-A8OP-01,,,,,,,,,,,,,,,,,,,72.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-26550.0,921.0,0.0,614.0,,90-99%,,2014-10-1,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Indeterminate,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf,A8OP,TUMOR FREE,YES,YES,10-19%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,614.0,0.0,614.0,0.0,614.0,0,614.0
TCGA-AC-A8OQ-01,,,,,,,,,,,,,,,,,,,72.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-26535.0,742.0,0.0,34.0,,,,2014-2-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Indeterminate,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf,A8OQ,TUMOR FREE,,YES,,,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Basal,0,34.0,0.0,34.0,0.0,34.0,0,34.0
TCGA-AC-A8OR-01,,,,,,,,,,,,,,,,,,,75.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-27605.0,98.0,0.0,40.0,,90-99%,,2014-2-26,FEMALE,,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf,A8OR,TUMOR FREE,,YES,90-99%,,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,40.0,0.0,40.0,0.0,40.0,0,40.0
TCGA-AC-A8OS-01,,,,,,,,,,,,,,,,,,,71.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-26248.0,,0.0,70.0,,90-99%,,2014-2-26,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Positive,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,MX,N0 (i-),T2,Stage IIA,,A8OS,TUMOR FREE,,YES,<10%,,Primary Tumor,1,7th,,,LIVING,2013.0,BRCA.LumA,0,70.0,0.0,70.0,0.0,70.0,0,70.0
TCGA-AN-A03X-01,Stage IIA,74.0,10.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,74.0,Left Upper Outer Quadrant,No axillary staging,Positive,Positive,Modified Radical Mastectomy,NO,-27163.0,,0.0,10.0,,,,2014-12-24,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Positive,,YES,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A03X,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A03Y-01,Stage IIA,66.0,10.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,66.0,Left Upper Outer Quadrant,No axillary staging,Positive,Positive,Modified Radical Mastectomy,NO,-24232.0,36.0,0.0,10.0,,,,2014-12-24,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,160.0,NO,Negative,,YES,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-AN-A03Y.76734A82-9137-4DA4-871E-D4EC1BC33831.pdf,A03Y,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumB,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A041-01,Stage IIB,29.0,7.0,Positive,FEMALE,Equivocal,Negative,M0,Positive,N1,7.0,0.0,LumA,Luminal B,Negative,T_Other,T2,LIVING,29.0,Left Upper Outer Quadrant,,Positive,Negative,,,-10812.0,,0.0,7.0,NO,,,2014-12-24,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Positive,,YES,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,,,No,M0,N1a,T2,Stage IIB,,A041,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,,LIVING,2010.0,BRCA.LumA,0,7.0,0.0,7.0,0.0,7.0,0,7.0
TCGA-AN-A046-01,Stage IIA,68.0,10.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,68.0,Right Lower Inner Quadrant,No axillary staging,Positive,Positive,Modified Radical Mastectomy,NO,-25158.0,27.0,0.0,10.0,,,,2014-12-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,150.0,NO,Negative,,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6.pdf,A046,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0AJ-01,Stage IIB,79.0,243.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,243.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,79.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-29131.0,63.0,0.0,303.0,,80-89%,,2014-12-23,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8522/3,C50.9,YES,Tumor resection,310.0,NO,Positive,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T3,Stage IIB,TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700.pdf,A0AJ,TUMOR FREE,NO,,40-49%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumB,0,303.0,0.0,303.0,0.0,303.0,0,303.0
TCGA-AN-A0AK-01,Stage IIA,76.0,223.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,223.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,76.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-27977.0,58.0,0.0,224.0,,80-89%,,2014-12-23,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,290.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417.pdf,A0AK,TUMOR FREE,NO,,<10%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumB,0,224.0,0.0,224.0,0.0,224.0,0,224.0
TCGA-AN-A0AL-01,Stage IIIB,41.0,197.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,197.0,0.0,Basal,Basal-like,Negative,T_Other,T4,LIVING,41.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-15286.0,49.0,0.0,227.0,,<10%,,2014-12-23,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,300.0,NO,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0,T4,Stage IIIB,TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf,A0AL,TUMOR FREE,NO,,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.Basal,0,227.0,0.0,227.0,0.0,227.0,0,227.0
TCGA-AN-A0AM-01,Stage IIA,56.0,5.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,5.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,56.0,Left Upper Outer Quadrant,No axillary staging,Positive,Negative,Modified Radical Mastectomy,NO,-20713.0,47.0,0.0,5.0,,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,350.0,NO,Negative,,YES,20.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7.pdf,A0AM,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumB,0,5.0,0.0,5.0,0.0,5.0,0,5.0
TCGA-AN-A0AR-01,Stage IIA,55.0,9.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,9.0,0.0,,Basal-like,Negative,T_Other,T2,LIVING,55.0,Right Upper Inner Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-20152.0,34.0,0.0,10.0,,,,2014-12-23,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,150.0,NO,Negative,,YES,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38.pdf,A0AR,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.Basal,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0AS-01,Stage IIIA,70.0,9.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,9.0,0.0,LumA,Luminal B,Negative,T_Other,T2,LIVING,70.0,Left Upper Outer Quadrant,No axillary staging,Positive,Negative,Modified Radical Mastectomy,NO,-25658.0,33.0,0.0,10.0,,,,2014-12-23,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,290.0,NO,Negative,,YES,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,4.0,0.0,False,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A.pdf,A0AS,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0AT-01,Stage IIA,62.0,10.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,62.0,Right Upper Inner Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-22798.0,,0.0,10.0,,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A0AT,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,,LIVING,2010.0,BRCA.Basal,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0FD-01,Stage IIA,71.0,195.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,195.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,71.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-26007.0,84.0,0.0,196.0,,80-89%,,2014-12-23,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,260.0,NO,Positive,Positive,YES,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3.pdf,A0FD,TUMOR FREE,NO,,10-19%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,196.0,0.0,196.0,0.0,196.0,0,196.0
TCGA-AN-A0FF-01,Stage IA,32.0,140.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,140.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,32.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-11929.0,75.0,0.0,172.0,,90-99%,,2014-12-23,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,300.0,NO,Negative,,NO,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0,T1b,Stage IA,TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf,A0FF,TUMOR FREE,NO,,90-99%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumB,0,172.0,0.0,172.0,0.0,172.0,0,172.0
TCGA-AN-A0FK-01,Stage IIIB,88.0,212.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,212.0,0.0,LumA,Luminal B,Positive,T_Other,T4,LIVING,88.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-32462.0,69.0,0.0,213.0,,90-99%,,2014-12-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,340.0,NO,Positive,,YES,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T4,Stage IIIB,TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB.pdf,A0FK,TUMOR FREE,NO,,90-99%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,213.0,0.0,213.0,0.0,213.0,0,213.0
TCGA-AN-A0FL-01,Stage IIA,62.0,230.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,230.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,62.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-22805.0,69.0,0.0,231.0,,<10%,,2014-12-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,310.0,NO,Positive,,YES,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf,A0FL,TUMOR FREE,NO,,<10%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.Basal,0,231.0,0.0,231.0,0.0,231.0,0,231.0
TCGA-AN-A0FN-01,Stage IB,61.0,218.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,218.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,61.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22629.0,57.0,0.0,218.0,,90-99%,,2014-12-23,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Positive,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4.pdf,A0FN,TUMOR FREE,NO,,10-19%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,218.0,0.0,218.0,0.0,218.0,0,218.0
TCGA-AN-A0FS-01,Stage IB,55.0,191.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,191.0,0.0,LumA,Luminal A,Negative,T1,T1,LIVING,55.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-20352.0,44.0,0.0,210.0,,90-99%,,2014-12-23,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,170.0,NO,Positive,,YES,14.0,Negative,Peri (6-12 months since last menstrual period),,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf,A0FS,TUMOR FREE,NO,,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,210.0,0.0,210.0,0.0,210.0,0,210.0
TCGA-AN-A0FT-01,Stage IIB,63.0,183.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,183.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,63.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-23300.0,44.0,0.0,214.0,,90-99%,,2014-12-24,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,130.0,NO,Positive,,YES,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,0.0,False,No,M0,N1,T2,Stage IIB,TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769.pdf,A0FT,TUMOR FREE,NO,,90-99%,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,214.0,0.0,214.0,0.0,214.0,0,214.0
TCGA-AN-A0FV-01,Stage IIA,58.0,10.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,10.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,58.0,Right Upper Outer Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-21479.0,42.0,0.0,10.0,,,,2014-12-24,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,180.0,NO,Positive,,YES,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D.pdf,A0FV,TUMOR FREE,NO,,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.Her2,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0FW-01,Stage IIIA,67.0,11.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,11.0,0.0,LumA,Luminal A,Indeterminate,T_Other,T2,LIVING,67.0,Left Upper Outer Quadrant,No axillary staging,Positive,Indeterminate,Modified Radical Mastectomy,NO,-24692.0,41.0,0.0,11.0,,,,2014-12-24,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,180.0,NO,Negative,,YES,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,False,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908.pdf,A0FW,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,11.0,0.0,11.0,0.0,11.0,0,11.0
TCGA-AN-A0FX-01,Stage IIA,52.0,10.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,52.0,Left Upper Outer Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-19309.0,34.0,0.0,10.0,,,,2014-12-24,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,230.0,NO,Positive,,YES,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf,A0FX,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.Basal,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0FY-01,Stage IB,55.0,10.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,55.0,Left Upper Outer Quadrant,No axillary staging,Positive,Positive,Modified Radical Mastectomy,NO,-20347.0,34.0,0.0,10.0,,,,2014-12-24,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,170.0,NO,Negative,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2.pdf,A0FY,TUMOR FREE,NO,,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumB,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0FZ-01,Stage IIIA,45.0,10.0,Positive,FEMALE,Equivocal,Negative,M0,Positive,N2,10.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,45.0,Left Upper Outer Quadrant,No axillary staging,Positive,Negative,Modified Radical Mastectomy,NO,-16533.0,34.0,0.0,10.0,,,,2014-12-24,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,230.0,NO,Positive,,YES,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,0.0,False,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE.pdf,A0FZ,TUMOR FREE,NO,,,NO,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0G0-01,Stage IIA,56.0,16.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,16.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,56.0,Right Upper Inner Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-20504.0,34.0,0.0,16.0,,,,2014-12-24,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,210.0,NO,Negative,,YES,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4.pdf,A0G0,TUMOR FREE,YES,,,YES,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.Basal,0,16.0,0.0,16.0,0.0,16.0,0,16.0
TCGA-AN-A0XL-01,Stage IIA,61.0,10.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,61.0,Left Upper Outer Quadrant,,Positive,Positive,,,-22341.0,169.0,0.0,163.0,NO,,,2014-12-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,130.0,NO,Negative,,YES,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AN-A0XL.A85A959B-F18C-43D3-8BBF-770DA2189462.pdf,A0XL,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,163.0,0.0,163.0,0.0,163.0,0,163.0
TCGA-AN-A0XN-01,Stage IIIA,68.0,10.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,10.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,68.0,Right Upper Inner Quadrant,,Negative,Positive,,,-25029.0,163.0,0.0,10.0,NO,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,180.0,NO,Negative,,YES,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2.pdf,A0XN,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0XO-01,Stage IIIA,59.0,375.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,375.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,59.0,Left Upper Outer Quadrant,,Positive,Negative,,,-21640.0,163.0,0.0,375.0,NO,,,2014-12-23,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,190.0,NO,Negative,,YES,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D.pdf,A0XO,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,375.0,0.0,375.0,0.0,375.0,0,375.0
TCGA-AN-A0XP-01,Stage IIIA,69.0,9.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,9.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,69.0,Right Upper Inner Quadrant,,Positive,Positive,,,-25305.0,162.0,0.0,9.0,NO,,,2014-12-23,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,160.0,NO,Positive,,YES,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XP.80E9B7CE-0D5D-4C01-A8E3-E6345BE145EC.pdf,A0XP,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,9.0,0.0,9.0,0.0,9.0,0,9.0
TCGA-AN-A0XR-01,Stage IIIA,55.0,10.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,10.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,55.0,Left Upper Outer Quadrant,,Positive,Negative,,,-20381.0,155.0,0.0,10.0,NO,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,130.0,NO,Negative,,YES,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,7.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6.pdf,A0XR,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumB,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0XS-01,Stage IIIA,63.0,10.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,10.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,63.0,Left Upper Outer Quadrant,,Negative,Positive,,,-23358.0,120.0,0.0,10.0,NO,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,210.0,NO,Negative,,YES,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8.pdf,A0XS,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0XT-01,Stage IIIA,54.0,10.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,10.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant,,Positive,Negative,,,-19794.0,114.0,0.0,10.0,NO,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,160.0,NO,Negative,,YES,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05.pdf,A0XT,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0XU-01,Stage IIA,54.0,10.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,10.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant,,Negative,Negative,,,-20052.0,106.0,0.0,10.0,NO,,,2014-12-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,180.0,NO,Negative,,YES,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf,A0XU,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.Basal,0,10.0,0.0,10.0,0.0,10.0,0,10.0
TCGA-AN-A0XV-01,Stage IIIA,67.0,162.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,162.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,67.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-24779.0,121.0,0.0,162.0,NO,90-99%,,2014-12-23,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,100.0,NO,Positive,Negative,YES,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,7.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XV.5F626AB6-EEB5-4005-97C5-9E48D9FA7730.pdf,A0XV,TUMOR FREE,NO,YES,30-39%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,162.0,0.0,162.0,0.0,162.0,0,162.0
TCGA-AN-A0XW-01,Stage IIIA,36.0,170.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,170.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,36.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,,NO,-13208.0,121.0,0.0,170.0,NO,90-99%,,2014-12-23,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,270.0,NO,Positive,Negative,YES,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AN-A0XW.5CBC6417-4E3D-4E9C-AE93-A56B777EF2F4.pdf,A0XW,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,170.0,0.0,170.0,0.0,170.0,0,170.0
TCGA-AO-A03L-01,Stage IIIA,34.0,2442.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,2442.0,0.0,LumA,HER2-enriched,Positive,T_Other,T3,LIVING,34.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-12443.0,2456.0,0.0,2442.0,,70-79%,Scheduled Follow-up Submission,2011-12-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,680.0,NO,Positive,Negative,,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,,True,No,M0,N2,T3,Stage IIIA,TCGA-AO-A03L.FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D.pdf,A03L,TUMOR FREE,,,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.LumA,0,2442.0,0.0,2442.0,0.0,2442.0,0,2442.0
TCGA-AO-A03M-01,Stage IA,29.0,1455.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1455.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,29.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-10616.0,,0.0,1866.0,,70-79%,Scheduled Follow-up Submission,2012-4-4,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,,No,M0,N0 (i-),T1c,Stage I,,A03M,TUMOR FREE,,,60-69%,NO,Primary Tumor,1,6th,YES,,LIVING,2006.0,BRCA.LumA,0,1866.0,0.0,1866.0,0.0,1866.0,0,1866.0
TCGA-AO-A03N-01,Stage IIB,59.0,1645.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1645.0,0.0,LumB,HER2-enriched,Positive,T_Other,T2,LIVING,59.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-21816.0,1596.0,0.0,2031.0,,70-79%,Scheduled Follow-up Submission,2012-1-24,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,Negative,,,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-AO-A03N.44527CD3-6EC3-4861-8394-CEA005A17A9E.pdf,A03N,WITH TUMOR,,,<10%,NO,Primary Tumor,1,6th,YES,B,LIVING,2006.0,BRCA.LumB,0,2031.0,0.0,2031.0,1.0,1645.0,1,1645.0
TCGA-AO-A03O-01,Stage IIA,69.0,993.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2483.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,69.0,Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-25362.0,2694.0,0.0,,,,,2010-9-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,690.0,NO,Negative,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A03O.FE9C56C4-B6D4-4054-A58C-13642370052E.pdf,A03O,TUMOR FREE,,,,NO,Primary Tumor,1,,YES,A,DECEASED,2002.0,BRCA.LumB,1,2483.0,0.0,2483.0,0.0,2483.0,0,2483.0
TCGA-AO-A03R-01,Stage IIB,57.0,1707.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1707.0,0.0,Normal,Normal-like,Positive,T_Other,T2,LIVING,57.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-20930.0,1608.0,0.0,2091.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,Negative,,26.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE.pdf,A03R,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2005.0,BRCA.Normal,0,2091.0,0.0,2091.0,0.0,2091.0,0,2091.0
TCGA-AO-A03T-01,Stage IIB,42.0,1187.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1187.0,0.0,Normal,Normal-like,Positive,T_Other,T2,LIVING,42.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-15540.0,1031.0,0.0,2124.0,,90-99%,Scheduled Follow-up Submission,2013-5-22,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-AO-A03T.D5EF8C37-811E-42B7-84E5-E6ED71217971.pdf,A03T,TUMOR FREE,YES,,60-69%,NO,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.Normal,0,2124.0,0.0,2124.0,0.0,2124.0,0,2124.0
TCGA-AO-A03U-01,Stage IA,31.0,1727.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1796.0,1.0,Normal,Normal-like,Negative,T1,T1,DECEASED,31.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-11354.0,3254.0,0.0,,,<10%,Scheduled Follow-up Submission,2012-1-24,FEMALE,0,"Other, specify",No,C50.9,8502/3,C50.9,YES,Core needle biopsy,170.0,NO,Negative,Negative,,8.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-AO-A03U.A8AF94A0-F3C2-4AB0-AB0C-22BDA51AF546.pdf,A03U,TUMOR FREE,,,<10%,NO,Primary Tumor,1,6th,YES,B,DECEASED,2001.0,BRCA.Normal,1,1793.0,0.0,1793.0,0.0,1793.0,1,1614.0
TCGA-AO-A03V-01,Stage IA,41.0,886.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,886.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,41.0,Left Upper Inner Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-15284.0,670.0,0.0,1351.0,,90-99%,Scheduled Follow-up Submission,2012-1-24,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Negative,,,2.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-AO-A03V.63E34973-F630-4295-AC1B-94F81BBEBE41.pdf,A03V,TUMOR FREE,,,80-89%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1351.0,0.0,1351.0,0.0,1351.0,0,1351.0
TCGA-AO-A0J2-01,Stage IA,41.0,585.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,585.0,0.0,Her2,HER2-enriched,Negative,T1,T1,LIVING,41.0,Left Lower Inner Quadrant|Left,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-15324.0,668.0,0.0,997.0,,<10%,Scheduled Follow-up Submission,2011-8-22,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,Equivocal,Negative,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD.pdf,A0J2,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.Her2,0,997.0,0.0,997.0,0.0,997.0,0,997.0
TCGA-AO-A0J3-01,Stage IIB,67.0,302.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,302.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,67.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-24519.0,220.0,0.0,651.0,,<10%,Scheduled Follow-up Submission,2011-8-22,FEMALE,2+,"Other, specify",No,C50.9,8523/3,C50.9,YES,Core needle biopsy,1180.0,NO,Equivocal,Negative,,36.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1b,T2,Stage IIB,TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8.pdf,A0J3,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumB,0,651.0,0.0,651.0,0.0,651.0,0,651.0
TCGA-AO-A0J4-01,Stage IA,41.0,294.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,294.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,41.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-15052.0,224.0,0.0,1587.0,,<10%,Scheduled Follow-up Submission,2011-8-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,Negative,,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62.pdf,A0J4,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Basal,0,1587.0,0.0,1587.0,0.0,1587.0,0,1587.0
TCGA-AO-A0J6-01,Stage IIA,61.0,775.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,775.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,61.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-22462.0,748.0,0.0,1140.0,,<10%,Scheduled Follow-up Submission,2011-8-22,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,390.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271.pdf,A0J6,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.Basal,0,1140.0,0.0,1140.0,0.0,1140.0,0,1140.0
TCGA-AO-A0J7-01,Stage IIB,71.0,260.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,260.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,71.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-26281.0,177.0,0.0,618.0,,90-99%,,2011-8-22,FEMALE,1+,"Other, specify",No,C50.9,8523/3,C50.9,YES,Core needle biopsy,300.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-AO-A0J7.4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE.pdf,A0J7,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumB,0,618.0,0.0,618.0,0.0,618.0,0,618.0
TCGA-AO-A0J8-01,Stage IIA,61.0,277.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,277.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,61.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-22284.0,241.0,0.0,680.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,670.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08.pdf,A0J8,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,680.0,0.0,680.0,0.0,680.0,0,680.0
TCGA-AO-A0J9-01,Stage IIIC,61.0,1255.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,1255.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,61.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-22642.0,1207.0,0.0,1613.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,430.0,NO,,Negative,,32.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,15.0,0.0,True,No,M0,N3,T2,Stage IIIC,TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD.pdf,A0J9,WITH TUMOR,,,30-39%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,1613.0,0.0,1613.0,1.0,1066.0,1,1066.0
TCGA-AO-A0JA-01,Stage IIIC,36.0,346.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,346.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,36.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-13307.0,,0.0,655.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,11.0,,,No,M0,N3,T2,Stage IIIC,,A0JA,WITH TUMOR,,,<10%,NO,Primary Tumor,1,,YES,,LIVING,2009.0,BRCA.LumA,0,655.0,0.0,655.0,1.0,143.0,1,143.0
TCGA-AO-A0JB-01,Stage IIIA,50.0,1150.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1150.0,0.0,,Normal-like,Positive,T_Other,T3,LIVING,50.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-18561.0,,0.0,1542.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,,No,M0,N1a,T3,Stage IIIA,,A0JB,TUMOR FREE,,,60-69%,YES,Primary Tumor,1,,YES,,LIVING,2007.0,BRCA.Normal,0,1542.0,0.0,1542.0,0.0,1542.0,0,1542.0
TCGA-AO-A0JC-01,Stage IIA,64.0,1547.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1547.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,64.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-23404.0,1522.0,0.0,1547.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,550.0,NO,Negative,,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A0JC.A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B.pdf,A0JC,TUMOR FREE,,,50-59%,YES,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.LumA,0,1547.0,0.0,1547.0,0.0,1547.0,0,1547.0
TCGA-AO-A0JD-01,Stage IIIA,59.0,1813.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1813.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,59.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-21831.0,1863.0,0.0,2190.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,230.0,NO,Negative,Negative,,27.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,True,No,M0,N1a,T3,Stage IIIA,TCGA-AO-A0JD.E8A43FF3-3D98-45EE-9567-6EED4DA38274.pdf,A0JD,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,A,LIVING,2005.0,BRCA.LumB,0,2190.0,0.0,2190.0,0.0,2190.0,0,2190.0
TCGA-AO-A0JF-01,Stage IIA,68.0,354.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,354.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,68.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-24923.0,273.0,0.0,1980.0,,90-99%,Scheduled Follow-up Submission,2015-4-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,410.0,NO,Negative,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-AO-A0JF.D58E5D64-B5B9-4487-8E46-225AE3617C14.pdf,A0JF,TUMOR FREE,YES,,70-79%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,1980.0,0.0,1980.0,0.0,1980.0,0,1980.0
TCGA-AO-A0JI-01,Stage IIA,56.0,1172.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1172.0,0.0,LumA,Luminal B,Negative,T1,T1,LIVING,56.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Modified Radical Mastectomy,YES,-20694.0,,0.0,1528.0,,90-99%,Scheduled Follow-up Submission,2011-12-12,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,,No,M0,N1,T1c,Stage IIA,,A0JI,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,,LIVING,2007.0,BRCA.LumA,0,1528.0,0.0,1528.0,0.0,1528.0,0,1528.0
TCGA-AO-A0JJ-01,Stage IIB,54.0,1512.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1512.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-19758.0,,0.0,1887.0,,90-99%,Scheduled Follow-up Submission,2011-8-22,FEMALE,0,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,,44.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,,No,M0,N1a,T2,Stage IIB,,A0JJ,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,,YES,,LIVING,2006.0,BRCA.LumA,0,1887.0,0.0,1887.0,0.0,1887.0,0,1887.0
TCGA-AO-A0JL-01,Stage IIIA,59.0,1319.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,1319.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,59.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-21895.0,1332.0,0.0,1683.0,,<10%,Scheduled Follow-up Submission,2011-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,380.0,NO,Negative,Positive,,26.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,7.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722.pdf,A0JL,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.Basal,0,1683.0,0.0,1683.0,0.0,1683.0,0,1683.0
TCGA-AO-A0JM-01,Stage IIB,40.0,1826.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1826.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,40.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-14653.0,1828.0,0.0,2184.0,,90-99%,,2011-8-22,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,710.0,NO,Positive,Positive,,23.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05.pdf,A0JM,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2005.0,BRCA.LumB,0,2184.0,0.0,2184.0,0.0,2184.0,0,2184.0
TCGA-AO-A124-01,Stage IIA,38.0,3119.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,3119.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,38.0,Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Modified Radical Mastectomy,YES,-14174.0,3213.0,0.0,3506.0,,<10%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,"Other, specify",No,C50.9,8523/3,C50.9,YES,Core needle biopsy,730.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A.pdf,A124,TUMOR FREE,,,<10%,NO,Primary Tumor,1,5th,YES,A,LIVING,2002.0,BRCA.Basal,0,3506.0,0.0,3506.0,0.0,3506.0,0,3506.0
TCGA-AO-A125-01,Stage IIA,72.0,3018.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3018.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,72.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-26466.0,3193.0,0.0,3456.0,,50-59%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,"Other, specify",No,C50.9,8050/3,C50.9,YES,Core needle biopsy,90.0,NO,Negative,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872.pdf,A125,TUMOR FREE,,,90-99%,NO,Primary Tumor,1,5th,YES,A,LIVING,2002.0,BRCA.LumA,0,3456.0,0.0,3456.0,0.0,3456.0,0,3456.0
TCGA-AO-A126-01,Stage IIA,39.0,2850.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2850.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,39.0,Right Upper Inner Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-14264.0,3033.0,0.0,3307.0,,20-29%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,450.0,NO,Negative,Negative,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A126.A4BFA94D-166F-43D4-90B5-3C547F4026A0.pdf,A126,TUMOR FREE,,,60-69%,YES,Primary Tumor,1,,YES,A,LIVING,2002.0,BRCA.LumA,0,3307.0,0.0,3307.0,1.0,267.0,1,267.0
TCGA-AO-A128-01,Stage IIA,61.0,2877.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,2877.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,61.0,Right Lower Outer Quadrant|Right,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-22340.0,2960.0,0.0,3248.0,,<10%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,590.0,NO,Negative,Negative,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf,A128,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2002.0,BRCA.Basal,0,3248.0,0.0,3248.0,0.0,3248.0,0,3248.0
TCGA-AO-A129-01,Stage IIB,29.0,2923.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,2923.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,29.0,Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-10898.0,2915.0,0.0,3286.0,,<10%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,320.0,NO,Negative,Negative,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B.pdf,A129,TUMOR FREE,,,<10%,YES,Primary Tumor,1,5th,YES,A,LIVING,2002.0,BRCA.Basal,0,3286.0,0.0,3286.0,0.0,3286.0,0,3286.0
TCGA-AO-A12B-01,Stage IIA,63.0,2359.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2359.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,63.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-23150.0,2365.0,0.0,2989.0,,90-99%,Scheduled Follow-up Submission,2013-5-22,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,570.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F.pdf,A12B,TUMOR FREE,YES,,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.LumA,0,2989.0,0.0,2989.0,0.0,2989.0,0,2989.0
TCGA-AO-A12C-01,Stage IIB,42.0,1993.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1993.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,42.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-15469.0,2086.0,0.0,2372.0,,90-99%,Scheduled Follow-up Submission,2011-12-12,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,350.0,NO,Positive,Negative,,31.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-AO-A12C.7E9202F6-F2DB-4CC0-A10F-3D9A82E84242.pdf,A12C,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.LumA,0,2372.0,0.0,2372.0,0.0,2372.0,0,2372.0
TCGA-AO-A12D-01,Stage IIA,43.0,1948.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,1948.0,0.0,Her2,HER2-enriched,Negative,T1,T1,LIVING,43.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Modified Radical Mastectomy,YES,-15774.0,1948.0,0.0,2515.0,,<10%,Scheduled Follow-up Submission,2013-5-21,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,750.0,NO,Positive,Positive,NO,16.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-AO-A12D.9363D53D-BC3B-4AC0-8185-536C6DB3A6AE.pdf,A12D,TUMOR FREE,YES,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.Her2,0,2515.0,0.0,2515.0,0.0,2515.0,0,2515.0
TCGA-AO-A12E-01,Stage IIB,51.0,1742.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1742.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,51.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-18721.0,1822.0,0.0,2142.0,,80-89%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,630.0,NO,Negative,,,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,1.0,True,No,M0,N0 (i+),T3,Stage IIB,TCGA-AO-A12E.332675C9-53CB-4244-8480-82E1546DA7F2.pdf,A12E,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.LumA,0,2142.0,0.0,2142.0,0.0,2142.0,0,2142.0
TCGA-AO-A12F-01,Stage IIA,36.0,1471.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1471.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,36.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-13409.0,1578.0,0.0,1842.0,,<10%,Scheduled Follow-up Submission,2011-12-12,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,600.0,NO,Negative,,,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51.pdf,A12F,TUMOR FREE,,,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Basal,0,1842.0,0.0,1842.0,0.0,1842.0,0,1842.0
TCGA-AO-A12G-01,Stage IIA,75.0,1265.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1265.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,75.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-27705.0,1415.0,0.0,1639.0,,90-99%,Scheduled Follow-up Submission,2011-6-16,FEMALE,2+,"Other, specify",No,C50.9,8022/3,C50.9,YES,Core needle biopsy,280.0,NO,Positive,Negative,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F.pdf,A12G,TUMOR FREE,,,30-39%,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumA,0,1639.0,0.0,1639.0,0.0,1639.0,0,1639.0
TCGA-AO-A12H-01,Stage IIA,69.0,862.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,862.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,69.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-25515.0,1017.0,0.0,1234.0,,90-99%,Scheduled Follow-up Submission,2011-12-12,FEMALE,0,"Other, specify",No,C50.9,8523/3,C50.9,YES,Core needle biopsy,290.0,NO,Negative,,,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B.pdf,A12H,TUMOR FREE,,,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1234.0,0.0,1234.0,0.0,1234.0,0,1234.0
TCGA-AO-A1KO-01,Stage IIB,46.0,448.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,448.0,0.0,Normal,,Positive,T_Other,T3,LIVING,46.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-16817.0,832.0,0.0,622.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-20,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Excisional Biopsy,580.0,NO,Negative,,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,1.0,True,No,M0,N0 (i+),T3,Stage IIB,TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf,A1KO,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Normal,0,622.0,0.0,622.0,0.0,622.0,0,622.0
TCGA-AO-A1KP-01,Stage IIA,77.0,2513.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2513.0,0.0,LumB,,Positive,T1,T1,LIVING,77.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-28247.0,2604.0,0.0,2953.0,NO,80-89%,Scheduled Follow-up Submission,2012-2-20,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,Negative,Negative,,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,No,M0,N1,T1,Stage IIA,TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf,A1KP,TUMOR FREE,,YES,40-49%,NO,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.LumB,0,2953.0,0.0,2953.0,0.0,2953.0,0,2953.0
TCGA-AO-A1KQ-01,Stage IIIB,84.0,1519.0,Positive,MALE,Negative,Negative,M0,Positive,N1,1519.0,0.0,LumB,,Positive,T_Other,T4,LIVING,84.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-30859.0,1553.0,0.0,1882.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-20,MALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,540.0,NO,Negative,,,9.0,Negative,,NO,2.0,0.0,True,No,M0,N1,T4,Stage IIIB,TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf,A1KQ,TUMOR FREE,,YES,80-89%,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,1882.0,0.0,1882.0,0.0,1882.0,0,1882.0
TCGA-AO-A1KR-01,,51.0,2140.0,Negative,FEMALE,,,,,,2140.0,0.0,Basal,,Negative,,,LIVING,51.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-18900.0,1932.0,0.0,2513.0,NO,,Scheduled Follow-up Submission,2013-5-21,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,Negative,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf,A1KR,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.Basal,0,2513.0,0.0,2513.0,0.0,2513.0,0,2513.0
TCGA-AO-A1KS-01,Stage IIA,69.0,16.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,16.0,0.0,LumB,,Positive,T_Other,T2,LIVING,69.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-25230.0,147.0,0.0,350.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-20,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,420.0,NO,Equivocal,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf,A1KS,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,350.0,0.0,350.0,0.0,350.0,0,350.0
TCGA-AO-A1KT-01,Stage IIA,78.0,541.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,541.0,0.0,LumB,,Positive,T1,T1,LIVING,78.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-28660.0,617.0,0.0,541.0,NO,90-99%,,2011-4-1,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,1.0,True,[Discrepancy],M0,N1,T1,Stage IIA,TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf,A1KT,TUMOR FREE,,YES,40-49%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,541.0,0.0,541.0,0.0,541.0,0,541.0
TCGA-AQ-A04H-01,Stage IIIA,61.0,439.0,Positive,FEMALE,Positive,,,Positive,N2,439.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,61.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22539.0,,0.0,754.0,,90-99%,,2012-9-24,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Indeterminate,Positive,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,,No,MX,N2a,T2,Stage IIIA,,A04H,TUMOR FREE,YES,,20-29%,YES,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumB,0,754.0,0.0,754.0,0.0,754.0,0,754.0
TCGA-AQ-A04J-01,Stage IIA,45.0,499.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,499.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,45.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Simple Mastectomy,NO,-16615.0,118.0,0.0,819.0,,<10%,Scheduled Follow-up Submission,2012-2-20,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,,20.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0 (i+),T2,Stage IIA,TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf,A04J,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Basal,0,819.0,0.0,819.0,0.0,819.0,0,819.0
TCGA-AQ-A04L-01,Stage IIA,48.0,3344.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,3344.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,48.0,Right,Sentinel node biopsy alone,Positive,Negative,Modified Radical Mastectomy,NO,-17759.0,3403.0,0.0,3957.0,,60-69%,,2012-9-24,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,160.0,NO,Positive,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-AQ-A04L.40B58A7A-2A05-4AAF-B1D4-B418E4A56115.pdf,A04L,TUMOR FREE,YES,,,NO,Primary Tumor,1,5th,YES,B,LIVING,2001.0,BRCA.LumA,0,3957.0,0.0,3957.0,0.0,3957.0,0,3957.0
TCGA-AQ-A0Y5-01,Stage IIIA,70.0,,Positive,FEMALE,Positive,Negative,M0,Positive,N2,161.0,1.0,LumA,,Positive,T_Other,T2,DECEASED,70.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-25793.0,212.0,0.0,,NO,70-79%,,2011-4-7,FEMALE,2+,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Positive,Positive,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,5.0,,False,Yes,MX,N2a,T2,Stage IIIA,TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf,A0Y5,TUMOR FREE,,YES,40-49%,NO,Primary Tumor,1,7th,YES,A,DECEASED,2010.0,BRCA.LumA,1,172.0,0.0,172.0,0.0,172.0,0,172.0
TCGA-AQ-A1H2-01,Stage IIIA,84.0,197.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,197.0,0.0,LumA,,Positive,T_Other,T2,LIVING,84.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-30958.0,156.0,0.0,475.0,NO,90-99%,Scheduled Follow-up Submission,2012-1-3,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Indeterminate,Positive,,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,13.0,,False,No,MX,N2a,T2,Stage IIIA,TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf,A1H2,TUMOR FREE,,YES,10-19%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,475.0,0.0,475.0,0.0,475.0,0,475.0
TCGA-AQ-A1H3-01,Stage IIIC,49.0,138.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,138.0,0.0,LumA,,Positive,T_Other,T2,LIVING,49.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-18177.0,94.0,0.0,989.0,NO,90-99%,Scheduled Follow-up Submission,2013-10-28,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,300.0,NO,Negative,,NO,23.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,14.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf,A1H3,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,989.0,0.0,989.0,0.0,989.0,0,989.0
TCGA-AQ-A54N-01,,,,,,,,,,,,,,,,,,,51.0,Left Lower Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-18741.0,639.0,0.0,78.0,,,,2014-1-14,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,Equivocal,Negative,YES,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,Yes,M0,N0,T2,Stage IIA,TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf,A54N,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Basal,0,78.0,0.0,78.0,0.0,78.0,0,78.0
TCGA-AQ-A54O-01,,,,,,,,,,,,,,,,,,,51.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-18694.0,617.0,0.0,1001.0,,90-99%,,2014-1-14,MALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,360.0,NO,Negative,,NO,14.0,Negative,,NO,0.0,0.0,False,Yes,M0,N0,T2,Stage IIA,TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf,A54O,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumB,0,1001.0,0.0,1001.0,0.0,1001.0,0,1001.0
TCGA-AQ-A7U7-01,,,,,,,,,,,,,,,,,,,55.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-20239.0,223.0,0.0,304.0,,80-89%,,2014-12-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,NO,Negative,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,0.0,False,Yes,M0,N2a,T2,Stage IIIA,TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf,A7U7,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,DECEASED,2013.0,BRCA.LumA,1,584.0,0.0,584.0,0.0,584.0,0,584.0
TCGA-AR-A0TP-01,Stage II,43.0,2392.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2392.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,43.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,YES,-15812.0,,0.0,4275.0,,<10%,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A0TP,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,YES,,LIVING,2003.0,BRCA.Basal,0,4275.0,0.0,4275.0,0.0,4275.0,0,4275.0
TCGA-AR-A0TQ-01,Stage III,27.0,1500.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1500.0,0.0,LumB,Luminal B,Negative,T_Other,T3,LIVING,27.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Simple Mastectomy,NO,-9873.0,1512.0,0.0,2991.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,750.0,NO,Equivocal,Positive,NO,15.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1,T3,Stage IIIA,TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E.pdf,A0TQ,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,2991.0,0.0,2991.0,0.0,2991.0,0,2991.0
TCGA-AR-A0TR-01,Stage II,68.0,21.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,160.0,1.0,LumA,Luminal A,Positive,T_Other,T2,DECEASED,68.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-25190.0,1535.0,0.0,,,,Scheduled Follow-up Submission,2011-12-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",520.0,NO,Equivocal,Negative,,27.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF.pdf,A0TR,,,,,NO,Primary Tumor,1,,YES,A,DECEASED,2006.0,BRCA.LumA,1,160.0,,160.0,0.0,160.0,0,160.0
TCGA-AR-A0TS-01,Stage II,46.0,1138.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1138.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,46.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-17141.0,1549.0,0.0,2558.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,Negative,,NO,16.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf,A0TS,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Basal,0,2558.0,0.0,2558.0,0.0,2558.0,0,2558.0
TCGA-AR-A0TT-01,Stage III,53.0,1679.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1679.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,53.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,,-19679.0,1567.0,0.0,3316.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,310.0,NO,Negative,,NO,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,5.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A0TT.E9231B33-E1CE-4396-9F9E-03DBF049919A.pdf,A0TT,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,3316.0,0.0,3316.0,0.0,3316.0,0,3316.0
TCGA-AR-A0TU-01,Stage II,35.0,360.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,360.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,35.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,YES,-13039.0,1633.0,0.0,709.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,830.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3.pdf,A0TU,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Basal,0,709.0,0.0,709.0,0.0,709.0,0,709.0
TCGA-AR-A0TV-01,Stage II,66.0,904.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,904.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,66.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-24279.0,1716.0,0.0,2288.0,,90-99%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,550.0,NO,Equivocal,Negative,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A0TV.7594A7F8-1806-4B74-99EF-4E4C889E7BEA.pdf,A0TV,TUMOR FREE,NO,,,NO,Primary Tumor,1,6th,NO,A,LIVING,2005.0,BRCA.LumB,0,2288.0,0.0,2288.0,0.0,2288.0,0,2288.0
TCGA-AR-A0TW-01,Stage III,50.0,739.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,739.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,50.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-18263.0,,0.0,3009.0,,,Scheduled Follow-up Submission,2013-10-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,,27.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,,No,M0,N1,T3,Stage IIIA,,A0TW,TUMOR FREE,YES,,,NO,Primary Tumor,1,,YES,,LIVING,2005.0,BRCA.LumA,0,3009.0,0.0,3009.0,1.0,739.0,1,739.0
TCGA-AR-A0TX-01,Stage II,64.0,15.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,15.0,0.0,Her2,HER2-enriched,Positive,T1,T1,LIVING,64.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-23653.0,1976.0,0.0,1972.0,,<10%,Scheduled Follow-up Submission,2014-8-21,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,470.0,NO,Positive,,NO,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N1,T1,Stage IIA,TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8.pdf,A0TX,TUMOR FREE,,,,YES,Primary Tumor,1,,,A,LIVING,2005.0,BRCA.Her2,0,1972.0,0.0,1972.0,0.0,1972.0,0,1972.0
TCGA-AR-A0TY-01,Stage II,54.0,544.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1699.0,1.0,LumB,Luminal B,Negative,T_Other,T2,DECEASED,54.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,YES,-19836.0,2141.0,0.0,,,10-19%,Scheduled Follow-up Submission,2011-12-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,410.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3.pdf,A0TY,WITH TUMOR,,,,NO,Primary Tumor,1,,YES,A,DECEASED,2004.0,BRCA.LumB,1,1699.0,1.0,1699.0,1.0,544.0,1,544.0
TCGA-AR-A0TZ-01,Stage III,43.0,1313.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1313.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,43.0,Left Upper Outer Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-15720.0,2239.0,0.0,2316.0,,,Scheduled Follow-up Submission,2013-10-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,290.0,NO,Equivocal,Negative,NO,30.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,6.0,,True,No,M1,N2,T2,Stage IIIA,TCGA-AR-A0TZ.48F86416-8304-479E-B477-7C37A2F951A2.pdf,A0TZ,,YES,,,YES,Primary Tumor,1,,YES,A,DECEASED,2004.0,BRCA.LumA,1,3262.0,,3262.0,1.0,1313.0,1,1313.0
TCGA-AR-A0U0-01,Stage II,73.0,8.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,8.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,73.0,Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,YES,-26993.0,2289.0,0.0,1988.0,,,Scheduled Follow-up Submission,2014-9-18,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,370.0,NO,,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,2.0,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A.pdf,A0U0,TUMOR FREE,,,,YES,Primary Tumor,1,,,A,LIVING,2004.0,BRCA.Basal,0,1988.0,0.0,1988.0,0.0,1988.0,0,1988.0
TCGA-AR-A0U1-01,Stage II,36.0,185.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,185.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,36.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,NO,-13467.0,2301.0,0.0,4052.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,300.0,NO,Negative,,NO,31.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A0U1.007C609A-7874-4E39-BC4D-1EA81F4722EA.pdf,A0U1,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.Basal,0,4052.0,0.0,4052.0,0.0,4052.0,0,4052.0
TCGA-AR-A0U2-01,Stage III,47.0,1608.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,2551.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,47.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-17390.0,2395.0,0.0,,,10-19%,Scheduled Follow-up Submission,2011-12-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,150.0,NO,Negative,,,16.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,4.0,0.0,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F.pdf,A0U2,WITH TUMOR,,,,YES,Primary Tumor,1,,YES,A,DECEASED,2004.0,BRCA.LumB,1,2551.0,1.0,2551.0,1.0,1609.0,1,1609.0
TCGA-AR-A0U3-01,Stage II,59.0,2263.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2263.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,59.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-21755.0,,0.0,4080.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,,No,M0,N1,T2,Stage IIB,,A0U3,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,YES,,LIVING,2004.0,BRCA.LumA,0,4080.0,0.0,4080.0,0.0,4080.0,0,4080.0
TCGA-AR-A0U4-01,Stage II,54.0,1627.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1627.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,NO,-19729.0,,0.0,3261.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A0U4,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,YES,,LIVING,2006.0,BRCA.Basal,0,3261.0,0.0,3261.0,0.0,3261.0,0,3261.0
TCGA-AR-A1AH-01,Stage II,51.0,2298.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2298.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,51.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Negative,Other,,-18991.0,2368.0,0.0,3807.0,,10-19%,Scheduled Follow-up Submission,2014-12-31,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf,A1AH,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.Basal,0,3807.0,0.0,3807.0,0.0,3807.0,1,1136.0
TCGA-AR-A1AI-01,Stage II,47.0,1881.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1881.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,47.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,YES,-17229.0,1939.0,0.0,3296.0,,,Scheduled Follow-up Submission,2014-12-31,FEMALE,2+,Medullary Carcinoma,No,C50.9,8510/3,C50.9,YES,Fine needle aspiration biopsy,1050.0,NO,Equivocal,Negative,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf,A1AI,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.Basal,0,3296.0,0.0,3296.0,1.0,588.0,1,588.0
TCGA-AR-A1AJ-01,Stage I,83.0,1604.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1604.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,83.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,YES,-30489.0,1828.0,0.0,3072.0,,10-19%,Scheduled Follow-up Submission,2014-12-31,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf,A1AJ,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,NO,A,LIVING,2005.0,BRCA.Basal,0,3072.0,0.0,3072.0,0.0,3072.0,0,3072.0
TCGA-AR-A1AK-01,Stage I,70.0,1558.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1558.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,70.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-25825.0,,0.0,3159.0,,10-19%,Scheduled Follow-up Submission,2014-12-31,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1,Stage I,,A1AK,TUMOR FREE,YES,YES,10-19%,NO,Primary Tumor,1,6th,YES,,LIVING,2006.0,BRCA.LumA,0,3159.0,0.0,3159.0,0.0,3159.0,0,3159.0
TCGA-AR-A1AL-01,Stage III,60.0,1485.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1485.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,60.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-22023.0,1528.0,0.0,2971.0,,70-79%,Scheduled Follow-up Submission,2014-12-31,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,630.0,NO,Negative,,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N1,T3,Stage IIIA,TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf,A1AL,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumA,0,2971.0,0.0,2971.0,0.0,2971.0,0,2971.0
TCGA-AR-A1AM-01,,,,,,,,,,,,,,,,,,,52.0,Right Upper Outer Quadrant,,Positive,Positive,Simple Mastectomy,,-19123.0,,0.0,2991.0,,,,2015-3-30,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,,No,M0,N1,T3,Stage IIIA,,A1AM,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,,LIVING,2006.0,BRCA.LumA,0,2991.0,0.0,2991.0,0.0,2991.0,0,2991.0
TCGA-AR-A1AN-01,Stage II,46.0,1329.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1329.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,46.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-16974.0,1463.0,0.0,2920.0,,70-79%,Scheduled Follow-up Submission,2014-12-31,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf,A1AN,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumA,0,2920.0,0.0,2920.0,0.0,2920.0,0,2920.0
TCGA-AR-A1AO-01,Stage II,47.0,1324.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1324.0,0.0,Normal,Normal-like,Negative,T1,T1,LIVING,47.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,YES,-17332.0,1471.0,0.0,2618.0,,,Scheduled Follow-up Submission,2014-12-31,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,NO,39.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1,T1,Stage IIA,TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf,A1AO,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Normal,0,2618.0,0.0,2618.0,0.0,2618.0,0,2618.0
TCGA-AR-A1AP-01,Stage I,80.0,1215.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1215.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,80.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-29406.0,1450.0,0.0,2856.0,,70-79%,Scheduled Follow-up Submission,2014-12-31,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,310.0,NO,Equivocal,Negative,NO,1.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf,A1AP,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,2856.0,0.0,2856.0,0.0,2856.0,0,2856.0
TCGA-AR-A1AQ-01,Stage II,49.0,1309.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1309.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,49.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,YES,-18109.0,1424.0,0.0,3021.0,,,Scheduled Follow-up Submission,2014-12-31,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,180.0,NO,Equivocal,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf,A1AQ,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.Basal,0,3021.0,0.0,3021.0,0.0,3021.0,0,3021.0
TCGA-AR-A1AR-01,Stage III,50.0,,Negative,FEMALE,Negative,Negative,M0,Positive,N2,523.0,1.0,Basal,Basal-like,Negative,T1,T1,DECEASED,50.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,,-18482.0,1416.0,0.0,,,,Additional New Tumor Event,2012-2-27,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,5.0,,True,Yes,M0,N2,T1,Stage IIIA,TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf,A1AR,WITH TUMOR,,,,YES,Primary Tumor,1,6th,YES,A,DECEASED,2007.0,BRCA.Basal,1,524.0,1.0,524.0,1.0,268.0,1,268.0
TCGA-AR-A1AS-01,Stage II,54.0,1242.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1242.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,54.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Other,,-20028.0,1331.0,0.0,1150.0,,70-79%,Scheduled Follow-up Submission,2013-10-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,300.0,NO,Negative,,NO,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf,A1AS,TUMOR FREE,NO,YES,70-79%,YES,Primary Tumor,1,6th,NO,A,LIVING,2007.0,BRCA.LumA,0,1150.0,0.0,1150.0,0.0,1150.0,0,1150.0
TCGA-AR-A1AT-01,Stage II,62.0,,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1272.0,1.0,,HER2-enriched,Positive,T_Other,T2,DECEASED,62.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-22942.0,1339.0,0.0,,,<10%,Scheduled Follow-up Submission,2012-3-1,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,250.0,NO,Positive,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67.pdf,A1AT,,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,DECEASED,2007.0,BRCA.Her2,1,1272.0,,1272.0,0.0,1272.0,0,1272.0
TCGA-AR-A1AU-01,Stage III,39.0,1409.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1409.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,39.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-14564.0,1317.0,0.0,2868.0,,70-79%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,Equivocal,Negative,NO,37.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf,A1AU,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,2868.0,0.0,2868.0,0.0,2868.0,0,2868.0
TCGA-AR-A1AV-01,Stage II,68.0,1295.0,Positive,MALE,Negative,Negative,M0,Positive,N1,1295.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,68.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-24875.0,1233.0,0.0,1864.0,,70-79%,Scheduled Follow-up Submission,2013-10-2,MALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,420.0,NO,Negative,,NO,25.0,Negative,,NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf,A1AV,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,1864.0,0.0,1864.0,0.0,1864.0,0,1864.0
TCGA-AR-A1AW-01,Stage II,65.0,1072.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1072.0,0.0,LumB,Luminal A,Positive,T_Other,T2,LIVING,65.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-23855.0,1157.0,0.0,2632.0,,70-79%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,800.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf,A1AW,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumB,0,2632.0,0.0,2632.0,0.0,2632.0,0,2632.0
TCGA-AR-A1AX-01,Stage I,64.0,1103.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1103.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,64.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-23507.0,1140.0,0.0,2629.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,340.0,NO,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf,A1AX,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,2629.0,0.0,2629.0,0.0,2629.0,0,2629.0
TCGA-AR-A1AY-01,Stage I,65.0,614.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,614.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,65.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,YES,-23927.0,1085.0,0.0,1026.0,,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf,A1AY,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Basal,0,1026.0,0.0,1026.0,0.0,1026.0,0,1026.0
TCGA-AR-A24H-01,Stage II,65.0,3333.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3333.0,0.0,LumB,,Positive,T_Other,T2,LIVING,65.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-24046.0,,0.0,4894.0,,,Scheduled Follow-up Submission,2014-9-30,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A24H,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,5th,YES,,LIVING,2001.0,BRCA.LumB,0,4894.0,0.0,4894.0,0.0,4894.0,0,4894.0
TCGA-AR-A24K-01,Stage II,46.0,1548.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1548.0,0.0,LumB,,Positive,T_Other,T2,LIVING,46.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-16961.0,2325.0,0.0,1548.0,,10-19%,Scheduled Follow-up Submission,2013-10-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf,A24K,TUMOR FREE,YES,YES,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.LumB,0,1548.0,0.0,1548.0,0.0,1548.0,0,1548.0
TCGA-AR-A24L-01,Stage II,26.0,2221.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2221.0,0.0,LumA,,Positive,T_Other,T2,LIVING,26.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-9706.0,,0.0,2221.0,,10-19%,Scheduled Follow-up Submission,2013-10-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,2.0,,,No,M0,N1,T2,Stage IIB,,A24L,WITH TUMOR,YES,YES,10-19%,YES,Primary Tumor,1,6th,YES,,DECEASED,2005.0,BRCA.LumA,1,2866.0,1.0,2866.0,1.0,1414.0,1,1414.0
TCGA-AR-A24M-01,Stage III,38.0,1990.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1990.0,0.0,LumA,,Positive,T_Other,T2,LIVING,38.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-14119.0,2245.0,0.0,3660.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,400.0,NO,Negative,,NO,28.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf,A24M,TUMOR FREE,YES,YES,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.LumA,0,3660.0,0.0,3660.0,0.0,3660.0,0,3660.0
TCGA-AR-A24N-01,Stage I,54.0,2074.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2074.0,0.0,LumB,,Positive,T1,T1,LIVING,54.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-19989.0,2219.0,0.0,3035.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,310.0,NO,Equivocal,Negative,NO,4.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf,A24N,TUMOR FREE,NO,YES,10-19%,NO,Primary Tumor,1,6th,NO,A,LIVING,2005.0,BRCA.LumB,0,3035.0,0.0,3035.0,0.0,3035.0,0,3035.0
TCGA-AR-A24O-01,Stage III,43.0,1997.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1997.0,0.0,LumA,,Positive,T_Other,T3,LIVING,43.0,Left,,Positive,Positive,Modified Radical Mastectomy,,-15977.0,2213.0,0.0,3607.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Incisional Biopsy,700.0,NO,Negative,,NO,19.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,7.0,,True,No,M0,N2,T3,Stage IIIA,TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf,A24O,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2005.0,BRCA.LumA,0,3607.0,0.0,3607.0,1.0,2561.0,1,2561.0
TCGA-AR-A24P-01,Stage I,47.0,26.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,26.0,0.0,LumA,,Positive,T1,T1,LIVING,47.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-17490.0,2161.0,0.0,84.0,,10-19%,Scheduled Follow-up Submission,2012-5-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,Equivocal,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf,A24P,,,YES,10-19%,,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumA,0,84.0,0.0,84.0,0.0,84.0,0,84.0
TCGA-AR-A24Q-01,Stage II,49.0,2008.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2008.0,0.0,Basal,,Negative,T_Other,T3,LIVING,49.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,,-18084.0,1932.0,0.0,3172.0,,<10%,Scheduled Follow-up Submission,2014-9-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,590.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf,A24Q,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Basal,0,3172.0,0.0,3172.0,0.0,3172.0,0,3172.0
TCGA-AR-A24R-01,Stage III,45.0,1745.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1745.0,0.0,LumB,,Positive,T1,T1,LIVING,45.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-16642.0,1913.0,0.0,3430.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,300.0,NO,Negative,Negative,NO,28.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,6.0,,True,No,M0,N2,T1,Stage IIIA,TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf,A24R,TUMOR FREE,YES,YES,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,3430.0,0.0,3430.0,0.0,3430.0,0,3430.0
TCGA-AR-A24S-01,Stage I,61.0,1888.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1888.0,0.0,LumB,,Positive,T1,T1,LIVING,61.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-22587.0,1812.0,0.0,2976.0,,70-79%,Scheduled Follow-up Submission,2012-5-4,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,520.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf,A24S,,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,2976.0,0.0,2976.0,0.0,2976.0,0,2976.0
TCGA-AR-A24T-01,Stage III,46.0,1620.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,1620.0,0.0,LumA,,Positive,T_Other,T3,LIVING,46.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,,-17135.0,1786.0,0.0,3202.0,,10-19%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,490.0,NO,Equivocal,Negative,NO,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,15.0,,True,No,M0,N3,T3,Stage IIIC,TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf,A24T,TUMOR FREE,YES,YES,10-19%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumA,0,3202.0,0.0,3202.0,0.0,3202.0,0,3202.0
TCGA-AR-A24U-01,Stage II,47.0,1623.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,1623.0,0.0,Her2,,Negative,T1,T1,LIVING,47.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,,-17523.0,1763.0,0.0,3128.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,320.0,NO,Positive,,NO,25.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1,T1,Stage IIA,TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf,A24U,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Her2,0,3128.0,0.0,3128.0,0.0,3128.0,0,3128.0
TCGA-AR-A24V-01,Stage II,52.0,1648.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1648.0,0.0,LumA,,Positive,T_Other,T2,LIVING,52.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-19027.0,1720.0,0.0,3203.0,,80-89%,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,400.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf,A24V,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumA,0,3203.0,0.0,3203.0,0.0,3203.0,0,3203.0
TCGA-AR-A24W-01,,,,,,,,,,,,,LumA,,,,,,55.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-20123.0,,0.0,991.0,,,Scheduled Follow-up Submission,2013-10-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,,No,M0,N1,T2,Stage IIB,,A24W,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,,LIVING,2006.0,BRCA.LumA,0,1550.0,0.0,1550.0,0.0,1550.0,0,1550.0
TCGA-AR-A24X-01,Stage II,52.0,1465.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1465.0,0.0,LumA,,Positive,T_Other,T2,LIVING,52.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-19030.0,1717.0,0.0,3004.0,,80-89%,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,210.0,NO,Equivocal,Negative,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf,A24X,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumA,0,3004.0,0.0,3004.0,0.0,3004.0,0,3004.0
TCGA-AR-A24Z-01,Stage II,57.0,1574.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1574.0,0.0,LumB,,Positive,T_Other,T2,LIVING,57.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-20900.0,1673.0,0.0,3001.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf,A24Z,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,3001.0,0.0,3001.0,0.0,3001.0,0,3001.0
TCGA-AR-A250-01,Stage II,58.0,1707.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1707.0,0.0,LumB,,Negative,T_Other,T2,LIVING,58.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,,-21309.0,1629.0,0.0,2707.0,,70-79%,,2014-9-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,300.0,NO,Equivocal,Positive,NO,4.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf,A250,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.LumB,0,2707.0,0.0,2707.0,0.0,2707.0,0,2707.0
TCGA-AR-A251-01,Stage III,51.0,1373.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1373.0,0.0,Basal,,Negative,T_Other,T2,LIVING,51.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Other,,-18771.0,1611.0,0.0,3030.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,450.0,NO,Equivocal,Negative,NO,7.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf,A251,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2006.0,BRCA.Basal,0,3030.0,0.0,3030.0,0.0,3030.0,0,3030.0
TCGA-AR-A252-01,Stage I,50.0,1236.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1236.0,0.0,LumA,,Positive,T1,T1,LIVING,50.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-18611.0,1405.0,0.0,2838.0,,70-79%,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,480.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf,A252,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,2838.0,0.0,2838.0,0.0,2838.0,0,2838.0
TCGA-AR-A254-01,Stage III,50.0,1212.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,1212.0,0.0,Her2,,Positive,T_Other,T2,LIVING,50.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-18270.0,1381.0,0.0,2605.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",990.0,NO,Positive,,NO,30.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,9.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf,A254,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.Her2,0,2605.0,0.0,2605.0,0.0,2605.0,0,2605.0
TCGA-AR-A255-01,Stage I,62.0,1058.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,1058.0,0.0,LumA,,Positive,T1,T1,LIVING,62.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-22809.0,1225.0,0.0,2161.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,Positive,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf,A255,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,2161.0,0.0,2161.0,0.0,2161.0,0,2161.0
TCGA-AR-A256-01,Stage II,45.0,2854.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,2854.0,1.0,Basal,,Negative,T_Other,T2,DECEASED,45.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,YES,-16642.0,3740.0,0.0,,,,Scheduled Follow-up Submission,2012-5-11,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,210.0,NO,Negative,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf,A256,,,YES,,NO,Primary Tumor,1,5th,YES,A,DECEASED,2001.0,BRCA.Basal,1,2854.0,,2854.0,1.0,1640.0,1,1640.0
TCGA-AR-A2LE-01,,,,,,,,,,,,,LumA,,,,,,69.0,Right,Sentinel node biopsy alone,Positive,Negative,Other,YES,-25499.0,3755.0,0.0,5062.0,NO,,,2015-3-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,320.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf,A2LE,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,5th,,A,LIVING,2001.0,BRCA.LumA,0,5062.0,0.0,5062.0,0.0,5062.0,1,4203.0
TCGA-AR-A2LH-01,,,,,,,,,,,,,Normal,,,,,,55.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Modified Radical Mastectomy,,-20288.0,1661.0,0.0,,YES,,,2012-12-6,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1100.0,NO,Equivocal,Negative,NO,39.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,29.0,,True,No,M0,N3,T3,Stage III,TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf,A2LH,,YES,YES,,YES,Primary Tumor,1,6th,,A,DECEASED,2007.0,BRCA.Normal,1,616.0,,616.0,1.0,434.0,1,434.0
TCGA-AR-A2LJ-01,,,,,,,,,,,,,,,,,,,40.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-14723.0,1382.0,0.0,2632.0,NO,70-79%,,2015-3-30,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,540.0,NO,Positive,Positive,NO,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,MX,N1,T3,Stage IIIA,TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf,A2LJ,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2632.0,0.0,2632.0,0.0,2632.0,0,2632.0
TCGA-AR-A2LK-01,,,,,,,,,,,,,LumB,,,,,,62.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-22800.0,1340.0,0.0,1304.0,NO,70-79%,,2012-12-6,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,650.0,NO,Equivocal,Negative,NO,18.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,5.0,,True,No,M0,N2,T3,Stage III,TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf,A2LK,,YES,YES,,YES,Primary Tumor,1,6th,,A,DECEASED,2007.0,BRCA.LumB,1,1649.0,,1649.0,1.0,1304.0,1,1304.0
TCGA-AR-A2LL-01,,,,,,,,,,,,,LumB,,,,,,70.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-25747.0,1315.0,0.0,2012.0,NO,70-79%,,2013-10-2,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1300.0,NO,Equivocal,Negative,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,Yes,M0,N0,T3,Stage IIB,TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf,A2LL,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumB,0,2012.0,0.0,2012.0,0.0,2012.0,0,2012.0
TCGA-AR-A2LM-01,,,,,,,,,,,,,LumA,,,,,,49.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-18053.0,1339.0,0.0,1935.0,NO,70-79%,,2015-3-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,490.0,NO,,Negative,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1,T1,Stage II,TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf,A2LM,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,1935.0,0.0,1935.0,0.0,1935.0,0,1935.0
TCGA-AR-A2LN-01,,,,,,,,,,,,,LumA,,,,,,65.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-23992.0,513.0,0.0,1161.0,NO,70-79%,,2013-10-2,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1460.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf,A2LN,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1161.0,0.0,1161.0,0.0,1161.0,0,1161.0
TCGA-AR-A2LO-01,,,,,,,,,,,,,LumA,,,,,,46.0,Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,,-17080.0,486.0,0.0,1198.0,NO,70-79%,,2013-10-2,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1650.0,NO,Equivocal,Negative,,16.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf,A2LO,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1198.0,0.0,1198.0,0.0,1198.0,0,1198.0
TCGA-AR-A2LQ-01,,,,,,,,,,,,,Normal,,,,,,59.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,,-21865.0,449.0,0.0,1233.0,NO,70-79%,,2013-10-2,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,1270.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf,A2LQ,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.Normal,0,1233.0,0.0,1233.0,0.0,1233.0,0,1233.0
TCGA-AR-A2LR-01,,,,,,,,,,,,,Basal,,,,,,49.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,,-18214.0,447.0,0.0,1742.0,NO,,,2015-3-30,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,800.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,Yes,M0,N0,T1,Stage I,TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf,A2LR,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.Basal,0,1742.0,0.0,1742.0,0.0,1742.0,0,1742.0
TCGA-B6-A0I1-01,,,,,,,,,,,,,Basal,,,,,,73.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-26902.0,4248.0,0.0,,,,,2013-1-3,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,100.0,NO,,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf,A0I1,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,5th,,A,DECEASED,1998.0,BRCA.Basal,1,2361.0,0.0,2361.0,1.0,1120.0,1,1120.0
TCGA-B6-A0I5-01,Stage IIB,49.0,4549.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,4549.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,49.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-18038.0,7820.0,0.0,8556.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",50.0,NO,,,NO,13.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,5.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D.pdf,A0I5,TUMOR FREE,YES,,,NO,Primary Tumor,1,3rd,YES,A,LIVING,1988.0,BRCA.LumA,0,8556.0,0.0,8556.0,0.0,8556.0,0,8556.0
TCGA-B6-A0I6-01,Stage IIA,49.0,991.0,Negative,FEMALE,,Negative,M0,Positive,N1,997.0,1.0,Basal,Basal-like,Negative,T1,T1,DECEASED,49.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-18014.0,7362.0,0.0,,,,Scheduled Follow-up Submission,2011-6-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",200.0,NO,,,,32.0,Negative,Indeterminate (neither Pre or Postmenopausal),YES,6.0,,True,No,M0,N1,T1c,Stage IIA,TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9.pdf,A0I6,WITH TUMOR,,,,NO,Primary Tumor,1,3rd,YES,A,DECEASED,1990.0,BRCA.Basal,1,991.0,1.0,991.0,1.0,859.0,1,859.0
TCGA-B6-A0IA-01,Stage IIA,51.0,6718.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,6718.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,51.0,Right,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-18748.0,6664.0,0.0,8391.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,"Other, specify",No,C50.9,8523/3,C50.9,YES,"Other method, specify:",70.0,NO,,,NO,15.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf,A0IA,TUMOR FREE,YES,,,NO,Primary Tumor,1,,YES,A,LIVING,1992.0,BRCA.LumA,0,8391.0,0.0,8391.0,0.0,8391.0,0,8391.0
TCGA-B6-A0IC-01,,90.0,1542.0,Positive,FEMALE,Negative,,,Negative,N0,1542.0,1.0,LumA,Luminal B,Positive,T_Other,T2,DECEASED,90.0,Right,No axillary staging,Positive,Positive,Other,NO,-32872.0,6475.0,0.0,,,,Scheduled Follow-up Submission,2011-6-1,FEMALE,,"Other, specify",No,C50.9,8503/3,C50.9,YES,Fine needle aspiration biopsy,100.0,NO,,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,MX,NX,T2,Stage X,TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B.pdf,A0IC,TUMOR FREE,,,,NO,Primary Tumor,1,3rd,NO,A,DECEASED,1992.0,BRCA.LumA,1,1542.0,0.0,1542.0,0.0,1542.0,0,1542.0
TCGA-B6-A0IE-01,,38.0,1998.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1998.0,1.0,LumA,Normal-like,Negative,,TX,DECEASED,38.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Other,NO,-13982.0,,0.0,,,,Scheduled Follow-up Submission,2011-6-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8520/3,C50.9,YES,Incisional Biopsy,,,,,,24.0,Close,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,6.0,,,No,M0,N1b,T3,Stage IIIA,,A0IE,WITH TUMOR,,,,YES,Primary Tumor,1,4th,YES,,DECEASED,1995.0,BRCA.LumA,1,1993.0,1.0,1993.0,1.0,834.0,1,834.0
TCGA-B6-A0IH-01,Stage IIIA,81.0,,Positive,FEMALE,Negative,Negative,M0,Positive,N1,3418.0,1.0,LumA,Luminal A,Positive,T_Other,T3,DECEASED,81.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-29907.0,5388.0,0.0,,,,Scheduled Follow-up Submission,2011-6-2,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,110.0,NO,,,,27.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,25.0,,True,No,M0,N1b,T3,Stage IIIA,TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530.pdf,A0IH,,,YES,,YES,Primary Tumor,1,4th,YES,A,DECEASED,1995.0,BRCA.LumA,1,3418.0,,3418.0,0.0,3418.0,0,3418.0
TCGA-B6-A0IJ-01,Stage IIB,42.0,5383.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,5383.0,0.0,Basal,Basal-like,Positive,T_Other,T3,LIVING,42.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-15625.0,5350.0,0.0,7106.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,170.0,NO,,,NO,27.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD.pdf,A0IJ,TUMOR FREE,YES,,,NO,Primary Tumor,1,,YES,A,LIVING,1995.0,BRCA.Basal,0,7106.0,0.0,7106.0,0.0,7106.0,0,7106.0
TCGA-B6-A0IK-01,Stage IIIB,63.0,571.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,571.0,1.0,Her2,HER2-enriched,Negative,T_Other,T4,DECEASED,63.0,Left,,Negative,Negative,Lumpectomy,NO,-23150.0,5724.0,0.0,,,,Scheduled Follow-up Submission,2011-6-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",140.0,NO,,,,14.0,Positive,Indeterminate (neither Pre or Postmenopausal),YES,1.0,,True,No,M0,N1,T4,Stage IIIB,TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A.pdf,A0IK,WITH TUMOR,,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1994.0,BRCA.Her2,1,571.0,1.0,571.0,1.0,489.0,1,489.0
TCGA-B6-A0IM-01,Stage IIB,75.0,3836.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3836.0,0.0,LumA,Luminal B,Positive,T_Other,T3,LIVING,75.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-27557.0,4754.0,0.0,3836.0,,,Scheduled Follow-up Submission,2011-6-2,FEMALE,,"Other, specify",No,C50.9,8523/3,C50.9,YES,Fine needle aspiration biopsy,110.0,NO,,,,9.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734.pdf,A0IM,TUMOR FREE,,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1997.0,BRCA.LumA,1,3873.0,0.0,3873.0,0.0,3873.0,0,3873.0
TCGA-B6-A0IN-01,,45.0,2573.0,Positive,FEMALE,,,,Negative,N0,2573.0,1.0,LumB,Luminal A,Negative,T1,T1,DECEASED,45.0,Right Upper Outer Quadrant|Right,No axillary staging,Positive,Negative,Other,NO,-16705.0,5073.0,0.0,,,,Scheduled Follow-up Submission,2011-6-2,FEMALE,,"Other, specify",No,C50.9,8523/3,C50.9,YES,Fine needle aspiration biopsy,20.0,NO,,,,,Positive,Indeterminate (neither Pre or Postmenopausal),YES,,,True,No,MX,NX,T1c,Stage X,TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf,A0IN,WITH TUMOR,,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1996.0,BRCA.LumB,1,2573.0,1.0,2573.0,1.0,1412.0,1,1412.0
TCGA-B6-A0IO-01,Stage IIA,66.0,3350.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3350.0,0.0,LumA,Luminal A,Indeterminate,T_Other,T2,LIVING,66.0,Left,Axillary lymph node dissection alone,Positive,Indeterminate,Modified Radical Mastectomy,NO,-24322.0,,0.0,5042.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,,NO,17.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,,No,M0,N0 (i-),T2,Stage IIA,,A0IO,TUMOR FREE,YES,,,NO,Primary Tumor,1,,YES,,LIVING,2001.0,BRCA.LumA,0,5042.0,0.0,5042.0,0.0,5042.0,0,5042.0
TCGA-B6-A0IP-01,Stage IA,74.0,3374.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3374.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,74.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-27047.0,4565.0,0.0,3374.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,80.0,NO,,,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268.pdf,A0IP,TUMOR FREE,,YES,,NO,Primary Tumor,1,,NO,A,DECEASED,1997.0,BRCA.LumA,1,3926.0,0.0,3926.0,0.0,3926.0,0,3926.0
TCGA-B6-A0IQ-01,Stage IIIA,40.0,4284.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,4284.0,0.0,Basal,Basal-like,Negative,T_Other,T3,LIVING,40.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14669.0,5238.0,0.0,4285.0,,,Scheduled Follow-up Submission,2011-6-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",210.0,NO,,,,26.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,1.0,,True,No,M0,N1b,T3,Stage IIIA,TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf,A0IQ,TUMOR FREE,,,,YES,Primary Tumor,1,4th,YES,A,LIVING,1996.0,BRCA.Basal,0,4285.0,0.0,4285.0,0.0,4285.0,0,4285.0
TCGA-B6-A0RE-01,,61.0,6434.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,6434.0,0.0,Basal,Basal-like,Negative,,TX,LIVING,61.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-22449.0,,0.0,7777.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",,,,,NO,14.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,,No,M0,N0 (i-),TX,Stage X,,A0RE,TUMOR FREE,NO,,,YES,Primary Tumor,1,,NO,,LIVING,1989.0,BRCA.Basal,0,7777.0,0.0,7777.0,0.0,7777.0,0,7777.0
TCGA-B6-A0RG-01,Stage IIB,26.0,2082.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,2082.0,0.0,LumA,Luminal A,Negative,T_Other,T3,LIVING,26.0,Left,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-9840.0,6869.0,0.0,2082.0,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",160.0,NO,,,,19.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559.pdf,A0RG,TUMOR FREE,,,,NO,Primary Tumor,1,4th,YES,A,LIVING,1991.0,BRCA.LumA,0,2082.0,0.0,2082.0,0.0,2082.0,0,2082.0
TCGA-B6-A0RH-01,Stage IIA,51.0,5748.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,5748.0,0.0,Her2,HER2-enriched,Positive,T_Other,T2,LIVING,51.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-18759.0,6821.0,0.0,5749.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,130.0,NO,,,NO,23.0,Positive,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf,A0RH,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,DECEASED,1991.0,BRCA.Her2,1,6456.0,0.0,6456.0,1.0,2165.0,1,2165.0
TCGA-B6-A0RI-01,Stage IIIB,44.0,7125.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,7125.0,0.0,LumA,Luminal A,Positive,T_Other,T4,LIVING,44.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-16138.0,6755.0,0.0,7126.0,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",50.0,NO,,,,15.0,Negative,Indeterminate (neither Pre or Postmenopausal),YES,6.0,,True,No,M0,N1b,T4b,Stage IIIB,TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6.pdf,A0RI,WITH TUMOR,,,,YES,Primary Tumor,1,3rd,YES,A,LIVING,1992.0,BRCA.LumA,0,7126.0,0.0,7126.0,1.0,1100.0,1,1100.0
TCGA-B6-A0RL-01,Stage IIA,60.0,2469.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2469.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,60.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22238.0,6336.0,0.0,,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,170.0,NO,,,,16.0,Negative,,NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-B6-A0RL.6C50D456-A828-4514-92D2-01A5900B74F1.pdf,A0RL,TUMOR FREE,,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1993.0,BRCA.LumB,1,2469.0,0.0,2469.0,0.0,2469.0,0,2469.0
TCGA-B6-A0RN-01,Stage IA,60.0,5261.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,5261.0,0.0,LumA,Luminal A,Negative,T1,T1,LIVING,60.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-22077.0,6286.0,0.0,8008.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",130.0,NO,,,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF.pdf,A0RN,TUMOR FREE,YES,,,YES,Primary Tumor,1,,YES,A,LIVING,1993.0,BRCA.LumA,0,8008.0,0.0,8008.0,0.0,8008.0,0,8008.0
TCGA-B6-A0RO-01,Stage IIIB,71.0,4928.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,4928.0,0.0,LumA,Luminal A,Positive,T_Other,T4,LIVING,71.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-26269.0,6035.0,0.0,4929.0,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",140.0,NO,,,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,M0,N1a,T4,Stage IIIB,TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF.pdf,A0RO,TUMOR FREE,,,,NO,Primary Tumor,1,4th,YES,A,LIVING,1993.0,BRCA.LumA,0,4929.0,0.0,4929.0,0.0,4929.0,0,4929.0
TCGA-B6-A0RP-01,Stage IIIB,73.0,3126.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,3126.0,1.0,LumA,Luminal A,Positive,T_Other,T2,DECEASED,73.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-26941.0,,0.0,,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,"Other method, specify:",,,,,,15.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,,,No,M0,N1b,T2,[Discrepancy],,A0RP,WITH TUMOR,,,,NO,Primary Tumor,1,4th,YES,,DECEASED,1994.0,BRCA.LumA,1,3126.0,1.0,3126.0,1.0,2787.0,1,2787.0
TCGA-B6-A0RQ-01,Stage IIB,68.0,,Positive,FEMALE,Negative,Negative,M0,Negative,N0,4273.0,1.0,Normal,Luminal A,Positive,T_Other,T3,DECEASED,68.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-25010.0,5890.0,0.0,,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,160.0,NO,,,,14.0,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A.pdf,A0RQ,TUMOR FREE,,YES,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1994.0,BRCA.Normal,1,4267.0,0.0,4267.0,0.0,4267.0,0,4267.0
TCGA-B6-A0RS-01,Stage IIA,38.0,3062.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,3062.0,1.0,Her2,HER2-enriched,Negative,T_Other,T2,DECEASED,38.0,Left Lower Inner Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14134.0,,0.0,,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",,,,,,15.0,Negative,Indeterminate (neither Pre or Postmenopausal),YES,0.0,,,No,M0,N0 (i-),T2,Stage IIA,,A0RS,WITH TUMOR,,,,NO,Primary Tumor,1,3rd,YES,,DECEASED,1988.0,BRCA.Her2,1,3063.0,1.0,3063.0,1.0,2041.0,1,2041.0
TCGA-B6-A0RU-01,Stage IA,49.0,3991.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,3991.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,40.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,NO,-14920.0,7290.0,0.0,8605.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,"Other, specify",No,C50.9,8523/3,C50.9,YES,Tumor resection,170.0,NO,,,NO,15.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf,A0RU,TUMOR FREE,YES,,,YES,Primary Tumor,1,3rd,YES,A,LIVING,1990.0,BRCA.Basal,0,8605.0,0.0,8605.0,1.0,3076.0,1,3076.0
TCGA-B6-A0RV-01,Stage IIIA,42.0,4788.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,4788.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,42.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-15507.0,5165.0,0.0,5156.0,,,Scheduled Follow-up Submission,2011-7-12,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Incisional Biopsy,480.0,NO,,,,10.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,5.0,,True,No,M0,N2,T3,Stage IIIA,TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6.pdf,A0RV,TUMOR FREE,,,,YES,Primary Tumor,1,4th,YES,A,LIVING,1996.0,BRCA.LumA,0,5156.0,0.0,5156.0,0.0,5156.0,0,5156.0
TCGA-B6-A0WT-01,Stage IIB,61.0,5739.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,5739.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,61.0,Left Lower Inner Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22362.0,5606.0,0.0,5739.0,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,90.0,NO,,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F.pdf,A0WT,TUMOR FREE,,,,NO,Primary Tumor,1,4th,YES,A,LIVING,1995.0,BRCA.LumA,0,5739.0,0.0,5739.0,1.0,3862.0,1,3862.0
TCGA-B6-A0WV-01,Stage IIB,67.0,2422.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2422.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,67.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-24803.0,5531.0,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,30.0,NO,,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72.pdf,A0WV,TUMOR FREE,,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1995.0,BRCA.LumB,1,2417.0,0.0,2417.0,0.0,2417.0,0,2417.0
TCGA-B6-A0WW-01,,58.0,546.0,Positive,FEMALE,Negative,,,Positive,N1,557.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,58.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-21479.0,4664.0,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,30.0,NO,,,,18.0,Negative,Indeterminate (neither Pre or Postmenopausal),YES,5.0,,True,No,MX,N1b,T2,Stage X,TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9.pdf,A0WW,WITH TUMOR,,,,YES,Primary Tumor,1,4th,NO,A,DECEASED,1997.0,BRCA.LumB,1,558.0,1.0,558.0,1.0,447.0,1,447.0
TCGA-B6-A0WX-01,Stage IIIA,40.0,653.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,653.0,1.0,Basal,Basal-like,Negative,T_Other,T3,DECEASED,40.0,Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14784.0,4476.0,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,"Other, specify",No,C50.9,8520/3,C50.9,YES,Excisional Biopsy,300.0,NO,,,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,9.0,,True,No,M0,N1b,T3,Stage IIIA,TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf,A0WX,WITH TUMOR,,,,NO,Primary Tumor,1,5th,YES,A,DECEASED,1998.0,BRCA.Basal,1,639.0,1.0,639.0,1.0,563.0,1,563.0
TCGA-B6-A0WY-01,Stage IIIA,40.0,3410.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,3460.0,1.0,LumA,Luminal A,Negative,T_Other,T3,DECEASED,40.0,Left Lower Inner Quadrant|Left,Axillary lymph node dissection alone,Positive,Negative,Lumpectomy,NO,-14778.0,5294.0,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,30.0,NO,,,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,3.0,,True,No,M0,N1b,T3,Stage IIIA,TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F.pdf,A0WY,WITH TUMOR,,,,YES,Primary Tumor,1,4th,YES,A,DECEASED,1996.0,BRCA.LumA,1,3461.0,1.0,3461.0,1.0,2011.0,1,2011.0
TCGA-B6-A0WZ-01,Stage IIB,50.0,3941.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,3941.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,50.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-18584.0,,0.0,6292.0,,,Scheduled Follow-up Submission,2015-3-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,,,NO,21.0,Negative,Indeterminate (neither Pre or Postmenopausal),YES,11.0,,,No,M0,N1b,T2,Stage II,,A0WZ,TUMOR FREE,YES,,,YES,Primary Tumor,1,4th,YES,,LIVING,1996.0,BRCA.LumA,0,6292.0,0.0,6292.0,0.0,6292.0,1,5117.0
TCGA-B6-A0X0-01,Stage IA,54.0,,Positive,FEMALE,Negative,Negative,M0,Negative,N0,3945.0,1.0,LumA,Luminal A,Positive,T1,T1,DECEASED,54.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-19802.0,5243.0,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,"Other, specify",No,C50.919,8201/3,C50.9,YES,Fine needle aspiration biopsy,150.0,NO,,,,31.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage I,TCGA-B6-A0X0.84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8.pdf,A0X0,,,YES,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1996.0,BRCA.LumA,1,3945.0,,3945.0,0.0,3945.0,0,3945.0
TCGA-B6-A0X1-01,Stage IV,48.0,5671.0,Negative,FEMALE,,Positive,M1,Positive,N2,5671.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,48.0,Left,Axillary lymph node dissection alone,Negative,Negative,Other,NO,-17624.0,6035.0,0.0,5677.0,,,Scheduled Follow-up Submission,2015-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,240.0,NO,,,NO,21.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,16.0,,True,No,M1,N1,T2,Stage IIB,TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B.pdf,A0X1,TUMOR FREE,NO,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1994.0,BRCA.Basal,1,7455.0,0.0,7455.0,1.0,490.0,1,490.0
TCGA-B6-A0X4-01,Stage IIB,62.0,776.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,859.0,1.0,LumA,Luminal A,Positive,T_Other,T2,DECEASED,62.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22688.0,5323.0,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,110.0,NO,,,,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5.pdf,A0X4,WITH TUMOR,,,,NO,Primary Tumor,1,4th,YES,A,DECEASED,1996.0,BRCA.LumA,1,860.0,1.0,860.0,1.0,716.0,1,716.0
TCGA-B6-A0X5-01,Stage IIB,61.0,2097.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,2097.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,61.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22380.0,,0.0,,,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,,,,,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,3.0,,,No,M0,N1b,T2,Stage IIB,,A0X5,WITH TUMOR,,,,NO,Primary Tumor,1,4th,YES,,DECEASED,1995.0,BRCA.LumB,1,2097.0,1.0,2097.0,1.0,1343.0,1,1343.0
TCGA-B6-A1KC-01,Stage IIA,67.0,1326.0,Positive,FEMALE,,Negative,M0,Positive,N1,1326.0,0.0,LumB,,Negative,T_Other,T2,LIVING,67.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,NO,-24791.0,,0.0,1326.0,NO,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,,No,M0,N1,T2,Stage IIB,,A1KC,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2003.0,BRCA.LumB,0,1326.0,0.0,1326.0,0.0,1326.0,0,1326.0
TCGA-B6-A1KF-01,Stage IIB,68.0,3088.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,3088.0,0.0,Basal,,Negative,T_Other,T2,LIVING,68.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Other,NO,-24891.0,,0.0,3088.0,NO,,Scheduled Follow-up Submission,2011-8-29,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Equivocal,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,,No,M0,N1,T2,Stage IIB,,A1KF,TUMOR FREE,,YES,,YES,Primary Tumor,1,5th,YES,,LIVING,1998.0,BRCA.Basal,0,3088.0,0.0,3088.0,0.0,3088.0,0,3088.0
TCGA-B6-A1KI-01,Stage I,63.0,2236.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,2236.0,0.0,LumA,,Positive,T1,T1,LIVING,63.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,NO,-23031.0,2634.0,0.0,2236.0,NO,,Scheduled Follow-up Submission,2011-8-29,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,40.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf,A1KI,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.LumA,0,2236.0,0.0,2236.0,0.0,2236.0,0,2236.0
TCGA-B6-A1KN-01,Stage IIIB,57.0,4233.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,4233.0,0.0,LumB,,Negative,T_Other,T4,LIVING,57.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-21183.0,4537.0,0.0,4233.0,NO,,Scheduled Follow-up Submission,2011-8-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,,,,30.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,24.0,,True,No,M0,N1,T4b,Stage IIIB,TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf,A1KN,TUMOR FREE,,YES,,YES,Primary Tumor,1,5th,YES,A,LIVING,1998.0,BRCA.LumB,0,4233.0,0.0,4233.0,0.0,4233.0,0,4233.0
TCGA-B6-A2IU-01,,,,,,,,,,,,,LumA,,,,,,62.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22905.0,4665.0,0.0,5176.0,,,,2013-1-3,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,,,NO,28.0,Negative,Indeterminate (neither Pre or Postmenopausal),YES,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf,A2IU,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,5th,,A,LIVING,1998.0,BRCA.LumA,0,5176.0,0.0,5176.0,0.0,5176.0,1,4224.0
TCGA-B6-A400-01,,,,,,,,,,,,,,,,,,,43.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-16022.0,1610.0,0.0,215.0,,<10%,,2014-6-3,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,20.0,NO,Negative,,YES,5.0,Negative,,NO,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf,A400,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,215.0,0.0,215.0,0.0,215.0,0,215.0
TCGA-B6-A401-01,,,,,,,,,,,,,,,,,,,47.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-17438.0,1935.0,0.0,2596.0,,80-89%,,2014-6-3,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,30.0,NO,Negative,,NO,4.0,Negative,,NO,1.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf,A401,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2596.0,0.0,2596.0,0.0,2596.0,0,2596.0
TCGA-B6-A402-01,,,,,,,,,,,,,,,,,,,47.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-17314.0,1563.0,0.0,2134.0,,<10%,,2014-7-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,10.0,NO,Negative,,NO,3.0,Negative,,YES,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf,A402,WITH TUMOR,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,2281.0,0.0,2281.0,1.0,1516.0,1,1516.0
TCGA-B6-A408-01,,,,,,,,,,,,,,,,,,,55.0,Left,Axillary lymph node dissection alone,Positive,Positive,Simple Mastectomy,NO,-20102.0,,0.0,2072.0,,90-99%,,2014-6-3,FEMALE,2+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,,,Equivocal,Negative,NO,23.0,Negative,,NO,10.0,,,No,M0,N3a,T2,Stage IIIC,,A408,TUMOR FREE,YES,YES,60-69%,YES,Primary Tumor,1,6th,,,LIVING,2008.0,BRCA.LumA,0,2072.0,0.0,2072.0,0.0,2072.0,0,2072.0
TCGA-B6-A409-01,,,,,,,,,,,,,,,,,,,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,NO,-16178.0,1480.0,0.0,,,<10%,,2012-9-20,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,20.0,NO,Equivocal,Negative,,22.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,6.0,,True,No,M0,N2a,T1c,Stage IIIA,TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf,A409,WITH TUMOR,YES,YES,<10%,NO,Primary Tumor,1,6th,,A,DECEASED,2008.0,BRCA.Basal,1,573.0,1.0,573.0,1.0,456.0,1,456.0
TCGA-B6-A40B-01,,,,,,,,,,,,,,,,,,,76.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-27811.0,2467.0,0.0,3152.0,,90-99%,,2014-6-3,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,10.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1b,Stage I,TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf,A40B,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumA,0,3152.0,0.0,3152.0,0.0,3152.0,0,3152.0
TCGA-B6-A40C-01,,,,,,,,,,,,,,,,,,,51.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-18852.0,,0.0,2164.0,,50-59%,,2014-6-3,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,3.0,Negative,,NO,0.0,0.0,,No,M0,N0 (i-),T3,Stage IIB,,A40C,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,,LIVING,2005.0,BRCA.LumA,0,2164.0,0.0,2164.0,0.0,2164.0,0,2164.0
TCGA-BH-A0AU-01,Stage IIA,45.0,746.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,746.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,45.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-16688.0,583.0,0.0,1914.0,NO,,,2014-6-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Positive,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf,A0AU,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumB,0,1914.0,0.0,1914.0,0.0,1914.0,0,1914.0
TCGA-BH-A0AU-11,,45.0,746.0,,FEMALE,,,,,,746.0,0.0,Normal,,,,,LIVING,45.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-16688.0,,0.0,1914.0,NO,,,2014-6-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Positive,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A0AU,TUMOR FREE,NO,YES,,YES,Solid Tissue Normal,11,6th,,,LIVING,2008.0,BRCA.Normal,0,1914.0,0.0,1914.0,0.0,1914.0,0,1914.0
TCGA-BH-A0AV-01,Stage I,52.0,1180.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1180.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,52.0,Left Upper Inner Quadrant,,Negative,Negative,Other,,-19314.0,761.0,0.0,1820.0,NO,,,2014-5-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,,Negative,NO,2.0,Negative,,NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf,A0AV,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,1820.0,0.0,1820.0,0.0,1820.0,0,1820.0
TCGA-BH-A0AW-01,Stage IIA,56.0,622.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,622.0,0.0,Her2,HER2-enriched,Negative,T1,T1,LIVING,56.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Negative,Lumpectomy,NO,-20468.0,545.0,0.0,622.0,,,Scheduled Follow-up Submission,2010-11-3,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,50.0,NO,Positive,,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72.pdf,A0AW,TUMOR FREE,,,,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.Her2,0,622.0,0.0,622.0,0.0,622.0,0,622.0
TCGA-BH-A0AY-01,Stage IIA,62.0,777.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,777.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,62.0,Left Lower Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-22703.0,587.0,0.0,777.0,,,Scheduled Follow-up Submission,2010-11-3,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B.pdf,A0AY,TUMOR FREE,,,,NO,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,777.0,0.0,777.0,0.0,777.0,0,777.0
TCGA-BH-A0AY-11,,62.0,777.0,,FEMALE,,,,,,777.0,0.0,Normal,,,,,LIVING,62.0,Left Lower Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-22703.0,587.0,0.0,777.0,,,Scheduled Follow-up Submission,2010-11-3,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,360.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,,A0AY,TUMOR FREE,,,,NO,Solid Tissue Normal,11,,YES,A,LIVING,2008.0,BRCA.Normal,0,777.0,0.0,777.0,0.0,777.0,0,777.0
TCGA-BH-A0AZ-01,Stage IIIA,47.0,867.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,867.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,47.0,Right,,Positive,Positive,Other,,-17465.0,,0.0,1919.0,NO,,,2014-4-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,cM0 (i+),N1a,T3,Stage IIIA,,A0AZ,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,,LIVING,2008.0,BRCA.LumA,0,1919.0,0.0,1919.0,0.0,1919.0,0,1919.0
TCGA-BH-A0AZ-11,,47.0,867.0,,FEMALE,,,,,,867.0,0.0,Normal,,,,,LIVING,47.0,Right,,Positive,Positive,Other,,-17465.0,,0.0,1919.0,NO,,,2014-4-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,cM0 (i+),N1a,T3,Stage IIIA,,A0AZ,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,6th,,,LIVING,2008.0,BRCA.Normal,0,1919.0,0.0,1919.0,0.0,1919.0,0,1919.0
TCGA-BH-A0B0-01,Stage I,56.0,1427.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1427.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,56.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-20776.0,1223.0,0.0,2477.0,NO,,,2014-5-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,320.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE.pdf,A0B0,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,2477.0,0.0,2477.0,0.0,2477.0,0,2477.0
TCGA-BH-A0B1-01,Stage IIB,66.0,1148.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1148.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,66.0,Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-24315.0,1071.0,0.0,1148.0,,90-99%,Scheduled Follow-up Submission,2010-11-3,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,740.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0B1.BAEB6705-FCDC-4B40-B1CB-D926B8287F92.pdf,A0B1,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,1148.0,0.0,1148.0,0.0,1148.0,0,1148.0
TCGA-BH-A0B3-01,Stage IIB,53.0,1203.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1203.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,53.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,NO,-19479.0,1030.0,0.0,1203.0,,,Scheduled Follow-up Submission,2010-11-3,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Negative,,,29.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf,A0B3,TUMOR FREE,,,,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.Basal,0,1203.0,0.0,1203.0,0.0,1203.0,0,1203.0
TCGA-BH-A0B3-11,,53.0,1203.0,,FEMALE,,,,,,1203.0,0.0,Normal,,,,,LIVING,53.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,NO,-19479.0,,0.0,1203.0,,,Scheduled Follow-up Submission,2010-11-3,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,29.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,,No,M0,N1a,T2,Stage IIB,,A0B3,TUMOR FREE,,,,YES,Solid Tissue Normal,11,,YES,,LIVING,2007.0,BRCA.Normal,0,1203.0,0.0,1203.0,0.0,1203.0,0,1203.0
TCGA-BH-A0B4-01,Stage IIIA,65.0,1191.0,Positive,MALE,Positive,Negative,M0,Positive,N2,1191.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,65.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-23980.0,995.0,0.0,1191.0,,80-89%,Scheduled Follow-up Submission,2010-11-4,MALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,340.0,NO,Equivocal,Positive,,10.0,Negative,,NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2.pdf,A0B4,TUMOR FREE,,,50-59%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,1191.0,0.0,1191.0,0.0,1191.0,0,1191.0
TCGA-BH-A0B6-01,,,,,,,,,,,,,,,,,,,47.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-17346.0,,0.0,2483.0,NO,,,2014-7-10,FEMALE,,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Positive,,NO,4.0,Negative,,NO,0.0,,,Yes,M0,N0,T1c,Stage I,,A0B6,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,,LIVING,2006.0,BRCA.LumA,0,2483.0,0.0,2483.0,0.0,2483.0,0,2483.0
TCGA-BH-A0B7-01,Stage IIB,42.0,1733.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1733.0,0.0,Her2,HER2-enriched,Positive,T_Other,T2,LIVING,42.0,Right,,Positive,Positive,Other,,-15593.0,1391.0,0.0,2559.0,NO,,,2014-4-22,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,320.0,NO,Positive,,NO,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C.pdf,A0B7,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.Her2,0,2559.0,0.0,2559.0,0.0,2559.0,0,2559.0
TCGA-BH-A0B7-11,,42.0,1733.0,,FEMALE,,,,,,1733.0,0.0,Normal,,,,,LIVING,42.0,Right,,Positive,Positive,Other,,-15593.0,1391.0,0.0,2559.0,NO,,,2014-4-22,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,930.0,NO,Positive,,NO,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,,A0B7,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2006.0,BRCA.Normal,0,2559.0,0.0,2559.0,0.0,2559.0,0,2559.0
TCGA-BH-A0B8-01,Stage IB,64.0,1569.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1569.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,64.0,Right Upper Inner Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23380.0,,0.0,1569.0,,90-99%,Scheduled Follow-up Submission,2010-11-3,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0 (i-),T1b,Stage I,,A0B8,TUMOR FREE,,,30-39%,YES,Primary Tumor,1,,YES,,LIVING,2006.0,BRCA.LumA,0,1569.0,0.0,1569.0,0.0,1569.0,0,1569.0
TCGA-BH-A0B8-11,,64.0,1569.0,,FEMALE,,,,,,1569.0,0.0,Normal,,,,,LIVING,64.0,Right Upper Inner Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23380.0,1401.0,0.0,1569.0,,90-99%,Scheduled Follow-up Submission,2010-11-3,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,400.0,NO,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T1b,Stage I,,A0B8,TUMOR FREE,,,30-39%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2006.0,BRCA.Normal,0,1569.0,0.0,1569.0,0.0,1569.0,0,1569.0
TCGA-BH-A0B9-01,Stage IA,44.0,1572.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1572.0,0.0,,Basal-like,Negative,T1,T1,LIVING,44.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Sentinel node biopsy alone,Negative,Negative,Other,NO,-16310.0,1391.0,0.0,1572.0,,,Scheduled Follow-up Submission,2010-11-4,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,,,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf,A0B9,TUMOR FREE,,,,YES,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.Basal,0,1572.0,0.0,1572.0,0.0,1572.0,0,1572.0
TCGA-BH-A0BA-01,Stage IIIC,51.0,1132.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,1132.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,51.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-18839.0,1266.0,0.0,1132.0,,80-89%,Scheduled Follow-up Submission,2010-11-4,FEMALE,1+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,360.0,NO,Negative,,,27.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,27.0,,True,No,M0,N3a,T3,Stage IIIC,TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB.pdf,A0BA,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.LumA,0,1132.0,0.0,1132.0,0.0,1132.0,0,1132.0
TCGA-BH-A0BA-11,,51.0,1132.0,,FEMALE,,,,,,1132.0,0.0,Normal,,,,,LIVING,51.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-18839.0,1266.0,0.0,1132.0,,80-89%,Scheduled Follow-up Submission,2010-11-4,FEMALE,1+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,,,27.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,27.0,,True,No,M0,N3a,T3,Stage IIIC,,A0BA,TUMOR FREE,,,40-49%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2006.0,BRCA.Normal,0,1132.0,0.0,1132.0,0.0,1132.0,0,1132.0
TCGA-BH-A0BC-01,Stage IIIC,60.0,974.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,974.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,60.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-21949.0,1098.0,0.0,974.0,,90-99%,,2010-11-4,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,12.0,,True,No,M0,N3,T2,Stage IIIC,TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf,A0BC,TUMOR FREE,,,30-39%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,974.0,0.0,974.0,0.0,974.0,0,974.0
TCGA-BH-A0BC-11,,60.0,974.0,,FEMALE,,,,,,974.0,0.0,Normal,,,,,LIVING,60.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-21949.0,1098.0,0.0,974.0,,90-99%,,2010-11-4,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,12.0,,True,No,M0,N3,T2,Stage IIIC,,A0BC,TUMOR FREE,,,30-39%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2007.0,BRCA.Normal,0,974.0,0.0,974.0,0.0,974.0,0,974.0
TCGA-BH-A0BD-01,Stage IIA,47.0,554.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,554.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,47.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-17275.0,,0.0,554.0,,,Scheduled Follow-up Submission,2010-11-4,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,,No,M0,N1a,T1c,Stage IIA,,A0BD,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumB,0,554.0,0.0,554.0,0.0,554.0,0,554.0
TCGA-BH-A0BF-01,Stage IIB,56.0,781.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,781.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,56.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-20691.0,413.0,0.0,782.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1mi,T2,Stage IIB,TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf,A0BF,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,6th,,A,DECEASED,2009.0,BRCA.LumB,1,1324.0,0.0,1324.0,0.0,1324.0,0,1324.0
TCGA-BH-A0BG-01,Stage I,73.0,756.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,756.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,73.0,Left Lower Outer Quadrant,,Negative,Negative,Other,,-26988.0,798.0,0.0,1871.0,NO,,,2014-4-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,50.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1,Stage I,TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf,A0BG,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,1871.0,0.0,1871.0,0.0,1871.0,0,1871.0
TCGA-BH-A0BJ-01,Stage IIB,41.0,660.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,660.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,41.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-15027.0,595.0,0.0,660.0,,90-99%,,2010-11-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518.pdf,A0BJ,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,660.0,0.0,660.0,0.0,660.0,0,660.0
TCGA-BH-A0BJ-11,,41.0,660.0,,FEMALE,,,,,,660.0,0.0,Normal,,,,,LIVING,41.0,Left Upper Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-15027.0,595.0,0.0,660.0,,90-99%,,2010-11-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,2.0,,True,No,M0,N1a,T2,Stage IIB,,A0BJ,TUMOR FREE,,,70-79%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2008.0,BRCA.Normal,0,660.0,0.0,660.0,0.0,660.0,0,660.0
TCGA-BH-A0BL-01,Stage I,35.0,1339.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,1339.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,35.0,Right Upper Outer Quadrant,,Negative,Negative,Other,,-12841.0,1135.0,0.0,2278.0,NO,,,2014-5-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,60.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf,A0BL,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Basal,0,2278.0,0.0,2278.0,0.0,2278.0,0,2278.0
TCGA-BH-A0BM-01,Stage IIB,54.0,1117.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1117.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,54.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Lumpectomy,NO,-20049.0,1080.0,0.0,1876.0,,,Scheduled Follow-up Submission,2012-7-29,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21.pdf,A0BM,TUMOR FREE,,,,NO,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,1876.0,0.0,1876.0,0.0,1876.0,0,1876.0
TCGA-BH-A0BM-11,,54.0,1117.0,,FEMALE,,,,,,1117.0,0.0,Normal,,,,,LIVING,54.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Lumpectomy,NO,-20049.0,1080.0,0.0,1876.0,,,Scheduled Follow-up Submission,2012-7-29,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N1a,T2,Stage IIB,,A0BM,TUMOR FREE,,,,NO,Solid Tissue Normal,11,6th,YES,A,LIVING,2007.0,BRCA.Normal,0,1876.0,0.0,1876.0,0.0,1876.0,0,1876.0
TCGA-BH-A0BO-01,Stage I,54.0,1085.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1085.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,54.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-19767.0,1162.0,0.0,2197.0,NO,,,2014-7-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,290.0,NO,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T1b,Stage I,TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823.pdf,A0BO,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2197.0,0.0,2197.0,0.0,2197.0,0,2197.0
TCGA-BH-A0BP-01,Stage I,76.0,1481.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1481.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,76.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-27917.0,1217.0,0.0,1481.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6.pdf,A0BP,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,A,DECEASED,2006.0,BRCA.LumA,1,2296.0,0.0,2296.0,0.0,2296.0,0,2296.0
TCGA-BH-A0BQ-01,Stage I,39.0,826.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,826.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,39.0,Left,,Positive,Positive,Other,,-14494.0,1197.0,0.0,2255.0,NO,,,2014-4-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Positive,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037.pdf,A0BQ,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2255.0,0.0,2255.0,1.0,1709.0,1,1709.0
TCGA-BH-A0BQ-11,,39.0,826.0,,FEMALE,,,,,,826.0,0.0,Normal,,,,,LIVING,39.0,Left,,Positive,Positive,Other,,-14494.0,1197.0,0.0,2255.0,NO,,,2014-4-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,340.0,NO,Positive,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,,True,No,M0,N0,T1c,Stage I,,A0BQ,TUMOR FREE,NO,YES,,NO,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2255.0,0.0,2255.0,1.0,1709.0,1,1709.0
TCGA-BH-A0BR-01,Stage I,59.0,1632.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1632.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,59.0,Left Lower Inner Quadrant,,Positive,Positive,Other,,-21622.0,1170.0,0.0,2330.0,NO,,,2014-7-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8.pdf,A0BR,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2330.0,0.0,2330.0,0.0,2330.0,0,2330.0
TCGA-BH-A0BS-01,Stage IIIA,55.0,1640.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1640.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,55.0,Left,,Positive,Positive,Simple Mastectomy,,-20374.0,1164.0,0.0,2612.0,NO,,,2014-8-7,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,180.0,NO,,Negative,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N1c,T3,Stage IIIA,TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf,A0BS,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2612.0,0.0,2612.0,0.0,2612.0,0,2612.0
TCGA-BH-A0BS-11,,55.0,1640.0,,FEMALE,,,,,,1640.0,0.0,Normal,,,,,LIVING,55.0,Left,,Positive,Positive,Simple Mastectomy,,-20374.0,1164.0,0.0,2612.0,NO,,,2014-8-7,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,,Negative,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N1c,T3,Stage IIIA,,A0BS,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2612.0,0.0,2612.0,0.0,2612.0,0,2612.0
TCGA-BH-A0BT-01,Stage IIA,56.0,1386.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1386.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,56.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,-20625.0,1167.0,0.0,2365.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,,Negative,,NO,,,True,No,M0,N1mi,T1c,Stage IIA,TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019.pdf,A0BT,TUMOR FREE,YES,,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2365.0,0.0,2365.0,0.0,2365.0,0,2365.0
TCGA-BH-A0BT-11,,56.0,1386.0,,FEMALE,,,,,,1386.0,0.0,Normal,,,,,LIVING,56.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,-20625.0,1167.0,0.0,2365.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,Negative,,NO,,Negative,,NO,,,True,No,M0,N1mi,T1c,Stage IIA,,A0BT,TUMOR FREE,YES,,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2365.0,0.0,2365.0,0.0,2365.0,0,2365.0
TCGA-BH-A0BV-01,Stage IIB,78.0,1519.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1519.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,78.0,Right Upper Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-28699.0,1328.0,0.0,1519.0,,90-99%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,450.0,NO,Negative,,,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf,A0BV,TUMOR FREE,,,50-59%,NO,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.LumA,0,1519.0,0.0,1519.0,0.0,1519.0,0,1519.0
TCGA-BH-A0BV-11,,78.0,1519.0,,FEMALE,,,,,,1519.0,0.0,Normal,,,,,LIVING,78.0,Right Upper Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-28699.0,1328.0,0.0,1519.0,,90-99%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,,True,No,M0,N1a,T2,Stage IIB,,A0BV,TUMOR FREE,,,50-59%,NO,Solid Tissue Normal,11,,YES,A,LIVING,2006.0,BRCA.Normal,0,1519.0,0.0,1519.0,0.0,1519.0,0,1519.0
TCGA-BH-A0BW-01,Stage I,71.0,355.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,355.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,71.0,Left Lower Outer Quadrant,,Negative,Negative,Other,,-25974.0,1344.0,0.0,2371.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,,Negative,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf,A0BW,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.Basal,0,2371.0,0.0,2371.0,0.0,2371.0,0,2371.0
TCGA-BH-A0BW-11,,71.0,355.0,,FEMALE,,,,,,355.0,0.0,Normal,,,,,LIVING,71.0,Left Lower Outer Quadrant,,Negative,Negative,Other,,-25974.0,,0.0,2371.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,Negative,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A0BW,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,,LIVING,2006.0,BRCA.Normal,0,2371.0,0.0,2371.0,0.0,2371.0,0,2371.0
TCGA-BH-A0BZ-01,Stage IIIA,59.0,1492.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1492.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,59.0,Left,,Positive,Positive,Modified Radical Mastectomy,,-21856.0,1084.0,0.0,2255.0,NO,,,2014-4-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,830.0,NO,Negative,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf,A0BZ,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumB,0,2255.0,0.0,2255.0,0.0,2255.0,0,2255.0
TCGA-BH-A0BZ-11,,59.0,1492.0,,FEMALE,,,,,,1492.0,0.0,Normal,,,,,LIVING,59.0,Left,,Positive,Positive,Modified Radical Mastectomy,,-21856.0,1084.0,0.0,2255.0,NO,,,2014-4-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,620.0,NO,Negative,,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T3,Stage IIIA,,A0BZ,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2255.0,0.0,2255.0,0.0,2255.0,0,2255.0
TCGA-BH-A0C0-01,Stage IIA,62.0,1270.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1270.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,62.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-23006.0,,0.0,1270.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Positive,,35.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,,No,M0,N1a,T1c,Stage IIA,,A0C0,TUMOR FREE,,,60-69%,YES,Primary Tumor,1,,YES,,LIVING,2007.0,BRCA.LumB,0,1270.0,0.0,1270.0,0.0,1270.0,0,1270.0
TCGA-BH-A0C0-11,,62.0,1270.0,,FEMALE,,,,,,1270.0,0.0,Normal,,,,,LIVING,62.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-23006.0,1094.0,0.0,1270.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,330.0,NO,Equivocal,Positive,,35.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N1a,T1c,Stage IIA,,A0C0,TUMOR FREE,,,60-69%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2007.0,BRCA.Normal,0,1270.0,0.0,1270.0,0.0,1270.0,0,1270.0
TCGA-BH-A0C1-01,Stage IIIA,61.0,1338.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1338.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,61.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-22377.0,1073.0,0.0,1339.0,YES,,,2014-8-7,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,250.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,8.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02.pdf,A0C1,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,6th,,B,DECEASED,2007.0,BRCA.LumA,1,1411.0,1.0,1411.0,1.0,1123.0,1,1123.0
TCGA-BH-A0C3-01,Stage I,47.0,1464.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1464.0,0.0,LumB,Luminal B,Negative,T1,T1,LIVING,47.0,Left,,Positive,Negative,Other,,-17221.0,1335.0,0.0,2709.0,NO,,,2014-8-12,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf,A0C3,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumB,0,2709.0,0.0,2709.0,1.0,2674.0,1,2674.0
TCGA-BH-A0C3-11,,47.0,1464.0,,FEMALE,,,,,,1464.0,0.0,Normal,,,,,LIVING,47.0,Left,,Positive,Negative,Other,,-17221.0,1335.0,0.0,2709.0,NO,,,2014-8-12,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,,True,No,M0,N0,T1c,Stage I,,A0C3,WITH TUMOR,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2006.0,BRCA.Normal,0,2709.0,0.0,2709.0,1.0,2674.0,1,2674.0
TCGA-BH-A0C7-01,Stage IIB,48.0,1305.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1305.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,48.0,Left,,Positive,Negative,Simple Mastectomy,,-17871.0,1520.0,0.0,2767.0,NO,,,2014-5-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,,Positive,NO,18.0,Negative,Peri (6-12 months since last menstrual period),NO,1.0,,True,No,M0,N1mi,T2,Stage IIB,TCGA-BH-A0C7.880F3DC6-4342-4232-A04E-A128F1A8201D.pdf,A0C7,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,B,LIVING,2006.0,BRCA.LumB,0,2767.0,0.0,2767.0,0.0,2767.0,0,2767.0
TCGA-BH-A0DD-01,Stage IIB,58.0,1393.0,Positive,MALE,Positive,Negative,M0,Positive,N1,1393.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,58.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-21386.0,1248.0,0.0,2486.0,NO,,,2014-6-9,MALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,430.0,NO,Positive,Positive,NO,22.0,Negative,,NO,0.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf,A0DD,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumB,0,2486.0,0.0,2486.0,0.0,2486.0,0,2486.0
TCGA-BH-A0DD-11,,58.0,1393.0,,MALE,,,,,,1393.0,0.0,LumA,,,,,LIVING,58.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-21386.0,1248.0,0.0,2486.0,NO,,,2014-6-9,MALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,460.0,NO,Positive,Positive,NO,22.0,Negative,,NO,0.0,,True,No,M0,N1a,T2,Stage IIB,,A0DD,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,6th,,A,LIVING,2006.0,BRCA.LumA,0,2486.0,0.0,2486.0,0.0,2486.0,0,2486.0
TCGA-BH-A0DE-01,Stage IIA,62.0,948.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,948.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,62.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-22656.0,,0.0,2372.0,NO,,,2014-8-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A0DE,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,2372.0,0.0,2372.0,0.0,2372.0,0,2372.0
TCGA-BH-A0DG-01,Stage IIA,30.0,713.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,713.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,30.0,Right Upper Outer Quadrant,,Positive,Negative,Other,,-11204.0,,0.0,2041.0,NO,,,2014-8-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A0DG,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,2041.0,0.0,2041.0,0.0,2041.0,0,2041.0
TCGA-BH-A0DG-11,,30.0,713.0,,FEMALE,,,,,,713.0,0.0,Normal,,,,,LIVING,30.0,Right Upper Outer Quadrant,,Positive,Negative,Other,,-11204.0,972.0,0.0,2041.0,NO,,,2014-8-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,470.0,NO,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,,A0DG,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2041.0,0.0,2041.0,0.0,2041.0,0,2041.0
TCGA-BH-A0DH-01,Stage IIB,63.0,1156.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1156.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,63.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-23366.0,,0.0,1156.0,,90-99%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,28.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,3.0,,,No,M0,N1a,T2,Stage IIB,,A0DH,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,,LIVING,2007.0,BRCA.LumA,0,1156.0,0.0,1156.0,0.0,1156.0,0,1156.0
TCGA-BH-A0DH-11,,63.0,1156.0,,FEMALE,,,,,,1156.0,0.0,Normal,,,,,LIVING,63.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-23366.0,968.0,0.0,1156.0,,90-99%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Negative,,,28.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,3.0,,True,No,M0,N1a,T2,Stage IIB,,A0DH,TUMOR FREE,,,40-49%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2007.0,BRCA.Normal,0,1156.0,0.0,1156.0,0.0,1156.0,0,1156.0
TCGA-BH-A0DI-01,Stage IIB,63.0,673.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,673.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,63.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-23327.0,267.0,0.0,912.0,NO,,,2014-4-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,NO,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf,A0DI,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,912.0,0.0,912.0,0.0,912.0,0,912.0
TCGA-BH-A0DK-01,Stage IIA,49.0,423.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,423.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,49.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-18237.0,254.0,0.0,423.0,,,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,240.0,NO,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf,A0DK,TUMOR FREE,,,,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,423.0,0.0,423.0,0.0,423.0,0,423.0
TCGA-BH-A0DK-11,,49.0,423.0,,FEMALE,,,,,,423.0,0.0,LumA,,,,,LIVING,49.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-18237.0,254.0,0.0,423.0,,,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,550.0,NO,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,,A0DK,TUMOR FREE,,,,NO,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.LumA,0,423.0,0.0,423.0,0.0,423.0,0,423.0
TCGA-BH-A0DL-01,Stage IIA,64.0,1467.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1467.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,64.0,Left,,Positive,Negative,Other,,-23628.0,1074.0,0.0,2381.0,NO,,,2014-6-9,FEMALE,,"Other, specify",No,C50.9,8575/3,C50.9,YES,Core needle biopsy,350.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB.pdf,A0DL,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Basal,0,2381.0,0.0,2381.0,0.0,2381.0,0,2381.0
TCGA-BH-A0DL-11,,64.0,1467.0,,FEMALE,,,,,,1467.0,0.0,Normal,,,,,LIVING,64.0,Left,,Positive,Negative,Other,,-23628.0,,0.0,2381.0,NO,,,2014-6-9,FEMALE,,"Other, specify",No,C50.9,8575/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A0DL,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,,LIVING,2007.0,BRCA.Normal,0,2381.0,0.0,2381.0,0.0,2381.0,0,2381.0
TCGA-BH-A0DO-01,Stage I,78.0,525.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,525.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,78.0,Left Upper Inner Quadrant,,Positive,Positive,Simple Mastectomy,,-28529.0,454.0,0.0,1644.0,NO,,,2014-8-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,Yes,M0,N0,T1c,Stage I,TCGA-BH-A0DO.C75872B6-2260-41C3-9E21-91E4F52AD7EA.pdf,A0DO,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,6th,,B,LIVING,2009.0,BRCA.LumA,0,1644.0,0.0,1644.0,0.0,1644.0,0,1644.0
TCGA-BH-A0DO-11,,78.0,525.0,,FEMALE,,,,,,525.0,0.0,Normal,,,,,LIVING,78.0,Left Upper Inner Quadrant,,Positive,Positive,Simple Mastectomy,,-28529.0,,0.0,1644.0,NO,,,2014-8-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,Yes,M0,N0,T1c,Stage I,,A0DO,TUMOR FREE,NO,YES,,NO,Solid Tissue Normal,11,6th,,,LIVING,2009.0,BRCA.Normal,0,1644.0,0.0,1644.0,0.0,1644.0,0,1644.0
TCGA-BH-A0DP-01,Stage IIB,60.0,476.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,476.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,60.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-22199.0,293.0,0.0,476.0,,80-89%,,2010-11-16,FEMALE,0,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,510.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-BH-A0DP.F04188AB-51CE-4AA1-B72C-399BE7863235.pdf,A0DP,TUMOR FREE,,,80-89%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,476.0,0.0,476.0,0.0,476.0,0,476.0
TCGA-BH-A0DP-11,,60.0,476.0,,FEMALE,,,,,,476.0,0.0,Normal,,,,,LIVING,60.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-22199.0,293.0,0.0,476.0,,80-89%,,2010-11-16,FEMALE,0,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,290.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,,A0DP,TUMOR FREE,,,80-89%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,476.0,0.0,476.0,0.0,476.0,0,476.0
TCGA-BH-A0DQ-01,Stage IIB,42.0,98.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,98.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,42.0,Right Upper Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-15533.0,190.0,0.0,98.0,,60-69%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,,25.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D.pdf,A0DQ,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,98.0,0.0,98.0,0.0,98.0,0,98.0
TCGA-BH-A0DQ-11,,42.0,98.0,,FEMALE,,,,,,98.0,0.0,LumA,,,,,LIVING,42.0,Right Upper Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-15533.0,190.0,0.0,98.0,,60-69%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,,,25.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,,True,No,M0,N1,T2,Stage IIB,,A0DQ,TUMOR FREE,,,70-79%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.LumA,0,98.0,0.0,98.0,0.0,98.0,0,98.0
TCGA-BH-A0DS-01,Stage IIIA,71.0,77.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,77.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,71.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-25944.0,79.0,0.0,78.0,,70-79%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,8.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf,A0DS,TUMOR FREE,,,70-79%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,78.0,0.0,78.0,0.0,78.0,0,78.0
TCGA-BH-A0DT-01,Stage IIA,41.0,1170.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1170.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,41.0,Right,,Positive,Positive,Other,,-15078.0,,0.0,2403.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,M0,N1a,T1c,Stage IIA,,A0DT,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,2403.0,0.0,2403.0,0.0,2403.0,0,2403.0
TCGA-BH-A0DT-11,,41.0,1170.0,,FEMALE,,,,,,1170.0,0.0,Normal,,,,,LIVING,41.0,Right,,Positive,Positive,Other,,-15078.0,1044.0,0.0,2403.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,Negative,,NO,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1a,T1c,Stage IIA,,A0DT,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2403.0,0.0,2403.0,0.0,2403.0,0,2403.0
TCGA-BH-A0DV-01,Stage IIIA,54.0,1374.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1374.0,0.0,LumA,,Positive,T_Other,T2,LIVING,54.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,,Positive,Positive,Modified Radical Mastectomy,,-19781.0,975.0,0.0,2064.0,NO,,,2014-8-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,370.0,NO,Negative,,NO,9.0,Negative,Peri (6-12 months since last menstrual period),NO,9.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf,A0DV,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2064.0,0.0,2064.0,0.0,2064.0,0,2064.0
TCGA-BH-A0DV-11,,54.0,1374.0,,FEMALE,,,,,,1374.0,0.0,Normal,,,,,LIVING,54.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,,Positive,Positive,Modified Radical Mastectomy,,-19781.0,975.0,0.0,2064.0,NO,,,2014-8-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,NO,9.0,Negative,Peri (6-12 months since last menstrual period),NO,9.0,,True,No,M0,N2a,T2,Stage IIIA,,A0DV,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,,A,LIVING,2007.0,BRCA.Normal,0,2064.0,0.0,2064.0,0.0,2064.0,0,2064.0
TCGA-BH-A0DX-01,Stage I,62.0,1442.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1442.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,62.0,Left Upper Inner Quadrant,,Positive,Positive,Other,,-22833.0,,0.0,2156.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1b,Stage I,,A0DX,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.LumA,0,2156.0,0.0,2156.0,0.0,2156.0,0,2156.0
TCGA-BH-A0DZ-01,Stage IIB,43.0,495.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,495.0,0.0,LumA,HER2-enriched,Positive,T_Other,T2,LIVING,43.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-15980.0,308.0,0.0,495.0,,50-59%,,2010-11-16,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Positive,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD.pdf,A0DZ,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,495.0,0.0,495.0,0.0,495.0,0,495.0
TCGA-BH-A0DZ-11,,43.0,495.0,,FEMALE,,,,,,495.0,0.0,,,,,,LIVING,43.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-15980.0,,0.0,495.0,,50-59%,,2010-11-16,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Positive,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,,,No,M0,N1a,T2,Stage IIB,,A0DZ,TUMOR FREE,,,<10%,NO,Solid Tissue Normal,11,,YES,,LIVING,2009.0,BRCA.Normal,0,495.0,0.0,495.0,0.0,495.0,0,495.0
TCGA-BH-A0E0-01,Stage IIIC,38.0,133.0,Negative,FEMALE,Negative,Negative,M0,Positive,N3,133.0,0.0,Basal,Basal-like,Negative,T_Other,T3,LIVING,38.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14175.0,136.0,0.0,134.0,,,,2010-10-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,620.0,NO,Negative,,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,10.0,,True,No,M0,N3a,T3,Stage IIIC,TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf,A0E0,TUMOR FREE,,,,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Basal,0,134.0,0.0,134.0,0.0,134.0,0,134.0
TCGA-BH-A0E0-11,,38.0,133.0,,FEMALE,,,,,,133.0,0.0,Normal,,,,,LIVING,38.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14175.0,136.0,0.0,134.0,,,,2010-10-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,10.0,,True,No,M0,N3a,T3,Stage IIIC,,A0E0,TUMOR FREE,,,,YES,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,134.0,0.0,134.0,0.0,134.0,0,134.0
TCGA-BH-A0E1-01,Stage IIB,52.0,477.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,477.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,52.0,Left Upper Inner Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-19192.0,301.0,0.0,477.0,,70-79%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,990.0,NO,Equivocal,Negative,,17.0,Negative,Peri (6-12 months since last menstrual period),,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-BH-A0E1.891F4C63-8207-4CB8-AB59-A970CC6F1A1A.pdf,A0E1,TUMOR FREE,,,50-59%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,477.0,0.0,477.0,0.0,477.0,0,477.0
TCGA-BH-A0E1-11,,52.0,477.0,,FEMALE,,,,,,477.0,0.0,Normal,,,,,LIVING,52.0,Left Upper Inner Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-19192.0,301.0,0.0,477.0,,70-79%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,500.0,NO,Equivocal,Negative,,17.0,Negative,Peri (6-12 months since last menstrual period),,2.0,,True,No,M0,N1,T2,Stage IIB,,A0E1,TUMOR FREE,,,50-59%,NO,Solid Tissue Normal,11,,YES,A,LIVING,2009.0,BRCA.Normal,0,477.0,0.0,477.0,0.0,477.0,0,477.0
TCGA-BH-A0E2-01,Stage IIIA,49.0,435.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,435.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,49.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-18152.0,210.0,0.0,435.0,,90-99%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,,26.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,4.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf,A0E2,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,435.0,0.0,435.0,0.0,435.0,0,435.0
TCGA-BH-A0E6-01,Stage IA,69.0,292.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,292.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,69.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Negative,Negative,Other,NO,-25408.0,134.0,0.0,293.0,,,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf,A0E6,TUMOR FREE,,,,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.Basal,0,293.0,0.0,293.0,0.0,293.0,0,293.0
TCGA-BH-A0E7-01,Stage IIB,79.0,1362.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1362.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,79.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,-29115.0,1259.0,0.0,1363.0,,50-59%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,140.0,NO,Negative,,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0E7.CE32A294-10FC-4DBA-A779-FAEEBE677D38.pdf,A0E7,TUMOR FREE,,,60-69%,YES,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.LumA,0,1363.0,0.0,1363.0,0.0,1363.0,0,1363.0
TCGA-BH-A0E9-01,Stage IIB,53.0,1405.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1405.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,53.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-19415.0,1357.0,0.0,2489.0,NO,,,2014-5-1,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,480.0,NO,Negative,,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0E9.8FDACA3D-C172-4198-9BBB-8F9E5A5FF0D6.pdf,A0E9,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,B,LIVING,2006.0,BRCA.LumA,0,2489.0,0.0,2489.0,0.0,2489.0,0,2489.0
TCGA-BH-A0EA-01,Stage IIA,72.0,831.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,993.0,1.0,LumA,Luminal A,Positive,T1,T1,DECEASED,72.0,Left,,Positive,Positive,Other,,-26548.0,567.0,0.0,,NO,,,2014-4-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,Yes,M0,N1a,T1c,Stage IIA,TCGA-BH-A0EA.28231C7B-64EE-49AC-B7AB-9BADDDDCC17C.pdf,A0EA,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,DECEASED,2008.0,BRCA.LumA,1,991.0,0.0,991.0,0.0,991.0,0,991.0
TCGA-BH-A0EB-01,Stage IA,69.0,745.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,745.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,69.0,Right Lower Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-25259.0,,0.0,745.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,,No,M0,N0 (i-),T1c,Stage IA,,A0EB,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,,LIVING,2008.0,BRCA.LumA,0,745.0,0.0,745.0,0.0,745.0,0,745.0
TCGA-BH-A0EE-01,Stage IIB,68.0,943.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,943.0,0.0,Her2,HER2-enriched,Negative,T_Other,T3,LIVING,68.0,Right Upper Inner Quadrant|Right,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-24850.0,946.0,0.0,943.0,,,,2010-11-16,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,890.0,NO,Positive,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-BH-A0EE.B8664381-386A-44A2-AC3B-D69A4980A8EA.pdf,A0EE,TUMOR FREE,,,,NO,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.Her2,0,943.0,0.0,943.0,0.0,943.0,0,943.0
TCGA-BH-A0EI-01,Stage IIA,51.0,743.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,743.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,51.0,Right,,Positive,Positive,Other,,-18741.0,,0.0,1926.0,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),NO,2.0,,,No,M0,N1a,T1c,Stage IIA,,A0EI,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,,LIVING,2008.0,BRCA.LumA,0,1926.0,0.0,1926.0,0.0,1926.0,0,1926.0
TCGA-BH-A0GY-01,Stage IIA,67.0,923.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,923.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,67.0,Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-24493.0,745.0,0.0,923.0,,40-49%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,26.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,3.0,,True,No,M0,N1,T2,Stage IIA,TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62.pdf,A0GY,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,923.0,0.0,923.0,0.0,923.0,0,923.0
TCGA-BH-A0GZ-01,Stage IIA,62.0,328.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,328.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,62.0,Left Upper Inner Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,NO,-22714.0,206.0,0.0,328.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,60.0,NO,Equivocal,Negative,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-BH-A0GZ.C956B4B1-99E6-4823-886A-FA8FCD1E3E4D.pdf,A0GZ,TUMOR FREE,,,80-89%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,328.0,0.0,328.0,0.0,328.0,0,328.0
TCGA-BH-A0H0-01,Stage IA,69.0,461.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,461.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,69.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,NO,-25223.0,344.0,0.0,461.0,,50-59%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf,A0H0,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumB,0,461.0,0.0,461.0,0.0,461.0,0,461.0
TCGA-BH-A0H3-01,Stage I,46.0,1149.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1149.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,46.0,Left Upper Outer Quadrant,,Positive,Positive,Other,,-17152.0,773.0,0.0,1928.0,NO,,,2014-4-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,,Negative,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T1c,Stage I,TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf,A0H3,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,1928.0,0.0,1928.0,0.0,1928.0,0,1928.0
TCGA-BH-A0H5-01,Stage I,45.0,1080.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1080.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,45.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-16719.0,815.0,0.0,1620.0,NO,,,2014-4-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,410.0,NO,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage I,TCGA-BH-A0H5.C350A3BE-1709-427D-8E1D-E0BBA480A56D.pdf,A0H5,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.LumA,0,1620.0,0.0,1620.0,0.0,1620.0,0,1620.0
TCGA-BH-A0H5-11,,45.0,1080.0,,FEMALE,,,,,,1080.0,0.0,Normal,,,,,LIVING,45.0,Right Upper Outer Quadrant,,Positive,Positive,Other,,-16719.0,,0.0,1620.0,NO,,,2014-4-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0 (i-),T1c,Stage I,,A0H5,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,6th,,,LIVING,2008.0,BRCA.Normal,0,1620.0,0.0,1620.0,0.0,1620.0,0,1620.0
TCGA-BH-A0H6-01,Stage IA,82.0,747.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,747.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,82.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right,No axillary staging,Positive,Positive,Other,NO,-30125.0,,0.0,747.0,,50-59%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,0.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,,No,M0,NX,T1b,Stage I,,A0H6,TUMOR FREE,,,60-69%,YES,Primary Tumor,1,,YES,,LIVING,2008.0,BRCA.LumA,0,747.0,0.0,747.0,0.0,747.0,0,747.0
TCGA-BH-A0H7-01,Stage IIIA,65.0,701.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,701.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,65.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-23972.0,542.0,0.0,702.0,,70-79%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,440.0,NO,Negative,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,6.0,,True,No,M0,N2a,T1c,Stage IIIA,TCGA-BH-A0H7.CC7D1177-1638-4A80-A3AA-266ADC260EC9.pdf,A0H7,TUMOR FREE,,,30-39%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,702.0,0.0,702.0,0.0,702.0,0,702.0
TCGA-BH-A0H7-11,,65.0,701.0,,FEMALE,,,,,,701.0,0.0,Normal,,,,,LIVING,65.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-23972.0,542.0,0.0,702.0,,70-79%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,380.0,NO,Negative,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,6.0,,True,No,M0,N2a,T1c,Stage IIIA,,A0H7,TUMOR FREE,,,30-39%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2008.0,BRCA.Normal,0,702.0,0.0,702.0,0.0,702.0,0,702.0
TCGA-BH-A0H9-01,Stage IIA,69.0,1247.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1247.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,69.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,NO,-25289.0,1088.0,0.0,1247.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3.pdf,A0H9,TUMOR FREE,,,30-39%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,1247.0,0.0,1247.0,0.0,1247.0,0,1247.0
TCGA-BH-A0H9-11,,69.0,1247.0,,FEMALE,,,,,,1247.0,0.0,,,,,,LIVING,69.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,NO,-25289.0,1088.0,0.0,1247.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,,A0H9,TUMOR FREE,,,30-39%,YES,Solid Tissue Normal,11,,YES,A,LIVING,2007.0,BRCA.Normal,0,1247.0,0.0,1247.0,0.0,1247.0,0,1247.0
TCGA-BH-A0HA-01,Stage I,31.0,856.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,856.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,31.0,Right,,Positive,Positive,Other,,-11379.0,,0.0,1611.0,NO,,Scheduled Follow-up Submission,2013-5-17,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0 (i-),T1c,Stage I,,A0HA,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,6th,NO,,LIVING,2008.0,BRCA.LumA,0,1611.0,0.0,1611.0,0.0,1611.0,0,1611.0
TCGA-BH-A0HA-11,,31.0,856.0,,FEMALE,,,,,,856.0,0.0,Normal,,,,,LIVING,31.0,Right,,Positive,Positive,Other,,-11379.0,675.0,0.0,1611.0,NO,,Scheduled Follow-up Submission,2013-5-17,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,340.0,NO,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage I,,A0HA,TUMOR FREE,NO,YES,,NO,Solid Tissue Normal,11,6th,NO,A,LIVING,2008.0,BRCA.Normal,0,1611.0,0.0,1611.0,0.0,1611.0,0,1611.0
TCGA-BH-A0HB-01,Stage IA,55.0,806.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,806.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,55.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,NO,-20448.0,739.0,0.0,806.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HB.C7476B2B-0040-4013-8D30-06935E3FB897.pdf,A0HB,TUMOR FREE,,,30-39%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,806.0,0.0,806.0,0.0,806.0,0,806.0
TCGA-BH-A0HF-01,Stage IA,77.0,727.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,727.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,77.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,NO,-28233.0,549.0,0.0,727.0,,90-99%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,40.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HF.71291A56-C2DB-4EB9-8223-DD7563CBBDC9.pdf,A0HF,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,727.0,0.0,727.0,0.0,727.0,0,727.0
TCGA-BH-A0HI-01,Stage IA,78.0,619.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,619.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,78.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,YES,-28644.0,554.0,0.0,620.0,,50-59%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,20.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf,A0HI,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,620.0,0.0,620.0,0.0,620.0,0,620.0
TCGA-BH-A0HK-01,Stage IIB,81.0,178.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,178.0,0.0,LumA,Luminal A,Negative,T_Other,T2,LIVING,81.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-29751.0,35.0,0.0,178.0,,70-79%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,700.0,NO,Negative,,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-BH-A0HK.575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09.pdf,A0HK,TUMOR FREE,,,<10%,NO,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.LumA,0,178.0,0.0,178.0,0.0,178.0,0,178.0
TCGA-BH-A0HK-11,,81.0,178.0,,FEMALE,,,,,,178.0,0.0,Normal,,,,,LIVING,81.0,Right Upper Inner Quadrant|Right,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-29751.0,35.0,0.0,178.0,,70-79%,,2010-11-16,FEMALE,0,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,Negative,,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,,True,No,M0,N1,T2,Stage IIB,,A0HK,TUMOR FREE,,,<10%,NO,Solid Tissue Normal,11,,YES,A,LIVING,2010.0,BRCA.Normal,0,178.0,0.0,178.0,0.0,178.0,0,178.0
TCGA-BH-A0HL-01,Stage IIB,56.0,72.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,72.0,0.0,,Basal-like,Positive,T_Other,T2,LIVING,56.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-20804.0,352.0,0.0,72.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8503/3,C50.9,YES,Core needle biopsy,250.0,NO,Equivocal,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0HL.79DAEAE5-A177-40E0-9BFC-54DC9F544764.pdf,A0HL,TUMOR FREE,,,40-49%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,72.0,0.0,72.0,0.0,72.0,0,72.0
TCGA-BH-A0HN-01,Stage IA,67.0,516.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,516.0,0.0,,Basal-like,Positive,T1,T1,LIVING,67.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Other,NO,-24731.0,359.0,0.0,516.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,Equivocal,Negative,,2.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HN.CA7E5555-5898-411A-8A5B-9BA2239A2B30.pdf,A0HN,TUMOR FREE,,,90-99%,NO,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,516.0,0.0,516.0,0.0,516.0,0,516.0
TCGA-BH-A0HO-01,Stage IIA,48.0,76.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,76.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,48.0,Right Upper Outer Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-17710.0,224.0,0.0,76.0,,90-99%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,1.0,1.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2.pdf,A0HO,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,76.0,0.0,76.0,0.0,76.0,0,76.0
TCGA-BH-A0HP-01,Stage IIIA,65.0,414.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,414.0,0.0,LumA,Luminal A,Negative,T_Other,T3,LIVING,65.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-23883.0,346.0,0.0,414.0,,80-89%,,2010-11-16,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,720.0,NO,Negative,,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,8.0,,True,No,M0,N2a,T3,Stage IIIA,TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf,A0HP,TUMOR FREE,,,,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumA,0,414.0,0.0,414.0,0.0,414.0,0,414.0
TCGA-BH-A0HQ-01,Stage IIA,56.0,1121.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1121.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,56.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Positive,Other,YES,-20719.0,962.0,0.0,1121.0,,90-99%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-BH-A0HQ.A76A272F-675E-4E56-8761-96B71419A012.pdf,A0HQ,TUMOR FREE,,,90-99%,YES,Primary Tumor,1,,YES,A,LIVING,2007.0,BRCA.LumA,0,1121.0,0.0,1121.0,0.0,1121.0,0,1121.0
TCGA-BH-A0HU-01,Stage IA,52.0,392.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,392.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,52.0,Right Upper Outer Quadrant|Right,Sentinel node biopsy alone,Positive,Positive,Other,NO,-19216.0,394.0,0.0,392.0,,40-49%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,,1.0,Negative,Peri (6-12 months since last menstrual period),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HU.1F35A542-2795-4B1F-A846-7097B442C2D9.pdf,A0HU,TUMOR FREE,,,40-49%,YES,Primary Tumor,1,,YES,A,LIVING,2009.0,BRCA.LumB,0,392.0,0.0,392.0,0.0,392.0,0,392.0
TCGA-BH-A0HW-01,Stage IA,62.0,1560.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1560.0,0.0,LumB,Luminal B,Negative,T1,T1,LIVING,62.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel node biopsy alone,Positive,Negative,Other,NO,-22962.0,1591.0,0.0,1561.0,,90-99%,,2010-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-BH-A0HW.8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD.pdf,A0HW,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2006.0,BRCA.LumB,0,1561.0,0.0,1561.0,0.0,1561.0,0,1561.0
TCGA-BH-A0HX-01,Stage IIB,54.0,829.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,829.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,54.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-19900.0,672.0,0.0,829.0,,80-89%,,2010-11-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,2.0,2.0,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A0HX.8C4FEB77-99B6-4C73-9751-508953A874DC.pdf,A0HX,TUMOR FREE,,,50-59%,NO,Primary Tumor,1,,YES,A,LIVING,2008.0,BRCA.LumA,0,829.0,0.0,829.0,0.0,829.0,0,829.0
TCGA-BH-A0HY-01,Stage I,60.0,867.0,Positive,FEMALE,,Negative,M0,Negative,N0,867.0,0.0,LumB,HER2-enriched,Negative,T1,T1,LIVING,60.0,Left,,Positive,Negative,Other,,-22179.0,,0.0,1545.0,NO,,Scheduled Follow-up Submission,2013-5-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Positive,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A0HY,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumB,0,1545.0,0.0,1545.0,0.0,1545.0,0,1545.0
TCGA-BH-A0RX-01,Stage IIA,59.0,170.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,170.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,59.0,Left Upper Outer Quadrant|Left,Sentinel node biopsy alone,Negative,Negative,Other,NO,-21857.0,63.0,0.0,170.0,,<10%,,2010-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-BH-A0RX.57359A9F-7E5A-4599-918C-A95DCF0D9479.pdf,A0RX,TUMOR FREE,,,<10%,YES,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.Basal,0,170.0,0.0,170.0,0.0,170.0,0,170.0
TCGA-BH-A0W5-01,Stage IIA,77.0,543.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,543.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,77.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-28304.0,906.0,0.0,1288.0,,,Scheduled Follow-up Submission,2012-7-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Equivocal,Equivocal,,11.0,Negative,,NO,1.0,1.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-BH-A0W5.60F59595-928B-43BB-978F-9E5B48539EFA.pdf,A0W5,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1288.0,0.0,1288.0,0.0,1288.0,0,1288.0
TCGA-BH-A0W7-01,Stage IA,49.0,558.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,558.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,49.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-17996.0,,0.0,1363.0,,,Scheduled Follow-up Submission,2012-7-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,2.0,Negative,,NO,0.0,0.0,,No,M0,N0 (i-),T1c,Stage I,,A0W7,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,,LIVING,2008.0,BRCA.LumA,0,1363.0,0.0,1363.0,0.0,1363.0,0,1363.0
TCGA-BH-A0WA-01,Stage IA,82.0,372.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,372.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,82.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Other,,-30025.0,724.0,0.0,701.0,,,Scheduled Follow-up Submission,2012-7-29,FEMALE,,,No,C50.9,8575/3,C50.9,YES,Fine needle aspiration biopsy,80.0,NO,Negative,,,3.0,Negative,,NO,0.0,,True,No,M0,N0 (i-),T1c,Stage I,TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf,A0WA,TUMOR FREE,,,,NO,Primary Tumor,1,6th,NO,A,LIVING,2008.0,BRCA.Basal,0,701.0,0.0,701.0,0.0,701.0,0,701.0
TCGA-BH-A18F-01,Stage IIA,50.0,268.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,268.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,50.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-18594.0,114.0,0.0,1001.0,,70-79%,,2014-5-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,NO,1.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728.pdf,A18F,TUMOR FREE,YES,YES,40-49%,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1001.0,0.0,1001.0,0.0,1001.0,0,1001.0
TCGA-BH-A18G-01,Stage X,81.0,61.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,61.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,81.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,,-29820.0,78.0,0.0,149.0,,,,2014-8-27,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.5,8500/3,C50.5,YES,Core needle biopsy,100.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf,A18G,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,,,A,LIVING,2010.0,BRCA.Basal,0,149.0,0.0,149.0,0.0,149.0,0,149.0
TCGA-BH-A18H-01,Stage IB,63.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,63.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-23065.0,16.0,0.0,652.0,,,,2014-5-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Positive,Equivocal,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,Yes,M0,N0,T1b,Stage IA,TCGA-BH-A18H.DF536409-601F-489B-9F8A-A2B372BF9999.pdf,A18H,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,652.0,0.0,652.0,0.0,652.0,0,652.0
TCGA-BH-A18I-01,Stage IIA,53.0,220.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,220.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,53.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-19489.0,80.0,0.0,1093.0,,,,2014-4-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.2,8500/3,C50.2,YES,Core needle biopsy,100.0,NO,Positive,,NO,3.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,1.0,True,No,cM0 (i+),N1a,T1c,Stage IIA,TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C.pdf,A18I,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1093.0,0.0,1093.0,0.0,1093.0,0,1093.0
TCGA-BH-A18L-01,Stage IIB,50.0,372.0,Positive,FEMALE,,Negative,M0,Positive,N1,811.0,1.0,LumB,Luminal B,Positive,T_Other,T3,DECEASED,50.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-18519.0,,0.0,,NO,,,2011-6-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,3.0,Negative,,,1.0,1.0,,No,M0,N1mi,T3,Stage IIIA,,A18L,,,YES,,,Primary Tumor,1,6th,,,DECEASED,2003.0,BRCA.LumB,1,811.0,,811.0,0.0,811.0,0,811.0
TCGA-BH-A18L-11,,50.0,372.0,,FEMALE,,,,,,811.0,1.0,Normal,,,,,DECEASED,50.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-18519.0,2669.0,0.0,,NO,,,2011-6-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,530.0,NO,Negative,,,3.0,Negative,,,1.0,1.0,True,No,M0,N1mi,T3,Stage IIIA,,A18L,,,YES,,,Solid Tissue Normal,11,6th,,A,DECEASED,2003.0,BRCA.Normal,1,811.0,,811.0,0.0,811.0,0,811.0
TCGA-BH-A18M-01,Stage IIB,39.0,2207.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,2207.0,1.0,LumA,Luminal A,Positive,T_Other,T3,DECEASED,39.0,Left Upper Inner Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-14532.0,3629.0,0.0,,NO,,,2011-6-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.3,8500/3,C50.3,YES,Core needle biopsy,360.0,NO,Positive,Positive,,6.0,Negative,,,4.0,4.0,True,No,M0,N1,T3,Stage IIIA,TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D.pdf,A18M,,,YES,,,Primary Tumor,1,5th,,A,DECEASED,2001.0,BRCA.LumA,1,2207.0,,2207.0,0.0,2207.0,0,2207.0
TCGA-BH-A18M-11,,39.0,2207.0,,FEMALE,,,,,,2207.0,1.0,Normal,,,,,DECEASED,39.0,Left Upper Inner Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-14532.0,3629.0,0.0,,NO,,,2011-6-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.3,8500/3,C50.3,YES,Core needle biopsy,310.0,NO,Positive,Positive,,6.0,Negative,,,4.0,4.0,True,No,M0,N1,T3,Stage IIIA,,A18M,,,YES,,,Solid Tissue Normal,11,5th,,A,DECEASED,2001.0,BRCA.Normal,1,2207.0,,2207.0,0.0,2207.0,0,2207.0
TCGA-BH-A18N-01,Stage IIA,88.0,1148.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1148.0,1.0,LumA,Luminal A,Positive,T_Other,T2,DECEASED,88.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-32404.0,,0.0,,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,NO,26.0,Negative,,,2.0,2.0,,No,M0,N1b,T2,Stage IIA,,A18N,,NO,YES,,NO,Primary Tumor,1,,,,DECEASED,2001.0,BRCA.LumA,1,1148.0,,1148.0,0.0,1148.0,0,1148.0
TCGA-BH-A18N-11,,88.0,1148.0,,FEMALE,,,,,,1148.0,1.0,Normal,,,,,DECEASED,88.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-32404.0,3374.0,0.0,,NO,,,2014-5-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,590.0,NO,Negative,,NO,26.0,Negative,,,2.0,2.0,True,No,M0,N1b,T2,Stage IIA,,A18N,,NO,YES,,NO,Solid Tissue Normal,11,,,A,DECEASED,2001.0,BRCA.Normal,1,1148.0,,1148.0,0.0,1148.0,0,1148.0
TCGA-BH-A18Q-01,Stage IIB,56.0,1692.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1692.0,1.0,Basal,Basal-like,Negative,T_Other,T2,DECEASED,56.0,Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-20675.0,3417.0,0.0,,,,,2011-6-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.8,8500/3,C50.8,YES,Core needle biopsy,130.0,NO,Positive,Negative,,25.0,Negative,,,2.0,2.0,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf,A18Q,,,YES,,,Primary Tumor,1,,,A,DECEASED,2001.0,BRCA.Basal,1,1692.0,,1692.0,0.0,1692.0,0,1692.0
TCGA-BH-A18Q-11,,56.0,1692.0,,FEMALE,,,,,,1692.0,1.0,Normal,,,,,DECEASED,56.0,Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-20675.0,3417.0,0.0,,,,,2011-6-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.8,8500/3,C50.8,YES,Core needle biopsy,510.0,NO,Positive,Negative,,25.0,Negative,,,2.0,2.0,True,No,M0,N1b,T2,Stage IIB,,A18Q,,,YES,,,Solid Tissue Normal,11,,,A,DECEASED,2001.0,BRCA.Normal,1,1692.0,,1692.0,0.0,1692.0,0,1692.0
TCGA-BH-A18R-01,Stage IB,50.0,1099.0,Indeterminate,FEMALE,Positive,Negative,M0,Positive,N1,1141.0,1.0,Her2,HER2-enriched,Negative,T_Other,T2,DECEASED,50.0,Right Upper Outer Quadrant,,Indeterminate,Negative,Modified Radical Mastectomy,,-18524.0,,0.0,,NO,20-29%,,2011-7-3,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,,,Positive,Positive,,15.0,Negative,,,10.0,,,No,M0,N1,T2b,Stage IIA,,A18R,TUMOR FREE,,YES,,,Primary Tumor,1,,,,DECEASED,2001.0,BRCA.Her2,1,1142.0,0.0,1142.0,0.0,1142.0,0,1142.0
TCGA-BH-A18R-11,,50.0,1099.0,,FEMALE,,,,,,1141.0,1.0,Normal,,,,,DECEASED,50.0,Right Upper Outer Quadrant,,Indeterminate,Negative,Modified Radical Mastectomy,,-18524.0,3571.0,0.0,,NO,20-29%,,2011-7-3,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Incisional Biopsy,350.0,NO,Positive,Positive,,15.0,Negative,,,10.0,,True,No,M0,N1,T2b,Stage IIA,,A18R,TUMOR FREE,,YES,,,Solid Tissue Normal,11,,,A,DECEASED,2001.0,BRCA.Normal,1,1142.0,0.0,1142.0,0.0,1142.0,0,1142.0
TCGA-BH-A18S-01,Stage I,79.0,2009.0,Positive,FEMALE,,Negative,M0,Negative,N0,2009.0,1.0,LumA,Luminal A,Positive,T1,T1,DECEASED,79.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-28974.0,,0.0,,,,,2011-7-2,FEMALE,,Mucinous Carcinoma,No,C50.3,8523/3,C50.3,YES,Core needle biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,,No,M0,N0,T1c,Stage I,,A18S,TUMOR FREE,,YES,,,Primary Tumor,1,6th,,,DECEASED,2003.0,BRCA.LumA,1,2009.0,0.0,2009.0,0.0,2009.0,0,2009.0
TCGA-BH-A18S-11,,79.0,2009.0,,FEMALE,,,,,,2009.0,1.0,Normal,,,,,DECEASED,79.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-28974.0,,0.0,,,,,2011-7-2,FEMALE,,Mucinous Carcinoma,No,C50.3,8523/3,C50.3,YES,Core needle biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,0.0,,,No,M0,N0,T1c,Stage I,,A18S,TUMOR FREE,,YES,,,Solid Tissue Normal,11,6th,,,DECEASED,2003.0,BRCA.Normal,1,2009.0,0.0,2009.0,0.0,2009.0,0,2009.0
TCGA-BH-A18U-01,Stage IIIA,72.0,1317.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,1563.0,1.0,LumB,Luminal B,Positive,T_Other,T2,DECEASED,72.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-26426.0,2697.0,0.0,,,,,2011-7-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.4,8500/3,C50.4,YES,Core needle biopsy,530.0,NO,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,9.0,,True,No,M0,N2a,T2,Stage IIIA,TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726.pdf,A18U,TUMOR FREE,,YES,,,Primary Tumor,1,6th,,A,DECEASED,2003.0,BRCA.LumB,1,1563.0,0.0,1563.0,0.0,1563.0,0,1563.0
TCGA-BH-A18U-11,,72.0,1317.0,,FEMALE,,,,,,1563.0,1.0,Normal,,,,,DECEASED,72.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,,-26426.0,2697.0,0.0,,,,,2011-7-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.4,8500/3,C50.4,YES,Core needle biopsy,230.0,NO,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,9.0,,True,No,M0,N2a,T2,Stage IIIA,,A18U,TUMOR FREE,,YES,,,Solid Tissue Normal,11,6th,,A,DECEASED,2003.0,BRCA.Normal,1,1563.0,0.0,1563.0,0.0,1563.0,0,1563.0
TCGA-BH-A18V-01,Stage IIB,48.0,1555.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1555.0,1.0,Basal,Basal-like,Negative,T_Other,T2,DECEASED,48.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,-17682.0,3621.0,0.0,,YES,,,2011-7-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.4,8500/3,C50.4,YES,Core needle biopsy,300.0,NO,Negative,,,25.0,Negative,,,0.0,,True,No,M0,N1b,T2,Stage IIB,TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf,A18V,,,YES,,,Primary Tumor,1,5th,,A,DECEASED,2001.0,BRCA.Basal,1,1556.0,,1556.0,0.0,1556.0,0,1556.0
TCGA-BH-A18V-06,,48.0,1555.0,,FEMALE,,,,,,1555.0,1.0,Basal,,,,,DECEASED,48.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,-17682.0,,0.0,,YES,,,2011-7-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.4,8500/3,C50.4,YES,Core needle biopsy,,,Negative,,,25.0,Negative,,,0.0,,,No,M0,N1b,T2,Stage IIB,,A18V,,,YES,,,Metastatic,6,5th,,,DECEASED,2001.0,BRCA.Basal,1,1556.0,,1556.0,0.0,1556.0,0,1556.0
TCGA-BH-A18V-11,,48.0,1555.0,,FEMALE,,,,,,1555.0,1.0,Normal,,,,,DECEASED,48.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,-17682.0,3621.0,0.0,,YES,,,2011-7-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.4,8500/3,C50.4,YES,Core needle biopsy,450.0,NO,Negative,,,25.0,Negative,,,0.0,,True,No,M0,N1b,T2,Stage IIB,,A18V,,,YES,,,Solid Tissue Normal,11,5th,,A,DECEASED,2001.0,BRCA.Normal,1,1556.0,,1556.0,0.0,1556.0,0,1556.0
TCGA-BH-A1EN-01,Stage IIA,78.0,,Negative,FEMALE,Positive,Negative,M0,Negative,N0,2052.0,1.0,Her2,,Negative,T_Other,T2,DECEASED,78.0,Right,,Negative,Negative,Other,,-28724.0,4343.0,0.0,,NO,,,2011-9-3,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,140.0,NO,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,True,No,M0,NX,T2,Stage IIA,TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf,A1EN,TUMOR FREE,,,,,Primary Tumor,1,5th,,A,DECEASED,1999.0,BRCA.Her2,1,2127.0,0.0,2127.0,0.0,2127.0,0,2127.0
TCGA-BH-A1EN-11,,78.0,,,FEMALE,,,,,,2052.0,1.0,Normal,,,,,DECEASED,78.0,Right,,Negative,Negative,Other,,-28724.0,,0.0,,NO,,,2011-9-3,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,,,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,No,M0,NX,T2,Stage IIA,,A1EN,TUMOR FREE,,,,,Solid Tissue Normal,11,5th,,,DECEASED,1999.0,BRCA.Normal,1,2127.0,0.0,2127.0,0.0,2127.0,0,2127.0
TCGA-BH-A28O-01,,,,,,,,,,,,,,,,,,,50.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,NO,-18501.0,163.0,0.0,1120.0,NO,,,2014-8-27,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,80.0,NO,Negative,,NO,14.0,Negative,,NO,14.0,,True,No,M0,N3,T3a,Stage IIIC,TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf,A28O,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.Normal,0,1120.0,0.0,1120.0,0.0,1120.0,0,1120.0
TCGA-BH-A2L8-01,,,,,,,,,,,,,LumA,,,,,,45.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,NO,-16658.0,86.0,0.0,612.0,NO,70-79%,,2013-1-28,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,Negative,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-BH-A2L8.B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD.pdf,A2L8,TUMOR FREE,YES,YES,80-89%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,612.0,0.0,612.0,0.0,612.0,0,612.0
TCGA-BH-A42T-01,,,,,,,,,,,,,,,,,,,75.0,Left,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,,-27731.0,80.0,0.0,30.0,,,,2014-7-10,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,130.0,NO,Positive,Equivocal,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,1.0,True,No,M0,N0 (i+),T2,Stage IIA,TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf,A42T,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,DECEASED,2012.0,BRCA.LumB,1,320.0,0.0,320.0,0.0,320.0,0,320.0
TCGA-BH-A42U-01,,,,,,,,,,,,,,,,,,,80.0,Right,,Negative,Negative,Simple Mastectomy,,-29330.0,3080.0,0.0,3364.0,,,,2014-7-10,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,290.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf,A42U,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2004.0,BRCA.Normal,0,3364.0,0.0,3364.0,0.0,3364.0,0,3364.0
TCGA-BH-A42V-01,,,,,,,,,,,,,,,,,,,41.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,,-15158.0,197.0,0.0,635.0,,,,2014-7-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,60.0,NO,Negative,,NO,3.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1mi,T1c,Stage IB,TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf,A42V,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,635.0,0.0,635.0,0.0,635.0,0,635.0
TCGA-BH-A5IZ-01,,,,,,,,,,,,,,,,,,,51.0,Left,,Positive,Negative,Lumpectomy,,-18927.0,140.0,0.0,567.0,,,,2014-8-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Negative,Negative,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,cM0 (i+),N1a,T2,Stage IIB,TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf,A5IZ,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,567.0,0.0,567.0,0.0,567.0,0,567.0
TCGA-BH-A5J0-01,,,,,,,,,,,,,,,,,,,63.0,Left,,Positive,Positive,Simple Mastectomy,,-23072.0,,0.0,715.0,,,,2014-8-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage IA,,A5J0,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.LumA,0,715.0,0.0,715.0,0.0,715.0,0,715.0
TCGA-BH-A6R8-01,,,,,,,,,,,,,,,,,,,46.0,Left,,Positive,Positive,Lumpectomy,,-16829.0,260.0,0.0,293.0,,,,2014-8-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,,Negative,NO,4.0,Negative,,NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf,A6R8,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,293.0,0.0,293.0,0.0,293.0,0,293.0
TCGA-BH-A6R9-01,,,,,,,,,,,,,,,,,,,61.0,Left,,Negative,Positive,Modified Radical Mastectomy,,-22325.0,237.0,0.0,160.0,,,,2014-8-15,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf,A6R9,TUMOR FREE,NO,,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Normal,0,160.0,0.0,160.0,0.0,160.0,0,160.0
TCGA-BH-A8FY-01,,,,,,,,,,,,,,,,,,,87.0,Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant,,Positive,Positive,Simple Mastectomy,,-31932.0,477.0,0.0,,,,,2014-3-25,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,200.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,Yes,M0,N0 (i+),T1c,Stage IA,TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf,A8FY,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,DECEASED,2012.0,BRCA.LumA,1,295.0,0.0,295.0,0.0,295.0,0,295.0
TCGA-BH-A8FZ-01,,,,,,,,,,,,,,,,,,,58.0,Left,,Positive,Positive,Simple Mastectomy,,-21343.0,468.0,0.0,574.0,,,,2014-8-27,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,190.0,NO,Equivocal,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1b,Stage IA,TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf,A8FZ,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Normal,0,574.0,0.0,574.0,0.0,574.0,0,574.0
TCGA-BH-A8G0-01,,,,,,,,,,,,,,,,,,,54.0,Left,,Positive,Positive,Simple Mastectomy,,-19975.0,436.0,0.0,662.0,,,,2014-8-27,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,NO,3.0,Negative,Peri (6-12 months since last menstrual period),NO,3.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf,A8G0,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,662.0,0.0,662.0,0.0,662.0,0,662.0
TCGA-BH-AB28-01,,,,,,,,,,,,,,,,,,,53.0,Left,,Positive,Positive,Modified Radical Mastectomy,,-19570.0,105.0,0.0,287.0,,,,2015-2-25,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,440.0,NO,Negative,Indeterminate,NO,20.0,Negative,,NO,3.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf,AB28,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,287.0,0.0,287.0,0.0,287.0,0,287.0
TCGA-C8-A12K-01,Stage IIB,80.0,0.0,,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,Basal,Basal-like,,T_Other,T2,LIVING,80.0,Right Upper Inner Quadrant,Other (specify),,,Other,NO,-29463.0,57.0,0.0,0.0,,,,2011-4-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",970.0,NO,,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf,A12K,TUMOR FREE,,,,,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Basal,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-C8-A12L-01,Stage IIA,67.0,0.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,0.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,67.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,-24710.0,62.0,0.0,363.0,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",460.0,NO,Equivocal,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-C8-A12L.150DD5CB-1CA0-4110-95A7-6476B5B6FC24.pdf,A12L,TUMOR FREE,,,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.Her2,0,363.0,0.0,363.0,0.0,363.0,0,363.0
TCGA-C8-A12M-01,Stage IIA,70.0,0.0,Positive,FEMALE,,Negative,M0,Negative,N0,0.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,70.0,Left,Axillary lymph node dissection alone,Positive,Negative,Other,,-25811.0,57.0,0.0,358.0,,,Scheduled Follow-up Submission,2011-12-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",510.0,NO,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-C8-A12M.76F67AA2-4E17-48F5-810B-E4F4338902DC.pdf,A12M,TUMOR FREE,,,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumB,0,358.0,0.0,358.0,0.0,358.0,0,358.0
TCGA-C8-A12N-01,Stage IIA,58.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,58.0,Right,Axillary lymph node dissection alone,Positive,Positive,Other,,-21428.0,57.0,0.0,358.0,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",290.0,NO,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-C8-A12N.A845013D-BF15-42FB-8BFE-FCE206E943FE.pdf,A12N,TUMOR FREE,,,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumA,0,358.0,0.0,358.0,0.0,358.0,0,358.0
TCGA-C8-A12O-01,Stage IIA,50.0,0.0,Positive,FEMALE,,Negative,M0,Negative,N0,0.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,50.0,Left,Axillary lymph node dissection alone,Positive,Positive,Other,,-18506.0,57.0,0.0,385.0,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",650.0,NO,Negative,,,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-C8-A12O.273152AA-7B4C-4AE5-9231-1A3160058C74.pdf,A12O,TUMOR FREE,,,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumA,0,385.0,0.0,385.0,0.0,385.0,0,385.0
TCGA-C8-A12P-01,Stage IIB,55.0,0.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,55.0,Left,,Negative,Negative,Other,,-20332.0,57.0,0.0,358.0,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",380.0,NO,Positive,,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A12P.F04324BB-F0B1-4948-9189-7833646029F1.pdf,A12P,TUMOR FREE,,,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.Her2,0,358.0,0.0,358.0,0.0,358.0,0,358.0
TCGA-C8-A12T-01,Stage IIA,43.0,0.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,0.0,0.0,Her2,HER2-enriched,Positive,T_Other,T2,LIVING,43.0,Left,Axillary lymph node dissection alone,Positive,Positive,Other,NO,,51.0,0.0,0.0,NO,,,2011-4-11,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",540.0,NO,Positive,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A12T.4D751232-CD64-468E-AEBF-46F94FB6281F.pdf,A12T,TUMOR FREE,,YES,,,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Her2,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-C8-A12U-01,Stage IB,46.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,46.0,Right,Axillary lymph node dissection alone,Positive,Positive,Other,,-17045.0,57.0,0.0,385.0,NO,,Scheduled Follow-up Submission,2012-1-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",580.0,NO,Negative,,,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A12U.B6428344-2D68-404B-AD9F-CA6E0B0552B2.pdf,A12U,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.LumB,0,385.0,0.0,385.0,0.0,385.0,0,385.0
TCGA-C8-A12W-01,Stage IIIB,49.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumB,Luminal B,Positive,T_Other,T4,LIVING,49.0,Left,Axillary lymph node dissection alone,Positive,Positive,Other,,-18140.0,57.0,0.0,385.0,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",890.0,NO,Negative,,,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N1,T4,Stage IIIB,TCGA-C8-A12W.8A64D890-ABEF-4AF2-8915-D17DA89B8FC5.pdf,A12W,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumB,0,385.0,0.0,385.0,0.0,385.0,0,385.0
TCGA-C8-A12X-01,Stage IIB,62.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,62.0,Left,Axillary lymph node dissection alone,Positive,Positive,Other,,-22889.0,57.0,0.0,385.0,NO,,Scheduled Follow-up Submission,2011-12-2,FEMALE,1+,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,"Other method, specify:",410.0,NO,Negative,,,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A12X.B3FCE052-931C-4798-A188-F04A2178A5F6.pdf,A12X,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumA,0,385.0,0.0,385.0,0.0,385.0,0,385.0
TCGA-C8-A12Y-01,Stage IIB,44.0,0.0,,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumA,Luminal A,,T_Other,T2,LIVING,44.0,Left,Axillary lymph node dissection alone,,,Other,,,57.0,0.0,1476.0,NO,,,2015-3-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",380.0,NO,,,NO,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A12Y.28E368DA-56B9-4BB1-99C3-7FF2CEC964CF.pdf,A12Y,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.LumA,0,1476.0,0.0,1476.0,0.0,1476.0,0,1476.0
TCGA-C8-A12Z-01,Stage II,45.0,0.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,45.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,-16508.0,69.0,0.0,382.0,NO,,,2015-3-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,490.0,NO,Positive,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A12Z.89B312D1-9FDD-4756-9C15-5442B428F75A.pdf,A12Z,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Her2,0,382.0,0.0,382.0,0.0,382.0,0,382.0
TCGA-C8-A130-01,Stage IIIA,52.0,0.0,Positive,FEMALE,Equivocal,Negative,M0,Positive,N2,0.0,0.0,LumB,HER2-enriched,Positive,T_Other,T3,LIVING,52.0,Left,Axillary lymph node dissection alone,Positive,Positive,Other,,-19117.0,89.0,0.0,370.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,550.0,NO,Equivocal,,NO,8.0,Negative,Peri (6-12 months since last menstrual period),NO,,,True,No,M0,N2,T3,Stage IIIA,TCGA-C8-A130.3E24D3A0-9741-4635-89DB-EED4BA3F6AAA.pdf,A130,TUMOR FREE,[Discrepancy],YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumB,0,370.0,0.0,370.0,0.0,370.0,0,370.0
TCGA-C8-A131-01,Stage III,82.0,0.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,0.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,82.0,Left,Axillary lymph node dissection alone,Negative,Negative,Other,,-29966.0,163.0,0.0,411.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,460.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf,A131,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.Basal,0,411.0,0.0,411.0,0.0,411.0,0,411.0
TCGA-C8-A132-01,Stage II,56.0,0.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,56.0,Left,Axillary lymph node dissection alone,Positive,Positive,Other,,-20471.0,162.0,0.0,383.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,420.0,NO,,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A132.175224E6-3A06-4799-B695-704C254A847C.pdf,A132,TUMOR FREE,[Discrepancy],YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumA,0,383.0,0.0,383.0,0.0,383.0,0,383.0
TCGA-C8-A133-01,Stage IIIA,65.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumA,Luminal A,Positive,T_Other,T3,LIVING,65.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-23922.0,119.0,0.0,0.0,,,,2011-4-15,FEMALE,,"Other, specify",No,C50.9,8523/3,C50.9,YES,"Other method, specify:",480.0,NO,,,,26.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,True,No,M0,N1,T3,Stage IIIA,TCGA-C8-A133.C47488B4-0E7E-46FB-91C6-0BEA58695974.pdf,A133,TUMOR FREE,,YES,,,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.LumA,0,0.0,0.0,0.0,0.0,0.0,0,0.0
TCGA-C8-A134-01,Stage IIA,52.0,0.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,52.0,Left,Axillary lymph node dissection alone,Negative,Negative,Other,,-19010.0,,0.0,383.0,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,,NO,7.0,Negative,Peri (6-12 months since last menstrual period),NO,,,,No,M0,N0,T2,Stage IIA,,A134,TUMOR FREE,YES,,,NO,Primary Tumor,1,6th,YES,,LIVING,2010.0,BRCA.Basal,0,383.0,0.0,383.0,0.0,383.0,0,383.0
TCGA-C8-A135-01,Stage II,64.0,0.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,64.0,Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-23667.0,162.0,0.0,393.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,760.0,NO,Positive,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A135.7045ECC9-72B3-4AD3-A6C6-4F8C6914EAA1.pdf,A135,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.Her2,0,393.0,0.0,393.0,0.0,393.0,0,393.0
TCGA-C8-A137-01,Stage II,34.0,3.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,3.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,34.0,Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-12729.0,102.0,0.0,379.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,610.0,NO,Positive,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A137.140F8918-739F-498A-9A17-B307E40E6060.pdf,A137,WITH TUMOR,[Discrepancy],YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.Her2,0,379.0,0.0,379.0,1.0,136.0,1,136.0
TCGA-C8-A138-01,Stage III,54.0,7.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,7.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,54.0,Left,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,,-20053.0,93.0,0.0,380.0,NO,,Scheduled Follow-up Submission,2015-3-31,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,230.0,NO,Equivocal,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A138.3584F6CE-F9ED-441C-8714-BDF67C141CD6.pdf,A138,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.Her2,0,380.0,0.0,380.0,0.0,380.0,0,380.0
TCGA-C8-A1HE-01,Stage IIA,59.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,59.0,Right,Axillary lymph node dissection alone,Positive,Positive,Other,NO,,,0.0,375.0,NO,,Scheduled Follow-up Submission,2012-1-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",,,Equivocal,,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N0,T2,Stage IIA,,A1HE,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,,LIVING,2010.0,BRCA.LumA,0,375.0,0.0,375.0,0.0,375.0,0,375.0
TCGA-C8-A1HF-01,Stage IIA,48.0,0.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,0.0,0.0,Her2,HER2-enriched,Positive,T_Other,T2,LIVING,48.0,Left,Axillary lymph node dissection alone,Negative,Positive,Other,NO,,109.0,0.0,332.0,NO,,Scheduled Follow-up Submission,2011-12-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",460.0,NO,Positive,,,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf,A1HF,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.Her2,0,332.0,0.0,332.0,0.0,332.0,0,332.0
TCGA-C8-A1HG-01,Stage IIA,50.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,50.0,Right,Axillary lymph node dissection alone,Positive,Positive,Other,NO,,122.0,0.0,345.0,NO,,Scheduled Follow-up Submission,2011-12-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",300.0,NO,Negative,,,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf,A1HG,TUMOR FREE,,NO,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumB,0,345.0,0.0,345.0,0.0,345.0,0,345.0
TCGA-C8-A1HI-01,Stage IIIA,40.0,2.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,2.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,40.0,Right,Axillary lymph node dissection alone,Positive,Positive,Other,,,120.0,0.0,343.0,NO,,Scheduled Follow-up Submission,2011-12-2,FEMALE,1+,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,"Other method, specify:",490.0,NO,Negative,,,6.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf,A1HI,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumA,0,343.0,0.0,343.0,0.0,343.0,0,343.0
TCGA-C8-A1HJ-01,Stage II,53.0,5.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,5.0,0.0,Basal,,Negative,T_Other,T2,LIVING,53.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,-19629.0,121.0,0.0,5.0,NO,,,2011-6-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,1070.0,NO,Negative,,,10.0,Negative,Peri (6-12 months since last menstrual period),,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf,A1HJ,TUMOR FREE,,YES,,,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Basal,0,5.0,0.0,5.0,0.0,5.0,0,5.0
TCGA-C8-A1HK-01,Stage IIB,53.0,7.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,7.0,0.0,Her2,,Negative,T_Other,T2,LIVING,53.0,Right,Axillary lymph node dissection alone,Negative,Negative,Other,,,116.0,0.0,366.0,NO,,Scheduled Follow-up Submission,2011-12-2,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",460.0,NO,Positive,,,8.0,Negative,Peri (6-12 months since last menstrual period),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf,A1HK,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.Her2,0,366.0,0.0,366.0,0.0,366.0,0,366.0
TCGA-C8-A1HL-01,Stage IIIA,38.0,2.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,2.0,0.0,LumB,Luminal B,Negative,T_Other,T3,LIVING,38.0,Left,Axillary lymph node dissection alone,Positive,Negative,Other,,,94.0,0.0,317.0,NO,,Scheduled Follow-up Submission,2012-1-9,FEMALE,2+,"Other, specify",No,C50.9,8480/3,C50.9,YES,"Other method, specify:",980.0,NO,Equivocal,,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,Yes,M0,N1,T3,Stage IIIA,TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf,A1HL,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.LumB,0,317.0,0.0,317.0,0.0,317.0,0,317.0
TCGA-C8-A1HM-01,Stage II,74.0,6.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,6.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,74.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-27063.0,,0.0,375.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N0,T2,Stage IIA,,A1HM,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,YES,,LIVING,2010.0,BRCA.LumB,0,375.0,0.0,375.0,0.0,375.0,0,375.0
TCGA-C8-A1HN-01,Stage II,56.0,2.0,Positive,FEMALE,Equivocal,Negative,M0,Negative,N0,2.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,56.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-20712.0,88.0,0.0,394.0,NO,,Scheduled Follow-up Submission,2015-3-31,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Equivocal,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf,A1HN,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumB,0,394.0,0.0,394.0,0.0,394.0,0,394.0
TCGA-C8-A1HO-01,Stage III,34.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,0.0,0.0,LumA,,Positive,T_Other,T3,LIVING,34.0,Left Upper Inner Quadrant,,Positive,Positive,[Discrepancy],,-12715.0,52.0,0.0,375.0,,,,2015-3-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,380.0,NO,Negative,,NO,,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,M0,N3,T3,Stage IIIC,TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf,A1HO,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.LumA,0,375.0,0.0,375.0,0.0,375.0,0,375.0
TCGA-C8-A26V-01,Stage III,47.0,9.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,9.0,0.0,LumB,,Positive,T_Other,T3,LIVING,47.0,Right,,Positive,Positive,Modified Radical Mastectomy,,-17468.0,143.0,0.0,616.0,,,,2015-3-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",310.0,NO,Negative,,NO,,Negative,Peri (6-12 months since last menstrual period),NO,,,True,No,M0,N2,T3,Stage IIIA,TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf,A26V,TUMOR FREE,YES,NO,,YES,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.LumB,0,616.0,0.0,616.0,0.0,616.0,0,616.0
TCGA-C8-A26W-01,Stage II,58.0,7.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,7.0,0.0,LumB,,Positive,T_Other,T2,LIVING,58.0,Left Upper Outer Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-21391.0,142.0,0.0,381.0,,,,2015-3-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,300.0,NO,Equivocal,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf,A26W,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.LumB,0,381.0,0.0,381.0,0.0,381.0,0,381.0
TCGA-C8-A26X-01,Stage II,58.0,11.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,11.0,0.0,Her2,,Negative,T1,T1,LIVING,58.0,Right Upper Outer Quadrant,,Negative,Negative,Modified Radical Mastectomy,,-21463.0,136.0,0.0,376.0,,,,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,190.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N1,T1,Stage IIA,TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf,A26X,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Her2,0,376.0,0.0,376.0,0.0,376.0,0,376.0
TCGA-C8-A26Y-01,Stage II,90.0,13.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,13.0,0.0,Her2,,Negative,T_Other,T2,LIVING,90.0,Left Upper Outer Quadrant,,Negative,Negative,Modified Radical Mastectomy,,-32872.0,134.0,0.0,394.0,,,,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,140.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf,A26Y,TUMOR FREE,NO,NO,,NO,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Her2,0,394.0,0.0,394.0,0.0,394.0,0,394.0
TCGA-C8-A26Z-01,Stage IIA,59.0,4.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,4.0,0.0,LumA,,Positive,T_Other,T2,LIVING,59.0,Right Upper Inner Quadrant,,Positive,Positive,Other,,,125.0,0.0,470.0,NO,,Scheduled Follow-up Submission,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",470.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf,A26Z,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,NO,A,LIVING,2010.0,BRCA.LumA,0,470.0,0.0,470.0,0.0,470.0,0,470.0
TCGA-C8-A273-01,Stage IIB,29.0,6.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,6.0,0.0,LumA,,Positive,T_Other,T2,LIVING,29.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Other,,,168.0,0.0,513.0,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",590.0,NO,Negative,,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf,A273,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumA,0,513.0,0.0,513.0,0.0,513.0,0,513.0
TCGA-C8-A274-01,Stage IIA,63.0,1.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1.0,0.0,LumB,,Positive,T_Other,T2,LIVING,63.0,Right,,Positive,Positive,Other,,-23337.0,163.0,0.0,508.0,,,Scheduled Follow-up Submission,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",470.0,NO,Negative,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T2,Stage IIA,TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf,A274,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.LumB,0,508.0,0.0,508.0,0.0,508.0,0,508.0
TCGA-C8-A275-01,Stage IIA,56.0,1.0,,FEMALE,Positive,Negative,M0,Positive,N1,1.0,0.0,Her2,,,T1,T1,LIVING,56.0,Left Upper Outer Quadrant,,,,Other,,-20774.0,169.0,0.0,1.0,,,,2011-7-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,300.0,NO,,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,True,No,M0,N1,T1,Stage IIA,TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf,A275,TUMOR FREE,,NO,,,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.Her2,0,1.0,0.0,1.0,0.0,1.0,0,1.0
TCGA-C8-A278-01,Stage IIIA,61.0,1.0,Negative,FEMALE,Positive,Negative,M0,Positive,N2,1.0,0.0,Her2,,Negative,T_Other,T2,LIVING,61.0,Left,,Negative,Negative,Other,,-22598.0,163.0,0.0,297.0,,,Scheduled Follow-up Submission,2012-1-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",630.0,NO,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf,A278,TUMOR FREE,,NO,,NO,Primary Tumor,1,6th,YES,A,LIVING,2010.0,BRCA.Her2,0,297.0,0.0,297.0,0.0,297.0,0,297.0
TCGA-C8-A27A-01,Stage IIB,48.0,371.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,371.0,0.0,LumB,,Positive,T_Other,T2,LIVING,48.0,Right Upper Outer Quadrant,,Positive,Positive,Modified Radical Mastectomy,,-17779.0,435.0,0.0,747.0,,,,2015-3-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,230.0,NO,Negative,,NO,,Negative,Peri (6-12 months since last menstrual period),NO,,,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf,A27A,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,,A,LIVING,2010.0,BRCA.LumB,0,747.0,0.0,747.0,0.0,747.0,0,747.0
TCGA-C8-A27B-01,Stage IIB,48.0,30.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,30.0,0.0,Basal,,Negative,T_Other,T3,LIVING,48.0,Left,,Negative,Negative,Modified Radical Mastectomy,,-17763.0,93.0,0.0,439.0,,,,2015-3-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,240.0,NO,Negative,,NO,,Negative,Peri (6-12 months since last menstrual period),NO,,,True,No,M0,N0,T3,Stage IIB,TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf,A27B,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,6th,,A,LIVING,2011.0,BRCA.Basal,0,439.0,0.0,439.0,0.0,439.0,0,439.0
TCGA-C8-A3M7-01,,,,,,,,,,,,,LumA,,,,,,60.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-22096.0,,0.0,1.0,NO,,,2015-3-9,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,,,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,,No,M0,N0,T4b,Stage IIIB,,A3M7,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,,,DECEASED,2010.0,BRCA.LumA,1,1034.0,1.0,1034.0,1.0,1034.0,1,1034.0
TCGA-C8-A3M8-01,,,,,,,,,,,,,LumB,,,,,,68.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-24877.0,264.0,0.0,394.0,NO,,,2015-3-9,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,280.0,NO,Positive,,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,M0,N0,T1c,Stage IA,TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf,A3M8,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumB,0,394.0,0.0,394.0,0.0,394.0,0,394.0
TCGA-C8-A8HP-01,,,,,,,,,,,,,,,,,,,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-21613.0,231.0,0.0,396.0,,,,2015-1-15,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Core needle biopsy,240.0,NO,Positive,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf,A8HP,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Her2,0,396.0,0.0,396.0,0.0,396.0,0,396.0
TCGA-C8-A8HQ-01,,,,,,,,,,,,,,,,,,,53.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-19432.0,185.0,0.0,380.0,,,,2015-1-22,FEMALE,,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,300.0,NO,Negative,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,4.0,True,No,M0,N1,T2,Stage IIB,TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf,A8HQ,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,380.0,0.0,380.0,0.0,380.0,0,380.0
TCGA-C8-A8HR-01,,,,,,,,,,,,,,,,,,,49.0,Right,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-17921.0,162.0,0.0,408.0,,,,2015-1-20,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,420.0,NO,,,NO,8.0,Negative,Peri (6-12 months since last menstrual period),NO,5.0,,True,No,M0,N2,T3,Stage IIIA,TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf,A8HR,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Normal,0,408.0,0.0,408.0,0.0,408.0,0,408.0
TCGA-D8-A13Y-01,Stage IA,52.0,362.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,362.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,52.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-19028.0,184.0,0.0,1728.0,,70-79%,Scheduled Follow-up Submission,2015-4-29,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,430.0,NO,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181.pdf,A13Y,TUMOR FREE,YES,,70-79%,NO,Primary Tumor,1,,YES,A,LIVING,2010.0,BRCA.LumB,0,1728.0,0.0,1728.0,0.0,1728.0,0,1728.0
TCGA-D8-A13Z-01,Stage X,51.0,210.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,210.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,51.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-18942.0,214.0,0.0,635.0,,,Scheduled Follow-up Submission,2012-1-14,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,470.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,9.0,,False,No,M0,N2a,T2,,TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf,A13Z,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Her2,0,635.0,0.0,635.0,0.0,635.0,0,635.0
TCGA-D8-A140-01,Stage IIB,62.0,403.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,403.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,62.0,Left Upper Outer Quadrant|Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22900.0,204.0,0.0,403.0,,,Scheduled Follow-up Submission,2011-6-20,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,400.0,NO,Positive,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A140.D78476E6-799F-4DED-A219-CBFE2DE3C77B.pdf,A140,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,403.0,0.0,403.0,0.0,403.0,0,403.0
TCGA-D8-A141-01,Stage X,40.0,113.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,113.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,40.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-14626.0,,0.0,626.0,,,Scheduled Follow-up Submission,2012-1-14,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,15.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,1.0,,,No,M0,N1,T1c,,,A141,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,626.0,0.0,626.0,0.0,626.0,0,626.0
TCGA-D8-A142-01,Stage IIB,74.0,425.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,425.0,0.0,Basal,Basal-like,Negative,T_Other,T3,LIVING,74.0,Left Lower Outer Quadrant|Left,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-27313.0,212.0,0.0,425.0,,,Scheduled Follow-up Submission,2011-6-20,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,490.0,NO,Equivocal,Negative,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T3,Stage IIB,TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf,A142,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,425.0,0.0,425.0,0.0,425.0,0,425.0
TCGA-D8-A143-01,Stage IIA,51.0,431.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,431.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,51.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-18984.0,211.0,0.0,431.0,,,Scheduled Follow-up Submission,2011-7-4,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf,A143,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,431.0,0.0,431.0,0.0,431.0,0,431.0
TCGA-D8-A145-01,Stage IIA,80.0,410.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,410.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,80.0,Right Upper Inner Quadrant|Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-29280.0,191.0,0.0,410.0,,,Scheduled Follow-up Submission,2011-7-4,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Equivocal,Negative,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-D8-A145.1D26CB97-536A-4D10-A593-73C3A846BB13.pdf,A145,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,410.0,0.0,410.0,0.0,410.0,0,410.0
TCGA-D8-A146-01,Stage IIA,57.0,344.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,344.0,0.0,LumA,,Positive,T_Other,T2,LIVING,57.0,Right Upper Outer Quadrant|Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-20861.0,221.0,0.0,643.0,NO,,Scheduled Follow-up Submission,2012-1-15,FEMALE,1+,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,230.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,Yes,MX,N0,T2,Stage IIA,TCGA-D8-A146.79749F5D-329A-400D-8511-C4CF479C1FCC.pdf,A146,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,643.0,0.0,643.0,0.0,643.0,0,643.0
TCGA-D8-A147-01,Stage X,45.0,2.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,2.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,45.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,,-16736.0,163.0,0.0,584.0,,,Scheduled Follow-up Submission,2012-1-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,130.0,NO,Negative,,,1.0,Negative,Indeterminate (neither Pre or Postmenopausal),NO,0.0,,False,No,M0,N0,T2,,TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf,A147,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,584.0,0.0,584.0,0.0,584.0,0,584.0
TCGA-D8-A1J8-01,Stage IIB,77.0,256.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,256.0,0.0,LumB,,Positive,T_Other,T2,LIVING,77.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-28444.0,,0.0,431.0,,70-79%,Scheduled Follow-up Submission,2011-7-18,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,,No,M0,N1a,T2,Stage IIB,,A1J8,TUMOR FREE,,,70-79%,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumB,0,431.0,0.0,431.0,0.0,431.0,0,431.0
TCGA-D8-A1J9-01,Stage IA,48.0,248.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,248.0,0.0,LumB,,Negative,T1,T1,LIVING,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,,-17879.0,211.0,0.0,532.0,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,230.0,NO,Positive,,,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf,A1J9,TUMOR FREE,,,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,532.0,0.0,532.0,0.0,532.0,0,532.0
TCGA-D8-A1JA-01,Stage X,60.0,18.0,Negative,FEMALE,Positive,Negative,M0,Negative,N0,18.0,0.0,Her2,,Negative,T_Other,T4,LIVING,60.0,Left Upper Outer Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-21918.0,194.0,0.0,502.0,,<10%,Scheduled Follow-up Submission,2012-1-19,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",310.0,NO,Positive,,,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,,,False,No,M0,NX,T4b,,TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf,A1JA,WITH TUMOR,,NO,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Her2,0,502.0,0.0,502.0,1.0,431.0,1,431.0
TCGA-D8-A1JB-01,Stage IIB,54.0,0.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,54.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-19822.0,232.0,0.0,1688.0,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,350.0,NO,Equivocal,Positive,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf,A1JB,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1688.0,0.0,1688.0,0.0,1688.0,0,1688.0
TCGA-D8-A1JC-01,Stage IIIA,59.0,178.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,178.0,0.0,LumB,,Positive,T_Other,T2,LIVING,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-21898.0,201.0,0.0,480.0,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",180.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,False,No,M0,N2a,T2,Stage IIIA,TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf,A1JC,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,480.0,0.0,480.0,0.0,480.0,0,480.0
TCGA-D8-A1JD-01,Stage IIB,41.0,273.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,273.0,0.0,LumB,,Positive,T_Other,T2,LIVING,41.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-15166.0,230.0,0.0,552.0,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,400.0,NO,Negative,,,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf,A1JD,TUMOR FREE,,,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,552.0,0.0,552.0,0.0,552.0,0,552.0
TCGA-D8-A1JE-01,Stage IIA,62.0,57.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,57.0,0.0,LumB,,Positive,T1,T1,LIVING,62.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22683.0,,0.0,575.0,,,Scheduled Follow-up Submission,2012-1-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,,No,M0,N1a,T1c,Stage IIA,,A1JE,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumB,0,575.0,0.0,575.0,0.0,575.0,0,575.0
TCGA-D8-A1JF-01,Stage IIIA,79.0,96.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,96.0,0.0,Her2,,Negative,T1,T1,LIVING,79.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-29199.0,,0.0,366.0,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",,,Negative,,,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,8.0,,,No,M0,N2a,T1c,Stage IIIA,,A1JF,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.Her2,0,366.0,0.0,366.0,0.0,366.0,0,366.0
TCGA-D8-A1JG-01,Stage IIA,62.0,187.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,187.0,0.0,Her2,,Negative,T_Other,T2,LIVING,62.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-22878.0,,0.0,1612.0,,,Scheduled Follow-up Submission,2015-4-29,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",,,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1JG,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.Her2,0,1612.0,0.0,1612.0,0.0,1612.0,0,1612.0
TCGA-D8-A1JH-01,Stage IA,56.0,426.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,426.0,0.0,LumA,,Positive,T1,T1,LIVING,56.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-20497.0,263.0,0.0,426.0,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,140.0,NO,Negative,,,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf,A1JH,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,426.0,0.0,426.0,0.0,426.0,0,426.0
TCGA-D8-A1JI-01,Stage IIA,54.0,21.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,21.0,0.0,LumB,,Positive,T1,T1,LIVING,54.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-20072.0,226.0,0.0,577.0,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,190.0,NO,Negative,,,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,MX,N1a,T1c,Stage IIA,TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf,A1JI,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,577.0,0.0,577.0,0.0,577.0,0,577.0
TCGA-D8-A1JJ-01,Stage IIA,54.0,274.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,274.0,0.0,LumB,,Positive,T_Other,T2,LIVING,54.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-19966.0,260.0,0.0,611.0,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf,A1JJ,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,611.0,0.0,611.0,0.0,611.0,0,611.0
TCGA-D8-A1JK-01,Stage IIA,90.0,109.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,109.0,0.0,Basal,,Positive,T_Other,T2,LIVING,90.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Positive,Modified Radical Mastectomy,,-32872.0,261.0,0.0,612.0,,,Scheduled Follow-up Submission,2012-1-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,270.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf,A1JK,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.Basal,0,612.0,0.0,612.0,0.0,612.0,0,612.0
TCGA-D8-A1JL-01,Stage IIA,72.0,265.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,265.0,0.0,Basal,,Negative,T_Other,T2,LIVING,72.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-26484.0,,0.0,611.0,,,Scheduled Follow-up Submission,2012-1-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1JL,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.Basal,0,611.0,0.0,611.0,0.0,611.0,0,611.0
TCGA-D8-A1JM-01,Stage IIB,59.0,238.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,238.0,0.0,Basal,,Negative,T_Other,T2,LIVING,59.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,,-21602.0,243.0,0.0,590.0,,<10%,Scheduled Follow-up Submission,2012-1-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,350.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1JM.947954F1-4CBA-42D3-99B2-6BE6E44E5239.pdf,A1JM,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,590.0,0.0,590.0,0.0,590.0,0,590.0
TCGA-D8-A1JN-01,Stage IIIC,80.0,217.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,217.0,0.0,LumA,,Positive,T_Other,T3,LIVING,80.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-29331.0,273.0,0.0,620.0,,,Scheduled Follow-up Submission,2012-1-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Incisional Biopsy,180.0,NO,Indeterminate,Negative,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,11.0,,False,No,MX,N3a,T3,Stage IIIC,TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf,A1JN,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,620.0,0.0,620.0,0.0,620.0,0,620.0
TCGA-D8-A1JP-01,Stage IA,73.0,167.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,167.0,0.0,LumA,,Positive,T1,T1,LIVING,73.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,,-26862.0,,0.0,639.0,,,Scheduled Follow-up Submission,2012-1-15,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,M0,N0,T1c,Stage IA,,A1JP,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,639.0,0.0,639.0,0.0,639.0,0,639.0
TCGA-D8-A1JS-01,Stage IA,77.0,371.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,371.0,0.0,LumA,,Positive,T1,T1,LIVING,77.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-28178.0,212.0,0.0,371.0,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,1+,"Other, specify",No,C50.9,8503/3,C50.9,YES,"Other method, specify:",190.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf,A1JS,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,371.0,0.0,371.0,0.0,371.0,0,371.0
TCGA-D8-A1JT-01,Stage IIA,70.0,405.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,405.0,0.0,LumB,,Positive,T_Other,T2,LIVING,70.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-25677.0,250.0,0.0,405.0,,70-79%,Scheduled Follow-up Submission,2011-7-18,FEMALE,2+,"Other, specify",No,C50.9,8523/3,C50.9,YES,Fine needle aspiration biopsy,250.0,NO,Equivocal,Negative,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf,A1JT,TUMOR FREE,,YES,70-79%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,405.0,0.0,405.0,0.0,405.0,0,405.0
TCGA-D8-A1JU-01,Stage IA,51.0,447.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,447.0,0.0,LumA,,Positive,T1,T1,LIVING,51.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,,-18733.0,295.0,0.0,447.0,,,Scheduled Follow-up Submission,2011-7-18,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,450.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf,A1JU,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,447.0,0.0,447.0,0.0,447.0,0,447.0
TCGA-D8-A1X5-01,Stage IIIC,81.0,171.0,Positive,FEMALE,Positive,Negative,M0,Positive,N3,171.0,0.0,LumB,,Positive,T_Other,T2,LIVING,81.0,Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-29734.0,197.0,0.0,565.0,NO,,Scheduled Follow-up Submission,2012-3-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,240.0,NO,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,14.0,,False,No,MX,N3a,T2,Stage IIIC,TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf,A1X5,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,565.0,0.0,565.0,0.0,565.0,0,565.0
TCGA-D8-A1X6-01,Stage IIIA,80.0,236.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,236.0,0.0,LumB,,Positive,T_Other,T3,LIVING,80.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-29256.0,173.0,0.0,541.0,NO,,Scheduled Follow-up Submission,2012-3-31,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,550.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,False,No,MX,N2a,T3,Stage IIIA,TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf,A1X6,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,541.0,0.0,541.0,0.0,541.0,0,541.0
TCGA-D8-A1X7-01,Stage IIA,40.0,85.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,85.0,0.0,LumB,,Positive,T_Other,T2,LIVING,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Simple Mastectomy,,-14858.0,141.0,0.0,509.0,NO,,Scheduled Follow-up Submission,2012-3-31,FEMALE,,"Other, specify",No,C50.9,8503/3,C50.9,YES,Fine needle aspiration biopsy,170.0,NO,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf,A1X7,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,509.0,0.0,509.0,0.0,509.0,0,509.0
TCGA-D8-A1X8-01,Stage IIA,62.0,272.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,272.0,0.0,LumA,,Indeterminate,T1,T1,LIVING,62.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Indeterminate,Modified Radical Mastectomy,NO,-22995.0,225.0,0.0,783.0,NO,,Scheduled Follow-up Submission,2012-10-19,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,360.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,9.0,0.0,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf,A1X8,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,783.0,0.0,783.0,0.0,783.0,0,783.0
TCGA-D8-A1XA-01,Stage IA,64.0,274.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,274.0,0.0,LumA,,Positive,T1,T1,LIVING,64.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23387.0,218.0,0.0,839.0,NO,,Scheduled Follow-up Submission,2012-12-3,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",140.0,NO,Equivocal,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf,A1XA,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,839.0,0.0,839.0,0.0,839.0,0,839.0
TCGA-D8-A1XB-01,Stage IIB,62.0,201.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,201.0,0.0,LumA,,Positive,T_Other,T2,LIVING,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22976.0,251.0,0.0,552.0,NO,,Scheduled Follow-up Submission,2012-3-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf,A1XB,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,552.0,0.0,552.0,0.0,552.0,0,552.0
TCGA-D8-A1XD-01,Stage IIIA,36.0,155.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,155.0,0.0,LumA,,Positive,T1,T1,LIVING,36.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-13510.0,188.0,0.0,522.0,NO,,Scheduled Follow-up Submission,2012-3-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,[Discrepancy],210.0,NO,Negative,,,18.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,6.0,,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf,A1XD,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,522.0,0.0,522.0,0.0,522.0,0,522.0
TCGA-D8-A1XG-01,Stage IIIB,86.0,196.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,196.0,0.0,LumA,,Negative,T_Other,T4,LIVING,86.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,YES,-31748.0,169.0,0.0,448.0,NO,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",590.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,False,No,M0,N1a,T4b,Stage IIIB,TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf,A1XG,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,448.0,0.0,448.0,0.0,448.0,0,448.0
TCGA-D8-A1XJ-01,Stage IIIA,76.0,352.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,352.0,0.0,Her2,,Positive,T_Other,T3,LIVING,76.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-27967.0,295.0,0.0,663.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,3+,"Other, specify",No,C50.9,8523/3,C50.9,YES,Fine needle aspiration biopsy,440.0,NO,Positive,,,43.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf,A1XJ,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Her2,0,664.0,0.0,664.0,0.0,664.0,0,664.0
TCGA-D8-A1XK-01,Stage IB,55.0,326.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,326.0,0.0,Basal,,Negative,T_Other,T2,LIVING,55.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,,-20092.0,275.0,0.0,441.0,NO,,Scheduled Follow-up Submission,2012-2-4,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,260.0,NO,Negative,,,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf,A1XK,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,441.0,0.0,441.0,0.0,441.0,0,441.0
TCGA-D8-A1XL-01,Stage IIB,34.0,319.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,319.0,0.0,LumB,,Positive,T_Other,T2,LIVING,34.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,,-12668.0,282.0,0.0,606.0,NO,,Scheduled Follow-up Submission,2012-3-31,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,260.0,NO,Equivocal,Negative,,13.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,False,No,MX,N1a,T2,Stage IIB,TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf,A1XL,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,606.0,0.0,606.0,0.0,606.0,0,606.0
TCGA-D8-A1XM-01,Stage IA,57.0,218.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,218.0,0.0,LumA,,Positive,T1,T1,LIVING,57.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-21056.0,189.0,0.0,538.0,NO,,Scheduled Follow-up Submission,2012-3-19,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,200.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf,A1XM,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,538.0,0.0,538.0,0.0,538.0,0,538.0
TCGA-D8-A1XO-01,Stage IIB,56.0,242.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,242.0,0.0,LumA,,Positive,T_Other,T2,LIVING,56.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-20606.0,,0.0,1682.0,NO,,Scheduled Follow-up Submission,2015-4-29,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,,No,M0,N1a,T2,Stage IIB,,A1XO,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,1682.0,0.0,1682.0,0.0,1682.0,0,1682.0
TCGA-D8-A1XQ-01,Stage IIA,69.0,177.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,177.0,0.0,Basal,,Negative,T_Other,T2,LIVING,69.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-25345.0,158.0,0.0,499.0,NO,,Scheduled Follow-up Submission,2012-3-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf,A1XQ,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.Basal,0,499.0,0.0,499.0,0.0,499.0,0,499.0
TCGA-D8-A1XR-01,Stage IIB,56.0,168.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,168.0,0.0,LumB,,Positive,T_Other,T2,LIVING,56.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-20488.0,162.0,0.0,482.0,NO,,Scheduled Follow-up Submission,2012-3-6,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Negative,,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf,A1XR,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,482.0,0.0,482.0,0.0,482.0,0,482.0
TCGA-D8-A1XS-01,Stage IIIC,48.0,18.0,Positive,MALE,Positive,Negative,M0,Positive,N3,18.0,0.0,LumB,,Positive,T_Other,T2,LIVING,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-17708.0,164.0,0.0,496.0,NO,,Scheduled Follow-up Submission,2012-3-19,MALE,3+,"Other, specify",No,C50.9,8507/3,C50.9,YES,Core needle biopsy,340.0,NO,Positive,,,28.0,Negative,,NO,25.0,0.0,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf,A1XS,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,496.0,0.0,496.0,0.0,496.0,0,496.0
TCGA-D8-A1XT-01,Stage IIA,61.0,193.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,193.0,0.0,Her2,,Negative,T1,T1,LIVING,61.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-22448.0,144.0,0.0,506.0,NO,,Scheduled Follow-up Submission,2012-3-26,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,230.0,NO,Positive,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,False,No,M0,N1a,T1c,Stage IIA,TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf,A1XT,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Her2,0,506.0,0.0,506.0,0.0,506.0,0,506.0
TCGA-D8-A1XU-01,Stage IA,56.0,149.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,149.0,0.0,LumA,,Positive,T1,T1,LIVING,56.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,NO,-20715.0,102.0,0.0,395.0,NO,,Scheduled Follow-up Submission,2012-3-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf,A1XU,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,395.0,0.0,395.0,0.0,395.0,0,395.0
TCGA-D8-A1XV-01,Stage IIA,84.0,146.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,146.0,0.0,LumA,,Positive,T_Other,T2,LIVING,84.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,NO,-30830.0,103.0,0.0,461.0,NO,,Scheduled Follow-up Submission,2012-3-19,FEMALE,2+,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Fine needle aspiration biopsy,420.0,NO,Equivocal,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf,A1XV,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,461.0,0.0,461.0,0.0,461.0,0,461.0
TCGA-D8-A1XW-01,Stage IIA,53.0,117.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,117.0,0.0,Normal,,Positive,T_Other,T2,LIVING,53.0,Left Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Positive,Modified Radical Mastectomy,NO,-19478.0,76.0,0.0,1309.0,NO,,Scheduled Follow-up Submission,2015-4-29,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,310.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf,A1XW,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,1309.0,0.0,1309.0,0.0,1309.0,0,1309.0
TCGA-D8-A1XZ-01,Stage IIIA,81.0,120.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,120.0,0.0,LumB,,Negative,T1,T1,LIVING,81.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,,-29916.0,98.0,0.0,466.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,130.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,6.0,,False,No,MX,N2a,T1c,Stage IIIA,TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf,A1XZ,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,466.0,0.0,466.0,0.0,466.0,0,466.0
TCGA-D8-A1Y2-01,Stage IIA,71.0,72.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,72.0,0.0,LumB,,Positive,T_Other,T2,LIVING,71.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-26021.0,65.0,0.0,433.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,470.0,NO,Indeterminate,Negative,,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,MX,N0,T2,Stage IIA,TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf,A1Y2,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,433.0,0.0,433.0,0.0,433.0,0,433.0
TCGA-D8-A1Y3-01,Stage IIIA,61.0,124.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,124.0,0.0,LumB,,Positive,T_Other,T2,LIVING,61.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,-22317.0,62.0,0.0,430.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,300.0,NO,Indeterminate,Negative,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,False,No,MX,N2a,T2,Stage IIIA,TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf,A1Y3,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,430.0,0.0,430.0,0.0,430.0,0,430.0
TCGA-D8-A27E-01,Stage IA,66.0,182.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,182.0,0.0,LumA,,Positive,T1,T1,LIVING,66.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,[Discrepancy],NO,-24315.0,204.0,0.0,530.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,1+,"Other, specify",No,C50.9,8523/3,C50.9,YES,Fine needle aspiration biopsy,110.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf,A27E,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,530.0,0.0,530.0,0.0,530.0,0,530.0
TCGA-D8-A27F-01,Stage IIA,40.0,227.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,227.0,0.0,Basal,,Negative,T_Other,T2,LIVING,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14731.0,166.0,0.0,488.0,NO,,Scheduled Follow-up Submission,2012-3-21,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",320.0,NO,Negative,,,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf,A27F,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,488.0,0.0,488.0,0.0,488.0,0,488.0
TCGA-D8-A27G-01,Stage IIA,75.0,209.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,209.0,0.0,LumA,,Positive,T_Other,T2,LIVING,75.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-27521.0,156.0,0.0,409.0,NO,,Scheduled Follow-up Submission,2012-3-21,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,170.0,NO,Equivocal,Negative,,31.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf,A27G,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,NO,A,LIVING,2010.0,BRCA.LumA,0,409.0,0.0,409.0,0.0,409.0,0,409.0
TCGA-D8-A27H-01,Stage IIA,72.0,140.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,140.0,0.0,Basal,,Negative,T_Other,T2,LIVING,72.0,Right Upper Outer Quadrant,No axillary staging,Negative,Negative,Modified Radical Mastectomy,NO,-26588.0,84.0,0.0,397.0,NO,,Scheduled Follow-up Submission,2012-3-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",170.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf,A27H,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,397.0,0.0,397.0,0.0,397.0,0,397.0
TCGA-D8-A27I-01,Stage IIIA,58.0,185.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,185.0,0.0,LumA,,Positive,T1,T1,LIVING,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-21327.0,132.0,0.0,439.0,NO,,Scheduled Follow-up Submission,2012-3-21,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,900.0,NO,Negative,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,0.0,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf,A27I,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,439.0,0.0,439.0,0.0,439.0,0,439.0
TCGA-D8-A27K-01,Stage IIB,47.0,118.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,118.0,0.0,LumA,,Positive,T_Other,T2,LIVING,47.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-17426.0,,0.0,1461.0,NO,,Scheduled Follow-up Submission,2015-4-29,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,NO,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,,No,M0,N1a,T2,Stage IIB,,A27K,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,1461.0,0.0,1461.0,0.0,1461.0,0,1461.0
TCGA-D8-A27L-01,Stage IIB,49.0,125.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,125.0,0.0,LumA,,Positive,T1,T1,LIVING,49.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-18025.0,84.0,0.0,499.0,NO,,Scheduled Follow-up Submission,2012-6-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N2a,T1c,Stage IIIA,TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf,A27L,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,499.0,0.0,499.0,0.0,499.0,0,499.0
TCGA-D8-A27M-01,Stage IIA,59.0,144.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,144.0,0.0,Basal,,Negative,T1,T1,LIVING,59.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Modified Radical Mastectomy,NO,-21910.0,83.0,0.0,410.0,NO,,Scheduled Follow-up Submission,2012-3-26,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,140.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf,A27M,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,410.0,0.0,410.0,0.0,410.0,0,410.0
TCGA-D8-A27N-01,Stage IIIA,36.0,145.0,Positive,FEMALE,Positive,Negative,M0,Positive,N2,145.0,0.0,LumB,,Positive,T_Other,T2,LIVING,36.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-13243.0,75.0,0.0,519.0,NO,,Scheduled Follow-up Submission,2012-3-26,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Positive,,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,0.0,False,No,M0,N2a,T2,Stage IIIA,TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf,A27N,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,519.0,0.0,519.0,0.0,519.0,0,519.0
TCGA-D8-A27P-01,Stage IIA,64.0,22.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,22.0,0.0,LumA,,Positive,T1,T1,LIVING,64.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,NO,-23576.0,37.0,0.0,49.0,NO,,Scheduled Follow-up Submission,2012-10-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",100.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf,A27P,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,NO,A,LIVING,2011.0,BRCA.LumA,0,49.0,0.0,49.0,0.0,49.0,0,49.0
TCGA-D8-A27R-01,Stage IIIC,41.0,90.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,90.0,0.0,LumB,,Positive,T_Other,T2,LIVING,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-15122.0,50.0,0.0,29.0,NO,,Scheduled Follow-up Submission,2012-4-28,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,440.0,NO,Equivocal,Negative,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,11.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf,A27R,TUMOR FREE,,YES,,,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumB,0,307.0,0.0,307.0,0.0,307.0,0,307.0
TCGA-D8-A27T-01,Stage IIIC,53.0,135.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,135.0,0.0,LumA,,Positive,T_Other,T2,LIVING,53.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-19591.0,68.0,0.0,398.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,170.0,NO,Negative,,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,12.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf,A27T,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,398.0,0.0,398.0,0.0,398.0,0,398.0
TCGA-D8-A27V-01,Stage IIA,62.0,73.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,73.0,0.0,LumA,,Positive,T_Other,T2,LIVING,62.0,Right Upper Outer Quadrant|Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-22958.0,,0.0,381.0,NO,,Scheduled Follow-up Submission,2012-3-29,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A27V,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,381.0,0.0,381.0,0.0,381.0,0,381.0
TCGA-D8-A27W-01,Stage IIIB,55.0,15.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,15.0,0.0,LumB,,Positive,T_Other,T4,LIVING,55.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-20173.0,43.0,0.0,373.0,NO,,Scheduled Follow-up Submission,2012-4-2,FEMALE,2+,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Fine needle aspiration biopsy,390.0,NO,Equivocal,Positive,,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T4b,Stage IIIB,TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf,A27W,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,373.0,0.0,373.0,0.0,373.0,0,373.0
TCGA-D8-A3Z5-01,,,,,,,,,,,,,,,,,,,54.0,Right,Other (specify),Positive,Positive,Simple Mastectomy,NO,-19846.0,418.0,0.0,1015.0,NO,,,2014-3-28,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,320.0,NO,Negative,,NO,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,19.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf,A3Z5,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1015.0,0.0,1015.0,0.0,1015.0,0,1015.0
TCGA-D8-A3Z6-01,,,,,,,,,,,,,,,,,,,56.0,Left,Other (specify),Positive,Positive,Modified Radical Mastectomy,NO,-20629.0,160.0,0.0,563.0,NO,,,2013-11-18,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,60.0,NO,Negative,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,19.0,,False,No,M0,N3a,T3,Stage IIIC,TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf,A3Z6,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,563.0,0.0,563.0,0.0,563.0,0,563.0
TCGA-D8-A4Z1-01,,,,,,,,,,,,,,,,,,,68.0,Right|Right Upper Inner Quadrant,No axillary staging,Positive,Positive,Simple Mastectomy,NO,-25097.0,,0.0,659.0,,70-79%,,2014-4-11,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage IA,,A4Z1,TUMOR FREE,YES,YES,10-19%,NO,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.LumA,0,659.0,0.0,659.0,0.0,659.0,0,659.0
TCGA-D8-A73U-01,,,,,,,,,,,,,,,,,,,88.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-32208.0,285.0,0.0,492.0,,70-79%,,2014-3-28,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,90.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf,A73U,WITH TUMOR,YES,NO,70-79%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,492.0,0.0,492.0,0.0,492.0,0,492.0
TCGA-D8-A73W-01,,,,,,,,,,,,,,,,,,,79.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Simple Mastectomy,NO,-29125.0,191.0,0.0,244.0,,70-79%,,2015-4-29,FEMALE,1+,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Tumor resection,230.0,NO,Negative,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,1.0,,False,No,MX,N1a,T3,Stage IIIA,TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf,A73W,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,,A,DECEASED,2013.0,BRCA.LumA,1,385.0,1.0,385.0,1.0,21.0,1,21.0
TCGA-D8-A73X-01,,,,,,,,,,,,,,,,,,,53.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-19607.0,140.0,0.0,767.0,,70-79%,,2015-4-29,FEMALE,1+,"Other, specify",No,C50.9,8211/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,False,No,M0,N0,T2,Stage IIA,TCGA-D8-A73X.9B227A4E-6237-4C95-B640-E64AFF0CC5F4.pdf,A73X,TUMOR FREE,YES,NO,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,767.0,0.0,767.0,0.0,767.0,0,767.0
TCGA-E2-A105-01,Stage IIA,79.0,1163.0,Positive,FEMALE,Equivocal,Negative,M0,Negative,N0,1163.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,79.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-28855.0,,0.0,1308.0,,,Scheduled Follow-up Submission,2011-9-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0 (i-),T2,Stage IIA,,A105,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,,LIVING,2007.0,BRCA.LumA,0,1308.0,0.0,1308.0,0.0,1308.0,0,1308.0
TCGA-E2-A106-01,Stage IB,34.0,1807.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1807.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,34.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-12528.0,,0.0,2541.0,,90-99%,Scheduled Follow-up Submission,2015-3-17,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,16.0,Close,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,M0,N1mi,T1c,Stage IB,,A106,TUMOR FREE,YES,,80-89%,NO,Primary Tumor,1,,YES,,LIVING,2006.0,BRCA.LumA,0,2541.0,0.0,2541.0,0.0,2541.0,0,2541.0
TCGA-E2-A107-01,Stage IIIA,54.0,1046.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,1046.0,0.0,,Luminal B,Negative,T_Other,T3,LIVING,54.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,NO,-20065.0,715.0,0.0,1047.0,,,Scheduled Follow-up Submission,2011-9-28,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,170.0,NO,Equivocal,Negative,,27.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,False,No,M0,N2a,T3,Stage IIIA,TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf,A107,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1047.0,0.0,1047.0,0.0,1047.0,0,1047.0
TCGA-E2-A108-01,Stage IIIA,64.0,837.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,837.0,0.0,Normal,Normal-like,Positive,T_Other,T2,LIVING,64.0,Right Upper Outer Quadrant,,Positive,Positive,Lumpectomy,,-23530.0,596.0,0.0,837.0,,,Scheduled Follow-up Submission,2011-9-28,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Negative,,,27.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,False,No,M0,N2a,T2,Stage IIIA,TCGA-E2-A108.DDBEE56C-F8E8-4A7D-8CF6-E0D63EE53FC4.pdf,A108,WITH TUMOR,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Normal,0,837.0,0.0,837.0,0.0,837.0,0,837.0
TCGA-E2-A109-01,Stage IIA,64.0,1417.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1417.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,64.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Simple Mastectomy,NO,-23521.0,,0.0,1417.0,,,Scheduled Follow-up Submission,2011-9-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0 (i-),T2,Stage IIA,,A109,TUMOR FREE,,,,NO,Primary Tumor,1,6th,YES,,LIVING,2007.0,BRCA.LumB,0,1417.0,0.0,1417.0,0.0,1417.0,0,1417.0
TCGA-E2-A10A-01,Stage IIB,41.0,1229.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,1229.0,0.0,LumA,Luminal B,Positive,T_Other,T3,LIVING,41.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-15085.0,1096.0,0.0,1229.0,,,Scheduled Follow-up Submission,2011-10-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,370.0,NO,Positive,Negative,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,0.0,0.0,False,No,M0,N0 (i-),T3,Stage IIB,TCGA-E2-A10A.AA1BACC4-0B3D-4E2E-865E-24B570DA4E74.pdf,A10A,WITH TUMOR,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,1229.0,0.0,1229.0,1.0,75.0,1,75.0
TCGA-E2-A10C-01,Stage IIB,54.0,1219.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1219.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-19849.0,995.0,0.0,1220.0,,,Scheduled Follow-up Submission,2011-9-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-E2-A10C.E8A61AAC-BFF5-4341-B051-EDD87515ECDC.pdf,A10C,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1220.0,0.0,1220.0,0.0,1220.0,0,1220.0
TCGA-E2-A10E-01,Stage IIA,64.0,865.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,865.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,64.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-23684.0,869.0,0.0,865.0,,,Scheduled Follow-up Submission,2011-9-26,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,Equivocal,Negative,,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A10E.CFB8EE09-41D3-4A39-A4AE-4CDEC84BB9BC.pdf,A10E,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,865.0,0.0,865.0,0.0,865.0,0,865.0
TCGA-E2-A10F-01,Stage IIA,47.0,878.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,878.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,47.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-17257.0,801.0,0.0,878.0,,,Scheduled Follow-up Submission,2011-9-27,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,Equivocal,Negative,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-E2-A10F.71C82089-E070-4C7B-B15B-0492DECCB3BF.pdf,A10F,TUMOR FREE,,,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,878.0,0.0,878.0,0.0,878.0,0,878.0
TCGA-E2-A14N-01,Stage IIB,37.0,1350.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1350.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,37.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,NO,-13743.0,1240.0,0.0,1434.0,NO,,Scheduled Follow-up Submission,2011-11-17,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,440.0,NO,Negative,,,38.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1,T2,Stage IIB,TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf,A14N,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.Basal,0,1434.0,0.0,1434.0,0.0,1434.0,0,1434.0
TCGA-E2-A14O-01,Stage IIIA,76.0,1172.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1172.0,0.0,LumB,Luminal B,Positive,T_Other,T3,LIVING,76.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-27837.0,1064.0,0.0,1359.0,NO,,Scheduled Follow-up Submission,2011-10-19,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,210.0,NO,Equivocal,Negative,,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1a,T3,Stage IIIA,TCGA-E2-A14O.42E9A561-B052-412E-B0FD-563DC097C3C5.pdf,A14O,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1359.0,0.0,1359.0,0.0,1359.0,0,1359.0
TCGA-E2-A14P-01,Stage IIIC,79.0,487.0,Negative,FEMALE,Positive,Negative,M0,Positive,N3,487.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,79.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-28923.0,965.0,0.0,1246.0,NO,,Scheduled Follow-up Submission,2011-10-20,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,290.0,NO,Positive,,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,,False,No,M0,N3,T2,Stage IIIC,TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C.pdf,A14P,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,NO,A,LIVING,2008.0,BRCA.Her2,0,1246.0,0.0,1246.0,0.0,1246.0,0,1246.0
TCGA-E2-A14Q-01,Stage IIA,50.0,974.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,974.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,50.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-18507.0,960.0,0.0,1163.0,NO,,Scheduled Follow-up Submission,2011-10-20,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Negative,,,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1mi,T2,Stage IIB,TCGA-E2-A14Q.42A1A073-69B4-4A66-A998-BE4366E0C89C.pdf,A14Q,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1163.0,0.0,1163.0,0.0,1163.0,0,1163.0
TCGA-E2-A14R-01,Stage IIA,62.0,845.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,845.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,62.0,Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-22686.0,910.0,0.0,1174.0,NO,,Scheduled Follow-up Submission,2011-10-24,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,190.0,NO,Negative,,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf,A14R,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Basal,0,1174.0,0.0,1174.0,0.0,1174.0,1,971.0
TCGA-E2-A14S-01,Stage I,65.0,834.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,834.0,0.0,LumB,Luminal B,Positive,T1,T1,LIVING,65.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23878.0,827.0,0.0,1009.0,NO,,Scheduled Follow-up Submission,2011-11-3,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,120.0,NO,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A14S.810B3936-DFF0-420C-BD6C-8D4990B8F536.pdf,A14S,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1009.0,0.0,1009.0,0.0,1009.0,0,1009.0
TCGA-E2-A14T-01,Stage IIA,52.0,890.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,890.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,52.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-19237.0,792.0,0.0,2311.0,NO,,Scheduled Follow-up Submission,2015-3-17,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,210.0,NO,Negative,Negative,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A14T.6C8B56C1-330B-4116-8B60-7A81A1983277.pdf,A14T,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,2311.0,0.0,2311.0,0.0,2311.0,0,2311.0
TCGA-E2-A14U-01,,,,,,,,,,,,,,,,,,,74.0,Right Upper Outer Quadrant,Other (specify),Positive,Positive,Lumpectomy,NO,-27389.0,796.0,0.0,1318.0,NO,,Scheduled Follow-up Submission,2012-7-11,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,70.0,NO,Equivocal,Negative,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf,A14U,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1318.0,0.0,1318.0,0.0,1318.0,0,1318.0
TCGA-E2-A14V-01,Stage IIB,53.0,748.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,748.0,0.0,Her2,HER2-enriched,Positive,T_Other,T2,LIVING,53.0,Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-19643.0,722.0,0.0,1042.0,NO,,Scheduled Follow-up Submission,2011-11-4,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,160.0,NO,Positive,,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,False,No,M0,N1,T2,Stage IIB,TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf,A14V,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Her2,0,1042.0,0.0,1042.0,0.0,1042.0,0,1042.0
TCGA-E2-A14W-01,Stage IIA,78.0,833.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,833.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,78.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-28664.0,,0.0,974.0,NO,,Scheduled Follow-up Submission,2011-11-4,MALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,,Positive,,5.0,Negative,,NO,0.0,,,No,M0,N0,T2,Stage IIA,,A14W,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,,LIVING,2008.0,BRCA.LumB,0,974.0,0.0,974.0,0.0,974.0,0,974.0
TCGA-E2-A14X-01,Stage IIIA,55.0,692.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,692.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,55.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-20105.0,652.0,0.0,972.0,NO,,Scheduled Follow-up Submission,2011-11-4,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,130.0,NO,Negative,,,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,False,No,M0,N2,T2,Stage IIIA,TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146.pdf,A14X,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,972.0,0.0,972.0,0.0,972.0,0,972.0
TCGA-E2-A14Y-01,Stage IIA,35.0,688.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,688.0,0.0,Basal,Basal-like,Positive,T_Other,T2,LIVING,35.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-13004.0,597.0,0.0,2109.0,NO,,Scheduled Follow-up Submission,2015-3-17,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,190.0,NO,Equivocal,Positive,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A14Y.957AC7B0-D613-4F97-BBBC-930EB95EE2E4.pdf,A14Y,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,2109.0,0.0,2109.0,0.0,2109.0,0,2109.0
TCGA-E2-A14Z-01,Stage I,64.0,518.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,518.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,64.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23682.0,519.0,0.0,518.0,NO,,Scheduled Follow-up Submission,2011-11-28,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,120.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A14Z.750D4149-BD70-4D7C-B915-9694BD1EC760.pdf,A14Z,WITH TUMOR,,YES,,YES,Primary Tumor,1,6th,YES,A,DECEASED,2009.0,BRCA.LumA,1,563.0,1.0,563.0,1.0,188.0,1,188.0
TCGA-E2-A150-01,Stage IIA,48.0,591.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,591.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,48.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-17580.0,506.0,0.0,1935.0,NO,,Scheduled Follow-up Submission,2015-3-18,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,180.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf,A150,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,1935.0,0.0,1935.0,0.0,1935.0,0,1935.0
TCGA-E2-A152-01,Stage I,56.0,588.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,588.0,0.0,Her2,HER2-enriched,Negative,T1,T1,LIVING,56.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,NO,-20705.0,,0.0,2128.0,NO,,Scheduled Follow-up Submission,2015-6-23,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Positive,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,,,No,M0,N0,T1c,Stage I,,A152,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.Her2,0,2128.0,0.0,2128.0,1.0,54.0,1,54.0
TCGA-E2-A153-01,Stage IIB,51.0,586.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,586.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,51.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-18875.0,,0.0,707.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,15.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,,No,M0,N1a,T2,Stage IIB,,A153,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumA,0,707.0,0.0,707.0,0.0,707.0,0,707.0
TCGA-E2-A153-11,,51.0,586.0,,FEMALE,,,,,,586.0,0.0,Normal,,,,,LIVING,51.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-18875.0,,0.0,707.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,15.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,,No,M0,N1a,T2,Stage IIB,,A153,TUMOR FREE,,YES,,YES,Solid Tissue Normal,11,6th,YES,,LIVING,2009.0,BRCA.Normal,0,707.0,0.0,707.0,0.0,707.0,0,707.0
TCGA-E2-A154-01,Stage I,68.0,325.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,325.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,68.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-24999.0,461.0,0.0,591.0,NO,90-99%,Scheduled Follow-up Submission,2011-11-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,400.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A154.8F8DCA87-B27A-429C-952A-186F8D4502AE.pdf,A154,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,591.0,0.0,591.0,0.0,591.0,0,591.0
TCGA-E2-A155-01,Stage IIB,58.0,553.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,553.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,58.0,Left Upper Inner Quadrant|Left Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-21348.0,457.0,0.0,640.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,280.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77.pdf,A155,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,640.0,0.0,640.0,0.0,640.0,0,640.0
TCGA-E2-A156-01,Stage I,61.0,481.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,481.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,61.0,Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-22422.0,,0.0,726.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A156,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumA,0,726.0,0.0,726.0,0.0,726.0,0,726.0
TCGA-E2-A158-01,Stage IIA,43.0,450.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,450.0,0.0,Basal,Basal-like,Negative,T1,T1,LIVING,43.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-15903.0,436.0,0.0,450.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,200.0,NO,Negative,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,Yes,M0,N1mi,T1c,Stage IIA,TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf,A158,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,450.0,0.0,450.0,0.0,450.0,0,450.0
TCGA-E2-A158-11,,43.0,450.0,,FEMALE,,,,,,450.0,0.0,Normal,,,,,LIVING,43.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-15903.0,436.0,0.0,450.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,170.0,NO,Negative,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,Yes,M0,N1mi,T1c,Stage IIA,,A158,TUMOR FREE,,YES,,NO,Solid Tissue Normal,11,6th,YES,A,LIVING,2009.0,BRCA.Normal,0,450.0,0.0,450.0,0.0,450.0,0,450.0
TCGA-E2-A159-01,Stage IIA,50.0,515.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,515.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,50.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-18621.0,434.0,0.0,762.0,NO,,Scheduled Follow-up Submission,2011-11-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,240.0,NO,,Negative,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf,A159,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,762.0,0.0,762.0,0.0,762.0,0,762.0
TCGA-E2-A15A-01,Stage IIIC,45.0,502.0,Positive,FEMALE,Negative,Negative,M0,Positive,N3,502.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,45.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-16750.0,,0.0,710.0,NO,,Scheduled Follow-up Submission,2011-11-10,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,13.0,,,No,M0,N3a,T2,Stage IIIC,,A15A,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumB,0,710.0,0.0,710.0,0.0,710.0,0,710.0
TCGA-E2-A15A-06,,45.0,502.0,,FEMALE,,,,,,502.0,0.0,LumB,,,,,LIVING,45.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-16750.0,426.0,0.0,710.0,NO,,Scheduled Follow-up Submission,2011-11-10,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,120.0,NO,Negative,,,19.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,13.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-E2-A15A.3687AF42-4BB3-46E2-8091-E0C5C84F15E6.pdf,A15A,TUMOR FREE,,YES,,YES,Metastatic,6,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,710.0,0.0,710.0,0.0,710.0,0,710.0
TCGA-E2-A15C-01,Stage I,61.0,496.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,496.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,61.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-22583.0,393.0,0.0,694.0,NO,,Scheduled Follow-up Submission,2011-11-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,200.0,NO,Equivocal,Negative,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510.pdf,A15C,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,694.0,0.0,694.0,0.0,694.0,0,694.0
TCGA-E2-A15D-01,Stage IIA,47.0,315.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,315.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,47.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-17224.0,393.0,0.0,526.0,NO,,Scheduled Follow-up Submission,2011-11-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,330.0,NO,Equivocal,Negative,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4.pdf,A15D,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,526.0,0.0,526.0,0.0,526.0,0,526.0
TCGA-E2-A15E-01,Stage IIA,40.0,517.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,517.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,40.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-14894.0,387.0,0.0,630.0,NO,,Scheduled Follow-up Submission,2011-11-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,520.0,NO,,Positive,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A15E.514D4C2E-8215-4770-9FC1-25F988232A85.pdf,A15E,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,630.0,0.0,630.0,0.0,630.0,0,630.0
TCGA-E2-A15E-06,,40.0,517.0,,FEMALE,,,,,,517.0,0.0,LumA,,,,,LIVING,40.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-14894.0,387.0,0.0,630.0,NO,,Scheduled Follow-up Submission,2011-11-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,60.0,NO,,Positive,,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A15E.57341F00-74F5-4015-B6D4-7BDED33F35A7.pdf,A15E,TUMOR FREE,,YES,,YES,Metastatic,6,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,630.0,0.0,630.0,0.0,630.0,0,630.0
TCGA-E2-A15F-01,Stage I,64.0,468.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,468.0,0.0,,Luminal A,Positive,T_Other,T2,LIVING,64.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23660.0,360.0,0.0,658.0,NO,90-99%,Scheduled Follow-up Submission,2011-11-10,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,190.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E.pdf,A15F,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,658.0,0.0,658.0,0.0,658.0,0,658.0
TCGA-E2-A15G-01,Stage IIA,76.0,315.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,315.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,76.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-28013.0,358.0,0.0,554.0,NO,,Scheduled Follow-up Submission,2011-11-14,FEMALE,1+,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,110.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15G.DD9FDF3B-29CA-4D11-8615-E2EEB5D601D1.pdf,A15G,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,554.0,0.0,554.0,0.0,554.0,0,554.0
TCGA-E2-A15H-01,Stage IIA,38.0,42.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,42.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,38.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-13985.0,357.0,0.0,393.0,NO,,Scheduled Follow-up Submission,2011-11-14,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,90.0,NO,Equivocal,Positive,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A15H.E4D1A7DC-62B1-44D8-A747-5A19842C6F69.pdf,A15H,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,393.0,0.0,393.0,0.0,393.0,0,393.0
TCGA-E2-A15I-01,Stage IIA,44.0,411.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,411.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,44.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-16163.0,344.0,0.0,1692.0,NO,90-99%,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,100.0,NO,Equivocal,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf,A15I,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1692.0,0.0,1692.0,0.0,1692.0,0,1692.0
TCGA-E2-A15I-11,,44.0,411.0,,FEMALE,,,,,,411.0,0.0,Normal,,,,,LIVING,44.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-16163.0,,0.0,1692.0,NO,90-99%,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Equivocal,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A15I,TUMOR FREE,YES,YES,90-99%,NO,Solid Tissue Normal,11,6th,YES,,LIVING,2009.0,BRCA.Normal,0,1692.0,0.0,1692.0,0.0,1692.0,0,1692.0
TCGA-E2-A15J-01,Stage I,51.0,463.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,463.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,51.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-18771.0,344.0,0.0,1640.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,210.0,NO,Equivocal,Negative,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A15J.352BF6A2-974B-440E-BB0B-DCD79874DAC3.pdf,A15J,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1640.0,0.0,1640.0,0.0,1640.0,0,1640.0
TCGA-E2-A15K-01,Stage IIA,58.0,34.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,34.0,0.0,LumB,Luminal B,Positive,T_Other,T2,LIVING,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-21514.0,309.0,0.0,275.0,NO,,Scheduled Follow-up Submission,2011-11-15,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,170.0,NO,Equivocal,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-E2-A15K.2BAC50DA-016F-4B5C-B8D1-DE75377EF0C7.pdf,A15K,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,275.0,0.0,275.0,0.0,275.0,0,275.0
TCGA-E2-A15K-06,,58.0,34.0,,FEMALE,,,,,,34.0,0.0,LumB,,,,,LIVING,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-21514.0,309.0,0.0,275.0,NO,,Scheduled Follow-up Submission,2011-11-15,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,280.0,NO,Equivocal,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-E2-A15K.72FE0659-6B7E-4129-B61D-C376C59C428F.pdf,A15K,TUMOR FREE,,YES,,YES,Metastatic,6,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,275.0,0.0,275.0,0.0,275.0,0,275.0
TCGA-E2-A15K-11,,58.0,34.0,,FEMALE,,,,,,34.0,0.0,,,,,,LIVING,58.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-21514.0,309.0,0.0,275.0,NO,,Scheduled Follow-up Submission,2011-11-15,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,120.0,NO,Equivocal,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,No,M0,N1a,T2,Stage IIB,,A15K,TUMOR FREE,,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2010.0,BRCA.Normal,0,275.0,0.0,275.0,0.0,275.0,0,275.0
TCGA-E2-A15L-01,Stage IIA,65.0,331.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,331.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,65.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-23845.0,289.0,0.0,626.0,NO,,Scheduled Follow-up Submission,2011-11-15,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,240.0,NO,Equivocal,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15L.C04B3267-9833-44D6-8C3D-45D7F829C38C.pdf,A15L,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,626.0,0.0,626.0,0.0,626.0,0,626.0
TCGA-E2-A15M-01,Stage IIA,66.0,234.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,234.0,0.0,LumA,Luminal B,Positive,T_Other,T2,LIVING,66.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-24266.0,287.0,0.0,235.0,NO,,Scheduled Follow-up Submission,2011-11-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,270.0,NO,Negative,,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15M.51601F8B-BA50-42C4-B0C9-B3581F80CD2C.pdf,A15M,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,DECEASED,2010.0,BRCA.LumA,1,336.0,0.0,336.0,0.0,336.0,0,336.0
TCGA-E2-A15M-11,,66.0,234.0,,FEMALE,,,,,,234.0,0.0,Normal,,,,,LIVING,66.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-24266.0,,0.0,235.0,NO,,Scheduled Follow-up Submission,2011-11-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,,,Negative,,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A15M,TUMOR FREE,,YES,,YES,Solid Tissue Normal,11,7th,YES,,DECEASED,2010.0,BRCA.Normal,1,336.0,0.0,336.0,0.0,336.0,0,336.0
TCGA-E2-A15O-01,Stage I,89.0,395.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,395.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,89.0,Left Upper Inner Quadrant,No axillary staging,Positive,Positive,Lumpectomy,NO,-32583.0,273.0,0.0,1545.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Equivocal,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,,,False,Yes,M0,NX,T1c,Stage I,TCGA-E2-A15O.AA4B6E2D-7503-4E51-BEA4-632CC994770A.pdf,A15O,TUMOR FREE,YES,NO,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1545.0,0.0,1545.0,1.0,1210.0,1,1210.0
TCGA-E2-A15P-01,Stage IA,61.0,315.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,315.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,61.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-22524.0,269.0,0.0,595.0,NO,,Scheduled Follow-up Submission,2011-11-16,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-E2-A15P.8C7442C0-540C-4023-BBFA-8482935259A7.pdf,A15P,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,595.0,0.0,595.0,0.0,595.0,0,595.0
TCGA-E2-A15R-01,Stage IIIA,64.0,330.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,330.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,64.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-23570.0,247.0,0.0,1732.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,140.0,NO,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A15R.0F708C6E-0262-46EE-8ED2-67E791D5C379.pdf,A15R,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1732.0,0.0,1732.0,0.0,1732.0,0,1732.0
TCGA-E2-A15S-01,Stage IIB,34.0,274.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,274.0,0.0,LumB,Luminal B,Negative,T_Other,T2,LIVING,34.0,Left Upper Inner Quadrant|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,NO,-12671.0,247.0,0.0,428.0,NO,,Scheduled Follow-up Submission,2011-11-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,560.0,NO,Equivocal,Negative,,17.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1,T2,Stage IIB,TCGA-E2-A15S.AF740239-D3E2-4C74-844E-0F5AD1A905ED.pdf,A15S,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,428.0,0.0,428.0,0.0,428.0,0,428.0
TCGA-E2-A15T-01,Stage IIA,65.0,267.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,267.0,0.0,,Luminal B,Positive,T_Other,T2,LIVING,65.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-24054.0,162.0,0.0,1563.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,360.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A.pdf,A15T,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumB,0,1563.0,0.0,1563.0,0.0,1563.0,0,1563.0
TCGA-E2-A1AZ-01,Stage IIB,63.0,1964.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,1964.0,0.0,Basal,Basal-like,Negative,T_Other,T2,LIVING,63.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-23230.0,2527.0,0.0,2329.0,NO,,Scheduled Follow-up Submission,2011-12-6,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,250.0,NO,Indeterminate,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf,A1AZ,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.Basal,0,2329.0,0.0,2329.0,0.0,2329.0,0,2329.0
TCGA-E2-A1B0-01,Stage IIIA,50.0,1271.0,Negative,FEMALE,Positive,Negative,M0,Positive,N2,1271.0,0.0,Her2,HER2-enriched,Negative,T_Other,T2,LIVING,50.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Modified Radical Mastectomy,NO,-18346.0,1315.0,0.0,1631.0,NO,,Scheduled Follow-up Submission,2011-12-7,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Positive,,,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf,A1B0,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.Her2,0,1631.0,0.0,1631.0,0.0,1631.0,0,1631.0
TCGA-E2-A1B1-01,Stage IIB,45.0,1361.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,1361.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,45.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-16603.0,1268.0,0.0,2653.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,300.0,NO,Equivocal,Positive,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf,A1B1,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,2653.0,0.0,2653.0,0.0,2653.0,0,2653.0
TCGA-E2-A1B4-01,Stage IIIA,74.0,911.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,911.0,0.0,LumA,Luminal A,Positive,T1,T1,LIVING,74.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-27241.0,798.0,0.0,911.0,NO,,Scheduled Follow-up Submission,2011-12-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,,True,No,M0,N2a,T1c,Stage IIIA,TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf,A1B4,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,DECEASED,2008.0,BRCA.LumA,1,1004.0,0.0,1004.0,0.0,1004.0,0,1004.0
TCGA-E2-A1B5-01,Stage IIA,46.0,774.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,774.0,0.0,LumA,Basal-like,Positive,T_Other,T2,LIVING,46.0,Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-17039.0,783.0,0.0,984.0,NO,,Scheduled Follow-up Submission,2011-12-8,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,260.0,NO,Negative,,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf,A1B5,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,984.0,0.0,984.0,0.0,984.0,0,984.0
TCGA-E2-A1B6-01,Stage IIA,44.0,338.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,338.0,0.0,,Luminal A,Negative,T_Other,T2,LIVING,44.0,Left,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-16370.0,,0.0,867.0,NO,,Scheduled Follow-up Submission,2011-12-8,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Equivocal,Negative,,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1B6,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,,LIVING,2008.0,BRCA.Basal,0,867.0,0.0,867.0,0.0,867.0,0,867.0
TCGA-E2-A1BD-01,Stage IIA,53.0,317.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,317.0,0.0,LumA,Luminal A,Positive,T_Other,T2,LIVING,53.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-19627.0,260.0,0.0,1133.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,100.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf,A1BD,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1133.0,0.0,1133.0,0.0,1133.0,0,1133.0
TCGA-E2-A1IE-01,Stage IIB,61.0,983.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,983.0,0.0,LumA,,Positive,T_Other,T2,LIVING,61.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-22510.0,,0.0,2362.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Equivocal,Negative,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,1.0,,,No,M0,N1,T2,Stage IIB,,A1IE,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2008.0,BRCA.LumA,0,2362.0,0.0,2362.0,1.0,1810.0,1,1810.0
TCGA-E2-A1IF-01,Stage I,74.0,956.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,956.0,0.0,LumA,,Positive,T1,T1,LIVING,74.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-27341.0,932.0,0.0,1138.0,NO,,Scheduled Follow-up Submission,2011-12-21,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,70.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf,A1IF,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1138.0,0.0,1138.0,0.0,1138.0,0,1138.0
TCGA-E2-A1IG-01,Stage IIB,45.0,755.0,Positive,FEMALE,,Negative,M0,Positive,N1,755.0,0.0,LumA,,Positive,T_Other,T2,LIVING,45.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-16757.0,,0.0,2140.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,M0,N1mi,T2,Stage IIB,,A1IG,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.LumA,0,2140.0,0.0,2140.0,0.0,2140.0,0,2140.0
TCGA-E2-A1IG-11,,45.0,755.0,,FEMALE,,,,,,755.0,0.0,Normal,,,,,LIVING,45.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-16757.0,679.0,0.0,2140.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,210.0,NO,Negative,,NO,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1mi,T2,Stage IIB,,A1IG,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,YES,A,LIVING,2009.0,BRCA.Normal,0,2140.0,0.0,2140.0,0.0,2140.0,0,2140.0
TCGA-E2-A1IH-01,Stage I,80.0,658.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,658.0,0.0,LumA,,Positive,T1,T1,LIVING,80.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-29444.0,883.0,0.0,1026.0,NO,,Scheduled Follow-up Submission,2011-12-21,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,80.0,NO,Equivocal,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf,A1IH,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1026.0,0.0,1026.0,0.0,1026.0,0,1026.0
TCGA-E2-A1II-01,Stage I,51.0,850.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,850.0,0.0,Basal,,Positive,T1,T1,LIVING,51.0,Left,Sentinel node biopsy alone,Negative,Positive,Lumpectomy,NO,-18788.0,,0.0,1025.0,NO,,Scheduled Follow-up Submission,2011-12-21,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A1II,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,,LIVING,2008.0,BRCA.Basal,0,1025.0,0.0,1025.0,0.0,1025.0,0,1025.0
TCGA-E2-A1IJ-01,Stage I,57.0,725.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,725.0,0.0,LumA,,Positive,T1,T1,LIVING,57.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-20956.0,707.0,0.0,865.0,NO,90-99%,Scheduled Follow-up Submission,2011-12-21,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,70.0,NO,Equivocal,Negative,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf,A1IJ,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,865.0,0.0,865.0,0.0,865.0,0,865.0
TCGA-E2-A1IK-01,Stage IIA,71.0,518.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,518.0,0.0,LumA,,Positive,T1,T1,LIVING,71.0,Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-26052.0,423.0,0.0,1800.0,NO,,Scheduled Follow-up Submission,2015-3-17,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,70.0,NO,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf,A1IK,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1800.0,0.0,1800.0,0.0,1800.0,0,1800.0
TCGA-E2-A1IL-01,Stage IIA,78.0,14.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,14.0,0.0,LumA,,Positive,T1,T1,LIVING,78.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-28495.0,417.0,0.0,118.0,NO,,Scheduled Follow-up Submission,2012-1-3,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,120.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf,A1IL,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,118.0,0.0,118.0,0.0,118.0,0,118.0
TCGA-E2-A1IN-01,Stage I,60.0,392.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,392.0,0.0,LumA,,Positive,T1,T1,LIVING,60.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-22199.0,,0.0,675.0,NO,,Scheduled Follow-up Submission,2012-1-4,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A1IN,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,675.0,0.0,675.0,0.0,675.0,0,675.0
TCGA-E2-A1IO-01,Stage I,37.0,448.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,448.0,0.0,LumA,,Positive,T1,T1,LIVING,37.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-13671.0,416.0,0.0,1855.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Equivocal,Negative,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf,A1IO,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,1855.0,0.0,1855.0,0.0,1855.0,0,1855.0
TCGA-E2-A1IU-01,Stage IA,60.0,127.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,127.0,0.0,LumA,,Positive,T1,T1,LIVING,60.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-22279.0,136.0,0.0,337.0,NO,,Scheduled Follow-up Submission,2012-1-4,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,270.0,NO,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0 (mol+),T1c,Stage IA,TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf,A1IU,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,337.0,0.0,337.0,0.0,337.0,0,337.0
TCGA-E2-A1L6-01,Stage IIA,44.0,1312.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1312.0,0.0,LumA,,Positive,T1,T1,LIVING,44.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-16403.0,1325.0,0.0,1648.0,NO,,Scheduled Follow-up Submission,2012-1-10,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,110.0,NO,Negative,,,6.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf,A1L6,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2007.0,BRCA.LumA,0,1648.0,0.0,1648.0,0.0,1648.0,0,1648.0
TCGA-E2-A1L7-01,Stage IIIA,40.0,633.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,633.0,0.0,LumB,,Negative,T_Other,T2,LIVING,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14854.0,548.0,0.0,1836.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,150.0,NO,Negative,,NO,20.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,7.0,,False,No,M0,N2,T2,Stage IIIA,TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf,A1L7,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,1836.0,0.0,1836.0,1.0,1619.0,1,1619.0
TCGA-E2-A1L7-11,,40.0,633.0,,FEMALE,,,,,,633.0,0.0,Normal,,,,,LIVING,40.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-14854.0,548.0,0.0,1836.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,280.0,NO,Negative,,NO,20.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,7.0,,False,No,M0,N2,T2,Stage IIIA,,A1L7,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,YES,A,LIVING,2009.0,BRCA.Normal,0,1836.0,0.0,1836.0,1.0,1619.0,1,1619.0
TCGA-E2-A1L8-01,Stage IIA,52.0,1015.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1015.0,0.0,LumA,,Positive,T_Other,T2,LIVING,52.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-19187.0,912.0,0.0,2240.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,180.0,NO,Equivocal,Negative,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,Yes,M0,N1a,T2,Stage IIB,TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf,A1L8,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,2240.0,0.0,2240.0,0.0,2240.0,0,2240.0
TCGA-E2-A1L9-01,Stage IIB,40.0,388.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,388.0,0.0,LumA,,Positive,T1,T1,LIVING,40.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-14868.0,465.0,0.0,598.0,NO,80-89%,Scheduled Follow-up Submission,2012-1-11,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,40.0,NO,Negative,,,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,False,No,M0,N1mi,T1c,Stage IIA,TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf,A1L9,TUMOR FREE,,YES,80-89%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,598.0,0.0,598.0,0.0,598.0,0,598.0
TCGA-E2-A1LA-01,Stage IIA,59.0,463.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,463.0,0.0,LumA,,Positive,T1,T1,LIVING,59.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-21773.0,581.0,0.0,748.0,NO,,Scheduled Follow-up Submission,2012-1-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,40.0,NO,Equivocal,Negative,,35.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T1c,Stage IIA,TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf,A1LA,TUMOR FREE,,YES,,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumA,0,748.0,0.0,748.0,0.0,748.0,0,748.0
TCGA-E2-A1LB-01,Stage IIB,41.0,972.0,Negative,FEMALE,Positive,Negative,M0,Positive,N1,972.0,0.0,Her2,,Negative,T_Other,T2,LIVING,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-15283.0,909.0,0.0,2306.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,190.0,NO,Positive,,NO,25.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,False,No,M0,N1,T2,Stage IIB,TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf,A1LB,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Her2,0,2306.0,0.0,2306.0,0.0,2306.0,0,2306.0
TCGA-E2-A1LB-11,,41.0,972.0,,FEMALE,,,,,,972.0,0.0,Normal,,,,,LIVING,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-15283.0,,0.0,2306.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Positive,,NO,25.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,,,No,M0,N1,T2,Stage IIB,,A1LB,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,6th,YES,,LIVING,2008.0,BRCA.Normal,0,2306.0,0.0,2306.0,0.0,2306.0,0,2306.0
TCGA-E2-A1LE-01,,,,,,,,,,,,,,,,,,,71.0,Right Upper Inner Quadrant|Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,NO,-26239.0,986.0,0.0,,NO,,Scheduled Follow-up Submission,2012-1-18,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,600.0,NO,Positive,,,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,27.0,,False,No,M0,N3a,T2,Stage IIIC,TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf,A1LE,WITH TUMOR,,YES,,YES,Primary Tumor,1,6th,YES,A,DECEASED,2008.0,BRCA.Her2,1,879.0,1.0,879.0,1.0,361.0,1,361.0
TCGA-E2-A1LG-01,Stage IIA,50.0,350.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,350.0,0.0,Basal,,Negative,T_Other,T2,LIVING,50.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-18492.0,252.0,0.0,1523.0,NO,,Scheduled Follow-up Submission,2015-3-16,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,310.0,NO,Equivocal,Negative,NO,19.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,False,Yes,M0,N0,T2,Stage IIA,TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf,A1LG,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,1523.0,0.0,1523.0,0.0,1523.0,0,1523.0
TCGA-E2-A1LH-01,Stage I,59.0,2875.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,2875.0,0.0,Basal,,Negative,T1,T1,LIVING,59.0,Right,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-21628.0,2998.0,0.0,3247.0,NO,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,130.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T1c,Stage I,TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf,A1LH,TUMOR FREE,,YES,,YES,Primary Tumor,1,5th,YES,A,LIVING,2002.0,BRCA.Basal,0,3247.0,0.0,3247.0,0.0,3247.0,0,3247.0
TCGA-E2-A1LH-11,,59.0,2875.0,,FEMALE,,,,,,2875.0,0.0,Normal,,,,,LIVING,59.0,Right,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-21628.0,,0.0,3247.0,NO,,Scheduled Follow-up Submission,2012-1-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T1c,Stage I,,A1LH,TUMOR FREE,,YES,,YES,Solid Tissue Normal,11,5th,YES,,LIVING,2002.0,BRCA.Normal,0,3247.0,0.0,3247.0,0.0,3247.0,0,3247.0
TCGA-E2-A1LK-01,Stage IIIC,84.0,,Negative,FEMALE,Negative,Negative,M0,Positive,N1,266.0,1.0,Basal,,Negative,T_Other,T3,DECEASED,84.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-30757.0,,0.0,,NO,,Scheduled Follow-up Submission,2012-1-12,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,Equivocal,Negative,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,11.0,,,No,M0,N3a,T4b,Stage IIIC,,A1LK,WITH TUMOR,,YES,,NO,Primary Tumor,1,6th,NO,,DECEASED,2008.0,BRCA.Basal,1,266.0,1.0,266.0,1.0,155.0,1,155.0
TCGA-E2-A1LL-01,Stage IIIA,73.0,1014.0,Negative,FEMALE,Negative,Negative,M0,Positive,N2,1014.0,0.0,Basal,,Negative,T_Other,T3,LIVING,73.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Simple Mastectomy,NO,-27028.0,988.0,0.0,1309.0,NO,,Scheduled Follow-up Submission,2012-1-17,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,290.0,NO,Negative,,,44.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,5.0,,False,No,MX,N2a,T3,Stage IIIA,TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf,A1LL,WITH TUMOR,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Basal,0,1309.0,0.0,1309.0,1.0,1303.0,1,1303.0
TCGA-E2-A1LS-01,Stage IA,46.0,239.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,239.0,0.0,Basal,,Negative,T1,T1,LIVING,46.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-16887.0,176.0,0.0,1604.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,100.0,NO,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T1c,Stage IA,TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf,A1LS,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,1604.0,0.0,1604.0,0.0,1604.0,0,1604.0
TCGA-E2-A1LS-11,,46.0,239.0,,FEMALE,,,,,,239.0,0.0,Normal,,,,,LIVING,46.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-16887.0,176.0,0.0,1604.0,NO,,Scheduled Follow-up Submission,2015-2-9,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,280.0,NO,Negative,,NO,5.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,False,No,M0,N0,T1c,Stage IA,,A1LS,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2010.0,BRCA.Normal,0,1604.0,0.0,1604.0,0.0,1604.0,0,1604.0
TCGA-E2-A2P5-01,,,,,,,,,,,,,,,,,,,78.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-28621.0,219.0,0.0,515.0,NO,,Scheduled Follow-up Submission,2014-11-26,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,260.0,NO,,Negative,NO,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,21.0,,True,Yes,M0,N3,T2,Stage IIIC,TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf,A2P5,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumA,1,821.0,1.0,821.0,1.0,597.0,1,597.0
TCGA-E2-A2P6-01,,,,,,,,,,,,,,,,,,,77.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-28411.0,,0.0,1051.0,NO,,Scheduled Follow-up Submission,2014-11-26,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,,Negative,NO,5.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,,No,M0,N1,T2,Stage IIB,,A2P6,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,1051.0,0.0,1051.0,0.0,1051.0,0,1051.0
TCGA-E2-A56Z-01,,,,,,,,,,,,,,,,,,,69.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-25282.0,254.0,0.0,252.0,,10-19%,,2014-11-6,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,150.0,NO,Equivocal,Negative,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf,A56Z,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumB,0,252.0,0.0,252.0,0.0,252.0,0,252.0
TCGA-E2-A570-01,,,,,,,,,,,,,,,,,,,47.0,Right Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-17456.0,416.0,0.0,931.0,,,,2014-6-27,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Equivocal,Negative,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1mi,T1c,Stage IB,TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf,A570,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,931.0,0.0,931.0,0.0,931.0,0,931.0
TCGA-E2-A572-01,,,,,,,,,,,,,,,,,,,72.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-26399.0,560.0,0.0,1208.0,,,,2014-9-17,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Equivocal,Negative,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,8.0,True,Yes,M0,N2,T2,Stage IIIA,TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf,A572,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1208.0,0.0,1208.0,0.0,1208.0,0,1208.0
TCGA-E2-A573-01,,,,,,,,,,,,,,,,,,,48.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Other,NO,-17689.0,,0.0,1062.0,,,,2014-6-27,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,4.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,,No,M0,N0,T1c,Stage IA,,A573,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,,LIVING,2011.0,BRCA.Basal,0,1062.0,0.0,1062.0,0.0,1062.0,0,1062.0
TCGA-E2-A574-01,,,,,,,,,,,,,,,,,,,44.0,Left,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,NO,-16195.0,429.0,0.0,1179.0,,,,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Equivocal,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf,A574,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Basal,0,1179.0,0.0,1179.0,0.0,1179.0,0,1179.0
TCGA-E2-A576-01,,,,,,,,,,,,,,,,,,,69.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-25350.0,343.0,0.0,1043.0,,,,2014-11-6,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,80.0,NO,Equivocal,Negative,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,MX,N0,T1c,Stage IA,TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf,A576,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1043.0,0.0,1043.0,0.0,1043.0,0,1043.0
TCGA-E2-A9RU-01,,,,,,,,,,,,,,,,,,,90.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Lumpectomy,YES,-32873.0,188.0,0.0,538.0,,70-79%,,2015-2-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,220.0,NO,Equivocal,Negative,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,12.0,,True,No,MX,N3a,T2,Stage IIIC,TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf,A9RU,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,538.0,0.0,538.0,0.0,538.0,0,538.0
TCGA-E9-A1N3-01,Stage IIIA,70.0,0.0,,FEMALE,Negative,Negative,M0,Positive,N2,0.0,0.0,LumA,,,T1,T1,LIVING,70.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-25714.0,65.0,0.0,1059.0,NO,,Scheduled Follow-up Submission,2014-7-22,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,230.0,NO,,,NO,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,7.0,,True,No,M0,N2,T1c,Stage IIIA,TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf,A1N3,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1059.0,0.0,1059.0,0.0,1059.0,0,1059.0
TCGA-E9-A1N4-01,Stage IIIA,41.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,41.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-15055.0,65.0,0.0,1000.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8520/3,C50.9,YES,Tumor resection,310.0,NO,Positive,,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,0.0,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf,A1N4,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1000.0,0.0,1000.0,0.0,1000.0,0,1000.0
TCGA-E9-A1N4-11,,41.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,41.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-15055.0,65.0,0.0,1000.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8520/3,C50.9,YES,Tumor resection,340.0,NO,Positive,,NO,7.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,4.0,0.0,True,No,M0,N2,T2,Stage IIIA,,A1N4,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2010.0,BRCA.Normal,0,1000.0,0.0,1000.0,0.0,1000.0,0,1000.0
TCGA-E9-A1N5-01,Stage IIB,45.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,45.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-16736.0,63.0,0.0,1120.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,190.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf,A1N5,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,1120.0,0.0,1120.0,0.0,1120.0,0,1120.0
TCGA-E9-A1N5-11,,45.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,45.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-16736.0,63.0,0.0,1120.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1,T2,Stage IIB,,A1N5,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2010.0,BRCA.Normal,0,1120.0,0.0,1120.0,0.0,1120.0,0,1120.0
TCGA-E9-A1N6-01,Stage IIB,52.0,0.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,52.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-19327.0,63.0,0.0,410.0,NO,,Scheduled Follow-up Submission,2014-8-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,220.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf,A1N6,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,YES,A,DECEASED,2010.0,BRCA.LumB,1,678.0,1.0,678.0,1.0,443.0,1,443.0
TCGA-E9-A1N6-11,,52.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,52.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,NO,-19327.0,63.0,0.0,410.0,NO,,Scheduled Follow-up Submission,2014-8-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,670.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,0.0,True,No,M0,N1,T2,Stage IIB,,A1N6,WITH TUMOR,YES,YES,,YES,Solid Tissue Normal,11,7th,YES,A,DECEASED,2010.0,BRCA.Normal,1,678.0,1.0,678.0,1.0,443.0,1,443.0
TCGA-E9-A1N8-01,Stage IIA,48.0,0.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,Basal,,,T_Other,T2,LIVING,48.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,,,NO,-17652.0,66.0,0.0,1039.0,NO,,Scheduled Follow-up Submission,2013-12-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,680.0,NO,Negative,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf,A1N8,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,1039.0,0.0,1039.0,0.0,1039.0,0,1039.0
TCGA-E9-A1N9-01,Stage IIA,58.0,0.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,Basal,,Positive,T_Other,T2,LIVING,58.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Positive,,YES,-21228.0,,0.0,1101.0,NO,,Scheduled Follow-up Submission,2014-4-8,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,,,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0,T2,Stage IIA,,A1N9,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.Basal,0,1101.0,0.0,1101.0,0.0,1101.0,0,1101.0
TCGA-E9-A1N9-11,,58.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,58.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Positive,,YES,-21228.0,44.0,0.0,1101.0,NO,,Scheduled Follow-up Submission,2014-4-8,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,1190.0,NO,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,,A1N9,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,1101.0,0.0,1101.0,0.0,1101.0,0,1101.0
TCGA-E9-A1NA-01,Stage IIA,58.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,58.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-21397.0,42.0,0.0,1112.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,110.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf,A1,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1112.0,0.0,1112.0,0.0,1112.0,0,1112.0
TCGA-E9-A1NA-11,,58.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,58.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-21397.0,42.0,0.0,1112.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,330.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,,A1,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,1112.0,0.0,1112.0,0.0,1112.0,0,1112.0
TCGA-E9-A1NC-01,Stage IIB,61.0,0.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,,,Positive,T_Other,T2,LIVING,61.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,Negative,Positive,,YES,-22355.0,38.0,0.0,1203.0,NO,,Scheduled Follow-up Submission,2013-2-26,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,200.0,NO,Positive,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1NC.AA1B707B-4DE8-4E0D-87CA-601760F4A6CF.pdf,A1NC,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,1203.0,0.0,1203.0,0.0,1203.0,0,1203.0
TCGA-E9-A1ND-01,Stage IIB,75.0,0.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,Basal,,Negative,T_Other,T2,LIVING,75.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,,YES,-27400.0,37.0,0.0,1266.0,NO,,Scheduled Follow-up Submission,2014-7-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,420.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf,A1ND,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,1266.0,0.0,1266.0,0.0,1266.0,0,1266.0
TCGA-E9-A1ND-11,,75.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,75.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,,YES,-27400.0,37.0,0.0,1266.0,NO,,Scheduled Follow-up Submission,2014-7-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,1070.0,NO,Positive,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,,A1ND,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,1266.0,0.0,1266.0,0.0,1266.0,0,1266.0
TCGA-E9-A1NE-01,Stage IIB,28.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,28.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-10564.0,31.0,0.0,1088.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8522/3,C50.9,YES,Tumor resection,280.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf,A1NE,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,1088.0,0.0,1088.0,0.0,1088.0,0,1088.0
TCGA-E9-A1NF-01,Stage IIA,60.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,60.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-21981.0,31.0,0.0,610.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,240.0,NO,Negative,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf,A1NF,WITH TUMOR,YES,YES,,NO,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumB,1,1072.0,1.0,1072.0,1.0,90.0,1,90.0
TCGA-E9-A1NF-11,,60.0,0.0,,FEMALE,,,,,,0.0,0.0,LumA,,,,,LIVING,60.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-21981.0,31.0,0.0,610.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,1520.0,NO,Negative,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,,A1NF,WITH TUMOR,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,DECEASED,2011.0,BRCA.LumA,1,1072.0,1.0,1072.0,1.0,90.0,1,90.0
TCGA-E9-A1NG-01,Stage IIA,62.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-22896.0,30.0,0.0,656.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,380.0,NO,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf,A1NG,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumA,1,786.0,0.0,786.0,0.0,786.0,0,786.0
TCGA-E9-A1NG-11,,62.0,0.0,,FEMALE,,,,,,0.0,0.0,Normal,,,,,LIVING,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-22896.0,30.0,0.0,656.0,NO,,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,740.0,NO,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,,A1NG,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,DECEASED,2011.0,BRCA.Normal,1,786.0,0.0,786.0,0.0,786.0,0,786.0
TCGA-E9-A1NH-01,Stage IIB,71.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumA,,Positive,T_Other,T2,LIVING,71.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-26221.0,30.0,0.0,576.0,NO,,,2012-9-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,140.0,NO,Negative,,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf,A1NH,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,576.0,0.0,576.0,0.0,576.0,0,576.0
TCGA-E9-A1NI-01,Stage IIA,51.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,51.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-18985.0,21.0,0.0,300.0,NO,,Scheduled Follow-up Submission,2013-11-27,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,280.0,NO,Negative,,YES,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf,A1NI,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,300.0,0.0,300.0,0.0,300.0,0,300.0
TCGA-E9-A1QZ-01,Stage IIA,61.0,0.0,,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,,,T_Other,T2,LIVING,61.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,,,,-22397.0,58.0,0.0,755.0,NO,,Scheduled Follow-up Submission,2014-10-7,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,590.0,NO,,,NO,19.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf,A1QZ,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,NO,A,LIVING,2011.0,BRCA.LumA,0,755.0,0.0,755.0,0.0,755.0,0,755.0
TCGA-E9-A1R3-01,Stage IIIC,70.0,64.0,,FEMALE,Negative,Negative,M0,Positive,N3,64.0,0.0,LumA,,,T_Other,T2,LIVING,70.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-25693.0,80.0,0.0,78.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,420.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,,True,No,M0,N3,T2,Stage IIIC,TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf,A1R3,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,78.0,0.0,78.0,0.0,78.0,0,78.0
TCGA-E9-A1R4-01,Stage IA,66.0,29.0,,FEMALE,Negative,Negative,M0,Negative,N0,29.0,0.0,LumB,,,T1,T1,LIVING,66.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,,NO,-24181.0,45.0,0.0,186.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",430.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf,A1R4,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,186.0,0.0,186.0,0.0,186.0,0,186.0
TCGA-E9-A1R5-01,Stage IA,63.0,42.0,,FEMALE,Negative,Negative,M0,Negative,N0,42.0,0.0,LumA,,,T1,T1,LIVING,63.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23116.0,58.0,0.0,92.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),370.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf,A1R5,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,92.0,0.0,92.0,0.0,92.0,0,92.0
TCGA-E9-A1R6-01,Stage IIA,63.0,84.0,,FEMALE,Negative,Negative,M0,Negative,N0,84.0,0.0,LumA,,,T_Other,T2,LIVING,63.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23347.0,100.0,0.0,339.0,NO,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),730.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf,A1R6,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,339.0,0.0,339.0,0.0,339.0,0,339.0
TCGA-E9-A1R7-01,Stage IIA,64.0,34.0,,FEMALE,Negative,Negative,M0,Negative,N0,34.0,0.0,LumB,,,T_Other,T2,LIVING,64.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23397.0,51.0,0.0,1467.0,NO,,Scheduled Follow-up Submission,2015-3-25,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),400.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf,A1R7,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1467.0,0.0,1467.0,0.0,1467.0,0,1467.0
TCGA-E9-A1R7-11,,64.0,34.0,,FEMALE,,,,,,34.0,0.0,Normal,,,,,LIVING,64.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23397.0,51.0,0.0,1467.0,NO,,Scheduled Follow-up Submission,2015-3-25,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),440.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,,A1R7,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,1467.0,0.0,1467.0,0.0,1467.0,0,1467.0
TCGA-E9-A1RA-01,Stage IA,48.0,29.0,,FEMALE,Negative,Negative,M0,Negative,N0,29.0,0.0,,,,T1,T1,LIVING,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,,NO,-17699.0,,0.0,1369.0,NO,,Scheduled Follow-up Submission,2014-11-20,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",,,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0,T1c,Stage IA,,A1RA,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,1369.0,0.0,1369.0,0.0,1369.0,0,1369.0
TCGA-E9-A1RB-01,Stage IIA,40.0,21.0,,FEMALE,Negative,Negative,M0,Negative,N0,21.0,0.0,LumB,,,T_Other,T2,LIVING,40.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-14755.0,39.0,0.0,633.0,NO,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),490.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf,A1RB,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumB,1,976.0,0.0,976.0,0.0,976.0,0,976.0
TCGA-E9-A1RB-11,,40.0,21.0,,FEMALE,,,,,,21.0,0.0,Normal,,,,,LIVING,40.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-14755.0,39.0,0.0,633.0,NO,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),640.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,,A1RB,TUMOR FREE,YES,YES,,NO,Solid Tissue Normal,11,7th,YES,A,DECEASED,2011.0,BRCA.Normal,1,976.0,0.0,976.0,0.0,976.0,0,976.0
TCGA-E9-A1RC-01,Stage IIIC,56.0,1228.0,,FEMALE,Negative,Negative,M0,Positive,N3,1228.0,0.0,LumA,,,T_Other,T4,LIVING,56.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-20795.0,1246.0,0.0,1224.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),620.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,0.0,True,No,M0,N3,T4b,Stage IIIC,TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf,A1RC,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2007.0,BRCA.LumA,0,1224.0,0.0,1224.0,0.0,1224.0,0,1224.0
TCGA-E9-A1RC-11,,56.0,1228.0,,FEMALE,,,,,,1228.0,0.0,LumA,,,,,LIVING,56.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-20795.0,1246.0,0.0,1224.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),1040.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,0.0,False,No,M0,N3,T4b,Stage IIIC,,A1RC,TUMOR FREE,,YES,,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2007.0,BRCA.LumA,0,1224.0,0.0,1224.0,0.0,1224.0,0,1224.0
TCGA-E9-A1RD-01,Stage IIA,67.0,20.0,,FEMALE,Negative,Negative,M0,Negative,N0,20.0,0.0,LumA,,,T_Other,T2,LIVING,67.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-24719.0,,0.0,34.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),,,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,M0,N0,T2,Stage IIA,,A1RD,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,34.0,0.0,34.0,0.0,34.0,0,34.0
TCGA-E9-A1RD-11,,67.0,20.0,,FEMALE,,,,,,20.0,0.0,Normal,,,,,LIVING,67.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-24719.0,38.0,0.0,34.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),640.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,,A1RD,TUMOR FREE,,YES,,NO,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,34.0,0.0,34.0,0.0,34.0,0,34.0
TCGA-E9-A1RE-01,Stage IIIA,74.0,47.0,,FEMALE,Negative,Negative,M0,Positive,N2,47.0,0.0,LumB,,,T_Other,T2,LIVING,74.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-27392.0,65.0,0.0,1419.0,NO,,Scheduled Follow-up Submission,2014-12-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),730.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,9.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf,A1RE,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1419.0,0.0,1419.0,0.0,1419.0,0,1419.0
TCGA-E9-A1RF-01,Stage IIIA,68.0,38.0,,FEMALE,Negative,Negative,M0,Positive,N2,38.0,0.0,LumA,,,T_Other,T2,LIVING,68.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-25119.0,56.0,0.0,200.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),330.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf,A1RF,TUMOR FREE,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,200.0,0.0,200.0,0.0,200.0,0,200.0
TCGA-E9-A1RF-11,,68.0,38.0,,FEMALE,,,,,,38.0,0.0,LumA,,,,,LIVING,68.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-25119.0,56.0,0.0,200.0,NO,,Scheduled Follow-up Submission,2013-9-19,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),1050.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,False,No,M0,N2,T2,Stage IIIA,,A1RF,TUMOR FREE,,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,200.0,0.0,200.0,0.0,200.0,0,200.0
TCGA-E9-A1RG-01,Stage IIIA,62.0,35.0,,FEMALE,Negative,Negative,M0,Positive,N2,35.0,0.0,,,,T1,T1,LIVING,62.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-22788.0,53.0,0.0,647.0,NO,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),540.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,,True,No,M0,N2,T1c,Stage IIIA,TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf,A1RG,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,647.0,0.0,647.0,0.0,647.0,0,647.0
TCGA-E9-A1RH-01,Stage IIA,63.0,14.0,,FEMALE,Negative,Negative,M0,Negative,N0,14.0,0.0,Her2,,,T_Other,T2,LIVING,63.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23224.0,32.0,0.0,1417.0,NO,,Scheduled Follow-up Submission,2015-1-28,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),410.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf,A1RH,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Her2,0,1417.0,0.0,1417.0,0.0,1417.0,0,1417.0
TCGA-E9-A1RH-11,,63.0,14.0,,FEMALE,,,,,,14.0,0.0,Normal,,,,,LIVING,63.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23224.0,32.0,0.0,1417.0,NO,,Scheduled Follow-up Submission,2015-1-28,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),720.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,M0,N0,T2,Stage IIA,,A1RH,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.Normal,0,1417.0,0.0,1417.0,0.0,1417.0,0,1417.0
TCGA-E9-A1RI-01,Stage IIIA,43.0,48.0,,FEMALE,,Negative,M0,Positive,N2,48.0,0.0,LumA,,,T1,T1,LIVING,43.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-15942.0,64.0,0.0,1449.0,NO,,Scheduled Follow-up Submission,2015-1-28,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),290.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,5.0,,True,No,M0,N2,T1c,Stage IIIA,TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf,A1RI,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,1449.0,0.0,1449.0,0.0,1449.0,0,1449.0
TCGA-E9-A1RI-11,,43.0,48.0,,FEMALE,,,,,,48.0,0.0,LumA,,,,,LIVING,43.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-15942.0,64.0,0.0,1449.0,NO,,Scheduled Follow-up Submission,2015-1-28,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),800.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,5.0,,False,No,M0,N2,T1c,Stage IIIA,,A1RI,TUMOR FREE,YES,YES,,YES,Solid Tissue Normal,11,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,1449.0,0.0,1449.0,0.0,1449.0,0,1449.0
TCGA-E9-A226-01,Stage IIIA,45.0,16.0,,FEMALE,Negative,Negative,M0,Positive,N2,16.0,0.0,LumB,,,T_Other,T2,LIVING,45.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-16511.0,48.0,0.0,628.0,NO,,Scheduled Follow-up Submission,2015-3-2,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),510.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,6.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf,A226,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumB,1,1048.0,1.0,1048.0,1.0,790.0,1,790.0
TCGA-E9-A227-01,Stage IIB,42.0,24.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,24.0,0.0,LumA,,Positive,T_Other,T2,LIVING,42.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-15602.0,66.0,0.0,975.0,NO,90-99%,Scheduled Follow-up Submission,2014-4-29,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,180.0,NO,Negative,,YES,17.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf,A227,TUMOR FREE,,YES,80-89%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,975.0,0.0,975.0,0.0,975.0,0,975.0
TCGA-E9-A228-01,Stage IIB,58.0,0.0,,FEMALE,Positive,Negative,M0,Positive,N1,0.0,0.0,LumB,,,T_Other,T2,LIVING,58.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,,,,-21294.0,42.0,0.0,1285.0,NO,,Scheduled Follow-up Submission,2014-9-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,740.0,NO,,,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf,A228,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1285.0,0.0,1285.0,0.0,1285.0,0,1285.0
TCGA-E9-A229-01,Stage IA,37.0,0.0,,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,,,T1,T1,LIVING,37.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,,,,,-13817.0,56.0,0.0,1148.0,NO,,Scheduled Follow-up Submission,2014-9-30,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,160.0,NO,,,NO,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf,A229,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,1148.0,0.0,1148.0,0.0,1148.0,0,1148.0
TCGA-E9-A22A-01,Stage IIA,74.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumB,,Negative,T_Other,T2,LIVING,74.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,,YES,-27288.0,59.0,0.0,1189.0,NO,10-19%,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,340.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf,A22A,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1189.0,0.0,1189.0,0.0,1189.0,0,1189.0
TCGA-E9-A22B-01,Stage IA,71.0,0.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,LumA,,Negative,T1,T1,LIVING,71.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,,YES,-26278.0,,0.0,1167.0,NO,10-19%,Scheduled Follow-up Submission,2014-9-2,FEMALE,,Mixed Histology (please specify),No,C50.9,8522/3,C50.9,YES,Tumor resection,,,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0,T1c,Stage IA,,A22B,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumA,0,1167.0,0.0,1167.0,0.0,1167.0,0,1167.0
TCGA-E9-A22D-01,Stage IIA,38.0,0.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,38.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-14115.0,52.0,0.0,1248.0,,10-19%,Scheduled Follow-up Submission,2013-2-1,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,620.0,NO,Positive,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf,A22D,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1248.0,0.0,1248.0,0.0,1248.0,0,1248.0
TCGA-E9-A22E-01,Stage IIIA,56.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,56.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-20574.0,52.0,0.0,1269.0,NO,10-19%,Scheduled Follow-up Submission,2014-8-13,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,620.0,NO,Positive,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,0.0,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf,A22E,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1269.0,0.0,1269.0,0.0,1269.0,0,1269.0
TCGA-E9-A22G-01,Stage IIIA,47.0,0.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,0.0,0.0,Basal,,Negative,T_Other,T2,LIVING,47.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,,YES,-17300.0,45.0,0.0,1239.0,NO,,Scheduled Follow-up Submission,2014-7-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,650.0,NO,Positive,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf,A22G,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,1239.0,0.0,1239.0,0.0,1239.0,0,1239.0
TCGA-E9-A22H-01,Stage IIB,42.0,0.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,0.0,0.0,LumB,,Positive,T_Other,T2,LIVING,42.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-15504.0,38.0,0.0,1232.0,NO,<10%,Scheduled Follow-up Submission,2014-8-4,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,500.0,NO,Positive,,NO,8.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf,A22H,TUMOR FREE,YES,YES,10-19%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,1232.0,0.0,1232.0,0.0,1232.0,0,1232.0
TCGA-E9-A243-01,Stage IIA,52.0,43.0,,FEMALE,Negative,Negative,M0,Negative,N0,43.0,0.0,Basal,,,T_Other,T2,LIVING,52.0,Right Upper Inner Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-19035.0,94.0,0.0,612.0,NO,,Scheduled Follow-up Submission,2014-2-18,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),270.0,NO,,,YES,10.0,Negative,Peri (6-12 months since last menstrual period),YES,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf,A243,WITH TUMOR,,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,612.0,0.0,612.0,1.0,305.0,1,305.0
TCGA-E9-A244-01,Stage IIA,54.0,20.0,,FEMALE,Negative,Negative,M0,Negative,N0,20.0,0.0,Basal,,,T_Other,T2,LIVING,54.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-19778.0,58.0,0.0,21.0,NO,,Scheduled Follow-up Submission,2012-4-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),310.0,NO,,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf,A244,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Basal,0,21.0,0.0,21.0,0.0,21.0,0,21.0
TCGA-E9-A245-01,Stage IIB,47.0,25.0,,FEMALE,Negative,Negative,M0,Positive,N1,25.0,0.0,LumA,,,T_Other,T2,LIVING,47.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-17363.0,62.0,0.0,26.0,NO,,Scheduled Follow-up Submission,2012-4-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),490.0,NO,,,,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf,A245,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumA,0,26.0,0.0,26.0,0.0,26.0,0,26.0
TCGA-E9-A247-01,Stage IB,59.0,12.0,,FEMALE,Negative,Negative,M0,Negative,N0,12.0,0.0,LumA,,,T1,T1,LIVING,59.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,,,,,-21562.0,49.0,0.0,1186.0,NO,,Scheduled Follow-up Submission,2014-7-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",370.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T1c,Stage IA,TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf,A247,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,1186.0,0.0,1186.0,0.0,1186.0,0,1186.0
TCGA-E9-A248-01,Stage IIA,51.0,21.0,,FEMALE,Negative,Negative,M0,Negative,N0,21.0,0.0,Her2,,,T_Other,T2,LIVING,51.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-18684.0,52.0,0.0,59.0,NO,,Scheduled Follow-up Submission,2012-4-25,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),540.0,NO,,,,10.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf,A248,TUMOR FREE,,YES,,NO,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.Her2,0,59.0,0.0,59.0,0.0,59.0,0,59.0
TCGA-E9-A249-01,Stage IIA,45.0,28.0,,FEMALE,Negative,Negative,M0,Negative,N0,28.0,0.0,LumB,,,T_Other,T2,LIVING,45.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-16689.0,59.0,0.0,217.0,NO,,Scheduled Follow-up Submission,2013-9-25,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),470.0,NO,,,YES,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf,A249,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,217.0,0.0,217.0,0.0,217.0,0,217.0
TCGA-E9-A24A-01,Stage IIA,69.0,10.0,,FEMALE,Negative,Negative,M0,Positive,N1,10.0,0.0,LumA,,,T1,T1,LIVING,69.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,,NO,-25370.0,41.0,0.0,747.0,NO,,Scheduled Follow-up Submission,2013-1-24,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",390.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1,T1c,Stage IIA,TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf,A24A,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,747.0,0.0,747.0,0.0,747.0,0,747.0
TCGA-E9-A295-01,,,,,,,,,,,,,LumA,,,,,,71.0,Right Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-25957.0,63.0,0.0,375.0,,80-89%,,2012-9-25,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,670.0,NO,Positive,,YES,7.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf,A295,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,375.0,0.0,375.0,0.0,375.0,0,375.0
TCGA-E9-A2JS-01,,,,,,,,,,,,,LumB,,,,,,72.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-26407.0,79.0,0.0,540.0,,,Scheduled Follow-up Submission,2013-2-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),420.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,1.0,,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf,A2JS,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,7th,YES,A,DECEASED,2011.0,BRCA.LumB,1,904.0,1.0,904.0,1.0,524.0,1,524.0
TCGA-E9-A2JT-01,,,,,,,,,,,,,LumA,,,,,,63.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Lumpectomy,NO,-23318.0,94.0,0.0,288.0,,,Scheduled Follow-up Submission,2013-2-15,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),260.0,NO,,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf,A2JT,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,288.0,0.0,288.0,0.0,288.0,0,288.0
TCGA-E9-A3HO-01,,,,,,,,,,,,,LumB,,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,Modified Radical Mastectomy,NO,-18046.0,,0.0,1158.0,NO,,Scheduled Follow-up Submission,2014-7-9,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),,,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,,No,M0,N0 (i-),T2,Stage IIA,,A3HO,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,YES,,LIVING,2011.0,BRCA.LumB,0,1158.0,0.0,1158.0,0.0,1158.0,0,1158.0
TCGA-E9-A3Q9-01,,,,,,,,,,,,,LumA,,,,,,78.0,Right Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,,YES,-28715.0,198.0,0.0,1001.0,NO,40-49%,,2014-5-20,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,580.0,NO,Indeterminate,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,22.0,0.0,True,No,M0,N3,T3,Stage IIIC,TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf,A3Q9,TUMOR FREE,YES,YES,40-49%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1001.0,0.0,1001.0,0.0,1001.0,0,1001.0
TCGA-E9-A3QA-01,,,,,,,,,,,,,,,,,,,33.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,,,,,-12142.0,282.0,0.0,918.0,NO,,,2014-10-2,FEMALE,,Medullary Carcinoma,No,C50.9,8510/3,C50.9,YES,Tumor resection,750.0,NO,,,NO,14.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf,A3QA,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Basal,0,918.0,0.0,918.0,0.0,918.0,0,918.0
TCGA-E9-A3X8-01,,,,,,,,,,,,,,,,,,,48.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-17588.0,233.0,0.0,926.0,NO,20-29%,,2014-5-20,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,260.0,NO,Positive,,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,4.0,0.0,True,No,M0,N1,T2,Stage IIB,TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf,A3X8,TUMOR FREE,YES,YES,20-29%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,926.0,0.0,926.0,0.0,926.0,0,926.0
TCGA-E9-A54X-01,,,,,,,,,,,,,,,,,,,85.0,Left|Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-31173.0,78.0,0.0,727.0,,90-99%,,2014-10-15,FEMALE,,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Core needle biopsy,220.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0 (i-),T1b,Stage IA,TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf,A54X,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumB,0,727.0,0.0,727.0,0.0,727.0,0,727.0
TCGA-E9-A54Y-01,,,,,,,,,,,,,,,,,,,63.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-23057.0,76.0,0.0,725.0,,90-99%,,2014-10-15,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Fine needle aspiration biopsy,370.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,8.0,,True,No,M0,N2,T2,Stage IIIA,TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf,A54Y,TUMOR FREE,NO,YES,50-59%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumB,0,725.0,0.0,725.0,0.0,725.0,0,725.0
TCGA-E9-A5FK-01,,,,,,,,,,,,,,,,,,,60.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-22199.0,77.0,0.0,812.0,,80-89%,,2015-1-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),490.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,,True,No,M0,N3,T2,Stage IIIC,TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf,A5FK,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,812.0,0.0,812.0,0.0,812.0,0,812.0
TCGA-E9-A5FL-01,,,,,,,,,,,,,,,,,,,65.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Modified Radical Mastectomy,NO,-24053.0,73.0,0.0,24.0,,,,2014-1-24,FEMALE,,Metaplastic Carcinoma,No,C50.9,8575/3,C50.9,YES,Cytology (e.g. Peritoneal or pleural fluid),590.0,NO,Negative,,YES,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T3,Stage IIB,TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf,A5FL,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,24.0,0.0,24.0,0.0,24.0,0,24.0
TCGA-E9-A5UO-01,,,,,,,,,,,,,,,,,,,41.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,,,Other,NO,-15050.0,98.0,0.0,785.0,,,,2015-1-30,FEMALE,,Mucinous Carcinoma,No,C50.9,8480/3,C50.9,YES,Fine needle aspiration biopsy,400.0,NO,,,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf,A5UO,TUMOR FREE,NO,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumB,0,785.0,0.0,785.0,0.0,785.0,0,785.0
TCGA-E9-A5UP-01,,,,,,,,,,,,,,,,,,,63.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,,,,NO,-23371.0,85.0,0.0,803.0,,,,2015-3-26,FEMALE,,"Other, specify",No,C50.9,8503/3,C50.9,YES,Tumor resection,140.0,NO,,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf,A5UP,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,803.0,0.0,803.0,0.0,803.0,0,803.0
TCGA-E9-A6HE-01,,,,,,,,,,,,,,,,,,,45.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,NO,-16697.0,,0.0,847.0,,90-99%,,2015-3-10,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,NO,12.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,12.0,,,No,MX,N3,T3,Stage IIIC,,A6HE,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.LumA,0,847.0,0.0,847.0,0.0,847.0,0,847.0
TCGA-EW-A1IW-01,Stage IIB,80.0,252.0,Positive,FEMALE,Positive,Negative,M0,Positive,N1,252.0,0.0,LumA,,Positive,T_Other,T2,LIVING,80.0,Right Lower Inner Quadrant|Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-29529.0,213.0,0.0,371.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,90.0,NO,Positive,,,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,MX,N1a,T2,Stage IIB,TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf,A1IW,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,371.0,0.0,371.0,0.0,371.0,0,371.0
TCGA-EW-A1IX-01,Stage IIA,48.0,1082.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1082.0,0.0,LumA,,Positive,T1,T1,LIVING,48.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-17597.0,1030.0,0.0,1208.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,,"Other, specify",No,C50.9,8524/3,C50.9,YES,Core needle biopsy,130.0,NO,Negative,,,27.0,Negative,Peri (6-12 months since last menstrual period),NO,1.0,1.0,True,No,MX,N1a,T1b,Stage IIA,TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf,A1IX,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1208.0,0.0,1208.0,0.0,1208.0,0,1208.0
TCGA-EW-A1IY-01,Stage I,38.0,258.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,258.0,0.0,LumB,,Positive,T1,T1,LIVING,38.0,Right Upper Inner Quadrant,Other (specify),Positive,Positive,Lumpectomy,YES,-14122.0,590.0,0.0,258.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-5,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,50.0,NO,Negative,,,6.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,MX,N0,T1c,Stage I,TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf,A1IY,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,258.0,0.0,258.0,0.0,258.0,0,258.0
TCGA-EW-A1IZ-01,Stage IIIA,53.0,260.0,Positive,FEMALE,Negative,Negative,M0,Positive,N2,260.0,0.0,,,Positive,T_Other,T2,LIVING,53.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-19706.0,194.0,0.0,554.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",130.0,NO,Negative,,,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,True,No,MX,N2a,T2,Stage IIIA,TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf,A1IZ,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,554.0,0.0,554.0,0.0,554.0,0,554.0
TCGA-EW-A1J1-01,Stage IIB,38.0,282.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,282.0,0.0,LumA,,Positive,T_Other,T2,LIVING,38.0,Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-14122.0,214.0,0.0,575.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-3,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,Negative,,,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf,A1J1,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,575.0,0.0,575.0,0.0,575.0,0,575.0
TCGA-EW-A1J2-01,Stage IIB,50.0,139.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,139.0,0.0,LumA,,Positive,T1,T1,LIVING,50.0,Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Other,YES,-18558.0,51.0,0.0,403.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,,21.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,1.0,True,No,MX,N1mi,T1c,[Discrepancy],TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf,A1J2,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,403.0,0.0,403.0,0.0,403.0,0,403.0
TCGA-EW-A1J3-01,Stage IA,61.0,252.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,252.0,0.0,LumA,,Positive,T1,T1,LIVING,61.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,YES,-22332.0,155.0,0.0,504.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,80.0,NO,Positive,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T1c,Stage IA,TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf,A1J3,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,504.0,0.0,504.0,0.0,504.0,0,504.0
TCGA-EW-A1J5-01,Stage IIB,59.0,227.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,227.0,0.0,LumA,,Positive,T_Other,T3,LIVING,59.0,Left,Sentinel node biopsy alone,Positive,Positive,Other,YES,-21559.0,123.0,0.0,477.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,180.0,NO,Negative,,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T3,Stage IIB,TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf,A1J5,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,477.0,0.0,477.0,0.0,477.0,0,477.0
TCGA-EW-A1J6-01,Stage I,70.0,595.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,595.0,0.0,LumB,,Positive,T1,T1,LIVING,70.0,Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-25830.0,528.0,0.0,875.0,NO,90-99%,Scheduled Follow-up Submission,2012-2-6,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T1c,Stage I,TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf,A1J6,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,875.0,0.0,875.0,0.0,875.0,0,875.0
TCGA-EW-A1OV-01,Stage IIB,56.0,522.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,522.0,0.0,Her2,,Negative,T_Other,T2,LIVING,56.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-20764.0,,0.0,789.0,NO,<10%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,,6.0,Close,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,,No,MX,N1mi,T2,Stage IIB,,A1OV,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.Her2,0,789.0,0.0,789.0,0.0,789.0,0,789.0
TCGA-EW-A1OW-01,Stage IIA,58.0,463.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,463.0,0.0,Basal,,Negative,T_Other,T2,LIVING,58.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-21465.0,444.0,0.0,694.0,NO,<10%,Scheduled Follow-up Submission,2012-3-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8090/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,,,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf,A1OW,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,694.0,0.0,694.0,0.0,694.0,0,694.0
TCGA-EW-A1OX-01,Stage IIA,43.0,562.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,562.0,0.0,LumB,,Positive,T_Other,T2,LIVING,43.0,Right Upper Inner Quadrant,Other (specify),Positive,Positive,Lumpectomy,YES,-15837.0,550.0,0.0,911.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,Mucinous Carcinoma,No,C50.9,8523/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf,A1OX,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,911.0,0.0,911.0,0.0,911.0,0,911.0
TCGA-EW-A1OY-01,Stage IIA,63.0,593.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,593.0,0.0,LumB,,Positive,T_Other,T2,LIVING,63.0,Left,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-23266.0,526.0,0.0,908.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-23,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,Negative,,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf,A1OY,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.LumB,0,908.0,0.0,908.0,0.0,908.0,0,908.0
TCGA-EW-A1OZ-01,Stage IIA,56.0,941.0,Positive,FEMALE,Positive,Negative,M0,Negative,N0,941.0,0.0,LumB,,Negative,T_Other,T2,LIVING,56.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Other,YES,-20664.0,928.0,0.0,1229.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Equivocal,Positive,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf,A1OZ,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1229.0,0.0,1229.0,0.0,1229.0,0,1229.0
TCGA-EW-A1P0-01,Stage IIB,55.0,1121.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,1121.0,0.0,LumB,,Negative,T_Other,T2,LIVING,55.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,NO,-20107.0,1142.0,0.0,1251.0,YES,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,"Other, specify",No,C50.9,8523/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,,,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,1.0,,True,No,MX,N1b,T2,Stage IIB,TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf,A1P0,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumB,0,1251.0,0.0,1251.0,1.0,1094.0,1,1094.0
TCGA-EW-A1P1-01,Stage IIIC,68.0,919.0,Negative,FEMALE,Negative,Negative,M0,Positive,N3,919.0,0.0,,,Negative,T_Other,T2,LIVING,68.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-24923.0,850.0,0.0,1210.0,YES,<10%,Scheduled Follow-up Submission,2012-3-8,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,,32.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,11.0,,True,No,MX,N3b,T2,Stage IIIC,TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf,A1P1,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Normal,0,1210.0,0.0,1210.0,1.0,1014.0,1,1014.0
TCGA-EW-A1P3-01,Stage IIA,48.0,987.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,987.0,0.0,LumA,,Positive,T_Other,T2,LIVING,48.0,Right Lower Outer Quadrant,Other (specify),Positive,Positive,Simple Mastectomy,YES,-17637.0,919.0,0.0,1611.0,NO,90-99%,Scheduled Follow-up Submission,2013-3-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,Yes,MX,N0,T2,Stage IIA,TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf,A1P3,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.LumA,0,1611.0,0.0,1611.0,0.0,1611.0,0,1611.0
TCGA-EW-A1P4-01,Stage IIA,43.0,501.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,501.0,0.0,Basal,,Negative,T_Other,T2,LIVING,43.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-15989.0,525.0,0.0,907.0,NO,<10%,Scheduled Follow-up Submission,2012-3-26,FEMALE,,Medullary Carcinoma,No,C50.9,8510/3,C50.9,YES,Core needle biopsy,290.0,NO,Negative,,,3.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0 (i-),T2,Stage IIA,TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf,A1P4,TUMOR FREE,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2009.0,BRCA.Basal,0,907.0,0.0,907.0,0.0,907.0,0,907.0
TCGA-EW-A1P5-01,Stage IIB,77.0,365.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,365.0,0.0,LumA,,Positive,T_Other,T2,LIVING,77.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-28177.0,,0.0,703.0,NO,90-99%,Scheduled Follow-up Submission,2012-5-15,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,,40.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,,No,M0,N1a,T2,Stage IIB,,A1P5,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,703.0,0.0,703.0,0.0,703.0,0,703.0
TCGA-EW-A1P7-01,Stage IIA,59.0,635.0,Negative,FEMALE,Negative,Negative,M0,Negative,N0,635.0,0.0,Normal,,Negative,T_Other,T2,LIVING,59.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-21750.0,,0.0,915.0,NO,<10%,Scheduled Follow-up Submission,2012-3-8,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,0.0,,No,M0,N0 (i-),T2,Stage IIA,,A1P7,WITH TUMOR,,YES,<10%,NO,Primary Tumor,1,6th,YES,,LIVING,2009.0,BRCA.Normal,0,915.0,0.0,915.0,1.0,729.0,1,729.0
TCGA-EW-A1P8-01,Stage IIIC,58.0,239.0,Negative,FEMALE,Negative,Negative,M0,Positive,N3,239.0,1.0,Basal,,Negative,T_Other,T2,DECEASED,58.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,NO,-21501.0,224.0,0.0,,YES,<10%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,160.0,NO,Negative,,,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,14.0,,True,No,M0,N3b,T2,Stage IIIC,TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf,A1P8,WITH TUMOR,,YES,<10%,NO,Primary Tumor,1,7th,YES,A,DECEASED,2010.0,BRCA.Basal,1,239.0,1.0,239.0,1.0,207.0,1,207.0
TCGA-EW-A1PA-01,Stage IIB,59.0,267.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,267.0,0.0,LumA,,Positive,T_Other,T2,LIVING,59.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-21837.0,220.0,0.0,575.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,60.0,NO,Negative,,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf,A1PA,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,575.0,0.0,575.0,0.0,575.0,0,575.0
TCGA-EW-A1PB-01,Stage IIIA,70.0,608.0,Negative,FEMALE,Negative,Negative,M0,Positive,N1,608.0,0.0,Basal,,Negative,T_Other,T3,LIVING,70.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Simple Mastectomy,NO,-25770.0,569.0,0.0,608.0,,<10%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,320.0,NO,Negative,,,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,MX,N1a,T3,Stage IIIA,TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf,A1PB,TUMOR FREE,,YES,<10%,NO,Primary Tumor,1,6th,NO,A,LIVING,2009.0,BRCA.Basal,0,608.0,0.0,608.0,0.0,608.0,0,608.0
TCGA-EW-A1PC-01,,,,,,,,,,,,,LumB,,,,,,66.0,Left,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,YES,-24434.0,146.0,0.0,187.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,,,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,MX,N0 (i-),T3,Stage IIB,TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf,A1PC,TUMOR FREE,,YES,50-59%,NO,Primary Tumor,1,7th,YES,B,LIVING,2011.0,BRCA.LumB,0,187.0,0.0,187.0,0.0,187.0,0,187.0
TCGA-EW-A1PD-01,Stage IIA,61.0,174.0,Positive,MALE,Positive,Negative,M0,Positive,N1,174.0,0.0,LumA,,Positive,T1,T1,LIVING,61.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-22536.0,112.0,0.0,424.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,MALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Equivocal,Positive,,7.0,Negative,,NO,2.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf,A1PD,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.LumA,0,424.0,0.0,424.0,0.0,424.0,0,424.0
TCGA-EW-A1PE-01,Stage IIA,56.0,139.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,139.0,0.0,LumA,,Positive,T1,T1,LIVING,56.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-20694.0,44.0,0.0,320.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8507/3,C50.9,YES,[Discrepancy],150.0,NO,Negative,,,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T1c,Stage IIA,TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf,A1PE,TUMOR FREE,,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,320.0,0.0,320.0,0.0,320.0,0,320.0
TCGA-EW-A1PF-01,Stage IA,50.0,139.0,Positive,FEMALE,Negative,Negative,M0,Negative,N0,139.0,0.0,LumA,,Positive,T1,T1,LIVING,50.0,Right Upper Outer Quadrant,Other (specify),Positive,Positive,Other,YES,-18384.0,,0.0,439.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0,T1c,Stage IA,,A1PF,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,7th,YES,,LIVING,2010.0,BRCA.LumA,0,439.0,0.0,439.0,0.0,439.0,0,439.0
TCGA-EW-A1PG-01,Stage IIB,53.0,875.0,Positive,FEMALE,Negative,Negative,M0,Positive,N1,875.0,0.0,Normal,,Positive,T_Other,T2,LIVING,53.0,Left Lower Inner Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-19464.0,829.0,0.0,1051.0,NO,90-99%,Scheduled Follow-up Submission,2012-3-8,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,210.0,NO,Equivocal,Negative,,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,1.0,True,No,MX,N1a,T2,Stage IIB,TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf,A1PG,TUMOR FREE,,YES,90-99%,NO,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Normal,0,1051.0,0.0,1051.0,0.0,1051.0,0,1051.0
TCGA-EW-A1PH-01,Stage IIA,52.0,139.0,Negative,FEMALE,,Negative,M0,Positive,N1,139.0,0.0,Basal,,Negative,T1,T1,LIVING,52.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-19073.0,77.0,0.0,607.0,NO,<10%,Scheduled Follow-up Submission,2013-3-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,70.0,NO,Negative,,NO,10.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,True,No,M0,N1a,T1c,Stage IIA,TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf,A1PH,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,YES,A,LIVING,2010.0,BRCA.Basal,0,607.0,0.0,607.0,0.0,607.0,0,607.0
TCGA-EW-A2FR-01,,,,,,,,,,,,,Her2,,,,,,59.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-21628.0,1015.0,0.0,1673.0,NO,<10%,Scheduled Follow-up Submission,2013-4-10,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Equivocal,Positive,NO,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,19.0,,True,No,MX,N3a,T1b,Stage IIIC,TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf,A2FR,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2008.0,BRCA.Her2,0,1673.0,0.0,1673.0,0.0,1673.0,0,1673.0
TCGA-EW-A2FS-01,,41.0,1173.0,Positive,FEMALE,,,,,,1173.0,0.0,LumA,,Negative,,,LIVING,41.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,YES,-15302.0,,0.0,1604.0,NO,90-99%,Scheduled Follow-up Submission,2013-4-10,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,8.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,MX,N1mi,T2,Stage IIB,,A2FS,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,YES,,LIVING,2008.0,BRCA.LumA,0,1604.0,0.0,1604.0,0.0,1604.0,0,1604.0
TCGA-EW-A2FV-01,,39.0,238.0,Positive,FEMALE,,,,,,238.0,0.0,LumA,,Positive,,,LIVING,39.0,Left Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-14316.0,133.0,0.0,788.0,NO,90-99%,Scheduled Follow-up Submission,2013-4-10,FEMALE,1+,"Other, specify",No,C50.9,8507/3,C50.9,YES,Excisional Biopsy,80.0,NO,Negative,,NO,32.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,29.0,,True,No,MX,N3a,T3,Stage IIIC,TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf,A2FV,TUMOR FREE,YES,,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumA,0,788.0,0.0,788.0,0.0,788.0,0,788.0
TCGA-EW-A2FW-01,,52.0,190.0,Positive,FEMALE,,,,,,190.0,0.0,LumB,,Positive,,,LIVING,52.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-19085.0,99.0,0.0,672.0,NO,90-99%,Scheduled Follow-up Submission,2013-4-10,FEMALE,1+,"Other, specify",No,C50.9,8503/3,C50.9,YES,Core needle biopsy,150.0,NO,Negative,,NO,6.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,MX,N0 (i-),T2,Stage IIA,TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf,A2FW,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,YES,A,LIVING,2011.0,BRCA.LumB,0,672.0,0.0,672.0,0.0,672.0,0,672.0
TCGA-EW-A3E8-01,,,,,,,,,,,,,,,,,,,60.0,Left|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,,-21922.0,505.0,0.0,1035.0,,,,2014-3-18,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,50.0,NO,Negative,,NO,2.0,Negative,,NO,0.0,,True,No,MX,N0,T3,Stage IIB,TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf,A3E8,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,B,LIVING,2011.0,BRCA.LumA,0,1035.0,0.0,1035.0,0.0,1035.0,0,1035.0
TCGA-EW-A3U0-01,,,,,,,,,,,,,,,,,,,61.0,Left,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Other,NO,-22520.0,182.0,0.0,532.0,NO,,,2013-4-9,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Negative,,NO,25.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,M0,N1a,T3,Stage IIIA,TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf,A3U0,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Basal,0,532.0,0.0,532.0,0.0,532.0,0,532.0
TCGA-EW-A423-01,,,,,,,,,,,,,,,,,,,75.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-27627.0,161.0,0.0,533.0,,50-59%,,2014-3-18,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,80.0,NO,Negative,,YES,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf,A423,TUMOR FREE,[Discrepancy],YES,<10%,[Discrepancy],Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,533.0,0.0,533.0,0.0,533.0,0,533.0
TCGA-EW-A424-01,,,,,,,,,,,,,,,,,,,51.0,Right,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-18850.0,141.0,0.0,715.0,,50-59%,,2014-3-18,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,Positive,,NO,1.0,Negative,,NO,0.0,1.0,True,No,MX,N1,T3,Stage IIIA,TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf,A424,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,715.0,0.0,715.0,0.0,715.0,0,715.0
TCGA-EW-A6SA-01,,,,,,,,,,,,,,,,,,,59.0,Left|Left Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Negative,Simple Mastectomy,YES,-21623.0,152.0,0.0,510.0,,50-59%,,2015-2-27,MALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,80.0,NO,Negative,,,4.0,Negative,,NO,,1.0,True,No,MX,N0 (i+),T2,Stage II,TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf,A6SA,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,510.0,0.0,510.0,0.0,510.0,0,510.0
TCGA-EW-A6SB-01,,,,,,,,,,,,,,,,,,,62.0,Left|Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Modified Radical Mastectomy,YES,-22844.0,244.0,0.0,760.0,,,,2015-3-12,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,200.0,NO,Negative,,,8.0,Negative,,NO,0.0,0.0,True,No,M0,N0,T2,Stage II,TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf,A6SB,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,760.0,0.0,760.0,0.0,760.0,0,760.0
TCGA-EW-A6SC-01,,,,,,,,,,,,,,,,,,,60.0,Left|Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-21918.0,350.0,0.0,952.0,,50-59%,,2015-3-12,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,160.0,NO,Negative,,NO,2.0,Negative,,NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf,A6SC,TUMOR FREE,YES,YES,40-49%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,952.0,0.0,952.0,0.0,952.0,0,952.0
TCGA-EW-A6SD-01,,,,,,,,,,,,,,,,,,,32.0,Left|Left Upper Outer Quadrant,,Negative,Negative,Lumpectomy,,-12006.0,441.0,0.0,1010.0,,<10%,,2015-3-14,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,,,,31.0,Negative,,NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf,A6SD,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Her2,0,1010.0,0.0,1010.0,0.0,1010.0,0,1010.0
TCGA-GI-A2C8-01,,,,,,,,,,,,,LumA,,,,,,63.0,Right,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,NO,-23103.0,2429.0,0.0,225.0,NO,90-99%,Scheduled Follow-up Submission,2012-5-8,FEMALE,,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,,10.0,Negative,,NO,0.0,,False,No,MX,N0,T4b,Stage IIIB,TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf,A2C8,,,YES,<10%,YES,Primary Tumor,1,6th,YES,A,LIVING,2004.0,BRCA.LumA,0,225.0,0.0,225.0,0.0,225.0,0,225.0
TCGA-GI-A2C8-11,,,,,,,,,,,,,LumA,,,,,,63.0,Right,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,NO,-23103.0,2429.0,0.0,225.0,NO,90-99%,Scheduled Follow-up Submission,2012-5-8,FEMALE,,Infiltrating Ductal Carcinoma,Yes,C50.9,8500/3,C50.9,YES,,100.0,NO,Negative,Negative,,10.0,Negative,,NO,0.0,,False,No,MX,N0,T4b,Stage IIIB,,A2C8,,,YES,<10%,YES,Solid Tissue Normal,11,6th,YES,A,LIVING,2004.0,BRCA.LumA,0,225.0,0.0,225.0,0.0,225.0,0,225.0
TCGA-GI-A2C9-01,,,,,,,,,,,,,Basal,,,,,,58.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-21534.0,2979.0,0.0,3342.0,NO,,Scheduled Follow-up Submission,2012-5-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0,T3,Stage IIB,TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf,A2C9,TUMOR FREE,,YES,,YES,Primary Tumor,1,6th,YES,A,LIVING,2003.0,BRCA.Basal,0,3342.0,0.0,3342.0,0.0,3342.0,0,3342.0
TCGA-GI-A2C9-11,,,,,,,,,,,,,Normal,,,,,,58.0,Right,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-21534.0,2979.0,0.0,3342.0,NO,,Scheduled Follow-up Submission,2012-5-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0,T3,Stage IIB,,A2C9,TUMOR FREE,,YES,,YES,Solid Tissue Normal,11,6th,YES,A,LIVING,2003.0,BRCA.Normal,0,3342.0,0.0,3342.0,0.0,3342.0,0,3342.0
TCGA-GM-A2D9-01,,69.0,,Positive,FEMALE,,,,,,1812.0,1.0,LumA,,Positive,,,DECEASED,69.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-25490.0,1910.0,0.0,,YES,90-99%,,2013-8-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf,A2D9,WITH TUMOR,YES,YES,40-49%,YES,Primary Tumor,1,6th,,A,DECEASED,2006.0,BRCA.LumA,1,1812.0,1.0,1812.0,1.0,536.0,1,536.0
TCGA-GM-A2DA-01,,46.0,5909.0,Positive,FEMALE,,,,,,5909.0,0.0,LumA,,Positive,,,LIVING,46.0,Right Upper Inner Quadrant|Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-16854.0,,0.0,5909.0,YES,90-99%,,2013-8-21,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,,,Equivocal,Positive,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,2.0,0.0,,No,M0,N1b,T2,Stage IIB,,A2DA,WITH TUMOR,YES,YES,50-59%,YES,Primary Tumor,1,4th,,,DECEASED,1993.0,BRCA.LumA,1,6593.0,1.0,6593.0,1.0,3014.0,1,3014.0
TCGA-GM-A2DB-01,,62.0,1615.0,Negative,FEMALE,,,,,,1615.0,0.0,Her2,,Negative,,,LIVING,62.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-22883.0,1644.0,0.0,2406.0,NO,<10%,,2013-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Negative,Negative,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf,A2DB,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.Her2,0,2406.0,0.0,2406.0,0.0,2406.0,0,2406.0
TCGA-GM-A2DC-01,,57.0,1628.0,Positive,FEMALE,,,,,,1628.0,0.0,LumA,,Positive,,,LIVING,57.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-21122.0,,0.0,2535.0,NO,90-99%,,2013-8-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,Negative,NO,21.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,,No,M0,N1a,T1c,Stage IIA,,A2DC,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,,LIVING,2006.0,BRCA.LumA,0,2535.0,0.0,2535.0,0.0,2535.0,0,2535.0
TCGA-GM-A2DD-01,,53.0,1309.0,Negative,FEMALE,,,,,,1309.0,0.0,Normal,,Negative,,,LIVING,53.0,Right,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-19415.0,,0.0,2282.0,NO,<10%,,2013-8-22,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,Yes,M0,N0 (i-),T1c,Stage I,,A2DD,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.Normal,0,2282.0,0.0,2282.0,0.0,2282.0,0,2282.0
TCGA-GM-A2DF-01,,53.0,1299.0,Negative,FEMALE,,,,,,1299.0,0.0,Basal,,Negative,,,LIVING,53.0,Left Lower Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Lumpectomy,NO,-19614.0,1372.0,0.0,2155.0,NO,<10%,,2013-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,100.0,NO,Negative,Negative,NO,32.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,False,No,M0,N1a,T1c,Stage IIA,TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf,A2DF,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Basal,0,2155.0,0.0,2155.0,0.0,2155.0,0,2155.0
TCGA-GM-A2DH-01,,58.0,1286.0,Negative,FEMALE,,,,,,1286.0,0.0,Her2,,Negative,,,LIVING,58.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-21344.0,,0.0,2193.0,NO,<10%,,2013-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,Negative,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,,No,M0,N0 (i+),T1c,Stage I,,A2DH,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,6th,,,LIVING,2007.0,BRCA.Her2,0,2193.0,0.0,2193.0,0.0,2193.0,0,2193.0
TCGA-GM-A2DI-01,,52.0,1883.0,Negative,FEMALE,,,,,,1883.0,0.0,LumA,,Negative,,,LIVING,52.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-19030.0,2144.0,0.0,2590.0,NO,<10%,,2013-8-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,150.0,NO,,Negative,NO,9.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,1.0,False,No,M0,N0 (i+),T1c,Stage I,TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf,A2DI,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumA,0,2590.0,0.0,2590.0,0.0,2590.0,0,2590.0
TCGA-GM-A2DK-01,,58.0,1896.0,Positive,FEMALE,,,,,,1896.0,0.0,LumA,,Negative,,,LIVING,58.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,YES,-21198.0,2109.0,0.0,2645.0,NO,90-99%,,2013-8-22,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf,A2DK,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumA,0,2645.0,0.0,2645.0,0.0,2645.0,0,2645.0
TCGA-GM-A2DL-01,,50.0,2762.0,Positive,FEMALE,,,,,,2762.0,0.0,LumA,,Positive,,,LIVING,50.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-18475.0,2723.0,0.0,3519.0,NO,90-99%,,2013-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,130.0,NO,Negative,,NO,2.0,Negative,Peri (6-12 months since last menstrual period),NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf,A2DL,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,A,LIVING,2003.0,BRCA.LumA,0,3519.0,0.0,3519.0,0.0,3519.0,0,3519.0
TCGA-GM-A2DM-01,,57.0,2331.0,Positive,FEMALE,,,,,,2331.0,0.0,LumA,,Positive,,,LIVING,57.0,Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-21160.0,2464.0,0.0,3226.0,NO,40-49%,,2013-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf,A2DM,TUMOR FREE,YES,YES,30-39%,YES,Primary Tumor,1,6th,,A,LIVING,2004.0,BRCA.LumA,0,3226.0,0.0,3226.0,0.0,3226.0,0,3226.0
TCGA-GM-A2DN-01,,58.0,2352.0,Positive,FEMALE,,,,,,2352.0,0.0,LumA,,Positive,,,LIVING,58.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-21288.0,2436.0,0.0,3091.0,NO,90-99%,,2013-8-22,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,NO,9.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf,A2DN,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,6th,,A,LIVING,2004.0,BRCA.LumA,0,3091.0,0.0,3091.0,0.0,3091.0,0,3091.0
TCGA-GM-A2DO-01,,54.0,1622.0,Positive,FEMALE,,,,,,1622.0,0.0,LumB,,Positive,,,LIVING,54.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-19842.0,1932.0,0.0,2596.0,NO,90-99%,,2013-8-22,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T1c,Stage I,TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf,A2DO,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumB,0,2596.0,0.0,2596.0,0.0,2596.0,0,2596.0
TCGA-GM-A3NW-01,,,,,,,,,,,,,,,,,,,63.0,Left Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Positive,Simple Mastectomy,YES,-23041.0,,0.0,3361.0,NO,,,2013-2-18,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,,No,M0,N0 (i-),T2,Stage IIA,,A3NW,TUMOR FREE,YES,YES,20-29%,NO,Primary Tumor,1,6th,,,LIVING,2003.0,BRCA.LumA,0,3361.0,0.0,3361.0,0.0,3361.0,0,3361.0
TCGA-GM-A3NY-01,,,,,,,,,,,,,LumA,,,,,,72.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Lumpectomy,NO,-26642.0,778.0,0.0,1162.0,NO,90-99%,,2013-2-19,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,140.0,NO,Negative,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,False,No,M0,N1a,T2,Stage IIB,TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf,A3NY,TUMOR FREE,YES,YES,20-29%,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,1162.0,0.0,1162.0,0.0,1162.0,0,1162.0
TCGA-GM-A3XG-01,,,,,,,,,,,,,,,,,,,46.0,Right|Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-16948.0,899.0,0.0,1330.0,,90-99%,,2013-8-20,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,270.0,NO,Negative,Negative,NO,26.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,0.0,False,No,M0,N1a,T3,Stage IIIA,TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf,A3XG,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,1330.0,0.0,1330.0,0.0,1330.0,0,1330.0
TCGA-GM-A3XL-01,,,,,,,,,,,,,,,,,,,49.0,Right|Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-18171.0,1779.0,0.0,2108.0,,<10%,,2013-4-8,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf,A3XL,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.Basal,0,2108.0,0.0,2108.0,0.0,2108.0,0,2108.0
TCGA-GM-A3XN-01,,,,,,,,,,,,,,,,,,,44.0,Left|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,NO,-16109.0,1627.0,0.0,2019.0,,80-89%,,2013-8-20,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Incisional Biopsy,100.0,NO,Negative,Negative,NO,34.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,0.0,False,No,M0,N2a,T1c,Stage IIIA,TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf,A3XN,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2019.0,0.0,2019.0,0.0,2019.0,0,2019.0
TCGA-GM-A4E0-01,,,,,,,,,,,,,,,,,,,67.0,Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-24788.0,1871.0,0.0,2191.0,,90-99%,,2013-8-21,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,210.0,NO,,Negative,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,10.0,1.0,False,No,M0,N3a,T3,Stage IIIC,TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf,A4E0,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,6th,,A,LIVING,2007.0,BRCA.LumA,0,2191.0,0.0,2191.0,0.0,2191.0,0,2191.0
TCGA-GM-A5PV-01,,,,,,,,,,,,,,,,,,,63.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-23215.0,499.0,0.0,412.0,,90-99%,,2013-4-12,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,190.0,NO,,Negative,,24.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf,A5PV,TUMOR FREE,YES,YES,30-39%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,412.0,0.0,412.0,0.0,412.0,0,412.0
TCGA-GM-A5PX-01,,,,,,,,,,,,,,,,,,,65.0,Left,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,YES,-23753.0,616.0,0.0,551.0,,90-99%,,2013-4-12,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,110.0,NO,Negative,Negative,,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,2.0,False,No,M0,N1mi,T2,Stage IIB,TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf,A5PX,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,551.0,0.0,551.0,0.0,551.0,0,551.0
TCGA-HN-A2NL-01,,,,,,,,,,,,,Basal,,,,,,56.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-20483.0,,0.0,79.0,,,,2014-5-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,170.0,NO,Negative,,YES,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf,A2NL,TUMOR FREE,YES,YES,,,Primary Tumor,1,6th,,A,LIVING,,BRCA.Basal,0,79.0,0.0,79.0,0.0,79.0,0,79.0
TCGA-HN-A2OB-01,,,,,,,,,,,,,,,,,,,45.0,Right|Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,NO,-16672.0,,0.0,1849.0,,,,2015-4-1,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,320.0,NO,Negative,Negative,NO,10.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),YES,2.0,,False,No,M0,N1,T2,Stage IIB,TCGA-HN-A2OB.32AE5A1A-703B-43C3-948A-719A90DDACC5.pdf,A2OB,WITH TUMOR,YES,YES,,YES,Primary Tumor,1,6th,,A,DECEASED,,BRCA.LumA,1,1900.0,1.0,1900.0,1.0,1543.0,1,1543.0
TCGA-JL-A3YW-01,,,,,,,,,,,,,,,,,,,49.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,,,0.0,360.0,,30-39%,,2012-11-8,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,,,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,,No,M0,N1,T2,Stage IIB,,A3YW,,NO,YES,30-39%,NO,Primary Tumor,1,7th,,,LIVING,2011.0,BRCA.Her2,0,360.0,0.0,360.0,0.0,360.0,0,360.0
TCGA-JL-A3YX-01,,,,,,,,,,,,,,,,,,,46.0,Left,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,,,306.0,0.0,352.0,,30-39%,,2012-11-8,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Tumor resection,900.0,NO,Positive,,,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf,A3YX,,NO,YES,30-39%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,352.0,0.0,352.0,0.0,352.0,0,352.0
TCGA-LD-A66U-01,,,,,,,,,,,,,,,,,,,44.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-16101.0,,0.0,646.0,,90-99%,,2014-7-30,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Negative,,NO,15.0,Negative,,NO,2.0,,,No,MX,N1mi,T2,Stage IIB,,A66U,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.LumA,0,646.0,0.0,646.0,0.0,646.0,0,646.0
TCGA-LD-A74U-01,,,,,,,,,,,,,,,,,,,79.0,Right,Axillary lymph node dissection alone,Positive,Negative,Lumpectomy,,-28981.0,59.0,0.0,402.0,,<10%,,2014-12-30,FEMALE,,"Other, specify",No,C50.9,8524/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,NO,12.0,Negative,,NO,11.0,,True,Yes,M0,N3a,T3,Stage IIIC,TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf,A74U,WITH TUMOR,YES,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,402.0,0.0,402.0,0.0,402.0,0,402.0
TCGA-LD-A7W6-01,,,,,,,,,,,,,,,,,,,54.0,Right|Right Upper Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-20077.0,91.0,0.0,404.0,,90-99%,,2014-12-30,FEMALE,,"Other, specify",No,C50.2,8524/3,C50.2,YES,Core needle biopsy,630.0,NO,Negative,,NO,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,M0,N1a,T2,Stage IIB,TCGA-LD-A7W6.859561F6-3113-45C8-8FBE-718BF860B582.pdf,A7W6,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,404.0,0.0,404.0,0.0,404.0,0,404.0
TCGA-LD-A9QF-01,,,,,,,,,,,,,,,,,,,73.0,Left,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,YES,-26869.0,85.0,0.0,323.0,,,,2014-12-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,190.0,NO,Positive,,NO,14.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T1c,Stage IA,TCGA-LD-A9QF.E8601979-AE05-4E4D-BB39-6B9C5E67D050.pdf,A9QF,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Normal,0,323.0,0.0,323.0,0.0,323.0,0,323.0
TCGA-LL-A440-01,,,,,,,,,,,,,,,,,,,61.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-22497.0,32.0,0.0,759.0,,90-99%,,2013-8-7,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,200.0,NO,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,Yes,MX,N0 (i-),T1c,Stage IA,TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf,A440,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,759.0,0.0,759.0,0.0,759.0,0,759.0
TCGA-LL-A441-01,,,,,,,,,,,,,,,,,,,62.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,YES,-22772.0,37.0,0.0,996.0,,,,2013-8-7,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,300.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0,T1c,Stage IA,TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf,A441,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Normal,0,996.0,0.0,996.0,0.0,996.0,0,996.0
TCGA-LL-A442-01,,,,,,,,,,,,,,,,,,,56.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-20495.0,60.0,0.0,889.0,,90-99%,,2013-8-7,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,Equivocal,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,Yes,MX,N0 (i-),T2,Stage IIA,TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf,A442,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,889.0,0.0,889.0,0.0,889.0,0,889.0
TCGA-LL-A50Y-01,,,,,,,,,,,,,,,,,,,84.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-30934.0,91.0,0.0,762.0,,90-99%,,2013-10-23,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,130.0,NO,Equivocal,Negative,NO,8.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,Yes,MX,N0,T2,Stage IIA,TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf,A50Y,TUMOR FREE,YES,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,762.0,0.0,762.0,0.0,762.0,0,762.0
TCGA-LL-A5YL-01,,,,,,,,,,,,,,,,,,,64.0,Right|Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,,-23395.0,84.0,0.0,519.0,,90-99%,,2014-5-19,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,570.0,NO,Positive,Negative,NO,23.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,3.0,0.0,False,No,MX,N1a,T2,Stage IIB,TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf,A5YL,,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,519.0,0.0,519.0,0.0,519.0,0,519.0
TCGA-LL-A5YM-01,,,,,,,,,,,,,,,,,,,88.0,Left|Left Upper Inner Quadrant,No axillary staging,Positive,Positive,Other,,-32478.0,131.0,0.0,466.0,,90-99%,,2014-3-14,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8541/3,C50.9,YES,Core needle biopsy,280.0,NO,Equivocal,Positive,NO,,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),YES,,,False,No,M0,NX,T4b,Stage IIIB,TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf,A5YM,WITH TUMOR,NO,NO,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumB,0,466.0,0.0,466.0,1.0,258.0,1,258.0
TCGA-LL-A5YN-01,,,,,,,,,,,,,,,,,,,46.0,Right|Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,NO,-16884.0,41.0,0.0,447.0,,90-99%,,2014-5-9,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,230.0,NO,Equivocal,Positive,NO,5.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0 (i-),T2,Stage IIA,TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf,A5YN,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,447.0,0.0,447.0,0.0,447.0,0,447.0
TCGA-LL-A5YO-01,,,,,,,,,,,,,,,,,,,50.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-18354.0,47.0,0.0,440.0,,,,2014-4-17,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,Negative,,NO,1.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,False,No,MX,N0,T1b,Stage IA,TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf,A5YO,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Her2,0,440.0,0.0,440.0,0.0,440.0,0,440.0
TCGA-LL-A5YP-01,,,,,,,,,,,,,,,,,,,49.0,Right|Right Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Modified Radical Mastectomy,NO,-18041.0,29.0,0.0,450.0,,<10%,,2014-5-8,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,490.0,NO,Negative,Positive,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,False,Yes,M0,N1a,T2,Stage IIB,TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf,A5YP,,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,450.0,0.0,450.0,0.0,450.0,0,450.0
TCGA-LL-A6FP-01,,,,,,,,,,,,,,,,,,,90.0,Right Upper Outer Quadrant,No axillary staging,Positive,Positive,Simple Mastectomy,NO,-32873.0,,0.0,677.0,,90-99%,,2014-8-25,FEMALE,2+,Infiltrating Lobular Carcinoma,Yes,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,Equivocal,Negative,NO,,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,MX,NX,T2,Stage IIA,,A6FP,TUMOR FREE,YES,NO,20-29%,NO,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.LumA,0,677.0,0.0,677.0,0.0,677.0,0,677.0
TCGA-LL-A6FQ-01,,,,,,,,,,,,,,,,,,,77.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-28375.0,128.0,0.0,80.0,,90-99%,,2014-4-2,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,Negative,,YES,18.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,7.0,0.0,False,No,MX,N2a,T2,Stage IIIA,TCGA-LL-A6FQ.5C3D9179-7434-4776-A2FF-68CEA0149C68.pdf,A6FQ,,NO,YES,80-89%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,80.0,0.0,80.0,0.0,80.0,0,80.0
TCGA-LL-A6FR-01,,,,,,,,,,,,,,,,,,,50.0,Right|Right Lower Inner Quadrant,Sentinel node biopsy alone,Negative,Positive,Lumpectomy,YES,-18520.0,30.0,0.0,489.0,,,,2014-8-25,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,250.0,NO,Equivocal,Positive,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf,A6FR,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,489.0,0.0,489.0,0.0,489.0,0,489.0
TCGA-LL-A73Y-01,,,,,,,,,,,,,,,,,,,67.0,Right|Right Upper Inner Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,NO,-24647.0,55.0,0.0,477.0,,,,2014-10-30,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,60.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0,T1c,Stage IA,TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf,A73Y,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,477.0,0.0,477.0,0.0,477.0,0,477.0
TCGA-LL-A740-01,,,,,,,,,,,,,,,,,,,61.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,YES,-22416.0,37.0,0.0,441.0,,,,2014-9-18,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,410.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf,A740,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,441.0,0.0,441.0,0.0,441.0,0,441.0
TCGA-LL-A7SZ-01,,,,,,,,,,,,,,,,,,,49.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Other,YES,-18161.0,63.0,0.0,594.0,,90-99%,,2014-10-29,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,Negative,,NO,11.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,2.0,0.0,False,No,MX,N1a,T2,Stage IIB,TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf,A7SZ,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,594.0,0.0,594.0,0.0,594.0,0,594.0
TCGA-LL-A7T0-01,,,,,,,,,,,,,,,,,,,70.0,Left Lower Inner Quadrant,Axillary lymph node dissection alone,Positive,Positive,Simple Mastectomy,NO,-25867.0,70.0,0.0,376.0,,90-99%,,2014-9-16,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,380.0,NO,Positive,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,No,M0,N1a,T2,Stage IIB,TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf,A7T0,TUMOR FREE,NO,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,376.0,0.0,376.0,0.0,376.0,0,376.0
TCGA-LL-A8F5-01,,,,,,,,,,,,,,,,,,,61.0,Right|Right Upper Inner Quadrant,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,YES,-22544.0,78.0,0.0,596.0,,20-29%,,2014-10-29,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,230.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,MX,N0 (i-),T2,Stage IIA,TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf,A8F5,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,596.0,0.0,596.0,0.0,596.0,0,596.0
TCGA-LL-A9Q3-01,,,,,,,,,,,,,,,,,,,69.0,Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-25477.0,80.0,0.0,532.0,,90-99%,,2014-10-30,FEMALE,3+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,610.0,NO,Positive,,NO,28.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,28.0,0.0,False,No,MX,N3a,T3,Stage IIIC,TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf,A9Q3,TUMOR FREE,YES,YES,<10%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,532.0,0.0,532.0,0.0,532.0,0,532.0
TCGA-MS-A51U-01,,,,,,,,,,,,,,,,,,,44.0,Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left,,Positive,Positive,Modified Radical Mastectomy,,-16213.0,129.0,0.0,681.0,NO,90-99%,,2014-6-4,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,190.0,NO,Negative,Negative,NO,18.0,Negative,,NO,2.0,,True,No,M0,N1,T2,Stage IIB,TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf,A51U,TUMOR FREE,YES,YES,20-29%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,681.0,0.0,681.0,0.0,681.0,0,681.0
TCGA-OK-A5Q2-01,,,,,,,,,,,,,,,,,,,59.0,Right,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,YES,-21555.0,,0.0,64.0,,90-99%,,2013-1-22,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,,,Negative,,,13.0,Negative,,NO,2.0,2.0,,No,MX,N1a,T2,Stage II,,A5Q2,,,YES,20-29%,,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.LumA,0,64.0,0.0,64.0,0.0,64.0,0,64.0
TCGA-OL-A5D6-01,,,,,,,,,,,,,,,,,,,71.0,Left Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,,-26052.0,1378.0,0.0,385.0,,,,2014-1-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,200.0,NO,,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf,A5D6,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,DECEASED,2009.0,BRCA.Normal,1,1104.0,0.0,1104.0,0.0,1104.0,0,1104.0
TCGA-OL-A5D7-01,,,,,,,,,,,,,,,,,,,70.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,,-25643.0,1415.0,0.0,1780.0,,,,2014-1-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,370.0,NO,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf,A5D7,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.Basal,0,1780.0,0.0,1780.0,0.0,1780.0,0,1780.0
TCGA-OL-A5DA-01,,,,,,,,,,,,,,,,,,,61.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Other,,-22411.0,1407.0,0.0,1783.0,,60-69%,,2014-1-10,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,"Other method, specify:",240.0,NO,,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,0.0,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A5DA.5049C91E-F4BB-4AA7-BE64-837168189379.pdf,A5DA,TUMOR FREE,NO,YES,60-69%,NO,Primary Tumor,1,6th,,A,LIVING,2009.0,BRCA.LumA,0,1783.0,0.0,1783.0,0.0,1783.0,0,1783.0
TCGA-OL-A5RU-01,,,,,,,,,,,,,,,,,,,63.0,Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,,-23108.0,826.0,0.0,1219.0,,90-99%,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,430.0,NO,,Negative,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,MX,N1,T1c,Stage IIA,TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf,A5RU,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1219.0,0.0,1219.0,0.0,1219.0,0,1219.0
TCGA-OL-A5RV-01,,,,,,,,,,,,,,,,,,,43.0,Right Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Modified Radical Mastectomy,NO,-15820.0,755.0,0.0,1062.0,,90-99%,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,370.0,NO,,Negative,NO,29.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,20.0,,True,No,MX,N3,T2,Stage IIIC,TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf,A5RV,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1062.0,0.0,1062.0,0.0,1062.0,0,1062.0
TCGA-OL-A5RW-01,,,,,,,,,,,,,,,,,,,40.0,Right Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Lumpectomy,,-14638.0,,0.0,1106.0,,,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Excisional Biopsy,,,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,1.0,,,No,MX,N1,T1c,Stage IIA,,A5RW,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,,LIVING,2010.0,BRCA.Basal,0,1106.0,0.0,1106.0,0.0,1106.0,0,1106.0
TCGA-OL-A5RX-01,,,,,,,,,,,,,,,,,,,51.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,,-18942.0,561.0,0.0,878.0,,90-99%,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,,Negative,NO,4.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,,,True,No,MX,N0,T1c,Stage IA,TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf,A5RX,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,878.0,0.0,878.0,0.0,878.0,0,878.0
TCGA-OL-A5RY-01,,,,,,,,,,,,,,,,,,,52.0,Right,Sentinel node biopsy alone,Positive,Negative,Lumpectomy,,-19216.0,421.0,0.0,752.0,,10-19%,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,"Other method, specify:",300.0,NO,,Positive,NO,25.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,True,No,MX,N1,T1c,Stage IIA,TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf,A5RY,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.Normal,0,752.0,0.0,752.0,0.0,752.0,0,752.0
TCGA-OL-A5RZ-01,,,,,,,,,,,,,,,,,,,57.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,,-21038.0,,0.0,679.0,,30-39%,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,,,,Positive,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,,No,MX,N0,T1b,Stage IA,,A5RZ,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,,,LIVING,2012.0,BRCA.Her2,0,679.0,0.0,679.0,0.0,679.0,0,679.0
TCGA-OL-A5S0-01,,,,,,,,,,,,,,,,,,,66.0,Right,Axillary lymph node dissection alone,Positive,Negative,Modified Radical Mastectomy,,-24139.0,279.0,0.0,620.0,,30-39%,,2014-2-14,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,530.0,NO,,Positive,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,,True,No,MX,N1a,T2,Stage IIB,TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB.pdf,A5S0,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,620.0,0.0,620.0,0.0,620.0,0,620.0
TCGA-OL-A66I-01,,,,,,,,,,,,,,,,,,,36.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,,-13458.0,1715.0,0.0,714.0,,,,2014-4-11,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,240.0,NO,,Negative,YES,13.0,Negative,,NO,0.0,,True,No,MX,N1mi,T1c,Stage IIA,TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf,A66I,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2008.0,BRCA.Basal,0,714.0,0.0,714.0,0.0,714.0,0,714.0
TCGA-OL-A66J-01,,,,,,,,,,,,,,,,,,,80.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,,-29345.0,,0.0,1996.0,,90-99%,,2014-4-11,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,,,,Negative,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,,No,MX,N0,T1c,Stage I,,A66J,TUMOR FREE,NO,YES,50-59%,YES,Primary Tumor,1,6th,,,LIVING,2008.0,BRCA.LumA,0,1996.0,0.0,1996.0,0.0,1996.0,0,1996.0
TCGA-OL-A66K-01,,,,,,,,,,,,,,,,,,,72.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,,-26299.0,981.0,0.0,1021.0,,70-79%,,2014-4-11,FEMALE,2+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,230.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf,A66K,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,7th,,A,DECEASED,2010.0,BRCA.LumA,1,1275.0,0.0,1275.0,0.0,1275.0,0,1275.0
TCGA-OL-A66L-01,,,,,,,,,,,,,,,,,,,71.0,Right Lower Inner Quadrant,,Positive,Positive,Lumpectomy,,-26186.0,952.0,0.0,1301.0,,90-99%,,2014-4-11,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,170.0,NO,,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,,,True,No,MX,N0,T1c,Stage IA,TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf,A66L,TUMOR FREE,NO,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1301.0,0.0,1301.0,0.0,1301.0,0,1301.0
TCGA-OL-A66N-01,,,,,,,,,,,,,,,,,,,59.0,Left,Sentinel node biopsy alone,Positive,Negative,Modified Radical Mastectomy,,-21608.0,505.0,0.0,792.0,,80-89%,,2014-4-11,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,310.0,NO,,Negative,NO,15.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,13.0,,True,No,MX,N3,T3,Stage IIIC,TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf,A66N,TUMOR FREE,NO,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,792.0,0.0,792.0,0.0,792.0,0,792.0
TCGA-OL-A66O-01,,,,,,,,,,,,,,,,,,,39.0,Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Modified Radical Mastectomy,,-14272.0,170.0,0.0,528.0,,90-99%,,2014-4-11,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,260.0,NO,,Negative,NO,17.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,3.0,,True,No,MX,N1a,T2,Stage IIB,TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf,A66O,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,528.0,0.0,528.0,0.0,528.0,0,528.0
TCGA-OL-A66P-01,,,,,,,,,,,,,,,,,,,75.0,Right,Sentinel node biopsy alone,Negative,Negative,Simple Mastectomy,,-27489.0,98.0,0.0,428.0,,,,2014-4-11,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,140.0,NO,,Negative,NO,2.0,Negative,,NO,,,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf,A66P,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Her2,0,428.0,0.0,428.0,0.0,428.0,0,428.0
TCGA-OL-A6VO-01,,,,,,,,,,,,,,,,,,,43.0,Right|Right Lower Outer Quadrant,Sentinel node biopsy alone,Negative,Negative,Lumpectomy,,-15780.0,507.0,0.0,858.0,,,,2014-5-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,120.0,NO,Negative,Negative,NO,7.0,Negative,,NO,0.0,,True,No,MX,N0,T1c,Stage IA,TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf,A6VO,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.Basal,0,858.0,0.0,858.0,0.0,858.0,0,858.0
TCGA-OL-A6VQ-01,,,,,,,,,,,,,,,,,,,49.0,Right,,Positive,Positive,Lumpectomy,,-18151.0,278.0,0.0,600.0,,90-99%,,2014-5-10,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,,110.0,NO,,Negative,NO,1.0,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,,True,No,MX,N0,T2,Stage IIA,TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf,A6VQ,TUMOR FREE,NO,YES,10-19%,NO,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,600.0,0.0,600.0,0.0,600.0,0,600.0
TCGA-OL-A6VR-01,,,,,,,,,,,,,,,,,,,48.0,Right,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Simple Mastectomy,,-17702.0,869.0,0.0,1220.0,,30-39%,,2014-5-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,380.0,NO,Negative,Negative,NO,2.0,Negative,,NO,0.0,,True,No,MX,N0,T1b,Stage IA,TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf,A6VR,TUMOR FREE,NO,YES,90-99%,NO,Primary Tumor,1,7th,,A,LIVING,2011.0,BRCA.LumA,0,1220.0,0.0,1220.0,0.0,1220.0,0,1220.0
TCGA-PE-A5DD-01,,,,,,,,,,,,,,,,,,,64.0,Right Lower Inner Quadrant,,Positive,Negative,Other,,-23686.0,2411.0,0.0,1953.0,,,,2014-10-13,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Incisional Biopsy,270.0,NO,Positive,Positive,YES,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf,A5DD,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,6th,,A,LIVING,2006.0,BRCA.LumA,0,1953.0,0.0,1953.0,0.0,1953.0,0,1953.0
TCGA-S3-A6ZF-01,,,,,,,,,,,,,,,,,,,64.0,Right|Right Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-23650.0,107.0,0.0,572.0,,90-99%,,2014-11-11,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,1350.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,No,M0,N0,T2,Stage IIA,TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf,A6ZF,TUMOR FREE,YES,YES,40-49%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,572.0,0.0,572.0,0.0,572.0,0,572.0
TCGA-S3-A6ZG-01,,,,,,,,,,,,,,,,,,,71.0,Left|Left Upper Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-26141.0,102.0,0.0,562.0,,90-99%,,2015-2-26,FEMALE,,Mixed Histology (please specify),No,C50.9,8520/3,C50.9,YES,Excisional Biopsy,980.0,NO,Negative,,NO,3.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,0.0,False,No,M0,N1,T2,Stage IIB,TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf,A6ZG,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,562.0,0.0,562.0,0.0,562.0,0,562.0
TCGA-S3-A6ZH-01,,,,,,,,,,,,,,,,,,,29.0,Left|Left Upper Outer Quadrant,Axillary lymph node dissection alone,Positive,Positive,Simple Mastectomy,NO,-10832.0,158.0,0.0,641.0,,90-99%,,2014-11-14,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,580.0,NO,Equivocal,Negative,NO,21.0,Negative,,NO,14.0,0.0,False,No,MX,N3a,T3,Stage IIIC,TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf,A6ZH,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,641.0,0.0,641.0,0.0,641.0,0,641.0
TCGA-S3-AA0Z-01,,,,,,,,,,,,,,,,,,,63.0,Left|Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,YES,-23314.0,204.0,0.0,629.0,,90-99%,,2015-2-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,330.0,NO,Equivocal,Negative,NO,12.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,M0,N1a,T2,Stage IIB,TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf,AA0Z,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,629.0,0.0,629.0,0.0,629.0,0,629.0
TCGA-S3-AA10-01,,,,,,,,,,,,,,,,,,,65.0,Right|Right Upper Outer Quadrant,Axillary lymph node dissection alone,Negative,Negative,Simple Mastectomy,NO,-24075.0,168.0,0.0,586.0,,,,2015-2-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Fine needle aspiration biopsy,410.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,True,No,M0,N0,T2,Stage IIA,TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf,AA10,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,586.0,0.0,586.0,0.0,586.0,0,586.0
TCGA-S3-AA11-01,,,,,,,,,,,,,,,,,,,67.0,Right,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-24813.0,148.0,0.0,421.0,,90-99%,,2014-11-7,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,280.0,NO,Equivocal,Negative,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,True,No,M0,N0,T2,Stage IIA,TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf,AA11,TUMOR FREE,YES,YES,60-69%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,421.0,0.0,421.0,0.0,421.0,0,421.0
TCGA-S3-AA12-01,,,,,,,,,,,,,,,,,,,82.0,Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Negative,Simple Mastectomy,NO,-30101.0,156.0,0.0,574.0,,90-99%,,2015-2-26,FEMALE,1+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,2190.0,NO,Negative,Negative,NO,16.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,Yes,MX,N1a,T3,Stage IIIA,TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf,AA12,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,574.0,0.0,574.0,0.0,574.0,0,574.0
TCGA-S3-AA14-01,,,,,,,,,,,,,,,,,,,47.0,Right,Sentinel node biopsy alone,Positive,Positive,Other,YES,-17352.0,127.0,0.0,529.0,,70-79%,,2015-2-26,FEMALE,3+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,290.0,NO,Positive,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,3.0,True,No,cM0 (i+),N0 (i+),T1,Stage I,TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf,AA14,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,529.0,0.0,529.0,0.0,529.0,0,529.0
TCGA-S3-AA15-01,,,,,,,,,,,,,,,,,,,51.0,Right|Right Upper Inner Quadrant,Sentinel lymph node biopsy plus axillary dissection,Negative,Negative,Simple Mastectomy,YES,-18659.0,93.0,0.0,525.0,,,,2015-4-10,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,990.0,NO,Negative,,NO,13.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,2.0,0.0,True,No,cM0 (i+),N1a,T2,Stage IIB,TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf,AA15,TUMOR FREE,YES,YES,,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.Basal,0,525.0,0.0,525.0,0.0,525.0,0,525.0
TCGA-S3-AA17-01,,,,,,,,,,,,,,,,,,,64.0,Right|Right Lower Outer Quadrant,Sentinel node biopsy alone,Positive,Positive,Simple Mastectomy,YES,-23642.0,92.0,0.0,424.0,,90-99%,,2014-11-11,FEMALE,2+,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,520.0,NO,Equivocal,Negative,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,1.0,True,Yes,cM0 (i+),N1mi,T2,Stage IIB,TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf,AA17,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumB,0,424.0,0.0,424.0,0.0,424.0,0,424.0
TCGA-V7-A7HQ-01,,,,,,,,,,,,,,,,,,,75.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-27684.0,,0.0,2033.0,,60-69%,,2015-3-31,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Tumor resection,,,,Negative,NO,18.0,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,,,No,M0,N2a,T1c,Stage IIIA,,A7HQ,TUMOR FREE,YES,YES,80-89%,YES,Primary Tumor,1,6th,,,LIVING,2009.0,BRCA.LumA,0,2033.0,0.0,2033.0,0.0,2033.0,0,2033.0
TCGA-W8-A86G-01,,,,,,,,,,,,,,,,,,,66.0,Left|Left Lower Inner Quadrant,Sentinel node biopsy alone,Positive,Positive,Lumpectomy,YES,-24125.0,126.0,0.0,347.0,,90-99%,,2014-9-25,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,210.0,NO,Negative,,NO,1.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,0.0,False,Yes,MX,N0 (i-),T2a,Stage IIA,TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf,A86G,TUMOR FREE,YES,YES,70-79%,NO,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,347.0,0.0,347.0,0.0,347.0,0,347.0
TCGA-WT-AB41-01,,,,,,,,,,,,,,,,,,,55.0,Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant,No axillary staging,Positive,Positive,Modified Radical Mastectomy,,,1415.0,0.0,1611.0,,90-99%,,2014-10-21,FEMALE,,Infiltrating Ductal Carcinoma,No,C50.9,8500/3,C50.9,YES,Core needle biopsy,110.0,NO,,,NO,2.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,1.0,,False,Yes,MX,N1mi,T2,Stage IIB,TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf,AB41,TUMOR FREE,YES,YES,<10%,NO,Primary Tumor,1,7th,,A,LIVING,2010.0,BRCA.LumA,0,1611.0,0.0,1611.0,0.0,1611.0,0,1611.0
TCGA-WT-AB44-01,,,,,,,,,,,,,,,,,,,77.0,Left,No axillary staging,Positive,Positive,Lumpectomy,,,656.0,0.0,883.0,,90-99%,,2014-10-21,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,20.0,NO,Negative,,NO,4.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,MX,N0 (i-),T1c,Stage IA,TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf,AB44,TUMOR FREE,YES,YES,90-99%,YES,Primary Tumor,1,7th,,A,LIVING,2012.0,BRCA.LumA,0,883.0,0.0,883.0,0.0,883.0,0,883.0
TCGA-XX-A899-01,,,,,,,,,,,,,,,,,,,46.0,Right Lower Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Modified Radical Mastectomy,NO,-17022.0,181.0,0.0,467.0,,90-99%,,2014-11-11,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,260.0,NO,Negative,,NO,22.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,5.0,0.0,False,No,MX,N2a,T1c,Stage IIIA,TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf,A899,TUMOR FREE,YES,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,467.0,0.0,467.0,0.0,467.0,0,467.0
TCGA-XX-A89A-01,,,,,,,,,,,,,,,,,,,68.0,Left Upper Outer Quadrant,,Positive,Positive,Simple Mastectomy,,-25000.0,174.0,0.0,488.0,,70-79%,,2014-11-11,FEMALE,,Infiltrating Lobular Carcinoma,No,C50.9,8520/3,C50.9,YES,Core needle biopsy,250.0,NO,Negative,,NO,11.0,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NO,0.0,,False,No,MX,N0,T3,Stage IIB,TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf,A89A,TUMOR FREE,NO,YES,70-79%,YES,Primary Tumor,1,7th,,A,LIVING,2013.0,BRCA.LumA,0,488.0,0.0,488.0,0.0,488.0,0,488.0
TCGA-Z7-A8R6-01,,,,,,,,,,,,,,,,,,,46.0,Left Upper Outer Quadrant,Sentinel lymph node biopsy plus axillary dissection,Positive,Positive,Lumpectomy,YES,-16955.0,3020.0,0.0,3256.0,,,,2014-7-9,FEMALE,1+,Infiltrating Lobular Carcinoma,No,C50.8,8022/3,C50.8,YES,Tumor resection,520.0,NO,Negative,,NO,2.0,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),NO,0.0,0.0,True,No,M0,N0,T1c,Stage I,TCGA-Z7-A8R6.9A5C8EDF-9243-4F55-9036-A400CF3F4CC1.pdf,A8R6,TUMOR FREE,YES,YES,,NO,Primary Tumor,1,6th,,A,LIVING,2005.0,BRCA.LumB,0,3256.0,0.0,3256.0,0.0,3256.0,0,3256.0
